
<html lang="en"     class="pb-page"  data-request-id="d6ca586f-5236-4781-bcb5-e67437f6d6bf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-23;requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.0c00919;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective" /></meta><meta name="dc.Creator" content="Xing-Jie  Dai" /></meta><meta name="dc.Creator" content="Ying  Liu" /></meta><meta name="dc.Creator" content="Xiao-Peng  Xiong" /></meta><meta name="dc.Creator" content="Lei-Peng  Xue" /></meta><meta name="dc.Creator" content="Yi-Chao  Zheng" /></meta><meta name="dc.Creator" content="Hong-Min  Liu" /></meta><meta name="dc.Description" content="Histone lysine-specific demethylase 1 (LSD1/KDM1A) has become an important and promising anticancer target since it was first identified in 2004 and specially demethylates lysine residues of histon..." /></meta><meta name="Description" content="Histone lysine-specific demethylase 1 (LSD1/KDM1A) has become an important and promising anticancer target since it was first identified in 2004 and specially demethylates lysine residues of histon..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 15, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00919" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00919" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00919" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00919" /></link>
        
    
    

<title>Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00919" /></meta><meta property="og:title" content="Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0009.jpeg" /></meta><meta property="og:description" content="Histone lysine-specific demethylase 1 (LSD1/KDM1A) has become an important and promising anticancer target since it was first identified in 2004 and specially demethylates lysine residues of histone H3K4me1/2 and H3K9me1/2. LSD1 is ubiquitously overexpressed in diverse cancers, and abrogation of LSD1 results in inhibition of proliferation, invasion, and migration in cancer cells. Over the past decade, a number of biologically active small-molecule LSD1 inhibitors have been developed. To date, six trans-2-phenylcyclopropylamine (TCP)-based LSD1 inhibitors (including TCP, ORY-1001, GSK-2879552, INCB059872, IMG-7289, and ORY-2001) that covalently bind to the flavin adenine dinucleotide (FAD) within the LSD1 catalytic cavity have already entered into clinical trials. Here, we provide an overview about the structures, activities, and structure–activity relationship (SAR) of TCP-based LSD1 inhibitors that mainly covers the literature from 2008 to date. The opportunities, challenges, and future research directions in this emerging and promising field are also discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00919"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00919">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00919&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00919&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00919&amp;href=/doi/10.1021/acs.jmedchem.0c00919" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 14197-14215</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00848" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00926" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.1c00570"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xing-Jie Dai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xing-Jie Dai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Lab of Advanced Drug Preparation Technologies, Ministry of Education of China, State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Drug Discovery and Development, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xing-Jie++Dai">Xing-Jie Dai</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ying Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Lab of Advanced Drug Preparation Technologies, Ministry of Education of China, State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Drug Discovery and Development, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Liu">Ying Liu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiao-Peng Xiong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiao-Peng Xiong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Lab of Advanced Drug Preparation Technologies, Ministry of Education of China, State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Drug Discovery and Development, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Peng++Xiong">Xiao-Peng Xiong</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lei-Peng Xue</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei-Peng Xue</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Lab of Advanced Drug Preparation Technologies, Ministry of Education of China, State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Drug Discovery and Development, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei-Peng++Xue">Lei-Peng Xue</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yi-Chao Zheng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yi-Chao Zheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Lab of Advanced Drug Preparation Technologies, Ministry of Education of China, State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Drug Discovery and Development, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +8637167781908. E-mail: <a href="/cdn-cgi/l/email-protection#f48d9d979c959b8e9c919a93b48e8e81da919081da979a"><span class="__cf_email__" data-cfemail="423b2b212a232d382a272c25023838376c2726376c212c">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yi-Chao++Zheng">Yi-Chao Zheng</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2662-3770" title="Orcid link">http://orcid.org/0000-0002-2662-3770</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Hong-Min Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong-Min Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Lab of Advanced Drug Preparation Technologies, Ministry of Education of China, State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Drug Discovery and Development, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +8637167781739. E-mail: <a href="/cdn-cgi/l/email-protection#2945405c41446953535c074c4d5c074a47"><span class="__cf_email__" data-cfemail="305c5945585d704a4a451e5554451e535e">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong-Min++Liu">Hong-Min Liu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6771-9421" title="Orcid link">http://orcid.org/0000-0001-6771-9421</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00919&amp;href=/doi/10.1021%2Facs.jmedchem.0c00919" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 14197–14215</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 15, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 May 2020</li><li><span class="item_label"><b>Published</b> online</span>15 September 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00919" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00919</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 <span class="NLM_copyright-holder">American Chemical Society</span></strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D14197%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXing-Jie%2BDai%252C%2BYing%2BLiu%252C%2BXiao-Peng%2BXiong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D23%26contentID%3Dacs.jmedchem.0c00919%26title%3DTranylcypromine%2BBased%2BLysine-Specific%2BDemethylase%2B1%2BInhibitor%253A%2BSummary%2Band%2BPerspective%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D14215%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00919"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2030</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00919" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xing-Jie&quot;,&quot;last_name&quot;:&quot;Dai&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Xiao-Peng&quot;,&quot;last_name&quot;:&quot;Xiong&quot;},{&quot;first_name&quot;:&quot;Lei-Peng&quot;,&quot;last_name&quot;:&quot;Xue&quot;},{&quot;first_name&quot;:&quot;Yi-Chao&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Hong-Min&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;14197-14215&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00919&quot;},&quot;abstract&quot;:&quot;Histone lysine-specific demethylase 1 (LSD1/KDM1A) has become an important and promising anticancer target since it was first identified in 2004 and specially demethylates lysine residues of histone H3K4me1/2 and H3K9me1/2. LSD1 is ubiquitously overexpressed in diverse cancers, and abrogation of LSD1 results in inhibition of proliferation, invasion, and migration in cancer cells. Over the past decade, a number of biologically active small-molecule LSD1 inhibitors have been developed. To date, six trans-2-phenylcyclopropylamine (TCP)-based LSD1 inhibitors (including TCP, ORY-1001, GSK-2879552, INCB059872, IMG-7289, and ORY-2001) that covalently bind to the flavin adenine dinucleotide (FAD) within the LSD1 catalytic cavity have already entered into clinical trials. Here, we provide an overview about the structures, activities, and structure–activity relationship (SAR) of TCP-based LSD1 inhibitors that mainly covers the literature from 2008 to date. The opportunities, challenges, and future research directions i&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00919&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00919" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00919&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00919" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00919&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00919" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00919&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00919&amp;href=/doi/10.1021/acs.jmedchem.0c00919" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00919" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00919" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00919%26sid%3Dliteratum%253Aachs%26pmid%3D32931269%26genre%3Darticle%26aulast%3DDai%26date%3D2020%26atitle%3DTranylcypromine%2BBased%2BLysine-Specific%2BDemethylase%2B1%2BInhibitor%253A%2BSummary%2Band%2BPerspective%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D23%26spage%3D14197%26epage%3D14215%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/jmcmar.2020.63.issue-23/20201210/jmcmar.2020.63.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Histone lysine-specific demethylase 1 (LSD1/KDM1A) has become an important and promising anticancer target since it was first identified in 2004 and specially demethylates lysine residues of histone H3K4me1/2 and H3K9me1/2. LSD1 is ubiquitously overexpressed in diverse cancers, and abrogation of LSD1 results in inhibition of proliferation, invasion, and migration in cancer cells. Over the past decade, a number of biologically active small-molecule LSD1 inhibitors have been developed. To date, six <i>trans</i>-2-phenylcyclopropylamine (TCP)-based LSD1 inhibitors (including TCP, ORY-1001, GSK-2879552, INCB059872, IMG-7289, and ORY-2001) that covalently bind to the flavin adenine dinucleotide (FAD) within the LSD1 catalytic cavity have already entered into clinical trials. Here, we provide an overview about the structures, activities, and structure–activity relationship (SAR) of TCP-based LSD1 inhibitors that mainly covers the literature from 2008 to date. The opportunities, challenges, and future research directions in this emerging and promising field are also discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Among the diverse epigenetic modifications on histone, including acetylation, methylation, phosphorylation, ubiquitination, hydroxylation, sumoylation, and glycosylation,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> histone methylation was originally considered as an irreversible process until histone lysine-specific demethylase 1 (LSD1/KDM1A) was identified by Shi’s group in 2004.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> LSD1 specifically erases the methyl groups from mono- and dimethylated histone 3 lysine 4 and lysine 9 by coordinating with CoREST in a flavin adenine dinucleotide (FAD)-dependent manner, thereby regulating target gene transcription by modulating the chromatin structure. In addition, LSD1 has also been reported to remove mono- and dimethyl groups from specific lysine residues on several non-histone proteins, such as DNA methyltransferase 1,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> p53 (protein 53),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> MYPT1 (myosin phosphatase targeting subunit 1),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> E2F1 (E2F transcription factor 1),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> STAT3 (signal transducer and activator of transcription 3),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and HIF1α (hypoxia-inducible factor 1α),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> which may lead to the dysregulation of their function.</div><div class="NLM_p">LSD1 is overexpressed or dysregulated in various cancers, including gastric cancer, small cell lung cancer (SCLC), breast cancer,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> neuroblastoma,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> acute myeloid leukemia (AML), retinoblastoma,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and prostate cancer.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> Pharmacological or genetic abrogation of LSD1 inhibits the proliferation and metastasis of diverse tumor cells.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16−19)</a> Therefore, LSD1 has emerged as an attractive anticancer drug target, and numerous LSD1 inhibitors have been developed over the last ten years.<a onclick="showRef(event, 'ref18 ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref18 ref20 ref21 ref22 ref23 ref24 ref25">(18,20−25)</a> So far, six <i>trans</i>-2-phenylcyclopropylamine (TCP)-based LSD1 inhibitors, including TCP, ORY-1001,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> GSK-2879552,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> INCB059872,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> IMG-7289, and ORY-2001, have reached the clinical trial stage alone or in combination with other therapeutics for the treatment of cancers and neurodegenerative disorders (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref16 ref20 ref31'); return false;" href="javascript:void(0);" class="ref ref16 ref20 ref31">(16,20,31)</a> Therefore, TCP has become an important druggable scaffold for developing potent LSD1 inhibitors.<a onclick="showRef(event, 'ref16 ref32'); return false;" href="javascript:void(0);" class="ref ref16 ref32">(16,32)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. LSD1 Inhibitors in Clinical Trials</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0007.gif" alt="" id="gr7" /></img><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Structural Basis for Designing New TCP-Based LSD1 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">LSD1 demethylates H3K4me1/2 and H3K9me1/2 through amine oxidation using FAD as a cofactor. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A, with oxygen, methylated lysine suffers single-electron oxidation of the amine to form the corresponding iminium cation by LSD1 coupling with FAD, generating FADH<sub>2</sub> and H<sub>2</sub>O<sub>2</sub>. The resulting iminium cation intermediate is unstable and can easily be hydrolyzed by H<sub>2</sub>O to obtain the demethylated product and formaldehyde. Simultaneously, FADH<sub>2</sub> is reoxidized to FAD by consuming O<sub>2</sub>, which forms H<sub>2</sub>O<sub>2</sub>. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B, TCP inactivates LSD1 through a single electron transfer mechanism, and then four different TCP-FAD adducts are obtained by the homolysis of the cyclopropyl ring through distinct pathways,<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33−35)</a> which is an irreversible catalytic process. First, FAD abstracts an electron from the nitrogen atom of TCP to form a cation radical, followed by cleavage reactions of the cyclopropyl ring to yield the C (<b>4a</b>) adduct <b>A</b> and five-membered ring adduct <b>B</b>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The covalent binding of two isomers of chiral TCPs with FAD gives N (<b>5</b>) adducts <b>C</b> and <b>D</b>.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C, the covalent TCP-FAD adduct is located in a hydrophobic pocket surrounded by V333, H564, T335, Y762, A899, and T810 residues. The benzene ring of the adduct has weak van der Waals forces with the methyl groups of T810 and T335 residues but has no additional contacts with the surrounding hydrophobic residues. This binding model indicates that the incorporation of hydrophobic substituents into the benzene ring may form more interactions with these hydrophobic residues, thus inhibiting LSD1 with higher potency.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structural basis for designing novel TCP-based LSD1 inhibitors. (A) Catalytic mechanism of LSD1. (B) Mechanism of LSD1 inhibition by forming the covalent TCP–FAD adducts. (C) Cocrystal structure of TCP–FAD adduct in LSD1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">3.  TCP-Based LSD1 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08712" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08712" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As LSD1 shares a similar catalytic structural domain and mechanism with other monoamine oxidases (MAOs), three known anti-MAO agents, including TCP, pargyline, and phenelzine, were evaluated for their LSD1 inhibitory activity. Among them, TCP was determined to be the most potent one with moderate LSD1 inhibitory activity (<i>K</i><sub>i</sub> = 243 μM) but poor selectivity.<a onclick="showRef(event, 'ref16 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref16 ref36 ref37">(16,36,37)</a> Currently, TCP is undergoing three clinical trials in combination with all-trans-retinoic acid (ATRA) to treat AML and myelodysplastic syndromes (MDS). In 2014, phase I/II trials were launched to assess the feasibility, safety, and biological activity of TCP/ATRA combination therapy for treating relapsed or refractory AML patients and AML patients who cannot tolerate intensive therapy (NCT02261779, EudraCT 2012-002154-23). Eighteen patients were treated with this combined treatment, and the overall response rate was 20%. Patients who did not reach clinical remission were observed for myeloid differentiation. Median overall survival (OS) was only 3.3 months. Increased levels of H3K4me1 and H3k4me2 were observed in AML blasts and white blood cells from several treated patients.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Another phase I trial was designed to explore the safety and tolerability of TCP/ATRA combination therapy for treating AML and MDS patients (NCT02273102). In 2016, the phase I/II study of sensitization of non-M3 AML blast cells to TCP/ATRA combination was initiated to determine the maximum-tolerated dose of TCP combined with fixed-dose ATRA and with fixed-dose Ara-C, to obtain the recommended phase II dose for AML or MDS patients and to evaluate the efficacy (NCT02717884). In 2020, Zhang et al. revealed that cotreatment with TCP and GSK-J1 (JMJD3 inhibitor) had synergistic therapeutic effects against head and neck squamous cell carcinoma <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The cocrystal structure of the LSD1–CoREST complex revealed that the activity pocket of LSD1 is larger and more hydrophilic than those of MAO-A and -B, which provides an important structural basis for developing novel potent and selective LSD1 inhibitors that fully engage neighboring residues.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">In this Perspective, we will summarize the chemical structures, bioactivities, and structure–activity relationship (SAR) of TCP-based LSD1 inhibitors reported in recent years and discuss their potential as therapeutic drugs. They are divided into five categories according to their molecular structure and substitution position, including compounds substituted on the phenyl of TCP, compounds substituted on the amino of TCP, miscellaneous substituted TCP-based compounds, compounds substituted on the cyclopropyl core of TCP, and conformationally constrained TCP-based compounds.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.1.  Compounds Substituted on the Phenyl of TCP</h3><div class="NLM_p">TCP is a weak and nonspecific LSD1 inhibitor; making substitutions on the phenyl ring to enhance its potency and specificity has been pursued in recent years.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In 2008, Gooden et al. designed the first series of TCP derivatives with substituents attached to the benzene ring and examined the inhibition kinetics for some representative compounds against LSD1.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Some derivatives (<i>para</i>-CF<sub>3</sub>, -Br, -Me) displayed higher LSD1 inhibitory activity than TCP but poor LSD1 selectivity against MAO-A and -B. Based on the cocrystal structures of TCP/<i>N</i>-propargyl lysine peptide–FAD adducts,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> NCL-1 and NCL-2 were designed by Miyata et al. in 2009, featuring the side chain of an amino acid at the <i>meta-</i> and <i>para</i>-positions of the TCP benzene ring, respectively (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The introduced benzylamino and benzoyl groups could be recognized by several hydrophobic amino acid residues around the LSD1 active site, and the resulting compounds showed enhanced cell permeability. Both NCL-1 and NCL-2 exhibited good selectively for LSD1 over MAO-A and -B. Furthermore, crystal structure analysis showed that the active pockets of MAO-A and -B<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> do not have sufficient space to accommodate bulky substituents on the TCP benzene ring, underscoring the importance of the amino acid moiety for LSD1 inhibitory activity and selectivity. Next, NCL-1 and NCL-2 were identified as cell-active LSD1 inhibitors against many kinds of cancer cell lines (GI<sub>50</sub> = 6–67 μM). Following studies confirmed that NCL-1 exhibited good anticancer activities in several solid tumors, including breast cancer,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> prostate cancer,<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> and glioma.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> Also, high-dose NCL-1 caused dysfunctional spermatogenesis and induced caspase-dependent apoptosis.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds substituted on the phenyl of TCP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2010, Mimasu et al. designed a new series of LSD1 inhibitors based on TCP-inhibited structural superposition of LSD1 and MAO-B.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Among them, S2101 was the most active (<i>K</i><sub>i</sub> = 0.61 μM) and exhibited stronger LSD1 inhibitory potency than TCP due to the <i>ortho</i>-substituent of the TCP benzene ring and two fluorines at <i>meta</i>-positions (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In addition, S2101 showed excellent selectivity for LSD1 over MAO-A and -B. The inhibition modes of compounds S2101 and 2-PFPA were also identified by crystal structure analysis, which revealed that a benzene ring at the <i>ortho</i>-position of TCP improved the inhibitor–FAD adduct stability through extra contacts with the surrounding LSD1 residues. In human HEK293T cells, S2101 exhibited about 50-fold stronger LSD1 inhibitory activity than TCP.</div><div class="NLM_p">In the same year, Binda et al. designed the first series of 4-amidophenylcyclopropylamine analogues by introducing some different large hydrophobic and hydrophilic groups at the <i>para</i>-position of the TCP benzene ring, such as compounds <b>1</b>, <b>2</b>, and MC2580 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> These derivatives were used to obtain more information about the differences in the binding sites of LSD1, lysine-specific demethylase 2 (LSD2/KDM2A), and MAO-A and -B to further enhance their LSD1 inhibitory selectivity. Among them, MC2580 exhibited the best LSD1 inhibitory potency and selectivity (LSD1 <i>K</i><sub>i</sub> = 1.3 μM, LSD2 <i>K</i><sub>i</sub> = 38 μM, MAO-A <i>K</i><sub>i</sub> = 1.2 μM, no inhibition for MAO-B). The striking potency difference observed in MAO-A and -B is due to the larger and more flexible MAO-A active cavity to accommodate these bulky molecules, which is not present in MAO-B.<a onclick="showRef(event, 'ref35 ref44'); return false;" href="javascript:void(0);" class="ref ref35 ref44">(35,44)</a> As APL is associated with the aberrant activities of several chromatin modifications, treating APL-derived NB4 cells with MC2580 for 6 h but not more than 12 h caused a selective and concentration-dependent increase in H3K4me2, indicating the irreversible mechanism of action of MC2580. In addition, MC2580 showed an obvious synergistic effect to inhibit cell growth and induce the differentiation of APL cells when combined with retinoic acid.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In 2020, the same group designed new TCP analogues carrying double-substituted benzamide residues at the <i>para</i>-position of their benzene rings. Among them, the most active compound, <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), exhibited potent LSD1 inhibitory activity (IC<sub>50</sub> = 90 nM) and high selectivity against MAO-A and -B. More importantly, compound <b>3</b> exhibited sub-micromolar cell growth inhibition against AML cell line MV4-11 (IC<sub>50</sub> = 0.4 μM) and APL cell line NB4 (IC<sub>50</sub> = 0.6 μM).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">In 2011, the enantioselective synthesis of TCP analogues designed as LSD1 inhibitors was first reported by Benelkebir et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The biological activity results indicated that the two enantiomers of TCP and its racemic mixture exhibited similar LSD1 inhibitory activity. Nevertheless, it was found that the activity of (1<i>R</i>,2<i>S</i>)-<b>4</b> (<i>para</i>-bromo-tranylcypromine) was over 1000-fold higher than that of TCP in the prostate cancer cell line LNCaP. The enhanced cell-based activity of (1<i>R</i>,2<i>S</i>)-<b>4</b> may be due to its improved cell permeability and lipophilicity compared with TCP (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_p">In 2015, <i>Z</i>-pyrole- and <i>Z</i>-indole-TCP derivatives that can interact more effectively with the binding pocket to improve LSD1 inhibitory activity and selectivity were developed by Rodriguez et al. (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The substituted pyrroles or indoles were then used to replace the chiral amino acid portion of MC2580 to develop novel derivatives with simplified structures. Among these two new series, the most effective compounds, <b>5</b> and <b>6</b>, displayed high LSD1 inhibitory potency (IC<sub>50</sub> = 32 nM and 40 nM, respectively). At the cellular level, they can inhibit LSD1 in NB4 cell lines, increase the expression of growth factor independent 1B (GFI-1B) and integrin alpha M (ITGAM), and block the growth of MV4-11 (AML cell line) and NB4 (APL cell line).</div><div class="NLM_p">In 2020, Borrello et al. developed a series of novel TCP analogues with a carboxamide group at the <i>para</i>-position of the benzene ring (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> These newly designed compounds were reverse amide isosteres of previously reported LSD1 inhibitors to avoid the toxicity caused by hydrolysis of the aniline amide. These compounds (such as the most effective compound <b>7</b>, which had sub-micromolar LSD1 inhibitory activity) exerted antiproliferative effects against a panel of AML cells. The participation of the LSD1 target in cells was proven by the effect on H3K4me2 protein expression and CD86, CD11b, and CD14 levels.</div><div class="NLM_p">LSD1 and Jumonji C (JmjC) domain-containing family members histone lysine demethylase 4A/C (KDM4A/C) are coexpressed and colocalized with the androgen receptor (AR) in prostate cancer. By combination of TCP with two JmjC inhibitors (4-carboxy-4′-carbomethoxy-2,2′-bipyridine and 5-carboxy-8-hydroxyquinoline), dual histone demethylase inhibitors (such as hybrids <b>8</b> and <b>9</b>) simultaneously inhibited LSD1 and JmjC KDMs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> In addition to promoting the methylation of H3K4 and H3K9, they also induced growth arrest and extensive apoptosis in prostate cancer cell line LNCaP and colon cancer cell line HCT 116, while little and no apoptosis were induced by compounds <b>8</b> and <b>9</b> in mesenchymal progenitor cells, demonstrating selective inhibition of cancer.</div><div class="NLM_p last">Histone deacetylases (HDACs) are also effective targets for anticancer therapy, and the HDAC1/2–LSD1–CoREST complex is usually associated with silencing of tumor suppressor genes.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> Hence, designing a dual-targeting agent is a good strategy for medicinal chemists to develop new candidate drugs. In 2018, Kalin et al.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> reported a synthetic hybrid compound, Corin, that was derived from TCP and entinostat (an HDAC inhibitor) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Corin exhibited dual inhibitory effect on LSD1 and HDAC, which was consistent with the mechanism that the active sites of HDAC1 and LSD1 were dually engaged by Corin’s warheads. Compared to its parent monofunctional inhibitors, Corin showed more potent antiproliferation properties in melanoma and cutaneous squamous cell carcinoma cell lines.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Moreover, Anastas et al. revealed that co-inhibition of HDACs and LSD1 with Corin potently decreases diffuse intrinsic pontine glioma (DIPG) cell growth <i>in vitro</i> and <i>in vivo</i> by promoting cell death and differentiation while suppressing cell cycle, which might provide a promising strategy for treating DIPG by simultaneously inhibiting LSD1 and HDACs.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In the same year, Milelli et al.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> designed a series of polyamine-based dual HDAC/LSD1 inhibitors by coupling vorinostat and TCP. Considering that polyamines can form additional interactions with negatively charged amino acids, different polyamines were used as linkers in this study, and compound <b>10</b> emerged as the most potent one, exhibiting excellent inhibitory activity toward HDAC1 (<i>K</i><sub>i</sub> = 42.52 nM) and LSD1 (IC<sub>50</sub> = 3.85 μM). In addition, compound <b>10</b> displayed stronger antiproliferation activity than vorinostat in breast cancer cell line MCF7 (IC<sub>50</sub> = 39.6 μM).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.2.  Compounds Substituted on the Amino of TCP</h3><div class="NLM_p">Most LSD1 inhibitors currently under clinical investigation are N-alkylated TCP derivatives. In 2013, using a ligand-based approach, a series of cyclic and short linear peptides were discovered as potent LSD1 inhibitors.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> In the same year, Ogasawara et al. designed a series of LSD1 inhibitors coupling TCP with a histone 3 mimetic peptide (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Among them, TCP-Lys-4 H3-21 exhibited high LSD1 potency (IC<sub>50</sub> = 0.16 μM) and high selectivity against MAO-A and -B (IC<sub>50</sub> > 100 μM). Nevertheless, TCP-Lys-4 H3-21 was found to be inactive in cancer cells possibly due to poor cell membrane permeability. Mechanically, peptide scaffolds served as carriers to deliver TCP into the LSD1 active pocket, followed by forming the TCP–FAD adduct to inhibit LSD1. The SAR studies indicated that the peptide chain length was very important for LSD1 inhibitory potency.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> This strategy was also employed to develop a series of small-molecule lysine–TCP conjugates (NCD series compounds) with potent antiproliferative effects against cervical cancer cell line HeLa and neuroblastoma cell line SH-SY5Y.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> In 2014, the same group investigated the LSD1 inhibitory activities of optically pure isomers of lysine–TCP hybrids NCD18, NCD25, and NCD41.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> It was found that (1<i>R</i>,2<i>S</i>)-NCD18 and (1<i>R</i>,2<i>S</i>)-NCD25 were 11-fold and 4-fold more potent than their corresponding enantiomers, respectively. Additionally, the LSD1 activity of (1<i>S</i>,2<i>R</i>)-NCD41 was about 4 times higher than that of its enantiomer. Molecular docking study suggested that these compounds interacted with hydrophobic amino acid residues and formed hydrogen bonds within the LSD1 catalytic cavity. In addition, the stereochemistry of TCP could also affect the inhibitory activity of LSD1. By regulating apoptosis and suppressing SRY (sex-determining region Y)-box 2 (SOX2) and Oct4, NCD38 and previously mentioned NCL-1 can effectively inhibit the growth of germ cell tumors <i>in vitro</i> and <i>in vivo</i> without adverse reactions, indicating that NCD38 and NCL-1 have the potential to be used as therapeutic agents for germ cell tumors.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds substituted on the amino of TCP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2018, Schulz-Fincke et al. designed a series of novel <i>N</i>-alkylated TCP derivatives resulting in some highly potent LSD1 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Among them, <i>N</i>-methyl sulfonamide <b>11</b> is the most potent LSD1 inhibitor (IC<sub>50</sub> = 187 nM) with high selectivity against MAO-A and -B. In this study, the introduction of a polar, nonbasic functional group can not only maintain the inhibitory activity of LSD1 but also improve the selectivity against MAO-A and -B and inhibit colony formation of leukemia cells effectively. Docking studies showed that the wide binding pocket of LSD1 can accommodate the selective binding of lipophilic and polar groups, while in MAO-A, the binding sites are narrower and most of them are lipophilic. These findings well explained the high selectivity of inhibitors with polar substituents.</div><div class="NLM_p">ORY-1001 (iadademstat; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), the most potent and selective <i>N</i>-substituted TCP-based LSD1 inhibitor to date, was developed by Oryzon Genomics, and it is now undergoing clinical trials to treat AML and solid tumors.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In 2013, a phase I clinical study to explore the pharmacokinetics (PK) and safety of ORY-1001 for treating relapsed or refractory acute leukemia (AL) showed that the recommended dose of ORY-1001 was well tolerated and promoted blast differentiation (EudraCT 2013-002447-29). In 2016, another phase I clinical study was initiated to evaluate the safety and tolerability of orally administered ORY-1001 for the treatment of relapsed, extensive-stage disease SCLC (NCT02913443). Combined with platinum-etoposide chemotherapy, preliminary studies to investigate the safety, tolerability, recommended dose, and efficacy of ORY-1001 against relapsed and extensive-stage disease SCLC are currently ongoing (EudraCT 2018-000469-35). Preliminary studies on the safety, tolerability, recommended dose, and efficacy of ORY-1001/azacitidine combination therapy in the first-line treatment of older AML patients are also in progress (EudraCT 2018-000482-36). Very recently, Oryzon Genomics presented new phase II clinical data on ORY-1001 in combination with azacitidine in elderly AML patients at the Congress of European Hematology Association.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> In biochemical level, ORY-1001 displayed potent LSD1 inhibitory activity (IC<sub>50</sub> = 18 nM) and high selectivity (>1000-fold higher than LSD2 and MAO-A and -B).<a onclick="showRef(event, 'ref26 ref70'); return false;" href="javascript:void(0);" class="ref ref26 ref70">(26,70)</a> In THP-1 cells, ORY-1001 induced H3K4me2 accumulation in a dose- and time-dependent manner and induced differentiation by inducing CD11b.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Moreover, it can induce THP-1 cell apoptosis and inhibit MV-4-11 cell proliferation and colony formation. Further <i>in vivo</i> study also confirmed that ORY-1001 can significantly inhibit the growth of tumors in rodent MV-4-11 xenografts. As a drug in clinical trial, ORY-1001 was found to be stable in hepatocytes with no inhibitory effect on cytochrome P450 enzymes (CYP) and human ether-a-go-go related gene and exhibited high activity, oral bioavailability, and <i>in vivo</i> target exposure. When ORY-1001 was applied in combination with standard-of-care drugs (such as ATRA, Ara-C/cytarabine, and quizartinib) and epigenetic inhibitors (such as DOT1L inhibitors EPZ-5676 and SGC-0946, DNMT1 inhibitors decitabine and azacitidine, HDAC inhibitor SAHA, and BCL2 inhibitor ABT-737) in MV-4-11, MOLM13, and MOLT4 cell lines; these combinations significantly suppressed tumor growth in an AML-xenograft model and prolonged survival in a T-cell AL patient derived xenograft (PDX) model.<a onclick="showRef(event, 'ref26 ref71'); return false;" href="javascript:void(0);" class="ref ref26 ref71">(26,71)</a> A recent report also indicated that ORY-1001/OTX015 (a BET protein inhibitor) combination treatment exhibited synergistic lethality effects on blast progenitor cells of AML.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> ORY-1001 also exhibited good inhibitory effect on the xenograft growth of responsive SCLC cell line NCI-H510A, but it was not very effective for the SCLC cell line NCI-H526.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> In 2020, Cuyàs reported that ORY-1001 inhibited breast cancer stem cell (CSC)-driven mammosphere formation, blocked the LSD1-targeted SOX2 enhancer activation, and significantly and selectively reduced the formation of mammospheres by CSC-like cells from a multidrug-resistant luminal-B breast cancer PDX.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div><div class="NLM_p">As one of the first two inhibitors in clinical trials, GSK2879552 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) is an orally active, potent, and selective <i>N</i>-substituted TCP-based LSD1 inactivator identified from 2.5 million compounds. With the aid of the cocrystal structure of the GSK2879552–FAD adduct (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQU">6NQU</a>), GSK2879552 was characterized as a mechanism-based inhibitor depending on the LSD1 catalytic activity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Moreover, anticancer activity evaluation using a panel of 165 cell lines suggested that GSK2879552 is narrowly active in SCLC and AML, and DNA hypomethylation may act as a biomarker to predict the response to GSK2879552 in SCLC. GSK2879552 has entered phase I/II clinical trials for treating high-risk MDS alone or in combination with azacytidine (NCT02929498), and two phase I clinical studies to treat AML (NCT02177812) and relapsed/refractory SCLC (NCT02034123), but all these clinical trials have been terminated due to the high incidence of some serious adverse events.</div><div class="NLM_p">INCB059872 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) is a new potent TCP-based small-molecule LSD1 inhibitor reported by Incyte Corporation in 2016.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> In preclinical models of human SCLC, INCB059872 can effectively inhibit SCLC cell proliferation with EC<sub>50</sub> values ranging from 47 to 377 nM.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> INCB059872 is presently undergoing four clinical trials for anticancer treatment. A phase I clinical study assessing the safety, pharmacokinetics, and efficacy of INCB059872 in patients with sickle cell disease was discontinued in 2019 due to a business decision not to pursue INCB059782 in sickle cell disease indication (NCT03132324). A phase I/II dose-escalation/expansion and safety study of INCB059872 in patients with advanced malignancies (NCT02712905, EudraCT 2017-001710-28) and a phase I clinical trial concerning the evaluation of the safety and preliminary efficacy of INCB059872 in relapsed or refractory Ewing sarcoma (ES) (NCT03514407, EudraCT 2018-000062-11) were also terminated due to business decision. A phase I/II study to explore the safety and tolerability of INCB059872 in combination with pembrolizumab and epacadostat for treating advanced solid tumors has been completed recently (NCT02959437). Further, a “basket” study of new therapies for MDS or myeloproliferative disorders is scheduled to conduct clinical I/II trials in 2020 (NCT04061421).</div><div class="NLM_p last">In 2017, Duan et al. designed a series of LSD1/HDACs dual inhibitors combined with <i>N</i>-substituted TCP derivatives and pharmacophore of HDAC inhibitors (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Among them, compound <b>12</b> showed the highest inhibitory activity against LSD1 (IC<sub>50</sub> = 1.20 μM), HDAC1 (IC<sub>50</sub> = 15 nM), and HDAC2 (IC<sub>50</sub> = 23 nM). The antiproliferative activities of compound <b>12</b> (IC<sub>50</sub> = 0.81–5.48 μM) against four cancer cell lines (MGC-803, MCF-7, SW-620, and A-549) are stronger than that of SAHA. Molecular docking experiments indicated that compound <b>12</b> fits well with the binding pockets in LSD1 and HDAC2 active sites, which provided potential prospects to develop more effective dual LSD1/HDACs inhibitors for cancer therapy.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.3.  Miscellaneous Substituted TCP-Based Compounds</h3><div class="NLM_p">In 2011, Neelamegam et al. reported new TCP derivatives by introducing different substituents at the benzene ring and amino group as LSD1 inhibitors for the treatment of brain disorders (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Among them, RN-1 and RN-7 exhibited the highest LSD1 inhibitory potency (IC<sub>50</sub> = 10 nM and 3 nM, respectively) and moderate selectivity against MAO-A and -B. A novel object recognition test was used to evaluate the influence of RN-1 on long-term memory. Mice systemically treated with RN-1 developed significant long-term memory impairment with short-term memory intact. In a subsequent study, it was reported that RN-1 is a promising γ-globulin inducer to treat sickle cell disease.<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77,78)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Miscellaneous substituted TCP-based compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">NCL-1 was the first cell-active LSD1 inhibitor designed by Ahmed Khan; in 2015, the same group further developed a series of <i>N</i>-alkylated NCL-1 analogues with higher LSD1 inhibitory potency and selectivity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Among them, compound <b>13</b> displayed LSD1 inhibitory activity about 6 times stronger than that of NCL-1 and compound <b>14</b>. Moreover, compound <b>13</b> exhibited moderate cellular activity with GI<sub>50</sub> of 42 μM in SH-SY5Y cells, but highly polar compound <b>14</b> was inactive in SH-SY5Y cells due to the poor cell membrane permeability.</div><div class="NLM_p">In 2017, Takeda Pharmaceuticals identified T-3775440 as a novel <i>N</i>-alkylated TCP-based LSD1 inhibitor (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> T-3775440 exhibited high LSD1 inhibitory potency with IC<sub>50</sub> values of 2.1 nM in the presence of CoREST and 20 nM without CoREST. In addition, T-3775440 showed excellent LSD1 selectivity against MAO-A and -B. At a cellular level, T-3775440 also inhibited the growth of AML and acute megakaryoblastic leukemia (AMKL) cells by inducing cell transdifferentiation. When T-3775440 was applied in combination with NEDD8-activating enzyme (NAE) inhibitor pevonedistat in AML, they exhibited a synergistic effect for AML treatment.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_p">Inspired by the potency of the TCP skeleton and hydrazone moiety, in 2017, our group developed a series of phenylalanyl hydrazone based TCP derivatives as novel small-molecule LSD1 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Among these newly synthesized compounds, compound <b>15</b> exhibited the strongest LSD1 inhibitory effect (IC<sub>50</sub> = 91.83 nM). In addition, compound <b>15</b> induced the accumulation of CD86 and H3K4me2 and inhibited gastric cancer cell proliferation. Our findings indicated that compound <b>15</b> can serve as a promising lead compound to target gastric cancer.</div><div class="NLM_p">In 2020, Niwa et al. introduced (2-aminopyrrolidine-1-yl) ethanone (APE) and (4-methylpiperazine-1-yl) ethanone (MPE) at the amino group of the previously reported S2101 to yield novel <i>N</i>-alkylated TCP-based LSD1 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(83)</a> Compared with S2101, newly synthesized compounds S2116 and S2157 showed improved LSD1 inhibitory potency with <i>K</i><sub>i</sub> values of 0.56 μM and 0.37 μM, respectively. S2116 and S2157 also showed high LSD1 inhibitory selectivity against MAOs, which may be due to steric restraints. The reported compound FCPA-MPE, bearing a fluoro-trifluoromethylphenyl group at the <i>para</i>-position of the benzene ring and MPE on the amino group of TCP, exhibited higher activity and selectivity for LSD1 inhibition than S2101. Crystal structural analysis of the complexes of LSD1 with S2101, S2116, S2157, and FCPA-MPE revealed that the <i>N</i>-substituents enhanced the LSD1 inhibitor activity without forming adducts with FAD.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(83)</a></div><div class="NLM_p">Sulfonamide is one of the most important amide isosteres commonly used in drug development.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(84)</a> In 2020, Liang et al.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(85)</a> introduced a sulfonamide group at the <i>para</i>-position of the TCP benzene ring to develop a novel series of LSD1 inhibitors (such as compound <b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Its LSD1 inhibitory activity was significantly improved by the introduction of sulfonamide. In addition, compound <b>17</b> obtained by introducing a Boc (<i>tert</i>-butoxycarbonyl) group at the amine group of compound <b>16</b> significantly increased antiproliferation activity against AML cells. Additional intracellular thermal shift and mass spectroscopy showed that the lipophilic Boc group was beneficial to cellular uptake and it can be easily removed under acidic conditions to obtain the real LSD1 inhibitors, which was further proved by the fact that an acidic inert pivaloyl replacing the Boc group (such as compound <b>18</b>) substantially reduced the antiproliferative effect on AML cells. Finally, compound <b>19</b> with appropriate lipophilicity was developed, which exhibited better LSD1 inhibitory activity and antiproliferative activity in AML cell lines.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(85)</a></div><div class="NLM_p">IMG-7289, bomedemstat (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) is an oral small-molecule LSD1 inhibitor developed by Imago BioSciences. A phase I clinical study of IMG-7289 alone or in combination with ATRA for treating AML and MDS has been completed in late 2018 (NCT02842827), but the clinical results have not yet been published. In addition, IMG-7289 transitioned from a phase I/IIa dose-finding study to a phase IIb trial to evaluate its safety, steady-state pharmacokinetics, and pharmacodynamics for the treatment of myelofibrosis (MF) (NCT03136185). The recently published clinical trial results revealed that IMG-7289 can be well tolerated in heterogeneous patients with advanced MF and limited treatment options, and it can also improve symptom burdens in the majority of patients and modestly reduce spleen sizes in some patients.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(86)</a> In 2018, Jutzi et al.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(87)</a> reported that IMG-7289 can normalize or improve blood cell counts, reduce spleen sizes, restore normal splenic architecture, decrease mutant allele burden, reduce marrow fibrosis, and improve survival in a JAK2<sup>V617F</sup> mouse model of myeloproliferative neoplasms (MPNs). Moreover, the combination of IMG-7289 and ruxolitinib (a JAK1/2 inhibitor) showed synergistic effects on normalizing the MPN phenotype in mice, which provides a theoretical basis to investigate combination therapy. These data strongly support its clinical study for myelofibrosis treatment.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(87)</a> In 2020, a single-center phase II clinical trial (NCT04081220) and a multicenter phase IIb clinical trial (NCT04254978) of IMG-7289 were carried out to treat essential thrombocythemia (ET). Furthermore, a phase II clinical study was initiated in 2020 to assess the hematologic effects of IMG-7289 therapy in ET and polycythemia vera (PV) patients that failed at least one standard therapy (NCT04262141).</div><div class="NLM_p">ORY-2001, vafidemstat (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), reported by Oryzon Genomics, is a novel orally bioavailable and brain penetrable TCP-based dual inhibitor for LSD1 and MAO-B.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(88)</a> Preclinical data from animal studies showed that ORY-2001 can restore memory and reduce aggressiveness and social avoidance of senescence-accelerated mouse prone 8 (SAMP-8) with accelerated aging and Alzheimer’s disease (AD). In addition, ORY-2001 can also restore behavioral deficits and protein levels of ubiquitin carboxyl-terminal esterase L1 (UCHL1) and Notch1 in SAMP-8 mice<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(89)</a> and downregulate S100A9 postoperative cognitive impairment and traumatic brain injury (TBI).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(90)</a> In a recent phase I clinical trial with healthy volunteers, ORY-2001 was found to be safe and capable of effectively reaching the brain. A phase IIa study to assess the safety and preliminary efficacy of ORY-2001 for treating mild-to-moderate AD was initiated in 2019 (NCT03867253). A Phase IIa “basket” clinical trial to investigate the safety, tolerability, and efficacy of ORY-2001 in aggression in subjects with AD, Lewy body dementia (LBD), borderline personality disorder (BPD), autism spectrum disorder (ASD), and adult attention deficit hyperactivity disorder (ADHD) have been completed in 2019 (EudraCT 2018-002140-88). A parallel clinical study evaluating its safety, tolerability, and efficacy in aggression in a moderate-to-severe AD population was carried out in 2019 (EudraCT 2019-001436-54). In addition, ORY-2001 exhibited a fast, strong, and long-lasting therapeutic effect on multiple sclerosis (MS) in several preclinical models. Now, ORY-2001 is in phase IIa trial for treating relapsing-remitting multiple sclerosis (RR) and secondary progressive (SP) MS (EudraCT 2017-002838-23). Like MERS-CoV, in COVID-19 it has been observed that the cytokines interleukin-6 (IL-6) and interleukin-1β (IL-1β) are central to trigger cytokine storm. In acute preclinical models of inflammation, ORY-2001 was shown to produce a rapid and strong decrease in IL-6, IL-1β, and other relevant immunomodulatory inflammatory cytokines including tumor necrosis factor-alpha (TNF-α) and interferon-γ (IFN-γ). In 2020, a phase II study was conducted to determine the tolerability and efficacy of ORY-2001 in combination with standard of care treatment to prevent acute respiratory distress syndrome (ARDS) in patients with severe COVID-19 (EudraCT 2020-001618-39).</div><div class="NLM_p last">In 2019, Wang et al. designed several dual LSD1/menin–MLL1 inhibitors that coupled TCP with the 6-trifluoroethylthienopyrimidine skeleton of inhibitors of menin–MLL1 (mixed lineage leukemia 1) interaction (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(91)</a> When the newly synthesized inhibitors bind to the menin–MLL1 complex, the TCP moiety is located in the solvent-exposed region of the menin–MLL1 interaction site. Similarly, when they interact with LSD1, the 6-trifluoroethylthiopyrimidine moiety of the molecule remains outside the enzyme. Among these novel chemotypes, compound <b>20</b> was the most active LSD1 inhibitor (IC<sub>50</sub> = 66.13 nM) with excellent selectivity against MAO-A and -B. Moreover, compound <b>20</b> showed moderate menin–MLL1 PPI inhibitory activity (IC<sub>50</sub> = 2.13 μM) and potent MV4-11 antiproliferative activity (IC<sub>50</sub> = 0.51 μM).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.4.  Compounds Substituted on the Cyclopropyl Core of TCP</h3><div class="NLM_p">To enhance the understanding of the pharmacological properties of TCP derivatives and to obtain insights into the mechanism-based inhibition caused by the formation of the covalent TCP–FAD adduct, introduction of substituents at the α- or β-position of TCP was carried out to develop more potent LSD1 inhibitors in recent years.<a onclick="showRef(event, 'ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref93 ref94 ref95">(92−94)</a> In 2014, Vianello et al. developed a series of single enantiomers of α-substituted TCP derivatives as LSD1 inhibitors.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(93)</a> It is worth mentioning that the inhibitory activity of these novel synthesized compounds was strongly dependent on the substitutions on the cyclopropyl ring, and hydrophobic groups (alkyl, phenyl, and benzyl) were also introduced to enhance the LSD1 inhibitory activity. Moreover, introduction of a bulkier group improved the LSD1 selectivity against MAO-A and -B, which can be explained because the catalytic domain of LSD1 is larger than that of MAO-A and -B. Among these newly synthesized compounds, compound <b>21</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) was the most potent one (IC<sub>50</sub> = 0.131 μM) with high selectivity against MAO-B, which gave new insight for developing more effective TCP-based LSD1 inhibitors. Compound <b>21</b> was also less potent than its opposite enantiomer and racemic counterparts. Further structural and biochemical analysis highlighted that stereoisomers had similar LSD1 inhibitory activity but formed different covalent FAD adducts. Encouraged by these promising results and considered that the mechanism involved the formation of benzyl radical, in the next year, the same group reasoned that small electron-withdrawing or electron-donating groups on the TCP benzene ring may induce significant improvements in the LSD1 inhibitory activity (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(92)</a> Among these synthesized 1-substituted TCP analogues, compound <b>23</b> exhibited the highest LSD1 inhibitory potency (IC<sub>50</sub> = 31 nM), 25-fold more active than compound <b>22</b>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compounds substituted on the cyclopropyl core of TCP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2017, Borrello et al. designed a series of novel TCP analogues bearing a fluorine at the β-position of the cyclopropyl ring (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(94)</a> Compounds <b>24</b> and <b>25</b>, adding a fluorine atom to TCP alone, exhibited decreased LSD1 inhibitory activity compared to TCP. However, continuing to introduce additional substitutions at the benzene ring has produced many fluorinated LSD1 inhibitors with higher potency than TCP. Compounds <b>26</b>–<b>30</b> with additional substitutions at the <i>para</i>- or <i>meta</i>-position of the TCP benzene ring were micromolar LSD1 enzyme inhibitors. At the cellular level, selected compounds <b>27</b>–<b>29</b> inhibited AML cell (MV4-11 and THP-1) proliferation and induced H3K4me2 and CD86, which confirmed the LSD1 target engagement.</div><div class="NLM_p last">All these studies mentioned above highlight the potential of modifications at the α- or β-position of the TCP scaffold as a feasible approach to develop novel LSD1 inhibitors with higher potency and selectivity.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.5.  Conformationally Constrained TCP-Based Compounds</h3><div class="NLM_p">The development of TCP-based inhibitors is mainly focused on the structural modifications on the benzene ring and the amino groups. Most of these derivatives are racemic mixtures of the <i>trans</i>-cyclopropanes; thus the majority of SAR studies were limited to the racemates. Given the expected difference in inhibitory potency of the two enantiomers,<a onclick="showRef(event, 'ref35 ref96'); return false;" href="javascript:void(0);" class="ref ref35 ref96">(35,95)</a> Ji et al. first presented SAR data of some novel conformationally restricted LSD1 inhibitors based on TCP, including their racemates and enantiomers (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(96)</a> Among them, compounds <b>30</b> and <b>31</b> were identified as the most potent LSD1 inhibitors with excellent selectivity over MAO-A and -B and LSD2. These two compounds were further demonstrated to induce CD86 expression in MV4-11 cells.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Conformationally constrained TCP-based compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Since spiro containing system is not only diverse in orientation but also novel in structure, it is increasingly being utilized in medicinal chemistry. In this case, the spirocycle constraint may have a notable effect on the LSD1 inhibitory activity and selectivity against LSD2 and MAO-A and -B. In 2018, based on the concept of conformational restriction, the same group further designed a series of novel LSD1 inhibitors by introducing the spiro ring at TCP (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(97)</a> Compounds <b>32</b> and <b>33</b>, the simple and direct spirocyclic analog of TCP, exhibited 28- and 129-fold more potent LSD1 inhibitory activity than TCP and little or moderate activity on MAO-B and MAO-A. To further explore the SAR, many different substituted benzyl groups were incorporated into the amino group to develop some novel potent LSD1 inhibitors (compounds <b>34</b>–<b>38</b>) with excellent selectivity. Further development of more potent and promising spirocyclic TCP-based LSD1 inhibitors deserves particular attention.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">4.  Summary and Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">LSD1 specifically removes the methyl group on mono- and dimethylated H3K4 and H3K9,<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(98)</a> and it is ubiquitously overexpressed in diverse tumors, indicating that LSD1 is an attractive target for cancer therapy. Small-molecule LSD1 inhibitors have been proven to inhibit cancer cell proliferation, invasion, and migration. Since LSD1 was identified in 2004,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> many types of LSD1 inhibitors with diverse chemical structures, including TCP derivatives, phenelzines, peptides, polyamines, natural products, amidoximes, aminothiazoles triazoles, pyrimidines, and triazole-fused pyridines, have been highly pursued over the past decade, and the most extensively studied LSD1 inhibitors are TCP-based small-molecule compounds.<a onclick="showRef(event, 'ref18 ref20 ref22 ref32 ref100'); return false;" href="javascript:void(0);" class="ref ref18 ref20 ref22 ref32 ref100">(18,20,22,32,99)</a> In this Perspective, we thoroughly cover the structures, biological activity evaluation, and SAR of TCP-based LSD1 inhibitors in recent years. Currently, six mechanism-based LSD1 inhibitors bearing the TCP skeleton are undergoing clinical trials against cancers alone or in combination with other agents (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), which suggests that TCP is a privileged scaffold for developing new mechanism-based FAD-dependent LSD1 inhibitors. From the aspect of SAR, these substituents and their positions on the TCP scaffold have significant impacts on the LSD1 inhibitory selectivity against MAO-A and -B (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), which helps to further understand the SAR and possible binding model with LSD1 and thereby develop more potent and selective LSD1 inhibitors by specific optimizations on the TCP scaffold. For example, introducing a basic moiety at the phenyl ring may enhance the potency by targeting the negatively charged regions.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(100)</a> In addition, according to the structural features of LSD1 and MAO-A and -B, many MAO inhibitors can be used as templates to rationally design new potent LSD1 inhibitors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> TCP-based derivatives contain at least two chiral centers, and previous studies have confirmed that the stereochemistry is critical for LSD1 inhibitory activity. Therefore, pharmacological and toxicological characteristics of all isomers should be studied to determine the isomers with higher activity when designing TCP-based LSD1 inhibitors.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(100)</a> Additionally, further investigations on the combination of TCP derivatives with other drugs for the treatment of other solid tumors are of significant research interest.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of Six Classes of TCP-Based LSD1 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0008.gif" alt="" id="gr8" /></img><div></div></div><div class="NLM_p">The mechanism of TCP-based LSD1 inhibitors is that TCP binds to FAD in LSD1 covalently and forms adducts in the binding pocket. Similar to TCP, LSD1 inhibitors based on phenelzine or pargyline also exert their inhibitory effects by covalently inactivating FAD. These mechanism-based inhibitors presented several drawbacks including poor selectivity and <i>in vivo</i> toxicity due to their irreversible binding with FAD and micromolar affinity with some targets, such as norepinephrine and dopamine transporter.<a onclick="showRef(event, 'ref26 ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref26 ref102 ref103">(26,101,102)</a> In addition, although these mechanism-based inhibitors produce enduring effects on the target of interest, they induce lasting off-target effects due to their nonspecific nature. Since the discovery of TCP as an irreversible LSD1 inhibitor, many TCP derivatives have been developed with improved selectivity over MAOs and reduced toxicity, and six TCP-based LAD1 inhibitors are currently being tested in clinical trials (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Both reversible and irreversible LSD1 inhibitors are attractive for cancer therapy. In comparison with irreversible LSD1 inhibitors, noncovalent reversible LSD1 inhibitors present potential advantages in phenotype and safety, and they are grouped into two categories: non-natural ones and natural products. In recent years, many research groups, including us,<a onclick="showRef(event, 'ref104 ref105 ref106 ref107 ref108 ref109 ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref104 ref105 ref106 ref107 ref108 ref109 ref110 ref111">(103−110)</a> have designed and synthesized numerous noncovalent reversible LSD1 inhibitors with reduced toxicity, potent preclinical antileukemic effects, and sub-micromolar potencies,<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(111)</a> including dithiocarbamates, aminothiazole triazoles, pyrimidines, and triazole-fused pyridines. For instance, in 2019, our group identified of a series of triazole-fused pyrimidine derivatives as highly potent LSD1 inhibitors, of which the most potent compound (IC<sub>50</sub> = 49 nM) inhibited LSD1 reversibly and was highly selective to LSD1 over MAO-A and -B. However, most reversible LSD1 inhibitors are still in the preclinical research stage, except CC-90011 and SP-2509 (seclidemstat) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). CC-90011, developed by Celgene, a potent, selective, and orally active pyrimidinone-based LSD1 inhibitor, has shown antiproliferative effects against cancer cells <i>in vitro</i> and in PDX models. Three clinical studies of CC-90011 alone or combined with other drugs are being conducted for the treatment of relapsed or refractory solid tumors and non-Hodgkin’s lymphomas (NCT02875223), advanced cancers (NCT04350463), and SCLC (NCT03850067). SP2509, developed by University of Utah, is a phenylethylidene-benzohydrazide reversible and noncompetitive LSD1 inhibitor with an IC<sub>50</sub> of 13 nM with no inhibitory activity against MAO-A and -B.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(101)</a> Two phase I clinical trials for the treatment of ES (NCT03600649) and solid tumors (NCT03895684) are currently ongoing. Several natural products, baicalin,<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(112)</a> polymyxins,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(113)</a> resveratrol,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(107)</a> α-mangostin,<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(114)</a><i>Scutellaria baicalensis</i> Georgi,<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(115)</a> curcumin,<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(116)</a> biochanin A,<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(117)</a> and protoberberine alkaloids,<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(118)</a> have been reported to inhibit LSD1; therefore natural products will become rich sources for identifying new reversible LSD1 inhibitors. As FAD is the cofactor of LSD1, compounds sharing similar structure with it can potentially compete for binding to LSD1 by occupying the FAD binding pocket, which represents a promising approach to the development of FAD-competitive reversible LSD1 inhibitors.<a onclick="showRef(event, 'ref104 ref109'); return false;" href="javascript:void(0);" class="ref ref104 ref109">(103,108)</a> For instance, in 2019, our group reported the FAD (ligand)-based design of fragment-like xanthine derivatives as LSD1 inhibitors, of which the most potent one possessed promising LSD1 inhibitory potency (IC<sub>50</sub> = 6.45 μM).<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(108)</a> In previously reported structures, the amino acid residues of the LSD1 active site share similar conformations;<a onclick="showRef(event, 'ref41 ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref41 ref120 ref121">(41,119,120)</a> thus the discovery of underexploited binding sites in the substrate-binding region may facilitate the design of new structure-based LSD1 reversible inhibitors. For instance, in 2020, Yang et al. designed macrocyclic peptide reversible LSD1 inhibitors based on the structures of H3 substrate analogues bound to LSD1, of which the most active macrocyclic peptide compound (<i>K</i><sub>i</sub> = 2.3 μM) exhibited >40-fold higher activity than the corresponding linear one, indicating that linear and macrocyclic peptides bind LSD1 differently.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(121)</a> Virtual screening against the catalytic pocket of LSD1 has been used to develop novel LSD1 inhibitors, but the high similarity of LSD1 with LSD2 and MAOs makes it difficult to develop highly selective LSD1 inhibitors. Developing molecules targeting other LSD1 demethylase activity domains and allosteric domains may yield potent inhibitors with excellent selectivity.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(122)</a></div><div class="NLM_p">As many oncogenes or tumor suppressor genes are regulated by multiple factors, some LSD1 inhibitors that can abrogate LSD1 mediated demethylation may not display good anticancer activity. Therefore, combination of LSD1 inhibitors with other drugs may be a promising solution to tackle this problem. LSD1 is also involved in a variety of signaling pathways and performs various functional interactions with other proteins; the combination of LSD1 inhibitors with some other potential targets and the dual inhibitors targeting LSD1 and other disease-associated proteins will lead to more pronounced and synergistic effects, thus providing new opportunities for cancer therapy. For instance, domatinostat (4SC-202), a small-molecule epigenetic modulator that inhibited both HDAC1 and LSD1, exerted a significant antineoplastic effect on urothelial carcinoma cells<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(123)</a> and had cytotoxic and cytostatic effects on atypical teratoid/rhabdoid tumors, targeting specific cell subpopulations, including those with cancer stem-like features, and can be used as an important potential cancer therapeutic.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(124)</a> Furthermore, extensive structural modifications on TCP with other pharmacophores have been carried out to develop more potent inhibitors for clinical evaluation, showing synergistic effect and the promising application of these LSD1 inhibitors in clinical treatment. For instance, in 2017, Ishikawa et al. reported a synergistic effect of T-3775440 (an LSD1 inhibitor) and pevonedistat (an NAE inhibitor), yielding excellent anti-AML effects, which indicated that the combination treatment with LSD1/NAE inhibitors deserves more attention and has great potential for the treatment of AML.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> A recent paper has shown that LSD1 ablation can stimulate antitumor immunity through induced expression of endogenous retroviruses (ERVs) and enable checkpoint blockade.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(125)</a> This study not only identified LSD1 as a promising inducer of antitumor immunity and responsiveness to immunotherapy but also provides a basis for the combination of LSD1 inhibitors and anti-PD-(L)1 for cancer therapy. As mentioned above, the combination therapy could be a feasible therapeutic strategy to improve individual potency of LSD1 inhibitors.</div><div class="NLM_p last">Beyond its most studied demethylase activity, LSD1 demethylase-independent function has also been reported to be involved in the development of cancer in recent years,<a onclick="showRef(event, 'ref127 ref128 ref129 ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref127 ref128 ref129 ref130 ref131">(126−130)</a> which can explain why it has insufficient catalytic inhibition in several cancers.<a onclick="showRef(event, 'ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref132 ref133">(131,132)</a> Thus, we anticipate that the development of small-molecule compounds to interfere the demethylase-independent functions of LSD1 will be a promising approach for the prevention and treatment of cancer.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00919" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-Chao Zheng</span> - <span class="hlFld-Affiliation affiliation">Key
Lab of Advanced Drug Preparation Technologies, Ministry of Education
of China, State Key Laboratory of Esophageal Cancer Prevention &
Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation,
Institute of Drug Discovery and Development, School of Pharmaceutical
Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2662-3770" title="Orcid link">http://orcid.org/0000-0002-2662-3770</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ccb5a5afa4ada3b6a4a9a2ab8cb6b6b9e2a9a8b9e2afa2"><span class="__cf_email__" data-cfemail="7801111b10191702101d161f3802020d561d1c0d561b16">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong-Min Liu</span> - <span class="hlFld-Affiliation affiliation">Key
Lab of Advanced Drug Preparation Technologies, Ministry of Education
of China, State Key Laboratory of Esophageal Cancer Prevention &
Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation,
Institute of Drug Discovery and Development, School of Pharmaceutical
Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6771-9421" title="Orcid link">http://orcid.org/0000-0001-6771-9421</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9cf0f5e9f4f1dce6e6e9b2f9f8e9b2fff2"><span class="__cf_email__" data-cfemail="c6aaafb3aeab86bcbcb3e8a3a2b3e8a5a8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xing-Jie Dai</span> - <span class="hlFld-Affiliation affiliation">Key
Lab of Advanced Drug Preparation Technologies, Ministry of Education
of China, State Key Laboratory of Esophageal Cancer Prevention &
Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation,
Institute of Drug Discovery and Development, School of Pharmaceutical
Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Liu</span> - <span class="hlFld-Affiliation affiliation">Key
Lab of Advanced Drug Preparation Technologies, Ministry of Education
of China, State Key Laboratory of Esophageal Cancer Prevention &
Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation,
Institute of Drug Discovery and Development, School of Pharmaceutical
Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Peng Xiong</span> - <span class="hlFld-Affiliation affiliation">Key
Lab of Advanced Drug Preparation Technologies, Ministry of Education
of China, State Key Laboratory of Esophageal Cancer Prevention &
Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation,
Institute of Drug Discovery and Development, School of Pharmaceutical
Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei-Peng Xue</span> - <span class="hlFld-Affiliation affiliation">Key
Lab of Advanced Drug Preparation Technologies, Ministry of Education
of China, State Key Laboratory of Esophageal Cancer Prevention &
Treatment, Key Laboratory of Henan Province for Drug Quality and Evaluation,
Institute of Drug Discovery and Development, School of Pharmaceutical
Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Xing-Jie Dai</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=BIO-d7e1765-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xing-Jie Dai</b> obtained his M.S. degree in medicinal chemistry from Zhengzhou University in 2016 under the supervision of Prof. Jingchao Tao and his Ph.D. degree in Organic Chemistry from University of Chinese Academy of Science in 2019 under the supervision of Prof. Xiao-Mei Zhang. In 2019, he joined the group of Prof. Hong-Min Liu as a postdoctoral researcher in the School of Pharmaceutical Sciences at Zhengzhou University. His research is dedicated to the design, synthesis, and evaluation of novel small-molecule epigenetic inhibitors.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Ying Liu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=BIO-d7e1770-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ying Liu</b> obtained his B.S. degree in Pharmaceutical Science from Henan University in 2014 and his M.S. in pharmaceutical chemistry from Zhengzhou University in 2017 under the supervision of Prof. Yu Ke. He is currently engaged in his fourth year Ph.D. studies at Zhengzhou University under the supervision of Prof. Dequan Yu and Prof. Hong-Min Liu. Now he works on the design, synthesis, and biological evaluation of natural product extracts used as anticancer agents.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Xiao-Peng Xiong</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=BIO-d7e1775-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xiao-Peng Xiong</b> obtained his B.S. degree in Clinical Pharmacy at Jilin University in 2019. He is currently studying for a Master’s degree in medicinal chemistry at Zhengzhou University under the direction of associate Prof. Yichao Zheng.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Lei-Peng Xue</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=BIO-d7e1780-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lei-Peng Xue</b> obtained his B.S. degree in pharmacy at Nanchang University in 2019. He is currently undergoing Master study in medicinal chemistry at Zhengzhou University.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Yi-Chao Zheng</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=BIO-d7e1785-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yi-Chao Zheng</b> got his B.S. degree in Pharmaceutical Science from China Pharmaceutical University in 2008, his M.S in Pharmacy from Katholieke Universiteit Leuven in 2010, and his Ph.D. in Medicinal Chemistry from Zhengzhou University in 2014 under the supervision of Prof. Hong-Min Liu. He is currently an associate professor in the School of Pharmaceutical Sciences at Zhengzhou University. His current research interest resides in the identification of epigenetic targeted drugs and their biological study.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Hong-Min Liu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=BIO-d7e1790-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hong-Min Liu</b> received his M.S. in Pharmaceutical Sciences from Department of Pharmaceutical Sciences, Kanazawa University, Japan, and Ph.D. in Division of Life Sciences, Department of Bioactive and Related Substances Chemistry, Kanazawa University, Japan. He was appointed as a professor in 1995 and has been the Dean of Key Lab of Advanced Drug Preparation Technologies, Ministry of Education of China, at Zhengzhou University since 2005. His work focuses on epigenetic targeted drug discovery.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27870" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by National Key Research Program of Proteins (No. 2018YFE0195100 for H.-M.L. and No. 2016YFA0501800), National Natural Science Foundation of China (Project No. 81602961 for Y.-C.Z.; Nos. 81430085 and 81773562 for H.-M.L.), and Science and Technology Innovation Talents of Henan Provincial Education Department (19IRTSTHN001 for Y.-C.Z.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADHD</td><td class="NLM_def"><p class="first last">adult attention deficit hyperactivity disorder</p></td></tr><tr><td class="NLM_term">AL</td><td class="NLM_def"><p class="first last">acute leukemia</p></td></tr><tr><td class="NLM_term">AMKL</td><td class="NLM_def"><p class="first last">acute megakaryoblastic leukemia</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">APE</td><td class="NLM_def"><p class="first last">(2-aminopyrrolidine-1-yl) ethenone</p></td></tr><tr><td class="NLM_term">APL</td><td class="NLM_def"><p class="first last">acute promyelocytic leukemia</p></td></tr><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">androgen receptor</p></td></tr><tr><td class="NLM_term">ARDS</td><td class="NLM_def"><p class="first last">acute respiratory distress syndrome</p></td></tr><tr><td class="NLM_term">ASD</td><td class="NLM_def"><p class="first last">autism spectrum disorder</p></td></tr><tr><td class="NLM_term">ATRA</td><td class="NLM_def"><p class="first last">all-<i>trans</i>-retinoic acid</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">BPD</td><td class="NLM_def"><p class="first last">borderline personality disorder</p></td></tr><tr><td class="NLM_term">CoREST</td><td class="NLM_def"><p class="first last">co-repressor of repressor element-1 silencing transcription factor (REST)</p></td></tr><tr><td class="NLM_term">CSC</td><td class="NLM_def"><p class="first last">cancer stem cells</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450 enzymes</p></td></tr><tr><td class="NLM_term">DIPG</td><td class="NLM_def"><p class="first last">diffuse intrinsic pontine glioma</p></td></tr><tr><td class="NLM_term">E2F1</td><td class="NLM_def"><p class="first last">E2F transcription factor 1</p></td></tr><tr><td class="NLM_term">ERVs</td><td class="NLM_def"><p class="first last">endogenous retroviruses</p></td></tr><tr><td class="NLM_term">ES</td><td class="NLM_def"><p class="first last">Ewing sarcoma</p></td></tr><tr><td class="NLM_term">ET</td><td class="NLM_def"><p class="first last">essential thrombocythemia</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">flavin adenine dinucleotide</p></td></tr><tr><td class="NLM_term">GFI-1B</td><td class="NLM_def"><p class="first last">growth factor independent 1B</p></td></tr><tr><td class="NLM_term">HDACs</td><td class="NLM_def"><p class="first last">histone deacetylases</p></td></tr><tr><td class="NLM_term">HIF1α</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor 1α</p></td></tr><tr><td class="NLM_term">IFN-γ</td><td class="NLM_def"><p class="first last">interferon-γ</p></td></tr><tr><td class="NLM_term">IL-1B</td><td class="NLM_def"><p class="first last">interleukin-1B</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin-6</p></td></tr><tr><td class="NLM_term">ITGAM</td><td class="NLM_def"><p class="first last">integrin alpha M</p></td></tr><tr><td class="NLM_term">JmjC</td><td class="NLM_def"><p class="first last">Jumonji C</p></td></tr><tr><td class="NLM_term">KDM4A/C</td><td class="NLM_def"><p class="first last">histone lysine demethylase 4A/C</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">Lewy body dementia</p></td></tr><tr><td class="NLM_term">LSD1</td><td class="NLM_def"><p class="first last">histone lysine-specific demethylase 1</p></td></tr><tr><td class="NLM_term">LSD2</td><td class="NLM_def"><p class="first last">lysine-specific demethylase 2</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">MDS</td><td class="NLM_def"><p class="first last">myelodysplastic syndromes</p></td></tr><tr><td class="NLM_term">MF</td><td class="NLM_def"><p class="first last">myelofibrosis</p></td></tr><tr><td class="NLM_term">MLL1</td><td class="NLM_def"><p class="first last">mixed lineage leukemia 1</p></td></tr><tr><td class="NLM_term">MPE</td><td class="NLM_def"><p class="first last">(4-methylpiperazine-1-yl) ethenone</p></td></tr><tr><td class="NLM_term">MPNs</td><td class="NLM_def"><p class="first last">myeloproliferative neoplasms</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">MYPT1</td><td class="NLM_def"><p class="first last">myosin phosphatase targeting subunit 1</p></td></tr><tr><td class="NLM_term">NAE</td><td class="NLM_def"><p class="first last">NEDD8-activating enzyme</p></td></tr><tr><td class="NLM_term">OS</td><td class="NLM_def"><p class="first last">overall survival</p></td></tr><tr><td class="NLM_term">p53</td><td class="NLM_def"><p class="first last">protein 53</p></td></tr><tr><td class="NLM_term">PDX</td><td class="NLM_def"><p class="first last">patient-derived xenograft</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">PV</td><td class="NLM_def"><p class="first last">polycythemia vera</p></td></tr><tr><td class="NLM_term">SAMP-8</td><td class="NLM_def"><p class="first last">senescence-accelerated mouse prone 8</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SCLC</td><td class="NLM_def"><p class="first last">small cell lung cancer</p></td></tr><tr><td class="NLM_term">SOX2</td><td class="NLM_def"><p class="first last">SRY (sex-determining region Y)-box 2</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">TBI</td><td class="NLM_def"><p class="first last">traumatic brain injury</p></td></tr><tr><td class="NLM_term">TCP</td><td class="NLM_def"><p class="first last"><i>trans</i>-2-phenylcyclopropylamine</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-alpha</p></td></tr><tr><td class="NLM_term">UCHL1</td><td class="NLM_def"><p class="first last">ubiquitin carboxyl-terminal esterase L1</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 132 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gelato, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischle, W.</span></span> <span> </span><span class="NLM_article-title">Role of histone modifications in defining chromatin structure and function</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1515/BC.2008.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1515%2FBC.2008.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18225984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFait7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=353-363&author=K.+A.+Gelatoauthor=W.+Fischle&title=Role+of+histone+modifications+in+defining+chromatin+structure+and+function&doi=10.1515%2FBC.2008.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of histone modifications in defining chromatin structure and function</span></div><div class="casAuthors">Gelato, Kathy A.; Fischle, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-363</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Chromosomes in eukaryotic cell nuclei are not uniformly organized, but rather contain distinct chromatin elements, with each state having a defined biochem. structure and biol. function.  These are recognizable by their distinct architectures and mol. components, which can change in response to cellular stimuli or metabolic requirements.  Chromatin elements are characterized by the fundamental histone and DNA components, as well as other assocd. non-histone proteins and factors.  Post-translational modifications of histones in particular often correlate with a specific chromatin structure and function.  Patterns of histone modifications are implicated as having a role in directing the level of chromatin compaction, as well as playing roles in multiple functional pathways directing the readout of distinct regions of the genome.  Here, the authors review the properties of various chromatin elements and the apparent links of histone modifications with chromatin organization and functional output.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm8YRKkBO4w7Vg90H21EOLACvtfcHk0lh9kNGCkyft4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFait7s%253D&md5=14b1db5766047ab8201007c5cde0405d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1515%2FBC.2008.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2008.048%26sid%3Dliteratum%253Aachs%26aulast%3DGelato%26aufirst%3DK.%2BA.%26aulast%3DFischle%26aufirst%3DW.%26atitle%3DRole%2520of%2520histone%2520modifications%2520in%2520defining%2520chromatin%2520structure%2520and%2520function%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26spage%3D353%26epage%3D363%26doi%3D10.1515%2FBC.2008.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whetstine, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casero, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Histone demethylation mediated by the nuclear amine oxidase homolog LSD1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.cell.2004.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=15620353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2004&pages=941-953&author=Y.+Shiauthor=F.+Lanauthor=C.+Matsonauthor=P.+Mulliganauthor=J.+R.+Whetstineauthor=P.+A.+Coleauthor=R.+A.+Caseroauthor=Y.+Shi&title=Histone+demethylation+mediated+by+the+nuclear+amine+oxidase+homolog+LSD1&doi=10.1016%2Fj.cell.2004.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Histone demethylation mediated by the nuclear amine oxidase homolog LSD1</span></div><div class="casAuthors">Shi, Yujiang; Lan, Fei; Matson, Caitlin; Mulligan, Peter; Whetstine, Johnathan R.; Cole, Philip A.; Casero, Robert A.; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-953</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Posttranslational modifications of histone N-terminal tails impact chromatin structure and gene transcription.  While the extent of histone acetylation is detd. by both acetyltransferases and deacetylases, it has been unclear whether histone methylation is also regulated by enzymes with opposing activities.  Here, we provide evidence that LSD1 (KIAA0601), a nuclear homolog of amine oxidases, functions as a histone demethylase and transcriptional corepressor.  LSD1 specifically demethylates histone H3 lysine 4, which is linked to active transcription.  Lysine demethylation occurs via an oxidn. reaction that generates formaldehyde.  Importantly, RNAi inhibition of LSD1 causes an increase in H3 lysine 4 methylation and concomitant derepression of target genes, suggesting that LSD1 represses transcription via histone demethylation.  The results thus identify a histone demethylase conserved from S. pombe to human and reveal dynamic regulation of histone methylation by both histone methylases and demethylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXHr-8kwGdXrVg90H21EOLACvtfcHk0lgy-ssERlNA3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlSitg%253D%253D&md5=3474569204255e90a832667ba654748b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DMatson%26aufirst%3DC.%26aulast%3DMulligan%26aufirst%3DP.%26aulast%3DWhetstine%26aufirst%3DJ.%2BR.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DCasero%26aufirst%3DR.%2BA.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DHistone%2520demethylation%2520mediated%2520by%2520the%2520nuclear%2520amine%2520oxidase%2520homolog%2520LSD1%26jtitle%3DCell%26date%3D2004%26volume%3D119%26spage%3D941%26epage%3D953%26doi%3D10.1016%2Fj.cell.2004.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurash, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1038/ng.268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fng.268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=19098913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=125-129&author=J.+Wangauthor=S.+Heviauthor=J.+K.+Kurashauthor=H.+Leiauthor=F.+Gayauthor=J.+Bajkoauthor=H.+Suauthor=W.+Sunauthor=H.+Changauthor=G.+Xuauthor=F.+Gaudetauthor=E.+Liauthor=T.+Chen&title=The+lysine+demethylase+LSD1+%28KDM1%29+is+required+for+maintenance+of+global+DNA+methylation&doi=10.1038%2Fng.268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation</span></div><div class="casAuthors">Wang, Jing; Hevi, Sarah; Kurash, Julia K.; Lei, Hong; Gay, Frederique; Bajko, Jeffrey; Su, Hui; Sun, Weitao; Chang, Hua; Xu, Guoliang; Gaudet, Francois; Li, En; Chen, Taiping</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-129</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone methylation and DNA methylation cooperatively regulate chromatin structure and gene activity.  How these two systems coordinate with each other remains unclear.  Here we study the biol. function of lysine-specific demethylase 1 (LSD1, also known as KDM1 and AOF2), which has been shown to demethylate histone H3 on lysine 4 (H3K4) and lysine 9 (H3K9).  We show that LSD1 is required for gastrulation during mouse embryogenesis.  Notably, targeted deletion of the gene encoding LSD1 (namely, Aof2) in embryonic stem (ES) cells induces progressive loss of DNA methylation.  This loss correlates with a decrease in DNA methyltransferase 1 (Dnmt1) protein, as a result of reduced Dnmt1 stability.  Dnmt1 protein is methylated in vivo, and its methylation is enhanced in the absence of LSD1.  Furthermore, Dnmt1 can be methylated by Set7/9 (also known as KMT7) and demethylated by LSD1 in vitro.  Our findings suggest that LSD1 demethylates and stabilizes Dnmt1, thus providing a previously unknown mechanistic link between the histone and DNA methylation systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSJgebl5_48LVg90H21EOLACvtfcHk0lgy-ssERlNA3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajtbbK&md5=37722ddd4564a79a0cd1c7b148c370d8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fng.268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.268%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHevi%26aufirst%3DS.%26aulast%3DKurash%26aufirst%3DJ.%2BK.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DGay%26aufirst%3DF.%26aulast%3DBajko%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DGaudet%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DThe%2520lysine%2520demethylase%2520LSD1%2520%2528KDM1%2529%2520is%2520required%2520for%2520maintenance%2520of%2520global%2520DNA%2520methylation%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D125%26epage%3D129%26doi%3D10.1038%2Fng.268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espejo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opravil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiekhattar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedford, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenuwein, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. L.</span></span> <span> </span><span class="NLM_article-title">p53 is regulated by the lysine demethylase LSD1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1038/nature06092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fnature06092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=17805299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFWrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2007&pages=105-108&author=J.+Huangauthor=R.+Senguptaauthor=A.+B.+Espejoauthor=M.+G.+Leeauthor=J.+A.+Dorseyauthor=M.+Richterauthor=S.+Opravilauthor=R.+Shiekhattarauthor=M.+T.+Bedfordauthor=T.+Jenuweinauthor=S.+L.+Berger&title=p53+is+regulated+by+the+lysine+demethylase+LSD1&doi=10.1038%2Fnature06092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">p53 is regulated by the lysine demethylase LSD1</span></div><div class="casAuthors">Huang, Jing; Sengupta, Roopsha; Espejo, Alexsandra B.; Lee, Min Gyu; Dorsey, Jean A.; Richter, Mario; Opravil, Susanne; Shiekhattar, Ramin; Bedford, Mark T.; Jenuwein, Thomas; Berger, Shelley L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">7158</span>),
    <span class="NLM_cas:pages">105-108</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P53, the tumor suppressor and transcriptional activator, is regulated by numerous post-translational modifications, including lysine methylation.  Histone lysine methylation has recently been shown to be reversible; however, it is not known whether non-histone proteins are substrates for demethylation.  Here we show that, in human cells, the histone lysine-specific demethylase LSD1 (refs. 3, 4) interacts with p53 to repress p53-mediated transcriptional activation and to inhibit the role of p53 in promoting apoptosis.  We find that, in vitro, LSD1 removes both monomethylation (K370me1) and dimethylation (K370me2) at K370, a previously identified Smyd2-dependent monomethylation site.  However, in vivo, LSD1 shows a strong preference to reverse K370me2, which is performed by a distinct, but unknown, methyltransferase.  Our results indicate that K370me2 has a different role in regulating p53 from that of K370me1: K370me1 represses p53 function, whereas K370me2 promotes assocn. with the coactivator 53BP1 (p53-binding protein 1) through tandem Tudor domains in 53BP1.  Further, LSD1 represses p53 function through the inhibition of interaction of p53 with 53BP1.  These observations show that p53 is dynamically regulated by lysine methylation and demethylation and that the methylation status at a single lysine residue confers distinct regulatory output.  Lysine methylation therefore provides similar regulatory complexity for non-histone proteins and for histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ggpbeqDqsbVg90H21EOLACvtfcHk0lhaD1LgLFbm7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFWrs7w%253D&md5=8bf23f859f97d21bf7008a6d6e1c4946</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature06092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06092%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSengupta%26aufirst%3DR.%26aulast%3DEspejo%26aufirst%3DA.%2BB.%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DDorsey%26aufirst%3DJ.%2BA.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DOpravil%26aufirst%3DS.%26aulast%3DShiekhattar%26aufirst%3DR.%26aulast%3DBedford%26aufirst%3DM.%2BT.%26aulast%3DJenuwein%26aufirst%3DT.%26aulast%3DBerger%26aufirst%3DS.%2BL.%26atitle%3Dp53%2520is%2520regulated%2520by%2520the%2520lysine%2520demethylase%2520LSD1%26jtitle%3DNature%26date%3D2007%26volume%3D449%26spage%3D105%26epage%3D108%26doi%3D10.1038%2Fnature06092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohmae, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokawa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurash, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamoto, R.</span></span> <span> </span><span class="NLM_article-title">Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-2446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F0008-5472.CAN-10-2446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=21115810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=655-660&author=H.+S.+Choauthor=T.+Suzukiauthor=N.+Dohmaeauthor=S.+Hayamiauthor=M.+Unokiauthor=M.+Yoshimatsuauthor=G.+Toyokawaauthor=M.+Takawaauthor=T.+Chenauthor=J.+K.+Kurashauthor=H.+I.+Fieldauthor=B.+A.+Ponderauthor=Y.+Nakamuraauthor=R.+Hamamoto&title=Demethylation+of+RB+regulator+MYPT1+by+histone+demethylase+LSD1+promotes+cell+cycle+progression+in+cancer+cells&doi=10.1158%2F0008-5472.CAN-10-2446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Demethylation of RB Regulator MYPT1 by Histone Demethylase LSD1 Promotes Cell Cycle Progression in Cancer Cells</span></div><div class="casAuthors">Cho, Hyun-Soo; Suzuki, Takehiro; Dohmae, Naoshi; Hayami, Shinya; Unoki, Motoko; Yoshimatsu, Masanori; Toyokawa, Gouji; Takawa, Masashi; Chen, Taiping; Kurash, Julia K.; Field, Helen I.; Ponder, Bruce A. J.; Nakamura, Yusuke; Hamamoto, Ryuji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">655-660</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Histone demethylase LSD1 (also known as KDM1 and AOF2) is active in various cancer cells, but its biol. significance in human carcinogenesis is unexplored.  In this study, we explored hypothesized interactions between LSD1 and MYPT1, a known regulator of RB1 phosphorylation.  We found that MYPT1 was methylated in vitro and in vivo by histone lysine methyltransferase SETD7 and demethylated by LSD1, identifying Lys 442 of MYPT1 as a target for methylation/demethylation by these enzymes.  LSD1 silencing increased MYPT1 protein levels, decreasing the steady state level of phosphorylated RB1 (Ser 807/811) and reducing E2F activity.  MYPT1 methylation status influenced the affinity of MYPT1 for the ubiquitin-proteasome pathway of protein turnover.  MYPT1 was unstable in murine cells deficient in SETD7, supporting the concept that MYPT1 protein stability is physiol. regulated by methylation status.  LSD1 overexpression could activate RB1 phosphorylation by inducing a destabilization of MYPT1 protein.  Taken together, our results comprise a novel cell cycle regulatory mechanism mediated by methylation/demethylation dynamics, and they reveal the significance of LSD1 overexpression in human carcinogenesis.  Cancer Res; 71(3); 655-60.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh4fxBs2QNSrVg90H21EOLACvtfcHk0lhaD1LgLFbm7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCis7c%253D&md5=4812d562b79453755b7c2eb8f74cc3eb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-2446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-2446%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DHayami%26aufirst%3DS.%26aulast%3DUnoki%26aufirst%3DM.%26aulast%3DYoshimatsu%26aufirst%3DM.%26aulast%3DToyokawa%26aufirst%3DG.%26aulast%3DTakawa%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DKurash%26aufirst%3DJ.%2BK.%26aulast%3DField%26aufirst%3DH.%2BI.%26aulast%3DPonder%26aufirst%3DB.%2BA.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DHamamoto%26aufirst%3DR.%26atitle%3DDemethylation%2520of%2520RB%2520regulator%2520MYPT1%2520by%2520histone%2520demethylase%2520LSD1%2520promotes%2520cell%2520cycle%2520progression%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D655%26epage%3D660%26doi%3D10.1158%2F0008-5472.CAN-10-2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talianidis, I.</span></span> <span> </span><span class="NLM_article-title">Lysine methylation regulates E2F1-induced cell death</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.molcel.2010.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=20603083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFejs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=152-160&author=H.+Kontakiauthor=I.+Talianidis&title=Lysine+methylation+regulates+E2F1-induced+cell+death&doi=10.1016%2Fj.molcel.2010.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine methylation regulates E2F1-induced cell death</span></div><div class="casAuthors">Kontaki, Haroula; Talianidis, Iannis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-160</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone-modifying enzymes can regulate DNA damage-induced apoptosis through modulation of p53 function.  Here, we show that, in p53-deficient tumor cells, Set9 and LSD1 regulate DNA damage-induced cell death in a manner opposite to that obsd. in p53+/+ cells, via modulation of E2F1 stabilization.  Set9 methylates E2F1 at lysine-185, which prevents E2F1 accumulation during DNA damage and activation of its proapoptotic target gene p73.  This Me mark is removed by LSD1, which is required for E2F1 stabilization and apoptotic function.  The mol. mechanism involves cross-talks between Lys methylation and other covalent modifications that affect E2F1 stability.  Methylation at Lys-185 inhibits acetylation and phosphorylation at distant positions and, in parallel, stimulates ubiquitination and degrdn. of the protein.  The findings illustrate that the function of methyltransferases can have opposing biol. outcomes depending on the specificity of transcription factor targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXEj98lICfQ7Vg90H21EOLACvtfcHk0lhaD1LgLFbm7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFejs7w%253D&md5=12b34f33cde33be3f37a53f8115aecde</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DKontaki%26aufirst%3DH.%26aulast%3DTalianidis%26aufirst%3DI.%26atitle%3DLysine%2520methylation%2520regulates%2520E2F1-induced%2520cell%2520death%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D39%26spage%3D152%26epage%3D160%26doi%3D10.1016%2Fj.molcel.2010.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chance, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, G. R.</span></span> <span> </span><span class="NLM_article-title">Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">21499</span>– <span class="NLM_lpage">21504</span>, <span class="refDoi"> DOI: 10.1073/pnas.1016147107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1016147107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=21098664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WisL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=21499-21504&author=J.+Yangauthor=J.+Huangauthor=M.+Dasguptaauthor=N.+Searsauthor=M.+Miyagiauthor=B.+Wangauthor=M.+R.+Chanceauthor=X.+Chenauthor=Y.+Duauthor=Y.+Wangauthor=L.+Anauthor=Q.+Wangauthor=T.+Luauthor=X.+Zhangauthor=Z.+Wangauthor=G.+R.+Stark&title=Reversible+methylation+of+promoter-bound+STAT3+by+histone-modifying+enzymes&doi=10.1073%2Fpnas.1016147107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes</span></div><div class="casAuthors">Yang, Jinbo; Huang, Jing; Dasgupta, Maupali; Sears, Nathan; Miyagi, Masaru; Wang, Benlian; Chance, Mark R.; Chen, Xing; Du, Yuping; Wang, Yuxin; An, Lizhe; Wang, Qin; Lu, Tao; Zhang, Xiaodong; Wang, Zhenghe; Stark, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">21499-21504, S21499/1-S21499/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Following its tyrosine phosphorylation, STAT3 is methylated on K140 by the histone Me transferase SET9 and demethylated by LSD1 when it is bound to a subset of the promoters that it activates.  Methylation of K140 is a neg. regulatory event, because its blockade greatly increases the steady-state amt. of activated STAT3 and the expression of many (i.e., SOCS3) but not all (i.e., CD14) STAT3 target genes.  Biol. relevance is shown by the observation that overexpression of SOCS3 when K140 cannot be methylated blocks the ability of cells to activate STAT3 in response to IL-6.  K140 methylation does not occur with mutants of STAT3 that do not enter nuclei or bind to DNA.  Following treatment with IL-6, events at the SOCS3 promoter occur in an ordered sequence, as shown by chromatin immunopptns.  Y705-phosphoryl-STAT3 binds first and S727 is then phosphorylated, followed by the coincident binding of SET9 and dimethylation of K140, and lastly by the binding of LSD1.  We conclude that the lysine methylation of promoter-bound STAT3 leads to biol. important down-regulation of the dependent responses and that SET9, which is known to help provide an activating methylation mark to H3K4, is recruited to the newly activated SOCS3 promoter by STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTNJmJCGOKwbVg90H21EOLACvtfcHk0ljEltssLbMFgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WisL%252FM&md5=255afed29b2b72fde8e2baf3d09a85dd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1016147107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1016147107%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDasgupta%26aufirst%3DM.%26aulast%3DSears%26aufirst%3DN.%26aulast%3DMiyagi%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DChance%26aufirst%3DM.%2BR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DStark%26aufirst%3DG.%2BR.%26atitle%3DReversible%2520methylation%2520of%2520promoter-bound%2520STAT3%2520by%2520histone-modifying%2520enzymes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D21499%26epage%3D21504%26doi%3D10.1073%2Fpnas.1016147107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croce, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, G.</span></span> <span> </span><span class="NLM_article-title">LSD1 demethylates HIF1alpha to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5512</span>– <span class="NLM_lpage">5521</span>, <span class="refDoi"> DOI: 10.1038/onc.2017.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fonc.2017.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28534506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyltLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=5512-5521&author=J.+Y.+Leeauthor=J.+H.+Parkauthor=H.+J.+Choiauthor=H.+Y.+Wonauthor=H.+S.+Jooauthor=D.+H.+Shinauthor=M.+K.+Parkauthor=B.+Hanauthor=K.+P.+Kimauthor=T.+J.+Leeauthor=C.+M.+Croceauthor=G.+Kong&title=LSD1+demethylates+HIF1alpha+to+inhibit+hydroxylation+and+ubiquitin-mediated+degradation+in+tumor+angiogenesis&doi=10.1038%2Fonc.2017.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis</span></div><div class="casAuthors">Lee, J-Y.; Park, J-H.; Choi, H-J.; Won, H-Y.; Joo, H-s; Shin, D-H.; Park, M. K.; Han, B.; Kim, K. P.; Lee, T. J.; Croce, C. M.; Kong, G.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5512-5521</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1), which has been considered as a potential therapeutic target in human cancer, has been known to regulate many biol. functions through its non-histone substrates.  Although LSD1-induced hypoxia-inducible factor alpha (HIF1α) demethylation has recently been proposed, the effect of LSD1 on the relationship between HIF1α post-translational modifications (PTMs) and HIF1α-induced tumor angiogenesis remains to be elucidated.  Here, we identify a new methylation site of the HIF1α protein antagonized by LSD1 and the interplay between HIF1α protein methylation and other PTMs in regulating tumor angiogenesis.  LSD1 demethylates HIF1α at lysine (K) 391, which protects HIF1α against ubiquitin-mediated protein degrdn.  LSD1 also directly suppresses PHD2-induced HIF1α hydroxylation, which has a mutually dependent interplay with Set9-mediated HIF1α methylation.  Moreover, the HIF1α acetylation that occurs in a HIF1α methylation-dependent manner is inhibited by the LSD1/NuRD complex.  HIF1α stabilized by LSD1 cooperates with CBP and MTA1 to enhance vascular endothelial growth factor (VEGF)-induced tumor angiogenesis.  Thus, LSD1 is a key regulator of HIF1α/VEGF-mediated tumor angiogenesis by antagonizing the crosstalk between PTMs involving HIF1α protein degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtgPa519Y26LVg90H21EOLACvtfcHk0ljPu9HFpRBOHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyltLvP&md5=99c96e8bcb4b3616e89961facf9602ea</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fonc.2017.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2017.158%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DWon%26aufirst%3DH.%2BY.%26aulast%3DJoo%26aufirst%3DH.%2BS.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DPark%26aufirst%3DM.%2BK.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DK.%2BP.%26aulast%3DLee%26aufirst%3DT.%2BJ.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DKong%26aufirst%3DG.%26atitle%3DLSD1%2520demethylates%2520HIF1alpha%2520to%2520inhibit%2520hydroxylation%2520and%2520ubiquitin-mediated%2520degradation%2520in%2520tumor%2520angiogenesis%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D5512%26epage%3D5521%26doi%3D10.1038%2Fonc.2017.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirfel, J.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1093%2Fcarcin%2Fbgp324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=20042638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFGmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=512-520&author=S.+Limauthor=A.+Janzerauthor=A.+Beckerauthor=A.+Zimmerauthor=R.+Schuleauthor=R.+Buettnerauthor=J.+Kirfel&title=Lysine-specific+demethylase+1+%28LSD1%29+is+highly+expressed+in+ER-negative+breast+cancers+and+a+biomarker+predicting+aggressive+biology&doi=10.1093%2Fcarcin%2Fbgp324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology</span></div><div class="casAuthors">Lim, Soyoung; Janzer, Andreas; Becker, Astrid; Zimmer, Andreas; Schuele, Roland; Buettner, Reinhard; Kirfel, Jutta</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">512-520</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Breast carcinogenesis is a multistep process involving both genetic and epigenetic changes.  Since epigenetic changes like histone modifications are potentially reversible processes, much effort has been directed toward understanding this mechanism with the goal of finding novel therapies as well as more refined diagnostic and prognostic tools in breast cancer.  Lysine-specific demethylase 1 (LSD1) plays a key role in the regulation of gene expression by removing the Me groups from methylated lysine 4 of histone H3 and lysine 9 of histone H3.  LSD1 is essential for mammalian development and involved in many biol. processes.  Considering recent evidence that LSD1 is involved in carcinogenesis, we investigated the role of LSD1 in breast cancer.  Therefore, we developed an ELISA to det. LSD1 protein levels in tissue specimens of breast cancer and measured very high LSD1 levels in estrogen receptor (ER)-neg. tumors.  Pharmacol. LSD1 inhibition resulted in growth inhibition of breast cancer cells.  Knockdown of LSD1 using small interfering RNA approach induced regulation of several proliferation-assocd. genes like p21, ERBB2 and CCNA2.  Addnl., we found that LSD1 is recruited to the promoters of these genes.  In summary, our data indicate that LSD1 may provide a predictive marker for aggressive biol. and a novel attractive therapeutic target for treatment of ER-neg. breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeX6QvvaygFLVg90H21EOLACvtfcHk0ljPu9HFpRBOHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFGmsrw%253D&md5=b94c60b52c6a440d71cdf5a8007ea97b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp324%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%26aulast%3DJanzer%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DKirfel%26aufirst%3DJ.%26atitle%3DLysine-specific%2520demethylase%25201%2520%2528LSD1%2529%2520is%2520highly%2520expressed%2520in%2520ER-negative%2520breast%2520cancers%2520and%2520a%2520biomarker%2520predicting%2520aggressive%2520biology%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D512%26epage%3D520%26doi%3D10.1093%2Fcarcin%2Fbgp324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span> <span> </span><span class="NLM_article-title">LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.cell.2009.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=19703393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCjs73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2009&pages=660-672&author=Y.+Wangauthor=H.+Zhangauthor=Y.+Chenauthor=Y.+Sunauthor=F.+Yangauthor=W.+Yuauthor=J.+Liangauthor=L.+Sunauthor=X.+Yangauthor=L.+Shiauthor=R.+Liauthor=Y.+Liauthor=Y.+Zhangauthor=Q.+Liauthor=X.+Yiauthor=Y.+Shang&title=LSD1+is+a+subunit+of+the+NuRD+complex+and+targets+the+metastasis+programs+in+breast+cancer&doi=10.1016%2Fj.cell.2009.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer</span></div><div class="casAuthors">Wang, Yan; Zhang, Hua; Chen, Yupeng; Sun, Yimin; Yang, Fen; Yu, Wenhua; Liang, Jing; Sun, Luyang; Yang, Xiaohan; Shi, Lei; Li, Ruifang; Li, Yanyan; Zhang, Yu; Li, Qian; Yi, Xia; Shang, Yongfeng</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) exerts pathway-specific activity in animal development and has been linked to several high-risk cancers.  Here, we report that LSD1 is an integral component of the Mi-2/nucleosome remodeling and deacetylase (NuRD) complex.  Transcriptional target anal. revealed that the LSD1/NuRD complexes regulate several cellular signaling pathways including TGFβ1 signaling pathway that are critically involved in cell proliferation, survival, and epithelial-to-mesenchymal transition.  We demonstrated that LSD1 inhibits the invasion of breast cancer cells in vitro and suppresses breast cancer metastatic potential in vivo.  We found that LSD1 is downregulated in breast carcinomas and that its level of expression is neg. correlated with that of TGFβ1.  Our data provide a mol. basis for the interplay of histone demethylation and deacetylation in chromatin remodeling.  By enlisting LSD1, the NuRD complex expands its chromatin remodeling capacity to include ATPase, histone deacetylase, and histone demethylase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngSfM5Ree9LVg90H21EOLACvtfcHk0ljmVAfazn8bBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCjs73F&md5=5b62ee7d574671b5cda39a2d173b8491</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYi%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DY.%26atitle%3DLSD1%2520is%2520a%2520subunit%2520of%2520the%2520NuRD%2520complex%2520and%2520targets%2520the%2520metastasis%2520programs%2520in%2520breast%2520cancer%26jtitle%3DCell%26date%3D2009%26volume%3D138%26spage%3D660%26epage%3D672%26doi%3D10.1016%2Fj.cell.2009.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrichs, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koster, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versteeg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajtler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein-Hitpass, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhfittig-Kulle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schüle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirfel, J.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2071</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-1735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F0008-5472.CAN-08-1735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=19223552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFSruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2065-2071&author=J.+H.+Schulteauthor=S.+Limauthor=A.+Schrammauthor=N.+Friedrichsauthor=J.+Kosterauthor=R.+Versteegauthor=I.+Oraauthor=K.+Pajtlerauthor=L.+Klein-Hitpassauthor=S.+Kuhfittig-Kulleauthor=E.+Metzgerauthor=R.+Sch%C3%BCleauthor=A.+Eggertauthor=R.+Buettnerauthor=J.+Kirfel&title=Lysine-specific+demethylase+1+is+strongly+expressed+in+poorly+differentiated+neuroblastoma%3A+implications+for+therapy&doi=10.1158%2F0008-5472.CAN-08-1735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: Implications for therapy</span></div><div class="casAuthors">Schulte, Johannes H.; Lim, Soyoung; Schramm, Alexander; Friedrichs, Nicolaus; Koster, Jan; Versteeg, Rogier; Ora, Ingrid; Pajtler, Kristian; Klein-Hitpass, Ludger; Kuhfittig-Kulle, Steffi; Metzger, Eric; Schuele, Roland; Eggert, Angelika; Buettner, Reinhard; Kirfel, Jutta</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2065-2071</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant epigenetic changes in DNA methylation and histone acetylation are hallmarks of most cancers, whereas histone methylation was previously considered to be irreversible and less versatile.  Recently, several histone demethylases were identified catalyzing the removal of Me groups from histone H3 lysine residues and thereby influencing gene expression.  Neuroblastomas continue to remain a clin. challenge despite advances in multimodal therapy.  Here, we address the functional significance of the chromatin-modifying enzyme lysine-specific demethylase 1 (LSD1) in neuroblastoma.  LSD1 expression correlated with adverse outcome and was inversely correlated with differentiation in neuroblastic tumors.  Differentiation of neuroblastoma cells resulted in down-regulation of LSD1.  Small interfering RNA-mediated knockdown of LSD1 decreased cellular growth, induced expression of differentiation-assocd. genes, and increased target gene-specific H3K4 methylation.  Moreover, LSD1 inhibition using monoamine oxidase inhibitors resulted in an increase of global H3K4 methylation and growth inhibition of neuroblastoma cells in vitro.  Finally, targeting LSD1 reduced neuroblastoma xenograft growth in vivo.  Here, we provide the first evidence that a histone demethylase, LSD1, is involved in maintaining the undifferentiated, malignant phenotype of neuroblastoma cells.  We show that inhibition of LSD1 reprograms the transcriptome of neuroblastoma cells and inhibits neuroblastoma xenograft growth.  Our results suggest that targeting histone demethylases may provide a novel option for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjmZreB7Q67Vg90H21EOLACvtfcHk0lgTsS1Kfw3E4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFSruro%253D&md5=4118d7f651c8abf8c32e296cc0030656</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-1735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-1735%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DJ.%2BH.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DSchramm%26aufirst%3DA.%26aulast%3DFriedrichs%26aufirst%3DN.%26aulast%3DKoster%26aufirst%3DJ.%26aulast%3DVersteeg%26aufirst%3DR.%26aulast%3DOra%26aufirst%3DI.%26aulast%3DPajtler%26aufirst%3DK.%26aulast%3DKlein-Hitpass%26aufirst%3DL.%26aulast%3DKuhfittig-Kulle%26aufirst%3DS.%26aulast%3DMetzger%26aufirst%3DE.%26aulast%3DSch%25C3%25BCle%26aufirst%3DR.%26aulast%3DEggert%26aufirst%3DA.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DKirfel%26aufirst%3DJ.%26atitle%3DLysine-specific%2520demethylase%25201%2520is%2520strongly%2520expressed%2520in%2520poorly%2520differentiated%2520neuroblastoma%253A%2520implications%2520for%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D2065%26epage%3D2071%26doi%3D10.1158%2F0008-5472.CAN-08-1735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takezawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, S.</span></span> <span> </span><span class="NLM_article-title">Transrepressive function of TLX requires the histone demethylase LSD1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3995</span>– <span class="NLM_lpage">4003</span>, <span class="refDoi"> DOI: 10.1128/MCB.02030-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1128%2FMCB.02030-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18391013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFanu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3995-4003&author=A.+Yokoyamaauthor=S.+Takezawaauthor=R.+Schuleauthor=H.+Kitagawaauthor=S.+Kato&title=Transrepressive+function+of+TLX+requires+the+histone+demethylase+LSD1&doi=10.1128%2FMCB.02030-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Transrepressive function of TLX requires the histone demethylase LSD1</span></div><div class="casAuthors">Yokoyama, Atsushi; Takezawa, Shinichiro; Schule, Roland; Kitagawa, Hirochika; Kato, Shigeaki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3995-4003</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">TLX is an orphan nuclear receptor (also called NR2E1) that regulates the expression of target genes by functioning as a constitutive transrepressor.  The physiol. significance of TLX in the cytodifferentiation of neural cells in the brain is known.  However, the corepressors supporting the transrepressive function of TLX have yet to be identified.  In this report, Y79 retinoblastoma cells were subjected to biochem. techniques to purify proteins that interact with TLX, and we identified LSD1 (also called KDM1), which appears to form a complex with CoREST and histone deacetylase 1.  LSD1 interacted with TLX directly through its SWIRM and amine oxidase domains.  LSD1 potentiated the transrepressive function of TLX through its histone demethylase activity as detd. by a luciferase assay using a genomically integrated reporter gene.  LSD1 and TLX were recruited to a TLX-binding site in the PTEN gene promoter, accompanied by the demethylation of H3K4me2 and deacetylation of H3.  Knockdown of either TLX or LSD1 derepressed expression of the endogenous PTEN gene and inhibited cell proliferation of Y79 cells.  Thus, the present study suggests that LSD1 is a prime corepressor for TLX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_Td2RFe3A7Vg90H21EOLACvtfcHk0lgTsS1Kfw3E4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFanu74%253D&md5=a415eb96d627b7b5de33d2341ea578ed</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.02030-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.02030-07%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DA.%26aulast%3DTakezawa%26aufirst%3DS.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DKitagawa%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DS.%26atitle%3DTransrepressive%2520function%2520of%2520TLX%2520requires%2520the%2520histone%2520demethylase%2520LSD1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D3995%26epage%3D4003%26doi%3D10.1128%2FMCB.02030-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jandausch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forne, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirfel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span> <span> </span><span class="NLM_article-title">Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">2704</span>– <span class="NLM_lpage">2709</span>, <span class="refDoi"> DOI: 10.1002/ijc.27555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fijc.27555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=22447389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlSis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=2704-2709&author=D.+Willmannauthor=S.+Limauthor=S.+Wetzelauthor=E.+Metzgerauthor=A.+Jandauschauthor=W.+Wilkauthor=M.+Jungauthor=I.+Forneauthor=A.+Imhofauthor=A.+Janzerauthor=J.+Kirfelauthor=H.+Waldmannauthor=R.+Schuleauthor=R.+Buettner&title=Impairment+of+prostate+cancer+cell+growth+by+a+selective+and+reversible+lysine-specific+demethylase+1+inhibitor&doi=10.1002%2Fijc.27555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor</span></div><div class="casAuthors">Willmann, Dominica; Lim, Soyoung; Wetzel, Stefan; Metzger, Eric; Jandausch, Anett; Wilk, Wolfram; Jung, Manfred; Forne, Ignasi; Imhof, Axel; Janzer, Andreas; Kirfel, Jutta; Waldmann, Herbert; Schuele, Roland; Buettner, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2704-2709</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Post-translational modifications of histones by chromatin modifying enzymes regulate chromatin structure and gene expression.  As deregulation of histone modifications contributes to cancer progression, inhibition of chromatin modifying enzymes such as histone demethylases is an attractive therapeutic strategy to impair cancer growth.  Lysine-specific demethylase 1 (LSD1) removes mono- and di-Me marks from lysine 4 or 9 of histone H3.  LSD1 in assocn. with the androgen receptor (AR) controls androgen-dependent gene expression and prostate tumor cell proliferation, thus highlighting LSD1 as a drug target.  By combining protein structure similarity clustering and in vitro screening, we identified Namoline, a γ-pyrone, as a novel, selective and reversible LSD1 inhibitor.  Namoline blocks LSD1 demethylase activity in vitro and in vivo.  Inhibition of LSD1 by Namoline leads to silencing of AR-regulated gene expression and severely impairs androgen-dependent proliferation in vitro and in vivo.  Thus, Namoline is a novel promising starting compd. for the development of therapeutics to treat androgen-dependent prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKxYi0f1zoOrVg90H21EOLACvtfcHk0lilnrEXG6W-Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlSis78%253D&md5=3104057823357b199b635e1a22071b2a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fijc.27555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27555%26sid%3Dliteratum%253Aachs%26aulast%3DWillmann%26aufirst%3DD.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DMetzger%26aufirst%3DE.%26aulast%3DJandausch%26aufirst%3DA.%26aulast%3DWilk%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DForne%26aufirst%3DI.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DJanzer%26aufirst%3DA.%26aulast%3DKirfel%26aufirst%3DJ.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DBuettner%26aufirst%3DR.%26atitle%3DImpairment%2520of%2520prostate%2520cancer%2520cell%2520growth%2520by%2520a%2520selective%2520and%2520reversible%2520lysine-specific%2520demethylase%25201%2520inhibitor%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D131%26spage%3D2704%26epage%3D2709%26doi%3D10.1002%2Fijc.27555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helczynski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudas, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mongan, N. P.</span></span> <span> </span><span class="NLM_article-title">The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2013.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.molonc.2013.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=23384557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVGnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=555-566&author=V.+Kashyapauthor=S.+Ahmadauthor=E.+M.+Nilssonauthor=L.+Helczynskiauthor=S.+Kennaauthor=J.+L.+Perssonauthor=L.+J.+Gudasauthor=N.+P.+Mongan&title=The+lysine+specific+demethylase-1+%28LSD1%2FKDM1A%29+regulates+VEGF-A+expression+in+prostate+cancer&doi=10.1016%2Fj.molonc.2013.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer</span></div><div class="casAuthors">Kashyap, Vasundhra; Ahmad, Shafqat; Nilsson, Emeli M.; Helczynski, Leszek; Kenna, Sinead; Persson, Jenny Liao; Gudas, Lorraine J.; Mongan, Nigel P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">555-566</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-7891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recurrent prostate cancer remains a major clin. challenge.  The lysine specific demethylase-1 (LSD1/KDM1A), together with the JmjC domain-contg. JMJD2A and JMJD2C proteins, have emerged as crit. regulators of histone lysine methylation.  The LSD1-JMJD2 complex functions as a transcriptional co-regulator of hormone activated androgen and estrogen receptors at specific gene promoters.  LSD1 also regulates DNA methylation and p53 function.  LSD1 is overexpressed in numerous cancers including prostate cancer through an unknown mechanism.  We investigated expression of the LSD1 and JMJD2A in malignant human prostate specimens.  We correlated LSD1 and JMJD2A expression with known mediators of prostate cancer progression: VEGF-A and cyclin A1.  We show that elevated expression of LSD1, but not JMJD2A, correlates with prostate cancer recurrence and with increased VEGF-A expression.  We show that functional depletion of LSD1 expression using siRNA in prostate cancer cells decreases VEGF-A and blocks androgen induced VEGF-A, PSA and Tmprss2 expression.  We demonstrate that pharmacol. inhibition of LSD1 reduces proliferation of both androgen dependent (LnCaP) and independent cell lines (LnCaP: C42, PC3).  We show a direct mechanistic link between LSD1 over-expression and increased activity of pro-angiogenic pathways.  New therapies targeting LSD1 activity should be useful in the treatment of hormone dependent and independent prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy47FR2bqB4LVg90H21EOLACvtfcHk0lilnrEXG6W-Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVGnurw%253D&md5=a77d7c25e03a603046e30cdc1c092c98</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2013.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2013.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DKashyap%26aufirst%3DV.%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DE.%2BM.%26aulast%3DHelczynski%26aufirst%3DL.%26aulast%3DKenna%26aufirst%3DS.%26aulast%3DPersson%26aufirst%3DJ.%2BL.%26aulast%3DGudas%26aufirst%3DL.%2BJ.%26aulast%3DMongan%26aufirst%3DN.%2BP.%26atitle%3DThe%2520lysine%2520specific%2520demethylase-1%2520%2528LSD1%252FKDM1A%2529%2520regulates%2520VEGF-A%2520expression%2520in%2520prostate%2520cancer%26jtitle%3DMol.%2520Oncol.%26date%3D2013%26volume%3D7%26spage%3D555%26epage%3D566%26doi%3D10.1016%2Fj.molonc.2013.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ketscher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jilg, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span> <span> </span><span class="NLM_article-title">LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e120</span> <span class="refDoi"> DOI: 10.1038/oncsis.2014.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Foncsis.2014.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25285406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSrtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&author=A.+Ketscherauthor=C.+A.+Jilgauthor=D.+Willmannauthor=B.+Hummelauthor=A.+Imhofauthor=V.+Russelerauthor=S.+Holzauthor=E.+Metzgerauthor=J.+M.+Mullerauthor=R.+Schule&title=LSD1+controls+metastasis+of+androgen-independent+prostate+cancer+cells+through+PXN+and+LPAR6&doi=10.1038%2Foncsis.2014.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6</span></div><div class="casAuthors">Ketscher, A.; Jilg, C. A.; Willmann, D.; Hummel, B.; Imhof, A.; Ruesseler, V.; Hoelz, S.; Metzger, E.; Mueller, J. M.; Schuele, R.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e120</span>CODEN:
                <span class="NLM_cas:coden">ONCOCT</span>;
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) was shown to control gene expression and cell proliferation of androgen-dependent prostate cancer (PCa) cells, whereas the role of LSD1 in androgen-independent metastatic prostate cancer remains elusive.  Here, we show that depletion of LSD1 leads to increased migration and invasion of androgen-independent PCa cells.  Transcriptome and cistrome analyses reveal that LSD1 regulates expression of lysophosphatidic acid receptor 6 (LPAR6) and cytoskeletal genes including the focal adhesion adaptor protein paxillin (PXN).  Enhanced LPAR6 signalling upon LSD1 depletion promotes migration with concomitant phosphorylation of PXN.  In mice LPAR6 overexpression enhances, whereas knockdown of LPAR6 abolishes metastasis of androgen-independent PCa cells.  Taken together, we uncover a novel mechanism of how LSD1 controls metastasis and identify LPAR6 as a promising therapeutic target to treat metastatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0AuIBVSe1xrVg90H21EOLACvtfcHk0liwWXID45LKDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSrtrnJ&md5=9dbae5b23a0744f6f2df84dc9d3af7d0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2014.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2014.34%26sid%3Dliteratum%253Aachs%26aulast%3DKetscher%26aufirst%3DA.%26aulast%3DJilg%26aufirst%3DC.%2BA.%26aulast%3DWillmann%26aufirst%3DD.%26aulast%3DHummel%26aufirst%3DB.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DRusseler%26aufirst%3DV.%26aulast%3DHolz%26aufirst%3DS.%26aulast%3DMetzger%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DJ.%2BM.%26aulast%3DSchule%26aufirst%3DR.%26atitle%3DLSD1%2520controls%2520metastasis%2520of%2520androgen-independent%2520prostate%2520cancer%2520cells%2520through%2520PXN%2520and%2520LPAR6%26jtitle%3DOncogenesis%26date%3D2014%26volume%3D3%26doi%3D10.1038%2Foncsis.2014.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Irreversible LSD1 Inhibitors: Application of tranylcypromine and its derivatives in cancer treatment</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2179</span>– <span class="NLM_lpage">2188</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160216154042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.2174%2F1568026616666160216154042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=26881714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVahtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2179-2188&author=Y.+C.+Zhengauthor=B.+Yuauthor=G.+Z.+Jiangauthor=X.+J.+Fengauthor=P.+X.+Heauthor=X.+Y.+Chuauthor=W.+Zhaoauthor=H.+M.+Liu&title=Irreversible+LSD1+Inhibitors%3A+Application+of+tranylcypromine+and+its+derivatives+in+cancer+treatment&doi=10.2174%2F1568026616666160216154042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment</span></div><div class="casAuthors">Zheng, Yi C.; Yu, Bin; Jiang, Guo Z.; Feng, Xue J.; He, Peng X.; Chu, Xiao Y.; Zhao, Wen; Liu, Hong M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2179-2188</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Due to the increasing costs and time consuming for new drug discovery, a large no. of pharmaceutical firms have chosen to modify the existing drug mols. for repositioning candidates with new or improved properties, esp. those with severe adverse effects, thereby accelerating the drug discovery process.  Such strategy has witnessed its success with several examples reported.  As the first identified histone lysine specific demethylase, lysine specific demethylase 1 (LSD1) is classified as a member of monoamine oxidase (MAO) superfamily, and specifically removes mono- and dimethylated histone 3 lysine 4 (H3K4) and H3 lysine 9 (H3K9).  It has been reported that LSD1 and its downstream targets are involved in cancer cell growth and metastasis.  Meanwhile, it is overexpressed in a variety of tumor cells.  Inactivating LSD1 specifically inhibits tumor progression and metastasis.  Hence, LSD1 inhibition may represent a new and promising direction in anti-cancer drug discovery.  Based on the structure and cofactor of LSD1, some clin. applied MAO inhibitors have been identified as LSD1 inactivators.  Among them, tranylcypromine presented the most potency against LSD1 and its derivs. were further developed by medicinal chemists in order to develop potent and selective LSD1 inhibitors.  Currently, a no. of tranylcypromine based LSD1 inhibitors have been developed and two of them, ORY-1001 and GSK2879552, are in clin. trials for cancer treatment.  This review highlights recent advances in the repurposing of tranylcypromine and its derivs. as irreversible LSD1 inhibitors for cancer treatment, which are conventionally used for the treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjwBd-ReWHu7Vg90H21EOLACvtfcHk0liwWXID45LKDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVahtb8%253D&md5=81b0fdfba4e6cea3636b70de73c246ce</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160216154042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160216154042%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DG.%2BZ.%26aulast%3DFeng%26aufirst%3DX.%2BJ.%26aulast%3DHe%26aufirst%3DP.%2BX.%26aulast%3DChu%26aufirst%3DX.%2BY.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DIrreversible%2520LSD1%2520Inhibitors%253A%2520Application%2520of%2520tranylcypromine%2520and%2520its%2520derivatives%2520in%2520cancer%2520treatment%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2179%26epage%3D2188%26doi%3D10.2174%2F1568026616666160216154042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Recent progress in histone demethylase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01758</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyrtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1308-1329&author=T.+E.+McAllisterauthor=K.+S.+Englandauthor=R.+J.+Hopkinsonauthor=P.+E.+Brennanauthor=A.+Kawamuraauthor=C.+J.+Schofield&title=Recent+progress+in+histone+demethylase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in Histone Demethylase Inhibitors</span></div><div class="casAuthors">McAllister, Tom E.; England, Katherine S.; Hopkinson, Richard J.; Brennan, Paul E.; Kawamura, Akane; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1308-1329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is increasing interest in targeting histone N-methyl-lysine demethylases (KDMs) with small mols. both for the generation of probes for target exploration and for therapeutic purposes.  Here we update on previous reviews on the inhibition of the lysine-specific demethylases (LSDs or KDM1s) and JmjC families of N-methyl-lysine demethylases (JmjC KDMs, KDM2-7), focusing on the academic and patent literature from 2014 to date.  We also highlight recent biochem., biol., and structural studies which are relevant to KDM inhibitor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWx0bnBT9cDrVg90H21EOLACvtfcHk0liEgylH8L_23Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyrtbfE&md5=f744b65af58dff765cdab8f9fea85310</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01758%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DT.%2BE.%26aulast%3DEngland%26aufirst%3DK.%2BS.%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DRecent%2520progress%2520in%2520histone%2520demethylase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1308%26epage%3D1329%26doi%3D10.1021%2Facs.jmedchem.5b01758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-M.</span></span> <span> </span><span class="NLM_article-title">Pharmacoepigenetics of LSD1 inhibitors in cancer</span>. <i>Pharmacoepigenetics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-813939-4.00014-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2FB978-0-12-813939-4.00014-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=523-530&author=B.+Yuauthor=H.-M.+Liu&title=Pharmacoepigenetics+of+LSD1+inhibitors+in+cancer&doi=10.1016%2FB978-0-12-813939-4.00014-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-813939-4.00014-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-813939-4.00014-0%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.-M.%26atitle%3DPharmacoepigenetics%2520of%2520LSD1%2520inhibitors%2520in%2520cancer%26jtitle%3DPharmacoepigenetics%26date%3D2019%26volume%3D10%26spage%3D523%26epage%3D530%26doi%3D10.1016%2FB978-0-12-813939-4.00014-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">Advances toward LSD1 inhibitors for cancer therapy</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1227</span>– <span class="NLM_lpage">1242</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.4155%2Ffmc-2017-0068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28722477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2qsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1227-1242&author=X.+Fuauthor=P.+Zhangauthor=B.+Yu&title=Advances+toward+LSD1+inhibitors+for+cancer+therapy&doi=10.4155%2Ffmc-2017-0068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Advances toward LSD1 inhibitors for cancer therapy</span></div><div class="casAuthors">Fu, Xiaoli; Zhang, Peng; Yu, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1227-1242</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  LSD1 has become an important biol. validated epigenetic target for cancer therapy since its identification in 2004.  LSD1 mediates many cellular signaling pathways and is involved in the initiation and development of cancers.  Aberrant overexpression of LSD1 has been obsd. in different types of cancers, and inactivation by small mols. suppresses cancer cell differentiation, proliferation, invasion and migration.  To date, a large no. of LSD1 inhibitors have been reported, RG6016, GSK-2879552, INCB059872, IMG-7289 and CC-90011 are currently undergoing clin. assessment for the treatment of acute myeloid leukemia, small-cell lung cancer, etc.  In this review, we briefly highlight recent advances of LSD1 inhibitors mainly covering the literatures from 2015 to 2017 and tentatively propose our perspectives on the design of new LSD1 inhibitors for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlJAzt51S4crVg90H21EOLACvtfcHk0liEgylH8L_23Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2qsLbK&md5=182f10eb7a2aea7b5c13f50f84f44c20</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0068%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DB.%26atitle%3DAdvances%2520toward%2520LSD1%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1227%26epage%3D1242%26doi%3D10.4155%2Ffmc-2017-0068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">LSD1/KDM1A inhibitors in clinical trials: advances and prospects</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">129</span>, <span class="refDoi"> DOI: 10.1186/s13045-019-0811-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1186%2Fs13045-019-0811-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31801559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BB3MfmsFylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=129&author=Y.+Fangauthor=G.+Liaoauthor=B.+Yu&title=LSD1%2FKDM1A+inhibitors+in+clinical+trials%3A+advances+and+prospects&doi=10.1186%2Fs13045-019-0811-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1/KDM1A inhibitors in clinical trials: advances and prospects</span></div><div class="casAuthors">Fang Yuan; Liao Guochao; Yu Bin; Yu Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hematology & oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Histone demethylase LSD1 plays key roles during carcinogenesis, targeting LSD1 is becoming an emerging option for the treatment of cancers.  Numerous LSD1 inhibitors have been reported to date, some of them such as TCP, ORY-1001, GSK-2879552, IMG-7289, INCB059872, CC-90011, and ORY-2001 currently undergo clinical assessment for cancer therapy, particularly for small lung cancer cells (SCLC) and acute myeloid leukemia (AML).  This review is to provide a comprehensive overview of LSD1 inhibitors in clinical trials including molecular mechanistic studies, clinical efficacy, adverse drug reactions, and PD/PK studies and offer prospects in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbk3-5OqEjmWlSCSgBhwJFfW6udTcc2eZ0mM1vvX1thrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MfmsFylsg%253D%253D&md5=112299f15281667341a55dea57f6c83b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1186%2Fs13045-019-0811-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13045-019-0811-9%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DB.%26atitle%3DLSD1%252FKDM1A%2520inhibitors%2520in%2520clinical%2520trials%253A%2520advances%2520and%2520prospects%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2019%26volume%3D12%26spage%3D129%26doi%3D10.1186%2Fs13045-019-0811-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC-803</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">4957</span>– <span class="NLM_lpage">4966</span>, <span class="refDoi"> DOI: 10.1002/jcb.26741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fjcb.26741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29384217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFWru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2018&pages=4957-4966&author=J.+L.+Maauthor=T.+Zhangauthor=F.+Z.+Suoauthor=J.+Changauthor=X.+B.+Wanauthor=X.+J.+Fengauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Lysine-specific+demethylase+1+activation+by+vitamin+B2+attenuates+efficacy+of+apatinib+for+proliferation+and+migration+of+gastric+cancer+cell+MGC-803&doi=10.1002%2Fjcb.26741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC-803</span></div><div class="casAuthors">Ma, Jin-Lian; Zhang, Ting; Suo, Feng-Zhi; Chang, Jiao; Wan, Xiang-Bin; Feng, Xue-Jian; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4957-4966</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">B vitamins play an essential role in the biosynthesis of nucleotides, replication of DNA, supply of methyl-groups, growth and repair of cells, aberrancies of which have all been implicated in carcinogenesis.  Although the potential role of vitamin B in relation to the risk of cancer, including breast, and colorectal cancer, has been investigated in several observational studies, the mechanism of action is still unclear.  In this study, vitamin B2 exhibited efficient activation of LSD1 by occupying the active sites where FAD stands.  Interestingly, vitamin B2 significantly downregulated expression of CD86, a sensitive surrogate biomarker of LSD1 inhibition, and showed marked activation of gastric cancer cell migration and invasion.  Meanwhile, vitamin B2 induced activation of LSD1 may attenuate the proliferation inhibition, and anti-migration effects of apatinib in gastric cancer cells.  These findings suggested that vitamin B supplementation may interfere with the efficacy of apatinib in patients with gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtbNe934XbYrVg90H21EOLACvtfcHk0ljo3ghn8p0mLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFWru7g%253D&md5=880045a3371a40e61de59ee0416e438f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fjcb.26741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.26741%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DX.%2BB.%26aulast%3DFeng%26aufirst%3DX.%2BJ.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DLysine-specific%2520demethylase%25201%2520activation%2520by%2520vitamin%2520B2%2520attenuates%2520efficacy%2520of%2520apatinib%2520for%2520proliferation%2520and%2520migration%2520of%2520gastric%2520cancer%2520cell%2520MGC-803%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2018%26volume%3D119%26spage%3D4957%26epage%3D4966%26doi%3D10.1002%2Fjcb.26741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaniskan, H. Ü.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of protein methyltransferases and demethylases</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">989</span>– <span class="NLM_lpage">1068</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00801</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00801" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslynsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2018&pages=989-1068&author=H.+%C3%9C.+Kaniskanauthor=M.+L.+Martiniauthor=J.+Jin&title=Inhibitors+of+protein+methyltransferases+and+demethylases&doi=10.1021%2Facs.chemrev.6b00801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Protein Methyltransferases and Demethylases</span></div><div class="casAuthors">Kaniskan, H. Umit; Martini, Michael L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">989-1068</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Post-translational modifications of histones by protein methyltransferases (PMTs) and histone demethylases (KDMs) play an important role in the regulation of gene expression and transcription and are implicated in cancer and many other diseases.  Many of these enzymes also target various nonhistone proteins impacting numerous crucial biol. pathways.  Given their key biol. functions and implications in human diseases, there has been a growing interest in assessing these enzymes as potential therapeutic targets.  Consequently, discovering and developing inhibitors of these enzymes has become a very active and fast-growing research area over the past decade.  In this review, the authors cover the discovery, characterization, and biol. application of inhibitors of PMTs and KDMs with emphasis on key advancements in the field.  The authors also discuss challenges, opportunities, and future directions in this emerging, exciting research field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJYjiYtw_n4rVg90H21EOLACvtfcHk0ljo3ghn8p0mLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslynsL8%253D&md5=1ed520c6b0c42d2aa8a7f66b0a2d4e40</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00801%26sid%3Dliteratum%253Aachs%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259C.%26aulast%3DMartini%26aufirst%3DM.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520protein%2520methyltransferases%2520and%2520demethylases%26jtitle%3DChem.%2520Rev.%26date%3D2018%26volume%3D118%26spage%3D989%26epage%3D1068%26doi%3D10.1021%2Facs.chemrev.6b00801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span> <span> </span><span class="NLM_article-title">Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases</span>. <i>Epigenetics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1080/15592294.2017.1290032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1080%2F15592294.2017.1290032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28277979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC1czks1GitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=340-352&author=H.+Niwaauthor=T.+Umehara&title=Structural+insight+into+inhibitors+of+flavin+adenine+dinucleotide-dependent+lysine+demethylases&doi=10.1080%2F15592294.2017.1290032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases</span></div><div class="casAuthors">Niwa Hideaki; Umehara Takashi; Umehara Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Epigenetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">340-352</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Until 2004, many researchers believed that protein methylation in eukaryotic cells was an irreversible reaction.  However, the discovery of lysine-specific demethylase 1 in 2004 drastically changed this view and the concept of chromatin regulation.  Since then, the enzymes responsible for lysine demethylation and their cellular substrates, biological significance, and selective regulation have become major research topics in epigenetics and chromatin biology.  Many cell-permeable inhibitors for lysine demethylases have been developed, including both target-specific and nonspecific inhibitors.  Structural understanding of how these inhibitors bind to lysine demethylases is crucial both for validation of the inhibitors as chemical probes and for the rational design of more potent, target-specific inhibitors.  This review focuses on published small-molecule inhibitors targeted at the two flavin adenine dinucleotide-dependent lysine demethylases, lysine-specific demethylases 1 and 2, and how the inhibitors interact with the tertiary structures of the enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyKG85Hfra9xjv2lLSLOxFfW6udTcc2eZSBzqoHD1e87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czks1GitA%253D%253D&md5=31f93c2cc7909c4197f5892f7f04af9d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1080%2F15592294.2017.1290032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15592294.2017.1290032%26sid%3Dliteratum%253Aachs%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DUmehara%26aufirst%3DT.%26atitle%3DStructural%2520insight%2520into%2520inhibitors%2520of%2520flavin%2520adenine%2520dinucleotide-dependent%2520lysine%2520demethylases%26jtitle%3DEpigenetics%26date%3D2017%26volume%3D12%26spage%3D340%26epage%3D352%26doi%3D10.1080%2F15592294.2017.1290032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">An overview on screening methods for lysine specific demethylase 1 (LSD1) Inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2496</span>– <span class="NLM_lpage">2504</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170509114321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.2174%2F0929867324666170509114321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28486922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFantbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=2496-2504&author=Y.+C.+Zhengauthor=J.+Changauthor=T.+Zhangauthor=F.+Z.+Suoauthor=X.+B.+Chenauthor=Y.+Liuauthor=B.+Zhaoauthor=B.+Yuauthor=H.+M.+Liu&title=An+overview+on+screening+methods+for+lysine+specific+demethylase+1+%28LSD1%29+Inhibitors&doi=10.2174%2F0929867324666170509114321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors</span></div><div class="casAuthors">Zheng, Yi-Chao; Chang, Jiao; Zhang, Ting; Suo, Feng-Zhi; Chen, Xiao-Bing; Liu, Ying; Zhao, Bing; Yu, Bin; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2496-2504</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: In the past few years, great of attention has been paid to the identification and characterization of selective and potent inhibitors of the first identified histone demethylase LSD1, which may erase mono- and di-methylated histone 3 lysine 4 and 9.  As the aberrant overexpression of LSD1 is involved in various pathol. processes, esp. cancer, obtaining selective and potent LSD1 inhibitors has emerged as a crucial issue in medicinal chem. research.  Method: Until now, several LSD1 inhibitor screening models have been established, including enzyme coupled assay, LC-MS based assay, and FRET based assay.  Nevertheless, due to some special instrument requirement and addnl. costs of LC-MS and FRET, the enzyme coupled assay is the most widely applied method for LSD1 inhibitor screening.  Result: We summarized and compared several reported in vitro LSD1 inhibitor screening models.  Each of them has distinct advantages and disadvantages, and none of these methods is perfect.  In order to exclude the false pos. results, at least one addnl. method should be applied to screen LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJeShKTm7x6rVg90H21EOLACvtfcHk0ljeE2_6WJmXMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFantbfM&md5=f95a9271848abfd32fa42d9f09205dad</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170509114321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170509114321%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DChen%26aufirst%3DX.%2BB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DAn%2520overview%2520on%2520screening%2520methods%2520for%2520lysine%2520specific%2520demethylase%25201%2520%2528LSD1%2529%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26spage%3D2496%26epage%3D2504%26doi%3D10.2174%2F0929867324666170509114321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Writers and erasers of histone lysine methylation with clinically applied modulators: promising target for cancer therapy</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5943</span>– <span class="NLM_lpage">5947</span>, <span class="refDoi"> DOI: 10.2174/1381612822666160715125417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.2174%2F1381612822666160715125417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27426130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1emsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=5943-5947&author=Y.+C.+Zhengauthor=J.+L.+Maauthor=Y.+Liuauthor=H.+M.+Liu&title=Writers+and+erasers+of+histone+lysine+methylation+with+clinically+applied+modulators%3A+promising+target+for+cancer+therapy&doi=10.2174%2F1381612822666160715125417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy</span></div><div class="casAuthors">Zheng, Yi-Chao; Ma, Jin-Lian; Liu, Ying; Liu, Hong M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5943-5947</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Histone lysine methylation can be modified by various writers and erasers.  Different from other epigenetic modifications, mono-, di, and tri- methylation distinctly modulate chromatin structure and thereby contribute to the regulation of DNA-based nuclear processes such as transcription, replication and repair on their target genes depending on different sites.  Modulators with opposing catalytic activities dynamically and precisely control levels of histone lysine methylation, and individual enzymes within these families have become candidate oncol. targets in recent years.  Until now, plenty of medicinal chemists try to pursue potent and selective inhibitor for KMTs and KDMs in order to have the potential anti-cancer agent, and several of the inhibitors have already enrolled in clinic.  Here, we discuss three histone lysine methylation modulators with their inhibitors in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlmyIdpVVQYrVg90H21EOLACvtfcHk0lg6TY3jzY9CrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1emsQ%253D%253D&md5=0c5ad31f6629b4699bfea1a515d0bdf9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F1381612822666160715125417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612822666160715125417%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DWriters%2520and%2520erasers%2520of%2520histone%2520lysine%2520methylation%2520with%2520clinically%2520applied%2520modulators%253A%2520promising%2520target%2520for%2520cancer%2520therapy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2016%26volume%3D22%26spage%3D5943%26epage%3D5947%26doi%3D10.2174%2F1381612822666160715125417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirapu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estiarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guibourt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdones, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lufino, M. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somervaille, T. C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willekens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valls, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fyfe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Palomino, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span> <span> </span><span class="NLM_article-title">ORY-1001, a potent and selective covalent KDM1A Inhibitor, for the treatment of acute leukemia</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ccell.2018.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29502954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsl2ktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=495-511&author=T.+Maesauthor=C.+Mascaroauthor=I.+Tirapuauthor=A.+Estiarteauthor=F.+Ciceriauthor=S.+Lunardiauthor=N.+Guibourtauthor=A.+Perdonesauthor=M.+M.+P.+Lufinoauthor=T.+C.+P.+Somervailleauthor=D.+H.+Wisemanauthor=C.+Duyauthor=A.+Melnickauthor=C.+Willekensauthor=A.+Ortegaauthor=M.+Martinellauthor=N.+Vallsauthor=G.+Kurzauthor=M.+Fyfeauthor=J.+C.+Castro-Palominoauthor=C.+Buesa&title=ORY-1001%2C+a+potent+and+selective+covalent+KDM1A+Inhibitor%2C+for+the+treatment+of+acute+leukemia&doi=10.1016%2Fj.ccell.2018.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia</span></div><div class="casAuthors">Maes, Tamara; Mascaro, Cristina; Tirapu, Inigo; Estiarte, Angels; Ciceri, Filippo; Lunardi, Serena; Guibourt, Nathalie; Perdones, Alvaro; Lufino, Michele M. P.; Somervaille, Tim C. P.; Wiseman, Dan H.; Duy, Cihangir; Melnick, Ari; Willekens, Christophe; Ortega, Alberto; Martinell, Marc; Valls, Nuria; Kurz, Guido; Fyfe, Matthew; Castro-Palomino, Julio Cesar; Buesa, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-511.e12</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The lysine-specific demethylase KDM1A is a key regulator of stem cell potential in acute myeloid leukemia (AML).  ORY-1001 is a highly potent and selective KDM1A inhibitor that induces H3K4me2 accumulation on KDM1A target genes, blast differentiation, and redn. of leukemic stem cell capacity in AML.  ORY-1001 exhibits potent synergy with std.-of-care drugs and selective epigenetic inhibitors, reduces growth of an AML xenograft model, and extends survival in a mouse PDX (patient-derived xenograft) model of T cell acute leukemia.  Surrogate pharmacodynamic biomarkers developed based on expression changes in leukemia cell lines were translated to samples from patients treated with ORY-1001.  ORY-1001 is a selective KDM1A inhibitor in clin. trials and is currently being evaluated in patients with leukemia and solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb2QFk3s8-eLVg90H21EOLACvtfcHk0liBT8HPSb6IzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsl2ktL8%253D&md5=68f69ade1b0110f3e0adf0173326e9b7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DT.%26aulast%3DMascaro%26aufirst%3DC.%26aulast%3DTirapu%26aufirst%3DI.%26aulast%3DEstiarte%26aufirst%3DA.%26aulast%3DCiceri%26aufirst%3DF.%26aulast%3DLunardi%26aufirst%3DS.%26aulast%3DGuibourt%26aufirst%3DN.%26aulast%3DPerdones%26aufirst%3DA.%26aulast%3DLufino%26aufirst%3DM.%2BM.%2BP.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26aulast%3DWiseman%26aufirst%3DD.%2BH.%26aulast%3DDuy%26aufirst%3DC.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DWillekens%26aufirst%3DC.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DMartinell%26aufirst%3DM.%26aulast%3DValls%26aufirst%3DN.%26aulast%3DKurz%26aufirst%3DG.%26aulast%3DFyfe%26aufirst%3DM.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DBuesa%26aufirst%3DC.%26atitle%3DORY-1001%252C%2520a%2520potent%2520and%2520selective%2520covalent%2520KDM1A%2520Inhibitor%252C%2520for%2520the%2520treatment%2520of%2520acute%2520leukemia%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26spage%3D495%26epage%3D511%26doi%3D10.1016%2Fj.ccell.2018.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitheman, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federowicz, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Aller, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butticello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnette, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degenhardt, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappalardi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouthamel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span> <span> </span><span class="NLM_article-title">A DNA Hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ccell.2015.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=26175415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Grt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=57-69&author=H.+P.+Mohammadauthor=K.+N.+Smithemanauthor=C.+D.+Kamatauthor=D.+Soongauthor=K.+E.+Federowiczauthor=G.+S.+Van+Allerauthor=J.+L.+Schneckauthor=J.+D.+Carsonauthor=Y.+Liuauthor=M.+Butticelloauthor=W.+G.+Bonnetteauthor=S.+A.+Gormanauthor=Y.+Degenhardtauthor=Y.+Baiauthor=M.+T.+McCabeauthor=M.+B.+Pappalardiauthor=J.+Kasparecauthor=X.+Tianauthor=K.+C.+McNultyauthor=M.+Rouseauthor=P.+McDevittauthor=T.+Hoauthor=M.+Crouthamelauthor=T.+K.+Hartauthor=N.+O.+Conchaauthor=C.+F.+McHughauthor=W.+H.+Millerauthor=D.+Dhanakauthor=P.+J.+Tumminoauthor=C.+L.+Carpenterauthor=N.+W.+Johnsonauthor=C.+L.+Hannauthor=R.+G.+Kruger&title=A+DNA+Hypomethylation+signature+predicts+antitumor+activity+of+LSD1+inhibitors+in+SCLC&doi=10.1016%2Fj.ccell.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC</span></div><div class="casAuthors">Mohammad, Helai P.; Smitheman, Kimberly N.; Kamat, Chandrashekhar D.; Soong, David; Federowicz, Kelly E.; Van Aller, Glenn S.; Schneck, Jess L.; Carson, Jeffrey D.; Liu, Yan; Butticello, Michael; Bonnette, William G.; Gorman, Shelby A.; Degenhardt, Yan; Bai, Yuchen; McCabe, Michael T.; Pappalardi, Melissa B.; Kasparec, Jiri; Tian, Xinrong; McNulty, Kenneth C.; Rouse, Meagan; McDevitt, Patrick; Ho, Thau; Crouthamel, Michelle; Hart, Timothy K.; Concha, Nestor O.; McHugh, Charles F.; Miller, William H.; Dhanak, Dashyant; Tummino, Peter J.; Carpenter, Christopher L.; Johnson, Neil W.; Hann, Christine L.; Kruger, Ryan G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Epigenetic dysregulation has emerged as an important mechanism in cancer.  Alterations in epigenetic machinery have become a major focus for targeted therapies.  The current report describes the discovery and biol. activity of a cyclopropylamine contg. inhibitor of Lysine Demethylase 1 (LSD1), GSK2879552.  This small mol. is a potent, selective, orally bioavailable, mechanism-based irreversible inactivator of LSD1.  A proliferation screen of cell lines representing a no. of tumor types indicated that small cell lung carcinoma (SCLC) is sensitive to LSD1 inhibition.  The subset of SCLC lines and primary samples that undergo growth inhibition in response to GSK2879552 exhibit DNA hypomethylation of a signature set of probes, suggesting this may be used as a predictive biomarker of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppluiM41UspbVg90H21EOLACvtfcHk0ljtPGPr6w11Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Grt7fJ&md5=863924e99fa3576dc1c67824b45462f8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DH.%2BP.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DKamat%26aufirst%3DC.%2BD.%26aulast%3DSoong%26aufirst%3DD.%26aulast%3DFederowicz%26aufirst%3DK.%2BE.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DSchneck%26aufirst%3DJ.%2BL.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DButticello%26aufirst%3DM.%26aulast%3DBonnette%26aufirst%3DW.%2BG.%26aulast%3DGorman%26aufirst%3DS.%2BA.%26aulast%3DDegenhardt%26aufirst%3DY.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DPappalardi%26aufirst%3DM.%2BB.%26aulast%3DKasparec%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DMcNulty%26aufirst%3DK.%2BC.%26aulast%3DRouse%26aufirst%3DM.%26aulast%3DMcDevitt%26aufirst%3DP.%26aulast%3DHo%26aufirst%3DT.%26aulast%3DCrouthamel%26aufirst%3DM.%26aulast%3DHart%26aufirst%3DT.%2BK.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCarpenter%26aufirst%3DC.%2BL.%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26aulast%3DHann%26aufirst%3DC.%2BL.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26atitle%3DA%2520DNA%2520Hypomethylation%2520signature%2520predicts%2520antitumor%2520activity%2520of%2520LSD1%2520inhibitors%2520in%2520SCLC%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D28%26spage%3D57%26epage%3D69%26doi%3D10.1016%2Fj.ccell.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitheman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R.</span></span> <span> </span><span class="NLM_article-title">212 Novel anti-tumor activity of targeted LSD1 inhibition by GSK2879552</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">72</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(14)70338-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2FS0959-8049%2814%2970338-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=72&author=H.+Mohammadauthor=K.+Smithemanauthor=G.+van+Allerauthor=M.+Cusanauthor=S.+Kamatauthor=Y.+Liuauthor=N.+Johnsonauthor=C.+Hannauthor=S.+Armstrongauthor=R.+Kruger&title=212+Novel+anti-tumor+activity+of+targeted+LSD1+inhibition+by+GSK2879552&doi=10.1016%2FS0959-8049%2814%2970338-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2814%2970338-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252814%252970338-7%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DH.%26aulast%3DSmitheman%26aufirst%3DK.%26aulast%3Dvan%2BAller%26aufirst%3DG.%26aulast%3DCusan%26aufirst%3DM.%26aulast%3DKamat%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DN.%26aulast%3DHann%26aufirst%3DC.%26aulast%3DArmstrong%26aufirst%3DS.%26aulast%3DKruger%26aufirst%3DR.%26atitle%3D212%2520Novel%2520anti-tumor%2520activity%2520of%2520targeted%2520LSD1%2520inhibition%2520by%2520GSK2879552%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2014%26volume%3D50%26spage%3D72%26doi%3D10.1016%2FS0959-8049%2814%2970338-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostalik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B.</span></span> <span> </span><span class="NLM_article-title">Abstract 4704: The evaluation of INCB059872, an FAD-directed inhibitor of LSD1, in preclinical models of human small cell lung cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4704</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-4704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F1538-7445.AM2016-4704" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4704&author=S.+H.+Leeauthor=X.+M.+Liuauthor=M.+Diamondauthor=V.+Dostalikauthor=M.+Favataauthor=C.+Heauthor=L.+Wuauthor=R.+Wynnauthor=W.+Yaoauthor=G.+Hollisauthor=R.+Huberauthor=P.+Scherleauthor=B.+Ruggeri&title=Abstract+4704%3A+The+evaluation+of+INCB059872%2C+an+FAD-directed+inhibitor+of+LSD1%2C+in+preclinical+models+of+human+small+cell+lung+cancer&doi=10.1158%2F1538-7445.AM2016-4704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-4704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-4704%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DX.%2BM.%26aulast%3DDiamond%26aufirst%3DM.%26aulast%3DDostalik%26aufirst%3DV.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26aulast%3DRuggeri%26aufirst%3DB.%26atitle%3DAbstract%25204704%253A%2520The%2520evaluation%2520of%2520INCB059872%252C%2520an%2520FAD-directed%2520inhibitor%2520of%2520LSD1%252C%2520in%2520preclinical%2520models%2520of%2520human%2520small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4704%26doi%3D10.1158%2F1538-7445.AM2016-4704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostalik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margulis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P.</span></span> <span> </span><span class="NLM_article-title">Abstract 4712: Discovery of INCB059872, a novel FAD-directed LSD1 inhibitor that is effective in preclinical models of human and murine AML</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4712</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-4712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F1538-7445.AM2016-4712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4712&author=S.+H.+Leeauthor=M.+Stubbsauthor=X.+M.+Liuauthor=M.+Diamondauthor=V.+Dostalikauthor=M.+Yeauthor=Y.+Loauthor=M.+Favataauthor=G.+Yangauthor=K.+Gallagherauthor=L.+Leffetauthor=C.+Heauthor=L.+Wuauthor=A.+Margulisauthor=M.+Covingtonauthor=R.+Wynnauthor=W.+Yaoauthor=G.+Hollisauthor=R.+Huberauthor=B.+Ruggeriauthor=P.+Scherle&title=Abstract+4712%3A+Discovery+of+INCB059872%2C+a+novel+FAD-directed+LSD1+inhibitor+that+is+effective+in+preclinical+models+of+human+and+murine+AML&doi=10.1158%2F1538-7445.AM2016-4712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-4712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-4712%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%2BM.%26aulast%3DDiamond%26aufirst%3DM.%26aulast%3DDostalik%26aufirst%3DV.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DGallagher%26aufirst%3DK.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DMargulis%26aufirst%3DA.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DScherle%26aufirst%3DP.%26atitle%3DAbstract%25204712%253A%2520Discovery%2520of%2520INCB059872%252C%2520a%2520novel%2520FAD-directed%2520LSD1%2520inhibitor%2520that%2520is%2520effective%2520in%2520preclinical%2520models%2520of%2520human%2520and%2520murine%2520AML%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4712%26doi%3D10.1158%2F1538-7445.AM2016-4712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romussi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brambillasca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cera, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Zuffo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifirò, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vultaggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecatiello, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasqualato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, C. W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of reversible inhibitors of KDM1A efficacious in acute myeloid leukemia models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">754</span>– <span class="NLM_lpage">759</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00604</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivFyisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=754-759&author=A.+Romussiauthor=A.+Cappaauthor=P.+Vianelloauthor=S.+Brambillascaauthor=M.+R.+Ceraauthor=R.+Dal+Zuffoauthor=G.+Fag%C3%A0author=R.+Fattoriauthor=L.+Morettiauthor=P.+Trifir%C3%B2author=M.+Villaauthor=S.+Vultaggioauthor=V.+Cecatielloauthor=S.+Pasqualatoauthor=G.+Dondioauthor=C.+W.+E.+Soauthor=S.+Minucciauthor=L.+Sartoriauthor=M.+Varasiauthor=C.+Mercurio&title=Discovery+of+reversible+inhibitors+of+KDM1A+efficacious+in+acute+myeloid+leukemia+models&doi=10.1021%2Facsmedchemlett.9b00604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models</span></div><div class="casAuthors">Romussi, Alessia; Cappa, Anna; Vianello, Paola; Brambillasca, Silvia; Cera, Maria Rosaria; Dal Zuffo, Roberto; Faga, Giovanni; Fattori, Raimondo; Moretti, Loris; Trifiro, Paolo; Villa, Manuela; Vultaggio, Stefania; Cecatiello, Valentina; Pasqualato, Sebastiano; Dondio, Giulio; So, Chi Wai Eric; Minucci, Saverio; Sartori, Luca; Varasi, Mario; Mercurio, Ciro</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">754-759</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1 or KDM1A) is a FAD-dependent enzyme that acts as a transcription corepressor or coactivator by regulating the methylation status of histone H3 lysines K4 and K9, resp.  KDM1A represents an attractive target for cancer therapy.  While, in the past, the main medicinal chem. strategy toward KDM1A inhibition was based on the optimization of ligands that irreversibly bind the FAD cofactor within the enzyme catalytic site, we and others have also identified reversible inhibitors.  Herein we reported the discovery of 5-imidazolylthieno[3,2-b]pyrroles, a new series of KDM1A inhibitors endowed with picomolar inhibitory potency, active in cells and efficacious after oral administration in murine leukemia models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiYpo0iHtNZLVg90H21EOLACvtfcHk0lhcCnPSF4M_ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivFyisL0%253D&md5=638d1b2f8653b1fa53f8d6278e297553</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00604%26sid%3Dliteratum%253Aachs%26aulast%3DRomussi%26aufirst%3DA.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DBrambillasca%26aufirst%3DS.%26aulast%3DCera%26aufirst%3DM.%2BR.%26aulast%3DDal%2BZuffo%26aufirst%3DR.%26aulast%3DFag%25C3%25A0%26aufirst%3DG.%26aulast%3DFattori%26aufirst%3DR.%26aulast%3DMoretti%26aufirst%3DL.%26aulast%3DTrifir%25C3%25B2%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DVultaggio%26aufirst%3DS.%26aulast%3DCecatiello%26aufirst%3DV.%26aulast%3DPasqualato%26aufirst%3DS.%26aulast%3DDondio%26aufirst%3DG.%26aulast%3DSo%26aufirst%3DC.%2BW.%2BE.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DSartori%26aufirst%3DL.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520reversible%2520inhibitors%2520of%2520KDM1A%2520efficacious%2520in%2520acute%2520myeloid%2520leukemia%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D754%26epage%3D759%26doi%3D10.1021%2Facsmedchemlett.9b00604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy</span>. <i>Epigenomics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.2217/epi-2015-0002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.2217%2Fepi-2015-0002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27102879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XotVSrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=651-666&author=Y.+C.+Zhengauthor=B.+Yuauthor=Z.+S.+Chenauthor=Y.+Liuauthor=H.+M.+Liu&title=TCPs%3A+privileged+scaffolds+for+identifying+potent+LSD1+inhibitors+for+cancer+therapy&doi=10.2217%2Fepi-2015-0002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy</span></div><div class="casAuthors">Zheng, Yi-Chao; Yu, Bin; Chen, Zhe-Sheng; Liu, Ying; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Epigenomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">651-666</span>CODEN:
                <span class="NLM_cas:coden">EPIGC7</span>;
        ISSN:<span class="NLM_cas:issn">1750-192X</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the first lysine-specific demethylase (KDM), lysine-specific demethylase 1 (LSD1), was characterized in 2004, several families of KDMs have been identified.  LSD1 can specifically demethylate H3K4me1/2, H3K9me1/2 as well as some nonhistone substrates.  It has been demonstrated to be an oncogene as well as a drug target.  Hence, tens of small-mol. LSD1 inhibitors have been designed, synthesized and applied for cancer treatment.  However, the two LSD1 inhibitors that have been advanced into early phase clin. trials are trans-2-phenylcyclopropylamine (TCP) derivs., which indicate that TCP is a druggable scaffold for LSD1 inhibitor.  Here, we review the design, synthesis and properties of reported TCP-based LSD1 inhibitors as well as their biol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtSkXNPl_7LVg90H21EOLACvtfcHk0lhcCnPSF4M_ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotVSrsrs%253D&md5=6f8021101929c931a6769dce538010c2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2217%2Fepi-2015-0002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fepi-2015-0002%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DTCPs%253A%2520privileged%2520scaffolds%2520for%2520identifying%2520potent%2520LSD1%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DEpigenomics%26date%3D2016%26volume%3D8%26spage%3D651%26epage%3D666%26doi%3D10.2217%2Fepi-2015-0002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culhane, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalili, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">8058</span>– <span class="NLM_lpage">8065</span>, <span class="refDoi"> DOI: 10.1021/bi700664y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi700664y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsVKmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=8058-8065&author=M.+Yangauthor=J.+C.+Culhaneauthor=L.+M.+Szewczukauthor=P.+Jaliliauthor=H.+L.+Ballauthor=M.+Machiusauthor=P.+A.+Coleauthor=H.+Yu&title=Structural+basis+for+the+inhibition+of+the+LSD1+histone+demethylase+by+the+antidepressant+trans-2-phenylcyclopropylamine&doi=10.1021%2Fbi700664y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Inhibition of the LSD1 Histone Demethylase by the Antidepressant trans-2-Phenylcyclopropylamine</span></div><div class="casAuthors">Yang, Maojun; Culhane, Jeffrey C.; Szewczuk, Lawrence M.; Jalili, Pegah; Ball, Haydn L.; Machius, Mischa; Cole, Philip A.; Yu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">8058-8065</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone modifications, such as acetylation and methylation, are important epigenetic marks that regulate diverse biol. processes that use chromatin as the template, including transcription.  Dysregulation of histone acetylation and methylation leads to the silencing of tumor suppressor genes and contributes to cancer progression.  Inhibitors of enzymes that catalyze the addn. and removal of these epigenetic marks thus have therapeutic potential for treating cancer.  Lysine-specific demethylase 1 (LSD1) is the first discovered histone lysine demethylase and with the help of its cofactor CoREST, specifically demethylates mono- and dimethylated histone H3 lysine 4 (H3-K4), thus repressing transcription.  Because LSD1 belongs to the family of FAD (FAD)-dependent amine oxidases, certain inhibitors of monoamine oxidases (MAOs), including the clin. used antidepressant trans-2-phenylcyclopropylamine (PCPA; tranylcypromine; Parnate), are also capable of inhibiting LSD1.  In this study, we have further measured the kinetic parameters of the inhibition of LSD1 by PCPA and detd. the crystal structure of LSD1-CoREST in the presence of PCPA.  Our structural and mass spectrometry analyses are consistent with PCPA forming a covalent adduct with FAD in LSD1 that is distinct from the FAD-PCPA adduct of MAO B.  The structure also reveals that the Ph ring of the FAD-PCPA adduct in LSD1 does not form extensive interactions with active-site residues.  This study thus provides the basis for designing more potent inhibitors of LSD1 that contain substitutions on the Ph ring of PCPA to fully engage neighboring residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLqcLmzpB1S7Vg90H21EOLACvtfcHk0lj-AaCzIgZZ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsVKmsr8%253D&md5=e11fe93832d46962b6c4848f682042d2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi700664y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700664y%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DCulhane%26aufirst%3DJ.%2BC.%26aulast%3DSzewczuk%26aufirst%3DL.%2BM.%26aulast%3DJalili%26aufirst%3DP.%26aulast%3DBall%26aufirst%3DH.%2BL.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520the%2520LSD1%2520histone%2520demethylase%2520by%2520the%2520antidepressant%2520trans-2-phenylcyclopropylamine%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D8058%26epage%3D8065%26doi%3D10.1021%2Fbi700664y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengoku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuzawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25Å</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2007.11.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bbrc.2007.11.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18039463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOktr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2008&pages=15-22&author=S.+Mimasuauthor=T.+Sengokuauthor=S.+Fukuzawaauthor=T.+Umeharaauthor=S.+Yokoyama&title=Crystal+structure+of+histone+demethylase+LSD1+and+tranylcypromine+at+2.25%C3%85&doi=10.1016%2Fj.bbrc.2007.11.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 Å</span></div><div class="casAuthors">Mimasu, Shinya; Sengoku, Toru; Fukuzawa, Seketsu; Umehara, Takashi; Yokoyama, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Transcriptional activity and chromatin structure accessibility are correlated with the methylation of specific histone residues.  Lysine-specific demethylase 1 (LSD1) is the 1st discovered histone demethylase, which demethylates Lys-4 or Lys-9 of histone H3, using FAD.  Among the known monoamine oxidase inhibitors, tranylcypromine (Parnate) showed the most potent inhibitory effect on LSD1.  Recently, the crystal structure of LSD1 and tranylcypromine was solved at 2.75 Å, revealing a 5-membered ring fused to the flavin of LSD1.  Here, the authors refined the crystal structure of the LSD1-tranylcypromine complex to 2.25 Å.  The 5-membered ring model did not fit completely with the electron d., giving Rwork/R free values of 0.226/0.254.  On the other hand, the N(5) adduct gave the lowest Rwork/Rfree values of 0.218/0.248, among the tested models.  These results imply that the LSD1-tranylcypromine complex is not completely composed of the 5-membered adduct, but partially contains an intermediate, such as the N(5) adduct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo__1EoL6D_NLVg90H21EOLACvtfcHk0lj-AaCzIgZZ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOktr7P&md5=b2f5185385eca05415fa4f3efcd64bdf</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2007.11.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2007.11.066%26sid%3Dliteratum%253Aachs%26aulast%3DMimasu%26aufirst%3DS.%26aulast%3DSengoku%26aufirst%3DT.%26aulast%3DFukuzawa%26aufirst%3DS.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520histone%2520demethylase%2520LSD1%2520and%2520tranylcypromine%2520at%25202.25%25C3%2585%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D366%26spage%3D15%26epage%3D22%26doi%3D10.1016%2Fj.bbrc.2007.11.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanenghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karytinos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forneris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tardugno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">6827</span>– <span class="NLM_lpage">6833</span>, <span class="refDoi"> DOI: 10.1021/ja101557k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja101557k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=6827-6833&author=C.+Bindaauthor=S.+Valenteauthor=M.+Romanenghiauthor=S.+Pilottoauthor=R.+Cirilliauthor=A.+Karytinosauthor=G.+Ciossaniauthor=O.+A.+Botrugnoauthor=F.+Fornerisauthor=M.+Tardugnoauthor=D.+E.+Edmondsonauthor=S.+Minucciauthor=A.+Matteviauthor=A.+Mai&title=Biochemical%2C+structural%2C+and+biological+evaluation+of+tranylcypromine+derivatives+as+inhibitors+of+histone+demethylases+LSD1+and+LSD2&doi=10.1021%2Fja101557k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2</span></div><div class="casAuthors">Binda, Claudia; Valente, Sergio; Romanenghi, Mauro; Pilotto, Simona; Cirilli, Roberto; Karytinos, Aristotele; Ciossani, Giuseppe; Botrugno, Oronza A.; Forneris, Federico; Tardugno, Maria; Edmondson, Dale E.; Minucci, Saverio; Mattevi, Andrea; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6827-6833</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">LSD1 and LSD2 histone demethylases are implicated in a no. of physiol. and pathol. processes, ranging from tumorigenesis to herpes virus infection.  A comprehensive structural, biochem., and cellular study is presented here to probe the potential of these enzymes for epigenetic therapies.  This approach employs tranylcypromine as a chem. scaffold for the design of novel demethylase inhibitors.  This drug is a clin. validated antidepressant known to target monoamine oxidases A and B.  These two flavoenzymes are structurally related to LSD1 and LSD2.  Mechanistic and crystallog. studies of tranylcypromine inhibition reveal a lack of selectivity and differing covalent modifications of the FAD cofactor depending on the enantiomeric form.  These findings are pharmacol. relevant, since tranylcypromine is currently administered as a racemic mixt.  A large set of tranylcypromine analogs were synthesized and screened for inhibitory activities.  We found that the common evolutionary origin of LSD and MAO enzymes, despite their unrelated functions and substrate specificities, is reflected in related ligand-binding properties.  A few compds. with partial enzyme selectivity were identified.  The biol. activity of one of these new inhibitors was evaluated with a cellular model of acute promyelocytic leukemia chosen since its pathogenesis includes aberrant activities of several chromatin modifiers.  Marked effects on cell differentiation and an unprecedented synergistic activity with antileukemia drugs were obsd.  These data demonstrate that these LSD1/2 inhibitors are of potential relevance for the treatment of promyelocytic leukemia and, more generally, as tools to alter chromatin state with promise of a block of tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH4F9uwn5Jx7Vg90H21EOLACvtfcHk0lhnyTQ5H7VCJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChur0%253D&md5=d6b28616bbb0455e139625fdb43696d3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fja101557k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja101557k%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DRomanenghi%26aufirst%3DM.%26aulast%3DPilotto%26aufirst%3DS.%26aulast%3DCirilli%26aufirst%3DR.%26aulast%3DKarytinos%26aufirst%3DA.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DTardugno%26aufirst%3DM.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520structural%252C%2520and%2520biological%2520evaluation%2520of%2520tranylcypromine%2520derivatives%2520as%2520inhibitors%2520of%2520histone%2520demethylases%2520LSD1%2520and%2520LSD2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D6827%26epage%3D6833%26doi%3D10.1021%2Fja101557k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiekhattar, R.</span></span> <span> </span><span class="NLM_article-title">Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2006.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.chembiol.2006.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=16793513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=563-567&author=M.+G.+Leeauthor=C.+Wynderauthor=D.+M.+Schmidtauthor=D.+G.+McCaffertyauthor=R.+Shiekhattar&title=Histone+H3+lysine+4+demethylation+is+a+target+of+nonselective+antidepressive+medications&doi=10.1016%2Fj.chembiol.2006.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive Medications</span></div><div class="casAuthors">Lee, Min Gyu; Wynder, Christopher; Schmidt, Dawn M.; McCafferty, Dewey G.; Shiekhattar, Ramin</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">563-567</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Demethylation of histone H3 lysine 4 is carried out by BHC110/LSD1, an enzyme with close homol. to monoamine oxidases (MAO).  Monoamine oxidase A or B are frequent targets of selective and nonselective small mol. inhibitors used for treatment of depression.  Here the authors show that in contrast to selective monoamine oxidase inhibitors such as pargyline, nonselective monoamine oxidase inhibitors potently inhibit nucleosomal demethylation of histone H3 lysine 4.  Tranylcypromine (brand name Parnate) displayed the best inhibitory activity with an IC50 of less than 2 μM.  Treatment of P19 embryonal carcinoma cells with tranylcypromine resulted in global increase in H3K4 methylation as well as transcriptional derepression of two BHC110 target genes, Egr1 and the pluripotent stem cell marker Oct4.  These results attest to the effectiveness of tranylcypromine as a small mol. inhibitor of histone demethylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpatbgTiqG1Y7Vg90H21EOLACvtfcHk0lhnyTQ5H7VCJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGqs7k%253D&md5=4a877937287bada8b6e885638926bff2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DWynder%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DD.%2BM.%26aulast%3DMcCafferty%26aufirst%3DD.%2BG.%26aulast%3DShiekhattar%26aufirst%3DR.%26atitle%3DHistone%2520H3%2520lysine%25204%2520demethylation%2520is%2520a%2520target%2520of%2520nonselective%2520antidepressive%2520medications%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D563%26epage%3D567%26doi%3D10.1016%2Fj.chembiol.2006.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, D. G.</span></span> <span> </span><span class="NLM_article-title">Trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4408</span>– <span class="NLM_lpage">4416</span>, <span class="refDoi"> DOI: 10.1021/bi0618621</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0618621" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivF2jsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=4408-4416&author=D.+M.+Schmidtauthor=D.+G.+McCafferty&title=Trans-2-Phenylcyclopropylamine+is+a+mechanism-based+inactivator+of+the+histone+demethylase+LSD1&doi=10.1021%2Fbi0618621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1</span></div><div class="casAuthors">Schmidt, Dawn M. Z.; McCafferty, Dewey G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4408-4416</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The catalytic domain of the flavin-dependent human histone demethylase, lysine-specific demethylase 1 (LSD1), belongs to the family of amine oxidases including polyamine oxidase and monoamine oxidase (MAO).  The authors previously assessed MAO inhibitors (MAOIs) for their ability to inhibit the reaction catalyzed by LSD1, demonstrating that trans-2-phenylcyclopropylamine (2-PCPA; tranylcypromine, Parnate) was the most potent inhibitor with respect to LSD1.  Here, the authors showed that 2-PCPA was a time-dependent, mechanism-based irreversible inhibitor of LSD1 with a Ki of 242 μM and a kinact of 0.0106 s-1.  2-PCPA showed limited selectivity for human MAOs vs. LSD1, with kinact/Ki values only 16-fold and 2.4-fold higher for MAO B and MAO A, resp.  Profiles of LSD1 activity and inactivation by 2-PCPA as a function of pH were consistent with a mechanism of inactivation dependent upon enzyme catalysis.  Mass spectrometry supported a role for FAD as the site of covalent modification by 2-PCPA.  These results will provide a foundation for the design of cyclopropylamine-based inhibitors that are selective for LSD1 to probe its role in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVK59U7IsBvbVg90H21EOLACvtfcHk0liRDZT45uNOKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivF2jsr0%253D&md5=02925342b86c7dbfb5f1a99fa5264adc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fbi0618621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0618621%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DD.%2BM.%26aulast%3DMcCafferty%26aufirst%3DD.%2BG.%26atitle%3DTrans-2-Phenylcyclopropylamine%2520is%2520a%2520mechanism-based%2520inactivator%2520of%2520the%2520histone%2520demethylase%2520LSD1%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D4408%26epage%3D4416%26doi%3D10.1021%2Fbi0618621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besenbeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenk, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mundmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gothert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noppeney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schliemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikesch, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornhauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serve, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platzbecker, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foerster, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burhenne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haefeli, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabst, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Tidow, C.</span></span>; <span class="NLM_contrib-group">Study Alliance Leukemia</span> <span> </span><span class="NLM_article-title">A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1038/s41375-020-0892-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fs41375-020-0892-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32561840" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=M.+Wassauthor=S.+Gollnerauthor=B.+Besenbeckauthor=R.+F.+Schlenkauthor=P.+Mundmannauthor=J.+R.+Gothertauthor=R.+Noppeneyauthor=C.+Schliemannauthor=J.+H.+Mikeschauthor=G.+Lenzauthor=M.+Dugasauthor=M.+Wermkeauthor=C.+Rolligauthor=M.+Bornhauserauthor=H.+Serveauthor=U.+Platzbeckerauthor=K.+I.+Foersterauthor=J.+Burhenneauthor=W.+E.+Haefeliauthor=L.+P.+Mullerauthor=M.+Binderauthor=C.+Pabstauthor=C.+Muller-Tidowauthor=Study+Alliance+Leukemia&title=A+proof+of+concept+phase+I%2FII+pilot+trial+of+LSD1+inhibition+by+tranylcypromine+combined+with+ATRA+in+refractory%2Frelapsed+AML+patients+not+eligible+for+intensive+therapy&doi=10.1038%2Fs41375-020-0892-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fs41375-020-0892-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41375-020-0892-z%26sid%3Dliteratum%253Aachs%26aulast%3DWass%26aufirst%3DM.%26aulast%3DGollner%26aufirst%3DS.%26aulast%3DBesenbeck%26aufirst%3DB.%26aulast%3DSchlenk%26aufirst%3DR.%2BF.%26aulast%3DMundmann%26aufirst%3DP.%26aulast%3DGothert%26aufirst%3DJ.%2BR.%26aulast%3DNoppeney%26aufirst%3DR.%26aulast%3DSchliemann%26aufirst%3DC.%26aulast%3DMikesch%26aufirst%3DJ.%2BH.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DDugas%26aufirst%3DM.%26aulast%3DWermke%26aufirst%3DM.%26aulast%3DRollig%26aufirst%3DC.%26aulast%3DBornhauser%26aufirst%3DM.%26aulast%3DServe%26aufirst%3DH.%26aulast%3DPlatzbecker%26aufirst%3DU.%26aulast%3DFoerster%26aufirst%3DK.%2BI.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DHaefeli%26aufirst%3DW.%2BE.%26aulast%3DMuller%26aufirst%3DL.%2BP.%26aulast%3DBinder%26aufirst%3DM.%26aulast%3DPabst%26aufirst%3DC.%26aulast%3DMuller-Tidow%26aufirst%3DC.%26aulast%3D%26atitle%3DA%2520proof%2520of%2520concept%2520phase%2520I%252FII%2520pilot%2520trial%2520of%2520LSD1%2520inhibition%2520by%2520tranylcypromine%2520combined%2520with%2520ATRA%2520in%2520refractory%252Frelapsed%2520AML%2520patients%2520not%2520eligible%2520for%2520intensive%2520therapy%26jtitle%3DLeukemia%26date%3D2020%26doi%3D10.1038%2Fs41375-020-0892-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">538</span>, <span class="refDoi"> DOI: 10.1038/s41416-019-0680-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fs41416-019-0680-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31848446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWks77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2020&pages=528-538&author=W.+Zhangauthor=J.+Chengauthor=P.+Diaoauthor=D.+Wangauthor=W.+Zhangauthor=H.+Jiangauthor=Y.+Wang&title=Therapeutically+targeting+head+and+neck+squamous+cell+carcinoma+through+synergistic+inhibition+of+LSD1+and+JMJD3+by+TCP+and+GSK-J1&doi=10.1038%2Fs41416-019-0680-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1</span></div><div class="casAuthors">Zhang, Wei; Cheng, Jie; Diao, Pengfei; Wang, Dongmiao; Jiang, Hongbing; Wang, Yanling</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">528-538</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: The histone demethylase LSD1 is a key mediator driving tumorigenesis, which holds potential as a promising therapeutic target.  However, treatment with LSD1 inhibitors alone failed to result in complete cancer regression.  Methods: The synergistic effects of TCP (a LSD1 inhibitor) and GSK-J1 (a JMJD3 inhibitor) against HNSCC were detd. in vitro and in preclin. animal models.  Genes modulated by chem. agents or siRNAs in HNSCC cells were identified by RNA-seq and further functionally interrogated by bioinformatics approach.  Integrative siRNA-mediated gene knockdown, rescue expt. and ChIP-qPCR assays were utilized to characterize the mediators underlying the therapeutic effects conferred by TCP and GSK-J1.  Results: Treatment with TCP and GSK-J1 impaired cell proliferation, induced apoptosis and senescence in vitro, which were largely recapitulated by simultaneous LSD1 and JMJD3 knockdown.  Combinational treatment inhibited tumor growth and progression in vivo.  Differentially expressed genes modulated by TCP and GSK-J1 were significantly enriched in cell proliferation, apoptosis and cancer-related pathways.  SPP1 was identified as the mediator of synergy underlying the pro-apoptosis effects conferred by TCP and GSK-J1.  Co-upregulation of LSD1 and JMJD3 assocd. with worse prognosis in patients with HNSCC.  Conclusions: Our findings revealed a novel therapeutic strategy of simultaneous LSD1 and JMJD3 inhibition against HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2WLQcQJoPeLVg90H21EOLACvtfcHk0liZ0x0HIg340Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWks77I&md5=ffcf18ad231f5d499c2b116239629163</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fs41416-019-0680-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-019-0680-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DDiao%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DTherapeutically%2520targeting%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%2520through%2520synergistic%2520inhibition%2520of%2520LSD1%2520and%2520JMJD3%2520by%2520TCP%2520and%2520GSK-J1%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2020%26volume%3D122%26spage%3D528%26epage%3D538%26doi%3D10.1038%2Fs41416-019-0680-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gooden, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabadi, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, D. G.</span></span> <span> </span><span class="NLM_article-title">Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3047</span>– <span class="NLM_lpage">3051</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2008.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18242989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3047-3051&author=D.+M.+Goodenauthor=D.+M.+Schmidtauthor=J.+A.+Pollockauthor=A.+M.+Kabadiauthor=D.+G.+McCafferty&title=Facile+synthesis+of+substituted+trans-2-arylcyclopropylamine+inhibitors+of+the+human+histone+demethylase+LSD1+and+monoamine+oxidases+A+and+B&doi=10.1016%2Fj.bmcl.2008.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B</span></div><div class="casAuthors">Gooden, David M.; Schmidt, Dawn M. Z.; Pollock, Julie A.; Kabadi, Ami M.; McCafferty, Dewey G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3047-3051</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A facile synthetic route to substituted trans-2-arylcyclopropylamines was developed to provide access to mechanism-based inhibitors of the human flavoenzyme oxidase lysine-specific histone demethylase LSD1 and related enzyme family members such as monoamine oxidases A and B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojt7YjHKC3yrVg90H21EOLACvtfcHk0liZ0x0HIg340Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVagurs%253D&md5=2459dcb4cde160186fc17c09258c5906</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DGooden%26aufirst%3DD.%2BM.%26aulast%3DSchmidt%26aufirst%3DD.%2BM.%26aulast%3DPollock%26aufirst%3DJ.%2BA.%26aulast%3DKabadi%26aufirst%3DA.%2BM.%26aulast%3DMcCafferty%26aufirst%3DD.%2BG.%26atitle%3DFacile%2520synthesis%2520of%2520substituted%2520trans-2-arylcyclopropylamine%2520inhibitors%2520of%2520the%2520human%2520histone%2520demethylase%2520LSD1%2520and%2520monoamine%2520oxidases%2520A%2520and%2520B%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3047%26epage%3D3051%26doi%3D10.1016%2Fj.bmcl.2008.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culhane, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gocke, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigam, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span> <span> </span><span class="NLM_article-title">Structural basis of histone demethylation by LSD1 revealed by suicide inactivation</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/nsmb1255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fnsmb1255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=17529991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVyjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=535-539&author=M.+Yangauthor=J.+C.+Culhaneauthor=L.+M.+Szewczukauthor=C.+B.+Gockeauthor=C.+A.+Brautigamauthor=D.+R.+Tomchickauthor=M.+Machiusauthor=P.+A.+Coleauthor=H.+Yu&title=Structural+basis+of+histone+demethylation+by+LSD1+revealed+by+suicide+inactivation&doi=10.1038%2Fnsmb1255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of histone demethylation by LSD1 revealed by suicide inactivation</span></div><div class="casAuthors">Yang, Maojun; Culhane, Jeffrey C.; Szewczuk, Lawrence M.; Gocke, Christian B.; Brautigam, Chad A.; Tomchick, Diana R.; Machius, Mischa; Cole, Philip A.; Yu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">535-539</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone methylation regulates diverse chromatin-templated processes, including transcription.  The recent discovery of the first histone lysine-specific demethylase (LSD1) has changed the long-held view that histone methylation is a permanent epigenetic mark.  LSD1 is a FAD-dependent amine oxidase that demethylates histone H3 Lys4 (H3-K4).  However, the mechanism by which LSD1 achieves its substrate specificity is unclear.  We report the crystal structure of human LSD1 with a propargylamine-derivatized H3 peptide covalently tethered to FAD.  H3 adopts three consecutive γ-turns, enabling an ideal side chain spacing that places its N terminus into an anionic pocket and positions methyl-Lys4 near FAD for catalysis.  The LSD1 active site cannot productively accommodate more than three residues on the N-terminal side of the methyllysine, explaining its H3-K4 specificity.  The unusual backbone conformation of LSD1-bound H3 suggests a strategy for designing potent LSD1 inhibitors with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocskIRV1aPVbVg90H21EOLACvtfcHk0lhzM3qgTE0mDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVyjtbs%253D&md5=51ba4fc92701ed0952d3f37e11ecda00</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1255%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DCulhane%26aufirst%3DJ.%2BC.%26aulast%3DSzewczuk%26aufirst%3DL.%2BM.%26aulast%3DGocke%26aufirst%3DC.%2BB.%26aulast%3DBrautigam%26aufirst%3DC.%2BA.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520of%2520histone%2520demethylation%2520by%2520LSD1%2520revealed%2520by%2520suicide%2520inactivation%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D535%26epage%3D539%26doi%3D10.1038%2Fnsmb1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span> <span> </span><span class="NLM_article-title">Identification of cell-active lysine specific demethylase 1-selective inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">17536</span>– <span class="NLM_lpage">17537</span>, <span class="refDoi"> DOI: 10.1021/ja907055q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja907055q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17536-17537&author=R.+Uedaauthor=T.+Suzukiauthor=K.+Minoauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyata&title=Identification+of+cell-active+lysine+specific+demethylase+1-selective+inhibitors&doi=10.1021%2Fja907055q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of cell-active lysine specific demethylase 1-selective inhibitors</span></div><div class="casAuthors">Ueda, Rie; Suzuki, Takayoshi; Mino, Koshiki; Tsumoto, Hiroki; Nakagawa, Hidehiko; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">17536-17537</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) plays a key role in the regulation of gene expression by removing the Me groups from methylated Lys4 of histone H3 (H3K4).  Here we report the identification of the first small-mol. LSD1-selective inhibitors.  These inhibitors show in vivo H3K4-methylating activity and antiproliferative activity and should be useful as lead structures for anticancer drugs and as tools for studying the biol. roles of LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH7uDFiErmKbVg90H21EOLACvtfcHk0lhzM3qgTE0mDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtbzO&md5=243e81a1d8d8cb3747f8307d5f42cd29</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja907055q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja907055q%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520cell-active%2520lysine%2520specific%2520demethylase%25201-selective%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D17536%26epage%3D17537%26doi%3D10.1021%2Fja907055q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukihara, T.</span></span> <span> </span><span class="NLM_article-title">Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates/inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">5739</span>– <span class="NLM_lpage">5744</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710626105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.0710626105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18391214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.+Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+of+human+monoamine+oxidase+A+at+2.2-A+resolution%3A+the+control+of+opening+the+entry+for+substrates%2Finhibitors&doi=10.1073%2Fpnas.0710626105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors</span></div><div class="casAuthors">Son, Se-Young; Mat, Jichun; Kondou, Youhei; Yoshimura, Masato; Yamashita, Eiki; Tsukihara, Tomitake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5744</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial outer membrane-anchored monoamine oxidase (MAO) is a biochem. important flavoenzyme that catalyzes the deamination of biogenic and xenobiotic amines.  Its 2 subtypes, MAOA and MAOB, are linked to several psychiatric disorders and therefore are interesting targets for drug design.  To understand the relation between structure and function of this enzyme, the authors extended their previously reported low-resoln. rat MAOA structure to the high-resoln. wild-type and G110A mutant structures of human MAOA complexed with the reversible inhibitor, harmine, at 2.2 and 2.17 Å, resp.  The high-resoln. MAOA structures were similar to those of rat MAOA and human MAOB, but different from the known structure of human MAOA, specifically regarding residues 108-118 and 210-216, which surround the substrate/inhibitor cavity.  The results confirmed that the inhibitor selectivity of MAOA and MAOB is caused by the structural differences arising from Ile-335 in MAOA vs. Tyr-326 in MAOB.  The structures exhibited a C-terminal transmembrane helix with clear electron d., as is also seen in rat MAOA.  Mutations on one residue of loop 108-118, Gly-110, which is far from the active center but close to the membrane surface, caused the solubilized enzyme to undergo a dramatic drop in activity, but have less effect when the enzyme was anchored in the membrane.  These results suggest that the flexibility of loop 108-118, facilitated by anchoring the enzyme into the membrane, is essential for controlling substrate access to the active site.  The authors report on the observation of the structure-function relation between a transmembrane helical anchor and an extra-membrane domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdm8Cs1NxHxLVg90H21EOLACvtfcHk0ljx1guIpGLfcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D&md5=7443fe77547220547312f7259df590df</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710626105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710626105%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520of%2520human%2520monoamine%2520oxidase%2520A%2520at%25202.2-A%2520resolution%253A%2520the%2520control%2520of%2520opening%2520the%2520entry%2520for%2520substrates%252Finhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744%26doi%3D10.1073%2Fpnas.0710626105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restelli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">9750</span>– <span class="NLM_lpage">9755</span>, <span class="refDoi"> DOI: 10.1073/pnas.1633804100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1633804100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=12913124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVejt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=9750-9755&author=C.+Bindaauthor=M.+Liauthor=F.+Hubalekauthor=N.+Restelliauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Insights+into+the+mode+of+inhibition+of+human+mitochondrial+monoamine+oxidase+B+from+high-resolution+crystal+structures&doi=10.1073%2Fpnas.1633804100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures</span></div><div class="casAuthors">Binda, Claudia; Li, Min; Hubalek, Frantisek; Restelli, Nadia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9750-9755</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO-B) is an outer mitochondrial membrane-bound enzyme that catalyzes the oxidative deamination of arylalkylamine neurotransmitters and has been a target for a no. of clin. used drug inhibitors.  The 1.7-Å structure of the reversible isatin-MAO-B complex has been detd.; it forms a basis for the interpretation of the enzyme's structure when bound to either reversible or irreversible inhibitors.  1,4-Diphenyl-2-butene is found to be a reversible MAO-B inhibitor, which occupies both the entrance and substrate cavity space in the enzyme.  Comparison of these two structures identifies Ile-199 as a "gate" between the two cavities.  Rotation of the side chain allows for either sepn. or fusion of the two cavities.  Inhibition of the enzyme with N-(2-aminoethyl)-p-chlorobenzamide results in the formation of a covalent N(5) flavin adduct with the Ph ring of the inhibitor occupying a position in the catalytic site overlapping that of isatin.  Inhibition of MAO-B with the clin. used trans-2-phenylcyclopropylamine results in the formation of a covalent C(4a) flavin adduct with an opened cyclopropyl ring and the Ph ring in a parallel orientation to the flavin.  The peptide bond between the flavin-substituted Cys-397 and Tyr-398 is in a cis conformation, which allows the proper orientation of the phenolic ring of Tyr-398 in the active site.  The flavin ring exists in a twisted nonplanar conformation, which is obsd. in the oxidized form as well as in both the N(5) and the C(4a) adducts.  An immobile water mol. is H-bonded to Lys-296 and to the N(5) of the flavin as obsd. in other flavin-dependent amine oxidases.  The active site cavities are highly apolar; however, hydrophilic areas exist near the flavin and direct the amine moiety of the substrate for binding and catalysis.  Small conformational changes are obsd. on comparison of the different inhibitor-enzyme complexes.  Future MAO-B drug design will need to consider "induced fit" contributions as an element in ligand-enzyme interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0K1SiYQtmN7Vg90H21EOLACvtfcHk0ljx1guIpGLfcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVejt7c%253D&md5=41ecf51fec3d1c4c811dc716c43beda5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1633804100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1633804100%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DRestelli%26aufirst%3DN.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DInsights%2520into%2520the%2520mode%2520of%2520inhibition%2520of%2520human%2520mitochondrial%2520monoamine%2520oxidase%2520B%2520from%2520high-resolution%2520crystal%2520structures%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D9750%26epage%3D9755%26doi%3D10.1073%2Fpnas.1633804100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cortez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekmal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Aguayo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Berestein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadlamudi, R. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer</span>. <i>Breast Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">R108</span>, <span class="refDoi"> DOI: 10.1186/bcr3229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1186%2Fbcr3229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=22812534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlyqtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R108&author=V.+Cortezauthor=M.+Mannauthor=S.+Tekmalauthor=T.+Suzukiauthor=N.+Miyataauthor=C.+Rodriguez-Aguayoauthor=G.+Lopez-Beresteinauthor=A.+K.+Soodauthor=R.+K.+Vadlamudi&title=Targeting+the+PELP1-KDM1+axis+as+a+potential+therapeutic+strategy+for+breast+cancer&doi=10.1186%2Fbcr3229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer</span></div><div class="casAuthors">Cortez, Valerie; Mann, Monica; Tekmal, Seshidhar; Suzuki, Takayoshi; Miyata, Naoki; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K.; Vadlamudi, Ratna K.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">R108</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: The estrogen receptor (ER) co-regulator proline glutamic acid and leucine-rich protein 1 (PELP1) is a proto-oncogene that modulates epigenetic changes on ER target gene promoters via interactions with lysine-specific histone demethylase 1 (KDM1).  In this study, we assessed the therapeutic potential of targeting the PELP1-KDM1 axis in vivo using liposomal (1,2-dioleoyl-sn-glycero-3-phosphatidylcholine; DOPC) siRNA to downregulate PELP1 expression and KDM1 inhibitors, pargyline and N-((1S)-3-(3-(trans-2-aminocyclopropyl)phenoxy)-1-(benzylcarbamoyl)propyl)benzamide using preclin. models.  Methods: Preclin. xenograft models were used to test the efficacy of drugs in vivo.  Ki-67 and terminal deoxynucleotidyl transferase dUTP nick end-labeling immunohistochem. anal. of epigenetic markers was performed on tumor tissues.  The in vitro effect of PELP1-KDM axis blockers was tested using proliferation, reporter gene, chromatin immunopptn. and real-time RT-PCR assays.  The efficacy of the KDM1 targeting drugs alone or in combination with letrozole and tamoxifen was tested using therapy-resistant model cells.  Results: Treatment of ER-pos. xenograft-based breast tumors with PELP1-siRNA-DOPC or pargyline reduced tumor vol. by 58.6% and 62%, resp.  In a postmenopausal model, in which tumor growth is stimulated solely by local estrogen synthesis, daily pargyline treatment reduced tumor vol. by 78%.  Immunohistochem. anal. of excised tumors revealed a combined decrease in cellular proliferation, induction of apoptosis and upregulation of inhibitory epigenetic modifications.  Pharmacol. inhibition of KDM1 in vitro increased inhibitory histone mark dimethylation of histone H3 at lysine 9 (H3K9me2) and decreased histone activation mark acetylation of H3K9 (H3K9Ac) on ER target gene promoters.  Combining KDM1 targeting drugs with current endocrine therapies substantially impeded growth and restored sensitivity of therapy-resistant breast cancer cells to treatment.  Conclusion: Our results suggest inhibition of PELP1-KDM1-mediated histone modifications as a potential therapeutic strategy for blocking breast cancer progression and therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQDxZ2Mh92HLVg90H21EOLACvtfcHk0lhH9iCxpwxFzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlyqtb3L&md5=19fe4fcd0f366188f7a32196ec6592d5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2Fbcr3229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr3229%26sid%3Dliteratum%253Aachs%26aulast%3DCortez%26aufirst%3DV.%26aulast%3DMann%26aufirst%3DM.%26aulast%3DTekmal%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DRodriguez-Aguayo%26aufirst%3DC.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DVadlamudi%26aufirst%3DR.%2BK.%26atitle%3DTargeting%2520the%2520PELP1-KDM1%2520axis%2520as%2520a%2520potential%2520therapeutic%2520strategy%2520for%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2012%26volume%3D14%26spage%3DR108%26doi%3D10.1186%2Fbcr3229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Etani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki-Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span> <span> </span><span class="NLM_article-title">NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2865</span>– <span class="NLM_lpage">2878</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.18632%2Foncotarget.3067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25605246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC2MvnvF2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2865-2878&author=T.+Etaniauthor=T.+Suzukiauthor=T.+Naikiauthor=A.+Naiki-Itoauthor=R.+Andoauthor=K.+Iidaauthor=N.+Kawaiauthor=K.+Tozawaauthor=N.+Miyataauthor=K.+Kohriauthor=S.+Takahashi&title=NCL1%2C+a+highly+selective+lysine-specific+demethylase+1+inhibitor%2C+suppresses+prostate+cancer+without+adverse+effect&doi=10.18632%2Foncotarget.3067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect</span></div><div class="casAuthors">Etani Toshiki; Naiki Taku; Ando Ryosuke; Iida Keitaro; Kawai Noriyasu; Tozawa Keiichi; Kohri Kenjiro; Suzuki Takayoshi; Naiki-Ito Aya; Takahashi Satoru; Miyata Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2865-78</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Herein, we investigated therapeutic potential of a novel histone lysine demethylase 1 (LSD1) inhibitor, NCL1, in prostate cancer.  Hormone-sensitive prostate cancer cells, (LNCaP) and castration resistant cancer cells (PC3 and PCai1) were treated with NCL1, and LSD1 expression and cell viability were assessed.  Prostate cancer cells showed strong LSD1 expression, and cell viability was decreased by NCL1.  ChIP analysis showed that NCL1 induced H3K9me2 accumulation at the promoters of androgen-responsive genes.  NCL1 also induced G1 cell cycle arrest and apoptosis.  In addition, autophagosomes and autolysosomes were induced by NCL1 treatment in LNCaP.  Furthermore, LC3-II expression was significantly increased by NCL1 and chloroquine.  In mice injected subcutaneously with PCai1 and intraperitoneally with NCL1, tumor volume was reduced with no adverse effects in NCL1-treated mice.  Finally, LSD1 expression in human cancer specimens was significantly higher than that in normal prostate glands.  In conclusion, NCL1 effectively suppressed prostate cancer growth without adverse events.  We suggest that NCL1 is a potential therapeutic agent for hormone-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9hizy4Ezi3IvKgEt20y1XfW6udTcc2eYfGUNkTPRTdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvnvF2qsQ%253D%253D&md5=6845c5c712fb2ca8ee06c0e31780ca67</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3067%26sid%3Dliteratum%253Aachs%26aulast%3DEtani%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNaiki%26aufirst%3DT.%26aulast%3DNaiki-Ito%26aufirst%3DA.%26aulast%3DAndo%26aufirst%3DR.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DKawai%26aufirst%3DN.%26aulast%3DTozawa%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DKohri%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DS.%26atitle%3DNCL1%252C%2520a%2520highly%2520selective%2520lysine-specific%2520demethylase%25201%2520inhibitor%252C%2520suppresses%2520prostate%2520cancer%2520without%2520adverse%2520effect%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D2865%26epage%3D2878%26doi%3D10.18632%2Foncotarget.3067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Etani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki-Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayasu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span> <span> </span><span class="NLM_article-title">NCL1, A highly selective lysine-specific demethylase 1 inhibitor, suppresses castration-resistant prostate cancer growth via regulation of apoptosis and autophagy</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">442</span>, <span class="refDoi"> DOI: 10.3390/jcm8040442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3390%2Fjcm8040442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitl2qtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=442&author=T.+Etaniauthor=T.+Naikiauthor=A.+Naiki-Itoauthor=T.+Suzukiauthor=K.+Iidaauthor=S.+Nozakiauthor=H.+Katoauthor=Y.+Nagayasuauthor=S.+Suzukiauthor=N.+Kawaiauthor=T.+Yasuiauthor=S.+Takahashi&title=NCL1%2C+A+highly+selective+lysine-specific+demethylase+1+inhibitor%2C+suppresses+castration-resistant+prostate+cancer+growth+via+regulation+of+apoptosis+and+autophagy&doi=10.3390%2Fjcm8040442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses castration-resistant prostate cancer growth via regulation of apoptosis and autophagy</span></div><div class="casAuthors">Etani, Toshiki; Naiki, Taku; Naiki-Ito, Aya; Suzuki, Takayoshi; Iida, Keitaro; Nozaki, Satoshi; Kato, Hiroyuki; Nagayasu, Yuko; Suzuki, Shugo; Kawai, Noriyasu; Yasui, Takahiro; Takahashi, Satoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Recent studies have shown that epigenetic alterations lead to oncogenic activation, thus indicating that these are therapeutic targets.  Herein, we analyzed the efficacy and therapeutic potential of our developed histone lysine demethylase 1 (LSD1) inhibitor, NCL1, in castration-resistant prostate cancer (CRPC).  The CRPC cell lines 22Rv1, PC3, and PCai1CS were treated with NCL1, and LSD1 expression and cell viability were assessed.  The epigenetic effects and mechanisms of NCL1 were also evaluated.  CRPC cells showed strong LSD1 expression, and cell viability was decreased by NCL1 in a dose-dependent manner.  Chromatin immunopptn. anal. indicated that NCL1 induced histone H3 lysine 9 dimethylation accumulation at promoters of P21.  As shown by Western blot and flow cytometry analyses, NCL1 also dose-dependently induced caspase-dependent apoptosis.  The stimulation of autophagy was obsd. in NCL1-treated 22Rv1 cells by transmission electron microscopy and LysoTracker anal.  Furthermore, WST-8 assay revealed that the anti-tumor effect of NCL1 was reinforced when autophagy was inhibited by chloroquine in 22Rv1 cells.  Combination index anal. revealed that a concurrent use of these drugs had a synergistic effect.  In ex vivo anal., castrated nude mice were injected s.c. with PCai1 cells and i.p. with NCL1.  Tumor vol. was found to be reduced with no adverse effects in NCL1-treated mice compared with controls.  Finally, immunohistochem. anal. using consecutive human specimens in pre- and post-androgen deprivation therapy demonstrated that LSD1 expression levels in CRPC, including neuroendocrine differentiation cases, were very high, and identical to levels obsd. in previously examd. prostate biopsy specimens.  NCL1 effectively suppressed prostate cancer growth in vitro and ex vivo without adverse events via the regulation of apoptosis and autophagy, suggesting that NCL1 is a potential therapeutic agent for CRPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyWK5Bza-8FLVg90H21EOLACvtfcHk0lhH9iCxpwxFzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitl2qtLrF&md5=759b1216a71d0288917314af1f725f89</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fjcm8040442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm8040442%26sid%3Dliteratum%253Aachs%26aulast%3DEtani%26aufirst%3DT.%26aulast%3DNaiki%26aufirst%3DT.%26aulast%3DNaiki-Ito%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DNozaki%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DNagayasu%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DKawai%26aufirst%3DN.%26aulast%3DYasui%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26atitle%3DNCL1%252C%2520A%2520highly%2520selective%2520lysine-specific%2520demethylase%25201%2520inhibitor%252C%2520suppresses%2520castration-resistant%2520prostate%2520cancer%2520growth%2520via%2520regulation%2520of%2520apoptosis%2520and%2520autophagy%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D442%26doi%3D10.3390%2Fjcm8040442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sareddy, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanadhapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surapaneni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadlamudi, R. K.</span></span> <span> </span><span class="NLM_article-title">Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2423</span>– <span class="NLM_lpage">2434</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fonc.2016.395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27893719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCnu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=2423-2434&author=G.+R.+Sareddyauthor=S.+Viswanadhapalliauthor=P.+Surapaneniauthor=T.+Suzukiauthor=A.+Brennerauthor=R.+K.+Vadlamudi&title=Novel+KDM1A+inhibitors+induce+differentiation+and+apoptosis+of+glioma+stem+cells+via+unfolded+protein+response+pathway&doi=10.1038%2Fonc.2016.395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway</span></div><div class="casAuthors">Sareddy, G. R.; Viswanadhapalli, S.; Surapaneni, P.; Suzuki, T.; Brenner, A.; Vadlamudi, R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2423-2434</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glioma stem cells (GSCs) have a central role in glioblastoma (GBM) development and chemo/radiation resistance, and their elimination is crit. for the development of efficient therapeutic strategies.  Recently, we showed that lysine demethylase KDM1A is overexpressed in GBM.  In the present study, we detd. whether KDM1A modulates GSCs stemness and differentiation and tested the utility of two novel KDM1A-specific inhibitors (NCL-1 and NCD-38) to promote differentiation and apoptosis of GSCs.  The efficacy of KDM1A targeting drugs was tested on purified GSCs isolated from established and patient-derived GBMs using both in vitro assays and in vivo orthotopic preclin. models.  Our results suggested that KDM1A is highly expressed in GSCs and knockdown of KDM1A using shRNA-reduced GSCs stemness and induced the differentiation.  Pharmacol. inhibition of KDM1A using NCL-1 and NCD-38 significantly reduced the cell viability, neurosphere formation and induced apoptosis of GSCs with little effect on differentiated cells.  In preclin. studies using orthotopic models, NCL-1 and NCD-38 significantly reduced GSCs-driven tumor progression and improved mice survival.  RNA-sequencing anal. showed that KDM1A inhibitors modulate several pathways related to stemness, differentiation and apoptosis.  Mechanistic studies showed that KDM1A inhibitors induce activation of the unfolded protein response (UPR) pathway.  These results strongly suggest that selective targeting of KDM1A using NCL-1 and NCD-38 is a promising therapeutic strategy for elimination of GSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDjv7Rh1PPRbVg90H21EOLACvtfcHk0ljKYoxpfFLoYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCnu7vK&md5=f8e7736d039b748021ea639aca1d8a98</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.395%26sid%3Dliteratum%253Aachs%26aulast%3DSareddy%26aufirst%3DG.%2BR.%26aulast%3DViswanadhapalli%26aufirst%3DS.%26aulast%3DSurapaneni%26aufirst%3DP.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DBrenner%26aufirst%3DA.%26aulast%3DVadlamudi%26aufirst%3DR.%2BK.%26atitle%3DNovel%2520KDM1A%2520inhibitors%2520induce%2520differentiation%2520and%2520apoptosis%2520of%2520glioma%2520stem%2520cells%2520via%2520unfolded%2520protein%2520response%2520pathway%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D2423%26epage%3D2434%26doi%3D10.1038%2Fonc.2016.395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sareddy, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonugunta, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brann, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadlamudi, R. K.</span></span> <span> </span><span class="NLM_article-title">KDM1 is a novel therapeutic target for the treatment of gliomas</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.18632%2Foncotarget.725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=23248157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC3s3isl2qtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=18-28&author=G.+R.+Sareddyauthor=B.+C.+Nairauthor=S.+K.+Krishnanauthor=V.+K.+Gonuguntaauthor=Q.+G.+Zhangauthor=T.+Suzukiauthor=N.+Miyataauthor=A.+J.+Brennerauthor=D.+W.+Brannauthor=R.+K.+Vadlamudi&title=KDM1+is+a+novel+therapeutic+target+for+the+treatment+of+gliomas&doi=10.18632%2Foncotarget.725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">KDM1 is a novel therapeutic target for the treatment of gliomas</span></div><div class="casAuthors">Sareddy Gangadhara R; Nair Binoj C; Krishnan Samaya K; Gonugunta Vijay K; Zhang Quan-guang; Suzuki Takayoshi; Miyata Naoki; Brenner Andrew J; Brann Darrell W; Vadlamudi Ratna K</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioma development is a multistep process, involving alterations in genetic and epigenetic mechanisms.  Understanding the mechanisms and enzymes that promote epigenetic changes in gliomas are urgently needed to identify novel therapeutic targets.  We examined the role of histone demethylase KDM1 in glioma progression.  KDM1 was overexpressed in gliomas and its expression positively correlated with histological malignancy.  Knockdown of KDM1 expression or its pharmacological inhibition using pargyline or NCL-1 significantly reduced the proliferation of glioma cells.  Inhibition of KDM1 promoted up regulation of the p53 target genes p21 and PUMA.  Patient-derived primary GBM cells expressed high levels of KDM1 and pharmacological inhibition of KDM1 decreased their proliferation.  Further, KDM1 inhibition reduced the expression of stemness markers CD133 and nestin in GBM cells.  Mouse xenograft assays revealed that inhibition of KDM1 significantly reduced glioma xenograft tumor growth.  Inhibition of KDM1 increased levels of H3K4-me2 and H3K9-Ac histone modifications, reduced H3K9-me2 modification and promoted expression of p53 target genes (p21 and PUMA), leading to apoptosis of glioma xenograft tumors.  Our results suggest that KDM1 is overexpressed in gliomas and could be a potential therapeutic target for the treatment of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTF-mJUXmh8xNenUz0lpNqnfW6udTcc2ea790anzklRvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3isl2qtQ%253D%253D&md5=43e27a0248dd0fc5e9cce613c589ec28</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.725%26sid%3Dliteratum%253Aachs%26aulast%3DSareddy%26aufirst%3DG.%2BR.%26aulast%3DNair%26aufirst%3DB.%2BC.%26aulast%3DKrishnan%26aufirst%3DS.%2BK.%26aulast%3DGonugunta%26aufirst%3DV.%2BK.%26aulast%3DZhang%26aufirst%3DQ.%2BG.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DBrenner%26aufirst%3DA.%2BJ.%26aulast%3DBrann%26aufirst%3DD.%2BW.%26aulast%3DVadlamudi%26aufirst%3DR.%2BK.%26atitle%3DKDM1%2520is%2520a%2520novel%2520therapeutic%2520target%2520for%2520the%2520treatment%2520of%2520gliomas%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D18%26epage%3D28%26doi%3D10.18632%2Foncotarget.725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki-Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, T.</span></span> <span> </span><span class="NLM_article-title">Mp38-08 Selective lysine specific demethylase 1 inhibitor, Ncl1, could cause testicular toxicity via the regulation of apoptosis</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">e572</span>, <span class="refDoi"> DOI: 10.1097/JU.0000000000000887.08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1097%2FJU.0000000000000887.08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2020&pages=e572&author=S.+Nozakiauthor=T.+Naikiauthor=S.+Iwatsukiauthor=A.+Naiki-Itoauthor=T.+Takedaauthor=T.+Etaniauthor=S.+Kurokawaauthor=S.+Takahashiauthor=Y.+Umemotoauthor=T.+Yasui&title=Mp38-08+Selective+lysine+specific+demethylase+1+inhibitor%2C+Ncl1%2C+could+cause+testicular+toxicity+via+the+regulation+of+apoptosis&doi=10.1097%2FJU.0000000000000887.08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1097%2FJU.0000000000000887.08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJU.0000000000000887.08%26sid%3Dliteratum%253Aachs%26aulast%3DNozaki%26aufirst%3DS.%26aulast%3DNaiki%26aufirst%3DT.%26aulast%3DIwatsuki%26aufirst%3DS.%26aulast%3DNaiki-Ito%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DT.%26aulast%3DEtani%26aufirst%3DT.%26aulast%3DKurokawa%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DUmemoto%26aufirst%3DY.%26aulast%3DYasui%26aufirst%3DT.%26atitle%3DMp38-08%2520Selective%2520lysine%2520specific%2520demethylase%25201%2520inhibitor%252C%2520Ncl1%252C%2520could%2520cause%2520testicular%2520toxicity%2520via%2520the%2520regulation%2520of%2520apoptosis%26jtitle%3DJ.%2520Urol.%26date%3D2020%26volume%3D203%26spage%3De572%26doi%3D10.1097%2FJU.0000000000000887.08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umezawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6494</span>– <span class="NLM_lpage">6503</span>, <span class="refDoi"> DOI: 10.1021/bi100299r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi100299r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFCmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6494-6503&author=S.+Mimasuauthor=N.+Umezawaauthor=S.+Satoauthor=T.+Higuchiauthor=T.+Umeharaauthor=S.+Yokoyama&title=Structurally+designed+trans-2-phenylcyclopropylamine+derivatives+potently+inhibit+histone+demethylase+LSD1%2FKDM1&doi=10.1021%2Fbi100299r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structurally Designed trans-2-Phenylcyclopropylamine Derivatives Potently Inhibit Histone Demethylase LSD1/KDM1</span></div><div class="casAuthors">Mimasu, Shinya; Umezawa, Naoki; Sato, Shin; Higuchi, Tsunehiko; Umehara, Takashi; Yokoyama, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">6494-6503</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1/KDM1) demethylates histone H3, in addn. to tumor suppressor p53 and DNA methyltransferase 1 (Dnmt1), thus regulating eukaryotic gene expression by altering chromatin structure.  Specific inhibitors of LSD1 are desired as anticancer agents, because LSD1 aberrations are assocd. with several cancers, and LSD1 inhibition restores the expression of abnormally silenced genes in cancerous cells.  In this study, we designed and synthesized several candidate compds. to inhibit LSD1, based on the structures of LSD1 and monoamine oxidase B (MAO-B), in complex with an antidepressant tranylcypromine (2-PCPA) deriv.  Compd. S2101 exhibited stronger LSD1 inhibition than tranylcypromine and the known small LSD1 inhibitors in LSD1 demethylation assays, with a kinact/KI value of 4560 M-1 s-1.  In comparison with tranylcypromine, the compd. displayed weaker inhibition to the monoamine oxidases.  The inhibition modes of the two 2-PCPA derivs., 2-PFPA and S1201, were identified by detn. of the inhibitor-bound LSD1 structures, which revealed the enhanced stability of the inhibitor-FAD adducts by their interactions with the surrounding LSD1 residues.  These mols. are potential pharmaceutical candidates for cancer or latent virus infection, as well as research tools for LSD1-related biol. investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIFRdqSvmn97Vg90H21EOLACvtfcHk0ljKYoxpfFLoYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFCmur8%253D&md5=26732b0cd1928d44263f8bb8790ace54</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbi100299r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi100299r%26sid%3Dliteratum%253Aachs%26aulast%3DMimasu%26aufirst%3DS.%26aulast%3DUmezawa%26aufirst%3DN.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DHiguchi%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DStructurally%2520designed%2520trans-2-phenylcyclopropylamine%2520derivatives%2520potently%2520inhibit%2520histone%2520demethylase%2520LSD1%252FKDM1%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D6494%26epage%3D6503%26doi%3D10.1021%2Fbi100299r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fioravanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mautone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Bello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corinti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwergel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vultaggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Tranylcypromine-based LSD1 inhibitors: structure-activity relationships, antiproliferative effects in leukemia, and gene target modulation</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">658</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fcmdc.201900730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32003940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtVehs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=643-658&author=R.+Fioravantiauthor=A.+Romanelliauthor=N.+Mautoneauthor=E.+Di+Belloauthor=A.+Rovereauthor=D.+Corintiauthor=C.+Zwergelauthor=S.+Valenteauthor=D.+Rotiliauthor=O.+A.+Botrugnoauthor=P.+Dessantiauthor=S.+Vultaggioauthor=P.+Vianelloauthor=A.+Cappaauthor=C.+Bindaauthor=A.+Matteviauthor=S.+Minucciauthor=C.+Mercurioauthor=M.+Varasiauthor=A.+Mai&title=Tranylcypromine-based+LSD1+inhibitors%3A+structure-activity+relationships%2C+antiproliferative+effects+in+leukemia%2C+and+gene+target+modulation&doi=10.1002%2Fcmdc.201900730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation</span></div><div class="casAuthors">Fioravanti, Rossella; Romanelli, Annalisa; Mautone, Nicola; Di Bello, Elisabetta; Rovere, Annarita; Corinti, Davide; Zwergel, Clemens; Valente, Sergio; Rotili, Dante; Botrugno, Oronza A.; Dessanti, Paola; Vultaggio, Stefania; Vianello, Paola; Cappa, Anna; Binda, Claudia; Mattevi, Andrea; Minucci, Saverio; Mercurio, Ciro; Varasi, Mario; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">643-658</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Abstr.: LSD1 is a lysine demethylase highly involved in initiation and development of cancer.  To design highly effective covalent inhibitors, a strategy is to fill its large catalytic cleft by designing tranylcypromine (TCP) analogs decorated with long, hindered substituents.  We prepd. three series of TCP analogs, carrying aroyl- and arylacetylamino (1 a-h), Z-amino acylamino (2 a-o), or double-substituted benzamide (3 a-n) residues at the C4 or C3 position of the Ph ring.  Further fragments obtained by chem. manipulation applied on the TCP scaffold (compds. 4 a-i) were also prepd.  When tested against LSD1, most of 1 and 3 exhibited IC50 values in the low nanomolar range, with 1 e and 3 a,d,f,g being also the most selective respect to monoamine oxidases.  In MV4-11 AML and NB4 APL cells compds. 3 were the most potent, displaying up to sub-micromolar cell growth inhibition against both cell lines (3 a) or against NB4 cells (3 c).  The most potent compds. in cellular assays were also able to induce the expression of LSD1 target genes, such as GFI-1b, ITGAM, and KCTD12, as functional read-out for LSD1 inhibition.  Mouse and human intrinsic clearance data highlighted the high metabolic stability of compds. 3 a, 3 d and 3 g.  Further studies will be performed on the new compds. 3 a and 3 c to assess their anticancer potential in different cancer contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXz4wd2RgF17Vg90H21EOLACvtfcHk0li8ZnKL1fvFYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtVehs74%253D&md5=31e9e04ed0a7264b19204019273b37c4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900730%26sid%3Dliteratum%253Aachs%26aulast%3DFioravanti%26aufirst%3DR.%26aulast%3DRomanelli%26aufirst%3DA.%26aulast%3DMautone%26aufirst%3DN.%26aulast%3DDi%2BBello%26aufirst%3DE.%26aulast%3DRovere%26aufirst%3DA.%26aulast%3DCorinti%26aufirst%3DD.%26aulast%3DZwergel%26aufirst%3DC.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DVultaggio%26aufirst%3DS.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DTranylcypromine-based%2520LSD1%2520inhibitors%253A%2520structure-activity%2520relationships%252C%2520antiproliferative%2520effects%2520in%2520leukemia%252C%2520and%2520gene%2520target%2520modulation%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D643%26epage%3D658%26doi%3D10.1002%2Fcmdc.201900730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benelkebir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duriez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulleid, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabb, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3709</span>– <span class="NLM_lpage">3716</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmc.2011.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=21382717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVyju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3709-3716&author=H.+Benelkebirauthor=C.+Hodgkinsonauthor=P.+J.+Duriezauthor=A.+L.+Haydenauthor=R.+A.+Bulleidauthor=S.+J.+Crabbauthor=G.+Packhamauthor=A.+Ganesan&title=Enantioselective+synthesis+of+tranylcypromine+analogues+as+lysine+demethylase+%28LSD1%29+inhibitors&doi=10.1016%2Fj.bmc.2011.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors</span></div><div class="casAuthors">Benelkebir, Hanae; Hodgkinson, Christopher; Duriez, Patrick J.; Hayden, Annette L.; Bulleid, Rosemary A.; Crabb, Simon J.; Packham, Graham; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3709-3716</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Asym. cyclopropanation of styrenes by tert-Bu diazoacetate followed by ester hydrolysis and Curtius rearrangement gave a series of tranylcypromine analogs as single enantiomers.  The o-, m-, and p-bromo analogs were all more active than tranylcypromine in a LSD1 enzyme assay.  The m- and p-bromo analogs were micromolar growth inhibitors of the LNCaP prostate cancer cell line as were the corresponding biphenyl analogs prepd. from the bromide by Suzuki crosscoupling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuHGveNGE6AbVg90H21EOLACvtfcHk0li8ZnKL1fvFYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVyju7s%253D&md5=a8517cf8753c76b1403b6354977fc2a2</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DBenelkebir%26aufirst%3DH.%26aulast%3DHodgkinson%26aufirst%3DC.%26aulast%3DDuriez%26aufirst%3DP.%2BJ.%26aulast%3DHayden%26aufirst%3DA.%2BL.%26aulast%3DBulleid%26aufirst%3DR.%2BA.%26aulast%3DCrabb%26aufirst%3DS.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DEnantioselective%2520synthesis%2520of%2520tranylcypromine%2520analogues%2520as%2520lysine%2520demethylase%2520%2528LSD1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3709%26epage%3D3716%26doi%3D10.1016%2Fj.bmc.2011.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stazi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Pyrrole- and indole-containing tranylcypromine derivatives as novel lysine-specific demethylase 1 inhibitors active on cancer cells</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1039/C4MD00507D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1039%2FC4MD00507D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=665-670&author=V.+Rodriguezauthor=S.+Valenteauthor=S.+Rovidaauthor=D.+Rotiliauthor=G.+Staziauthor=A.+Lucidiauthor=G.+Ciossaniauthor=A.+Matteviauthor=O.+A.+Botrugnoauthor=P.+Dessantiauthor=C.+Mercurioauthor=P.+Vianelloauthor=S.+Minucciauthor=M.+Varasiauthor=A.+Mai&title=Pyrrole-+and+indole-containing+tranylcypromine+derivatives+as+novel+lysine-specific+demethylase+1+inhibitors+active+on+cancer+cells&doi=10.1039%2FC4MD00507D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrole- and indole-containing tranylcypromine derivatives as novel lysine-specific demethylase 1 inhibitors active on cancer cells</span></div><div class="casAuthors">Rodriguez, Veronica; Valente, Sergio; Rovida, Stefano; Rotili, Dante; Stazi, Giulia; Lucidi, Alessia; Ciossani, Giuseppe; Mattevi, Andrea; Botrugno, Oronza A.; Dessanti, Paola; Mercurio, Ciro; Vianello, Paola; Minucci, Saverio; Varasi, Mario; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">665-670</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">On the basis of previous research showing the capability of N-carbobenzyloxy-(Z-)amino acid-tranylcypromine (-TCPA) derivs. to inhibit LSD1, we inserted at the 4-amino-TCPA moiety first a Z-Pro (9) and a Z-Gly (10) residue and then, after the encouraging data obtained for 9, a pyrrole and an indole ring in which the relative N1 position carried a acetophenone, a N-phenyl/benzylacetamide, or a Z chain (11a-f and 12a-f, resp.).  In both series, the Z-pyrrole and indole derivs. 11e, f and 12e, f displayed high LSD1 inhibitory activity.  The compds. are able to inhibit LSD1 in NB4 cells, increasing the expression of two related genes, GFI-1b and ITGAM, and to induce cell growth arrest in the AML MB4-11 and APL NB4 cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOllVHCuR7lLVg90H21EOLACvtfcHk0lhPqxutTNGERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrtb%252FN&md5=5ed5d4a172f787639bd9f4f84065c880</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1039%2FC4MD00507D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00507D%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DV.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DRovida%26aufirst%3DS.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DStazi%26aufirst%3DG.%26aulast%3DLucidi%26aufirst%3DA.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DPyrrole-%2520and%2520indole-containing%2520tranylcypromine%2520derivatives%2520as%2520novel%2520lysine-specific%2520demethylase%25201%2520inhibitors%2520active%2520on%2520cancer%2520cells%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D665%26epage%3D670%26doi%3D10.1039%2FC4MD00507D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, L.</span>; <span class="NLM_string-name">Benelkebir, H.</span>; <span class="NLM_string-name">Ganesan, P.</span>; <span class="NLM_string-name">Duriez, P. J.</span>; <span class="NLM_string-name">Packham, G.</span>; <span class="NLM_string-name">Crabb, S.</span>; <span class="NLM_string-name">Bailey, S.</span>; <span class="NLM_string-name">Bowles, K.</span>; <span class="NLM_string-name">Rushworth, S.</span>; <span class="NLM_string-name">Shafat, M.</span>; <span class="NLM_string-name">Tam, C. H.</span>; <span class="NLM_string-name">Borrello, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of carboxamides tranylcypromine analogues as LSD1 (KDM1A) inhibitors for AML</span>.  <i>ChemRxiv</i> <span class="NLM_year">2020</span>, <a href="https://chemrxiv.org/articles/preprint/Synthesis_of_Carboxamides_Tranylcypromine_Analogues_as_LSD1_KDM1A_Inhibitors_for_AML/11860824/1" class="extLink">10.26434/chemrxiv.11860824</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=L.+Douglas&author=H.+Benelkebir&author=P.+Ganesan&author=P.+J.+Duriez&author=G.+Packham&author=S.+Crabb&author=S.+Bailey&author=K.+Bowles&author=S.+Rushworth&author=M.+Shafat&author=C.+H.+Tam&author=T.+Borrello&title=Synthesis+of+carboxamides+tranylcypromine+analogues+as+LSD1+%28KDM1A%29+inhibitors+for+AML"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DL.%26atitle%3DSynthesis%2520of%2520carboxamides%2520tranylcypromine%2520analogues%2520as%2520LSD1%2520%2528KDM1A%2529%2520inhibitors%2520for%2520AML%26jtitle%3DChemRxiv%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrocco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yapp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1021/jm4012802</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012802" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=42-55&author=D.+Rotiliauthor=S.+Tomassiauthor=M.+Conteauthor=R.+Benedettiauthor=M.+Tortoriciauthor=G.+Ciossaniauthor=S.+Valenteauthor=B.+Marroccoauthor=D.+Labellaauthor=E.+Novellinoauthor=A.+Matteviauthor=L.+Altucciauthor=A.+Tumberauthor=C.+Yappauthor=O.+N.+Kingauthor=R.+J.+Hopkinsonauthor=A.+Kawamuraauthor=C.+J.+Schofieldauthor=A.+Mai&title=Pan-histone+demethylase+inhibitors+simultaneously+targeting+Jumonji+C+and+lysine-specific+demethylases+display+high+anticancer+activities&doi=10.1021%2Fjm4012802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities</span></div><div class="casAuthors">Rotili, Dante; Tomassi, Stefano; Conte, Mariarosaria; Benedetti, Rosaria; Tortorici, Marcello; Ciossani, Giuseppe; Valente, Sergio; Marrocco, Biagina; Labella, Donatella; Novellino, Ettore; Mattevi, Andrea; Altucci, Lucia; Tumber, Anthony; Yapp, Clarence; King, Oliver N. F.; Hopkinson, Richard J.; Kawamura, Akane; Schofield, Christopher J.; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-55</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In prostate cancer, two different types of histone lysine demethylases (KDM), LSD1/KDM1 and JMJD2/KDM4, are coexpressed and colocalize with the androgen receptor.  We designed and synthesized hybrid LSD1/JmjC or "pan-KDM" inhibitors by coupling the skeleton of tranylcypromine, a known LSD1 inhibitor, with 4-carboxy-4'-carbomethoxy-2,2'-bipyridine or 5-carboxy-8-hydroxyquinoline , two 2-oxoglutarate competitive templates developed for JmjC inhibition.  Hybrid compds. are able to simultaneously target both KDM families and have been validated as potential antitumor agents in cells.  Among them,two compds. increase H3K4 and H3K9 methylation levels in cells and cause growth arrest and substantial apoptosis in LNCaP prostate and HCT116 colon cancer cells.  When tested in non-cancer mesenchymal progenitor (MePR) cells, two compds. induced little and no apoptosis, resp., thus showing cancer-selective inhibiting action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-XAvtMSKOmLVg90H21EOLACvtfcHk0lhPqxutTNGERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltL7P&md5=9dbdf51a5c6b9b2881da746eb3955e90</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm4012802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012802%26sid%3Dliteratum%253Aachs%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DConte%26aufirst%3DM.%26aulast%3DBenedetti%26aufirst%3DR.%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DMarrocco%26aufirst%3DB.%26aulast%3DLabella%26aufirst%3DD.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DKing%26aufirst%3DO.%2BN.%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DPan-histone%2520demethylase%2520inhibitors%2520simultaneously%2520targeting%2520Jumonji%2520C%2520and%2520lysine-specific%2520demethylases%2520display%2520high%2520anticancer%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D42%26epage%3D55%26doi%3D10.1021%2Fjm4012802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Regulation of LSD1 histone demethylase activity by its associated factors</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2005.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.molcel.2005.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=16140033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyhtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=857-864&author=Y.-J.+Shiauthor=C.+Matsonauthor=F.+Lanauthor=S.+Iwaseauthor=T.+Babaauthor=Y.+Shi&title=Regulation+of+LSD1+histone+demethylase+activity+by+its+associated+factors&doi=10.1016%2Fj.molcel.2005.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of LSD1 histone demethylase activity by its associated factors</span></div><div class="casAuthors">Shi, Yu-Jiang; Matson, Caitlin; Lan, Fei; Iwase, Shigeki; Baba, Tadashi; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">857-864</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">LSD1 is a recently identified human lysine (K)-specific histone demethylase.  LSD1 is assocd. with HDAC1/2, with CoREST, a SANT domain-contg. corepressor, and with BHC80, a PHD domain-contg. protein, among others.  We show that CoREST confers on LSD1 the ability to demethylate nucleosomal substrates and that it protects LSD1 from proteasomal degrdn. in vivo.  We find hyperacetylated nucleosomes less susceptible to CoREST/LSD1-mediated demethylation, suggesting that hypoacetylated nucleosomes may be the preferred physiol. substrates.  This raises the possibility that histone deacetylases and LSD1 may collaborate to generate a repressive chromatin environment.  Consistent with this model, TSA treatment results in derepression of LSD1 target genes.  While CoREST pos. regulates LSD1 function, BHC80 inhibits CoREST/LSD1-mediated demethylation in vitro and may therefore confer neg. regulation.  Taken together, these findings suggest that LSD1-mediated histone demethylation is regulated dynamically in vivo.  This is expected to have profound effects on gene expression under both physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraharVnxcaMLVg90H21EOLACvtfcHk0lhPqxutTNGERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyhtbzK&md5=34ba238112151c6596dd6f6c7caa043e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.-J.%26aulast%3DMatson%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DIwase%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRegulation%2520of%2520LSD1%2520histone%2520demethylase%2520activity%2520by%2520its%2520associated%2520factors%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D857%26epage%3D864%26doi%3D10.1016%2Fj.molcel.2005.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">A systematic review of histone lysine-specific demethylase 1 and its inhibitors</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1071</span>, <span class="refDoi"> DOI: 10.1002/med.21350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fmed.21350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yqtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1032-1071&author=Y.+C.+Zhengauthor=J.+Maauthor=Z.+Wangauthor=J.+Liauthor=B.+Jiangauthor=W.+Zhouauthor=X.+Shiauthor=X.+Wangauthor=W.+Zhaoauthor=H.+M.+Liu&title=A+systematic+review+of+histone+lysine-specific+demethylase+1+and+its+inhibitors&doi=10.1002%2Fmed.21350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors</span></div><div class="casAuthors">Zheng, Yi-Chao; Ma, Jinlian; Wang, Zhiru; Li, Jinfeng; Jiang, Bailing; Zhou, Wenjuan; Shi, Xiaojing; Wang, Xixin; Zhao, Wen; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1032-1071</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Histone lysine-specific demethylase 1 (LSD1) is the first discovered and reported histone demethylase by Dr. Shi Yang's group in 2004.  It is classified as a member of amine oxidase superfamily, the common feature of which is using the FAD (FAD) as its cofactor.  Since it is located in cell nucleus and acts as a histone methylation eraser, LSD1 specifically removes mono- or dimethylated histone H3 lysine 4 (H3K4) and H3 lysine 9 (H3K9) through formaldehyde-generating oxidn.  It has been indicated that LSD1 and its downstream targets are involved in a wide range of biol. courses, including embryonic development and tumor-cell growth and metastasis.  LSD1 has been reported to be overexpressed in variety of tumors.  Inactivating LSD1 or downregulating its expression inhibits cancer-cell development.  LSD1 targeting inhibitors may represent a new insight in anticancer drug discovery.  This review summarizes recent studies about LSD1 and mainly focuses on the basic physiol. function of LSD1 and its involved mechanisms in pathophysiol. conditions, as well as the development of LSD1 inhibitors as potential anticancer therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7JXHHRI-QAbVg90H21EOLACvtfcHk0lh41RqVhAkVPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yqtrfN&md5=43b875856c2fe9f7a02857e7d6de73e6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fmed.21350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21350%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DA%2520systematic%2520review%2520of%2520histone%2520lysine-specific%2520demethylase%25201%2520and%2520its%2520inhibitors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2015%26volume%3D35%26spage%3D1032%26epage%3D1071%26doi%3D10.1002%2Fmed.21350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adejola, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusevich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeliazkov, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy Burman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eroglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proby, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwabe, J. W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alani, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">53</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02242-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fs41467-017-02242-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29302039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC1MznsFKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=53&author=J.+H.+Kalinauthor=M.+Wuauthor=A.+V.+Gomezauthor=Y.+Songauthor=J.+Dasauthor=D.+Haywardauthor=N.+Adejolaauthor=M.+Wuauthor=I.+Panovaauthor=H.+J.+Chungauthor=E.+Kimauthor=H.+J.+Robertsauthor=J.+M.+Robertsauthor=P.+Prusevichauthor=J.+R.+Jeliazkovauthor=S.+S.+Roy+Burmanauthor=L.+Fairallauthor=C.+Milanoauthor=A.+Erogluauthor=C.+M.+Probyauthor=A.+T.+Dinkova-Kostovaauthor=W.+W.+Hancockauthor=J.+J.+Grayauthor=J.+E.+Bradnerauthor=S.+Valenteauthor=A.+Maiauthor=N.+M.+Andersauthor=M.+A.+Rudekauthor=Y.+Huauthor=B.+Ryuauthor=J.+W.+R.+Schwabeauthor=A.+Matteviauthor=R.+M.+Alaniauthor=P.+A.+Cole&title=Targeting+the+CoREST+complex+with+dual+histone+deacetylase+and+demethylase+inhibitors&doi=10.1038%2Fs41467-017-02242-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors</span></div><div class="casAuthors">Kalin Jay H; Wu Mingxuan; Cole Philip A; Kalin Jay H; Das Jayanta; Hayward Dawn; Adejola Nkosi; Wu Mingxuan; Prusevich Polina; Eroglu Abdulkerim; Dinkova-Kostova Albena T; Cole Philip A; Wu Muzhou; Panova Izabela; Chung Hye Jin; Kim Edward; Roberts Holly J; Ryu Byungwoo; Alani Rhoda M; Gomez Andrea V; Mattevi Andrea; Song Yun; Fairall Louise; Milano Charles; Schwabe John W R; Roberts Justin M; Bradner James E; Jeliazkov Jeliazko R; Gray Jeffrey J; Roy Burman Shourya S; Gray Jeffrey J; Proby Charlotte M; Dinkova-Kostova Albena T; Hancock Wayne W; Gray Jeffrey J; Anders Nicole M; Rudek Michelle A; Valente Sergio; Mai Antonello; Hu Yong</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Here we report corin, a synthetic hybrid agent derived from the class I HDAC inhibitor (entinostat) and an LSD1 inhibitor (tranylcypromine analog).  Enzymologic analysis reveals that corin potently targets the CoREST complex and shows more sustained inhibition of CoREST complex HDAC activity compared with entinostat.  Cell-based experiments demonstrate that corin exhibits a superior anti-proliferative profile against several melanoma lines and cutaneous squamous cell carcinoma lines compared to its parent monofunctional inhibitors but is less toxic to melanocytes and keratinocytes.  CoREST knockdown, gene expression, and ChIP studies suggest that corin's favorable pharmacologic effects may rely on an intact CoREST complex.  Corin was also effective in slowing tumor growth in a melanoma mouse xenograft model.  These studies highlight the promise of a new class of two-pronged hybrid agents that may show preferential targeting of particular epigenetic regulatory complexes and offer unique therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6q8vQkB-NEHl8icjszYl0fW6udTcc2eZOis3YkJ_Od7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MznsFKiug%253D%253D&md5=83e70e824d89f6148286a69ae2868731</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02242-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02242-4%26sid%3Dliteratum%253Aachs%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DA.%2BV.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DHayward%26aufirst%3DD.%26aulast%3DAdejola%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DPanova%26aufirst%3DI.%26aulast%3DChung%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DH.%2BJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DPrusevich%26aufirst%3DP.%26aulast%3DJeliazkov%26aufirst%3DJ.%2BR.%26aulast%3DRoy%2BBurman%26aufirst%3DS.%2BS.%26aulast%3DFairall%26aufirst%3DL.%26aulast%3DMilano%26aufirst%3DC.%26aulast%3DEroglu%26aufirst%3DA.%26aulast%3DProby%26aufirst%3DC.%2BM.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DGray%26aufirst%3DJ.%2BJ.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DAnders%26aufirst%3DN.%2BM.%26aulast%3DRudek%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DRyu%26aufirst%3DB.%26aulast%3DSchwabe%26aufirst%3DJ.%2BW.%2BR.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DAlani%26aufirst%3DR.%2BM.%26aulast%3DCole%26aufirst%3DP.%2BA.%26atitle%3DTargeting%2520the%2520CoREST%2520complex%2520with%2520dual%2520histone%2520deacetylase%2520and%2520demethylase%2520inhibitors%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D53%26doi%3D10.1038%2Fs41467-017-02242-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastas, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zee, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrescu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nocco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonal, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suva, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filbin, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2019.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ccell.2019.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31631026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVSlsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=528-544&author=J.+N.+Anastasauthor=B.+M.+Zeeauthor=J.+H.+Kalinauthor=M.+Kimauthor=R.+Guoauthor=S.+Alexandrescuauthor=M.+A.+Blancoauthor=S.+Gieraauthor=S.+M.+Gillespieauthor=J.+Dasauthor=M.+Wuauthor=S.+Noccoauthor=D.+M.+Bonalauthor=Q.-D.+Nguyenauthor=M.+L.+Suvaauthor=B.+E.+Bernsteinauthor=R.+Alaniauthor=T.+R.+Golubauthor=P.+A.+Coleauthor=M.+G.+Filbinauthor=Y.+Shi&title=Re-programing+chromatin+with+a+bifunctional+LSD1%2FHDAC+inhibitor+induces+therapeutic+differentiation+in+DIPG&doi=10.1016%2Fj.ccell.2019.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG</span></div><div class="casAuthors">Anastas, Jamie N.; Zee, Barry M.; Kalin, Jay H.; Kim, Mirhee; Guo, Robyn; Alexandrescu, Sanda; Blanco, Mario Andres; Giera, Stefanie; Gillespie, Shawn M.; Das, Jayanta; Wu, Muzhou; Nocco, Sarah; Bonal, Dennis M.; Nguyen, Quang-De; Suva, Mario L.; Bernstein, Bradley E.; Alani, Rhoda; Golub, Todd R.; Cole, Philip A.; Filbin, Mariella G.; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">528-544.e10</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">H3K27M mutations resulting in epigenetic dysfunction are frequently obsd. in diffuse intrinsic pontine glioma (DIPGs), an incurable pediatric cancer.  We conduct a CRISPR screen revealing that knockout of KDM1A encoding lysine-specific demethylase 1 (LSD1) sensitizes DIPG cells to histone deacetylase (HDAC) inhibitors.  Consistently, Corin, a bifunctional inhibitor of HDACs and LSD1, potently inhibits DIPG growth in vitro and in xenografts.  Mechanistically, Corin increases H3K27me3 levels suppressed by H3K27M histones, and simultaneously increases HDAC-targeted H3K27ac and LSD1-targeted H3K4me1 at differentiation-assocd. genes.  Corin treatment induces cell death, cell-cycle arrest, and a cellular differentiation phenotype and drives transcriptional changes correlating with increased survival time in DIPG patients.  These data suggest a strategy for treating DIPG by simultaneously inhibiting LSD1 and HDACs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHX1Q6HDJoobVg90H21EOLACvtfcHk0lh41RqVhAkVPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVSlsr%252FL&md5=32c4c2c7f032812a95d424b19ca7039e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2019.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2019.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DAnastas%26aufirst%3DJ.%2BN.%26aulast%3DZee%26aufirst%3DB.%2BM.%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DAlexandrescu%26aufirst%3DS.%26aulast%3DBlanco%26aufirst%3DM.%2BA.%26aulast%3DGiera%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DS.%2BM.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DNocco%26aufirst%3DS.%26aulast%3DBonal%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DQ.-D.%26aulast%3DSuva%26aufirst%3DM.%2BL.%26aulast%3DBernstein%26aufirst%3DB.%2BE.%26aulast%3DAlani%26aufirst%3DR.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DFilbin%26aufirst%3DM.%2BG.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRe-programing%2520chromatin%2520with%2520a%2520bifunctional%2520LSD1%252FHDAC%2520inhibitor%2520induces%2520therapeutic%2520differentiation%2520in%2520DIPG%26jtitle%3DCancer%2520Cell%26date%3D2019%26volume%3D36%26spage%3D528%26epage%3D544%26doi%3D10.1016%2Fj.ccell.2019.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turrini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catanzaro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimognari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span> <span> </span><span class="NLM_article-title">Novel polyamine-based histone deacetylases-lysine demethylase 1 dual binding inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1001</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.02.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2018.02.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29496367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsF2ktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1001-1004&author=A.+Milelliauthor=C.+Marchettiauthor=E.+Turriniauthor=E.+Catanzaroauthor=R.+Mazzoneauthor=D.+Tomaselliauthor=C.+Fimognariauthor=V.+Tumiattiauthor=A.+Minarini&title=Novel+polyamine-based+histone+deacetylases-lysine+demethylase+1+dual+binding+inhibitors&doi=10.1016%2Fj.bmcl.2018.02.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors</span></div><div class="casAuthors">Milelli, Andrea; Marchetti, Chiara; Turrini, Eleonora; Catanzaro, Elena; Mazzone, Roberta; Tomaselli, Daniela; Fimognari, Carmela; Tumiatti, Vincenzo; Minarini, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1001-1004</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Epigenetic modulators Histone deacetylases (HDACs) and Lysine demethylase (LSD1) are validated targets for anticancer therapy.  Both HDAC1/2 and LSD1 are found in assocn. with the repressor protein Co-REST in a transcriptional corepressor complex, which is responsible for gene silencing.  Combined modulation of both targets results in a synergistic antiproliferative activity.  In the present investigation, the authors report about the design and synthesis of a series of polyamine-based HDACs-LSD1 dual binding inhibitors obtained by coupling Vorinostat and Tranylcypromine.  Compd. I emerged as the most promising of the synthesized series, showing good inhibitory activity towards HDAC1 and LSD1 either in vitro and in cell-based assay (Ki = 42.52±8.94 nM and IC50 = 3.85 μM, resp.).  Furthermore, at 70.0 μM compd. I induced a more pronounced cytotoxic effect than Vorinostat (68.6% vs. 56.6% of dead cells) in MCF7 cancer cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT9vK3NTBBprVg90H21EOLACvtfcHk0lgCdYknE1JJnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsF2ktL4%253D&md5=3821c6837a93fc19c03e6f3cb5ea848f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.02.034%26sid%3Dliteratum%253Aachs%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DTurrini%26aufirst%3DE.%26aulast%3DCatanzaro%26aufirst%3DE.%26aulast%3DMazzone%26aufirst%3DR.%26aulast%3DTomaselli%26aufirst%3DD.%26aulast%3DFimognari%26aufirst%3DC.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMinarini%26aufirst%3DA.%26atitle%3DNovel%2520polyamine-based%2520histone%2520deacetylases-lysine%2520demethylase%25201%2520dual%2520binding%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D1001%26epage%3D1004%26doi%3D10.1016%2Fj.bmcl.2018.02.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasinghe, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woster, P. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1021/ml4002997</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4002997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=29-33&author=I.+R.+Kumarasingheauthor=P.+M.+Woster&title=Synthesis+and+evaluation+of+novel+cyclic+Peptide+inhibitors+of+lysine-specific+demethylase+1&doi=10.1021%2Fml4002997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Novel Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1</span></div><div class="casAuthors">Kumarasinghe, Isuru R.; Woster, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) selectively removes Me groups from mono- and dimethylated histone 3 lysine 4 (H3K4), resulting in gene silencing.  LSD1 is overexpressed in many human cancers, resulting in aberrant silencing of tumor suppressor genes.  Thus, LSD1 is a validated target for the discovery of antitumor agents.  Using a ligand-based approach, the authors designed and synthesized a series of cyclic and linear peptides that are effective inhibitors of LSD1.  Linear peptide 7 and cyclic peptide 9 inhibited LSD1 in vitro by 91 and 94%, resp., at a concn. of 10 μM.  Compd. 9 was a potent LSD1 inhibitor (IC50 = 2.1 μM; Ki = 385 nM) and had moderate antitumor activity in the MCF-7 and Calu-6 cell lines in vitro.  Importantly, 9 is significantly more stable to hydrolysis in rat plasma than the linear analog 7.  The cyclic peptides described herein represent important lead structures in the search for inhibitors of flavin-dependent histone demethylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZKg9n5W93bVg90H21EOLACvtfcHk0lgCdYknE1JJnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrsr3F&md5=65810b4100bf4fb4fb10c204e77f88a0</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fml4002997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4002997%26sid%3Dliteratum%253Aachs%26aulast%3DKumarasinghe%26aufirst%3DI.%2BR.%26aulast%3DWoster%26aufirst%3DP.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520cyclic%2520Peptide%2520inhibitors%2520of%2520lysine-specific%2520demethylase%25201%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D29%26epage%3D33%26doi%3D10.1021%2Fml4002997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrello, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tardugno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellore, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabb, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1677</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1021/cb4001926</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4001926" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1677-1682&author=M.+Tortoriciauthor=M.+T.+Borrelloauthor=M.+Tardugnoauthor=L.+R.+Chiarelliauthor=S.+Pilottoauthor=G.+Ciossaniauthor=N.+A.+Velloreauthor=S.+G.+Baileyauthor=J.+Cowanauthor=M.+O%E2%80%99Connellauthor=S.+J.+Crabbauthor=G.+Packhamauthor=A.+Maiauthor=R.+Baronauthor=A.+Ganesanauthor=A.+Mattevi&title=Protein+recognition+by+short+peptide+reversible+inhibitors+of+the+chromatin-modifying+LSD1%2FCoREST+lysine+demethylase&doi=10.1021%2Fcb4001926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylase</span></div><div class="casAuthors">Tortorici, Marcello; Borrello, Maria Teresa; Tardugno, Maria; Chiarelli, Laurent R.; Pilotto, Simona; Ciossani, Giuseppe; Vellore, Nadeem A.; Bailey, Sarah G.; Cowan, Jonathan; O'Connell, Maria; Crabb, Simon J.; Packham, Graham; Mai, Antonello; Baron, Riccardo; Ganesan, A.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1677-1682</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The combinatorial assembly of protein complexes is at the heart of chromatin biol.  Lysine demethylase LSD1(KDM1A)/CoREST beautifully exemplifies this concept.  The active site of the enzyme tightly assocs. to the N-terminal domain of transcription factors of the SNAIL1 family, which therefore can competitively inhibit the binding of the N-terminal tail of the histone substrate.  Our enzymic, crystallog., spectroscopic, and computational studies reveal that LSD1/CoREST can bind to a hexapeptide derived from the SNAIL sequence through recognition of a pos. charged α-helical turn that forms upon binding to the enzyme.  Variations in sequence and length of this six amino acid ligand modulate affinities enabling the same binding site to differentially interact with proteins that exert distinct biol. functions.  The discovered short peptide inhibitors exhibit antiproliferative activities and lay the foundation for the development of peptidomimetic small mol. inhibitors of LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7SufQOwK-y7Vg90H21EOLACvtfcHk0lgCdYknE1JJnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVCmt7g%253D&md5=a8479b513e392e8acb78979e116dcffa</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fcb4001926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4001926%26sid%3Dliteratum%253Aachs%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DBorrello%26aufirst%3DM.%2BT.%26aulast%3DTardugno%26aufirst%3DM.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DPilotto%26aufirst%3DS.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DVellore%26aufirst%3DN.%2BA.%26aulast%3DBailey%26aufirst%3DS.%2BG.%26aulast%3DCowan%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DM.%26aulast%3DCrabb%26aufirst%3DS.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DProtein%2520recognition%2520by%2520short%2520peptide%2520reversible%2520inhibitors%2520of%2520the%2520chromatin-modifying%2520LSD1%252FCoREST%2520lysine%2520demethylase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1677%26epage%3D1682%26doi%3D10.1021%2Fcb4001926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuhara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">8620</span>– <span class="NLM_lpage">8624</span>, <span class="refDoi"> DOI: 10.1002/anie.201303999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fanie.201303999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGrsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=8620-8624&author=D.+Ogasawaraauthor=Y.+Itohauthor=H.+Tsumotoauthor=T.+Kakizawaauthor=K.+Minoauthor=K.+Fukuharaauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyataauthor=T.+Suzuki&title=Lysine-specific+demethylase+1-selective+inactivators%3A+protein-targeted+drug+delivery+mechanism&doi=10.1002%2Fanie.201303999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-specific demethylase 1-selective inactivators: Protein-targeted drug delivery mechanism</span></div><div class="casAuthors">Ogasawara, Daisuke; Itoh, Yukihiro; Tsumoto, Hiroki; Kakizawa, Taeko; Mino, Koshiki; Fukuhara, Kiyoshi; Nakagawa, Hidehiko; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio; Miyata, Naoki; Suzuki, Takayoshi</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">8620-8624</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of novel LSD1 (LSD1 = lysine-specific demethylase) inactivators based on new concept of LSD1-targeted PCPA (PCPA = trans-2-phenylcyclopropylamine) delivery have been designed.  This concept was tested with peptide 1a [1a = (ART-X-QTARKSTGGKAPRKQLA)] X = (I) and confirmed that 1a does indeed inhibit LSD1 selectively and efficiently by delivering PCPA directly to the LSD1 active site.  The enzyme is then inactivated by FAD-PCPA adduct formation, as in the case of PCPA itself.  This strategy could be applied to the design of nonpeptide, small-mol. LSD1 inactivators.  Mechanistic studies and biol. evaluations revealed that these small-mol. compds. are potent LSD1-selective inactivators (comparable to peptide 1a) in enzyme assays, and they also exhibit potent cell growth inhibitory activities against cancer cell lines.  This is the first time that a drug-carrier-type system has been employed to target a specific mol.  These novel LSD1-selective inactivators are considered to be candidates for anticancer agents, as well as bioprobes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqQOLhLwmv9rVg90H21EOLACvtfcHk0ljUxtXhnqJljA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGrsbnF&md5=71bd05a50aeb73431444f2588fba2dac</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fanie.201303999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201303999%26sid%3Dliteratum%253Aachs%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DKakizawa%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DFukuhara%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DLysine-specific%2520demethylase%25201-selective%2520inactivators%253A%2520protein-targeted%2520drug%2520delivery%2520mechanism%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D8620%26epage%3D8624%26doi%3D10.1002%2Fanie.201303999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kakizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span> <span> </span><span class="NLM_article-title">Histone H3 peptide based LSD1-selective inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1925</span>– <span class="NLM_lpage">1928</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2015.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25827526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1925-1928&author=T.+Kakizawaauthor=Y.+Otaauthor=Y.+Itohauthor=H.+Tsumotoauthor=T.+Suzuki&title=Histone+H3+peptide+based+LSD1-selective+inhibitors&doi=10.1016%2Fj.bmcl.2015.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Histone H3 peptide based LSD1-selective inhibitors</span></div><div class="casAuthors">Kakizawa, Taeko; Ota, Yosuke; Itoh, Yukihiro; Tsumoto, Hiroki; Suzuki, Takayoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1925-1928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of candidates for the histone H3 peptide based LSD1-selective inhibitor were designed and synthesized.  Among peptides, ART-X-QTARKSTGGKAPRKQLA and ARTKQTAR-X-STGGKAPRKQLA [X = substituted with phenylcyclopropylamine, 5-dihydro-1H-pyrrole and 1,2,3,6-tetrahydropyridine lysine (I), (II) and (III)].  Peptide ART-I-QTARKSTGGKAPRKQLA, which has a phenylcyclopropylamine (PCPA) moiety at Lys-4 of the 21 amino acid residues of histone H3, was the most potent LSD1-selective inhibitor.  Truncation studies of peptide ART-I-QTARKSTGGKAPRKQLA revealed the significance of the peptide sequence length.  These findings will be useful for the further development of histone H3 peptide based LSD1-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxO8fMkITrQ7Vg90H21EOLACvtfcHk0ljUxtXhnqJljA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgs7Y%253D&md5=1ea3add93c3eaa8a367433a6ddcb4dd9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DKakizawa%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DHistone%2520H3%2520peptide%2520based%2520LSD1-selective%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1925%26epage%3D1928%26doi%3D10.1016%2Fj.bmcl.2015.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis, LSD1 inhibitory activity, and LSD1 binding model of optically pure lysine-PCPA conjugates</span>. <i>Comput. Struct. Biotechnol. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e201402002</span> <span class="refDoi"> DOI: 10.5936/csbj.201402002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.5936%2Fcsbj.201402002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=24757500" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=Y.+Itohauthor=D.+Ogasawaraauthor=Y.+Otaauthor=T.+Mizukamiauthor=T.+Suzuki&title=Synthesis%2C+LSD1+inhibitory+activity%2C+and+LSD1+binding+model+of+optically+pure+lysine-PCPA+conjugates&doi=10.5936%2Fcsbj.201402002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.5936%2Fcsbj.201402002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5936%252Fcsbj.201402002%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520LSD1%2520inhibitory%2520activity%252C%2520and%2520LSD1%2520binding%2520model%2520of%2520optically%2520pure%2520lysine-PCPA%2520conjugates%26jtitle%3DComput.%2520Struct.%2520Biotechnol.%2520J.%26date%3D2014%26volume%3D9%26doi%3D10.5936%2Fcsbj.201402002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Etani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, T.</span></span> <span> </span><span class="NLM_article-title">Mp11-03 Novel selective lysine-specific demethylase 1 inhibitors suppress testicular tumor cell proliferation</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>203</i></span>, <span class="NLM_elocation-id">e135</span> <span class="refDoi"> DOI: 10.1097/JU.0000000000000831.03</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1097%2FJU.0000000000000831.03" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2020&author=T.+Etaniauthor=T.+Naikiauthor=S.+Nozakiauthor=T.+Nagaiauthor=K.+Iidaauthor=R.+Andoauthor=N.+Kawaiauthor=S.+Takahashiauthor=T.+Suzukiauthor=T.+Yasui&title=Mp11-03+Novel+selective+lysine-specific+demethylase+1+inhibitors+suppress+testicular+tumor+cell+proliferation&doi=10.1097%2FJU.0000000000000831.03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1097%2FJU.0000000000000831.03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJU.0000000000000831.03%26sid%3Dliteratum%253Aachs%26aulast%3DEtani%26aufirst%3DT.%26aulast%3DNaiki%26aufirst%3DT.%26aulast%3DNozaki%26aufirst%3DS.%26aulast%3DNagai%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DR.%26aulast%3DKawai%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYasui%26aufirst%3DT.%26atitle%3DMp11-03%2520Novel%2520selective%2520lysine-specific%2520demethylase%25201%2520inhibitors%2520suppress%2520testicular%2520tumor%2520cell%2520proliferation%26jtitle%3DJ.%2520Urol.%26date%3D2020%26volume%3D203%26doi%3D10.1097%2FJU.0000000000000831.03" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz-Fincke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greve, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubbert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludeke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity studies on N-substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2017.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29247860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFyju7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2018&pages=52-67&author=J.+Schulz-Finckeauthor=M.+Hauauthor=J.+Barthauthor=D.+Robaaauthor=D.+Willmannauthor=A.+Kurnerauthor=J.+Haasauthor=G.+Greveauthor=T.+Haydnauthor=S.+Fuldaauthor=M.+Lubbertauthor=S.+Ludekeauthor=T.+Bergauthor=W.+Sipplauthor=R.+Schuleauthor=M.+Jung&title=Structure-activity+studies+on+N-substituted+tranylcypromine+derivatives+lead+to+selective+inhibitors+of+lysine+specific+demethylase+1+%28LSD1%29+and+potent+inducers+of+leukemic+cell+differentiation&doi=10.1016%2Fj.ejmech.2017.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation</span></div><div class="casAuthors">Schulz-Fincke, Johannes; Hau, Mirjam; Barth, Jessica; Robaa, Dina; Willmann, Dominica; Kuerner, Andreas; Haas, Julian; Greve, Gabriele; Haydn, Tinka; Fulda, Simone; Luebbert, Michael; Luedeke, Steffen; Berg, Tobias; Sippl, Wolfgang; Schuele, Roland; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-67</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">FAD-dependent lysine-specific demethylase 1 (LSD1) is overexpressed or deregulated in many cancers such as AML and prostate cancer and hence is a promising anticancer target with first inhibitors in clin. trials.  Clin. candidates are N-substituted derivs. of the dual LSD1-/monoamine oxidase-inhibitor tranylcypromine (2-PCPA) with a basic amine function in the N-substituent.  These derivs. are selective over monoamine oxidases.  So far, only very limited information on structure-activity studies about this important class of LSD1 inhibitors is published in peer reviewed journals.  Here, we show that N-substituted 2-PCPA derivs. without a basic function or even a polar group are still potent inhibitors of LSD1 in vitro and effectively inhibit colony formation of leukemic cells in culture.  Yet, these lipophilic inhibitors also block the structurally related monoamine oxidases (MAO-A and MAO-B), which may be of interest for the treatment of neurodegenerative disorders, but this property is undesired for applications in cancer treatment.  The introduction of a polar, non-basic function led to optimized structures that retain potent LSD1 inhibitors but exhibit selectivity over MAOs and are highly potent in the suppression of colony formation of cultured leukemic cells.  Cellular target engagement is shown via a Cellular Thermal Shift Assay (CETSA) for LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS7XCIKeZiVrVg90H21EOLACvtfcHk0ljSgJmnKKrvMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFyju7zN&md5=f9460e47baf69fb33d4e314564591bd4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz-Fincke%26aufirst%3DJ.%26aulast%3DHau%26aufirst%3DM.%26aulast%3DBarth%26aufirst%3DJ.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DWillmann%26aufirst%3DD.%26aulast%3DKurner%26aufirst%3DA.%26aulast%3DHaas%26aufirst%3DJ.%26aulast%3DGreve%26aufirst%3DG.%26aulast%3DHaydn%26aufirst%3DT.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DLubbert%26aufirst%3DM.%26aulast%3DLudeke%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DStructure-activity%2520studies%2520on%2520N-substituted%2520tranylcypromine%2520derivatives%2520lead%2520to%2520selective%2520inhibitors%2520of%2520lysine%2520specific%2520demethylase%25201%2520%2528LSD1%2529%2520and%2520potent%2520inducers%2520of%2520leukemic%2520cell%2520differentiation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D144%26spage%3D52%26epage%3D67%26doi%3D10.1016%2Fj.ejmech.2017.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somervaille, T. C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arevalo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xaus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, R.</span></span> <span> </span><span class="NLM_article-title">Iadademstat shows efficacy in elderly AML patients in combination with azacitidine. Alice Trial</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">3839</span>– <span class="NLM_lpage">3839</span>, <span class="refDoi"> DOI: 10.1182/blood-2019-125121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1182%2Fblood-2019-125121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2019&pages=3839-3839&author=C.+Buesaauthor=T.+C.+P.+Somervailleauthor=M.+Arevaloauthor=J.+Xausauthor=S.+Gutierrezauthor=R.+Bullock&title=Iadademstat+shows+efficacy+in+elderly+AML+patients+in+combination+with+azacitidine.+Alice+Trial&doi=10.1182%2Fblood-2019-125121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1182%2Fblood-2019-125121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2019-125121%26sid%3Dliteratum%253Aachs%26aulast%3DBuesa%26aufirst%3DC.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26aulast%3DArevalo%26aufirst%3DM.%26aulast%3DXaus%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DS.%26aulast%3DBullock%26aufirst%3DR.%26atitle%3DIadademstat%2520shows%2520efficacy%2520in%2520elderly%2520AML%2520patients%2520in%2520combination%2520with%2520azacitidine.%2520Alice%2520Trial%26jtitle%3DBlood%26date%3D2019%26volume%3D134%26spage%3D3839%26epage%3D3839%26doi%3D10.1182%2Fblood-2019-125121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carceller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span> <span> </span><span class="NLM_article-title">Advances in the development of histone lysine demethylase inhibitors</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.coph.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=26057211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1Slt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=52-60&author=T.+Maesauthor=E.+Carcellerauthor=J.+Salasauthor=A.+Ortegaauthor=C.+Buesa&title=Advances+in+the+development+of+histone+lysine+demethylase+inhibitors&doi=10.1016%2Fj.coph.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the development of histone lysine demethylase inhibitors</span></div><div class="casAuthors">Maes, Tamara; Carceller, Elena; Salas, Jordi; Ortega, Alberto; Buesa, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-60</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The covalent modification of histones is closely assocd. with regulation of gene transcription.  Chromatin modifications have been suggested to represent an epigenetic code that is dynamically 'written' and 'erased' by specialized proteins, and 'read', or interpreted, by proteins that translate the code into gene expression changes.  Initially thought to be an irreversible process, histone methylation is now known to be reversed by demethylases, FAD dependent amineoxidases and by iron(II)-alpha-ketoglutarate dependent deoxygenases of the Jumonji family.  Altered histone demethylase activities have been assocd. with human disease, including cancer.  The first wave of novel investigational drugs directed against KDM1A has recently entered the clinic, and the first specific inhibitor targeting a Jumonji KDM is advancing in preclin. regulatory studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCr97IlCYFrVg90H21EOLACvtfcHk0ljSgJmnKKrvMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1Slt7o%253D&md5=02e8a5f8d426743be1eb209c329bd3ed</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DT.%26aulast%3DCarceller%26aufirst%3DE.%26aulast%3DSalas%26aufirst%3DJ.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DBuesa%26aufirst%3DC.%26atitle%3DAdvances%2520in%2520the%2520development%2520of%2520histone%2520lysine%2520demethylase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2015%26volume%3D23%26spage%3D52%26epage%3D60%26doi%3D10.1016%2Fj.coph.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bose, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konopleva, M. Y.</span></span> <span> </span><span class="NLM_article-title">ORY-1001: Overcoming the differentiation block in AML</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ccell.2018.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29533778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksVent7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=342-343&author=P.+Boseauthor=M.+Y.+Konopleva&title=ORY-1001%3A+Overcoming+the+differentiation+block+in+AML&doi=10.1016%2Fj.ccell.2018.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">ORY-1001: Overcoming the Differentiation Block in AML</span></div><div class="casAuthors">Bose, Prithviraj; Konopleva, Marina Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-343</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In this issue of Cancer Cell, Maes and colleagues report in vitro and in vivo findings with ORY-1001-an oral, highly potent and selective covalent small-mol. inhibitor of lysine-specific demethylase 1 (LSD1)-in development for acute myeloid leukemia (AML), as well as correlative data from two AML patients receiving ORY-1001.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHnFqnbjs2W7Vg90H21EOLACvtfcHk0ljSgJmnKKrvMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksVent7s%253D&md5=cf628b6d2e99903626cedc4b497aacdb</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DP.%26aulast%3DKonopleva%26aufirst%3DM.%2BY.%26atitle%3DORY-1001%253A%2520Overcoming%2520the%2520differentiation%2520block%2520in%2520AML%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26spage%3D342%26epage%3D343%26doi%3D10.1016%2Fj.ccell.2018.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mill, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthakur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadia, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K. N.</span></span> <span> </span><span class="NLM_article-title">Synergistic pre-clinical activity of targeted inhibition of KDM1A and BET proteins against human AML blast progenitor cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">3930</span>– <span class="NLM_lpage">3930</span>, <span class="refDoi"> DOI: 10.1182/blood-2018-99-114198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1182%2Fblood-2018-99-114198" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2018&pages=3930-3930&author=W.+Fiskusauthor=C.+P.+Millauthor=R.+Soldiauthor=R.+Hanauthor=D.+T.+Saenzauthor=A.+J.+Nowakauthor=B.+Sunauthor=D.+N.+Saenzauthor=C.+D.+DiNardoauthor=G.+Borthakurauthor=T.+M.+Kadiaauthor=W.+Jinauthor=T.+Ganeshauthor=V.+Raoauthor=J.+D.+Khouryauthor=S.+Sharmaauthor=K.+N.+Bhalla&title=Synergistic+pre-clinical+activity+of+targeted+inhibition+of+KDM1A+and+BET+proteins+against+human+AML+blast+progenitor+cells&doi=10.1182%2Fblood-2018-99-114198"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1182%2Fblood-2018-99-114198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2018-99-114198%26sid%3Dliteratum%253Aachs%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DMill%26aufirst%3DC.%2BP.%26aulast%3DSoldi%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DR.%26aulast%3DSaenz%26aufirst%3DD.%2BT.%26aulast%3DNowak%26aufirst%3DA.%2BJ.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DSaenz%26aufirst%3DD.%2BN.%26aulast%3DDiNardo%26aufirst%3DC.%2BD.%26aulast%3DBorthakur%26aufirst%3DG.%26aulast%3DKadia%26aufirst%3DT.%2BM.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DRao%26aufirst%3DV.%26aulast%3DKhoury%26aufirst%3DJ.%2BD.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26atitle%3DSynergistic%2520pre-clinical%2520activity%2520of%2520targeted%2520inhibition%2520of%2520KDM1A%2520and%2520BET%2520proteins%2520against%2520human%2520AML%2520blast%2520progenitor%2520cells%26jtitle%3DBlood%26date%3D2018%26volume%3D132%26spage%3D3930%26epage%3D3930%26doi%3D10.1182%2Fblood-2018-99-114198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Augert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunblatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liggitt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacPherson, D.</span></span> <span> </span><span class="NLM_article-title">Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">eaau2922</span> <span class="refDoi"> DOI: 10.1126/scisignal.aau2922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1126%2Fscisignal.aau2922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30723171" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&author=A.+Augertauthor=E.+Eastwoodauthor=A.+H.+Ibrahimauthor=N.+Wuauthor=E.+Grunblattauthor=R.+Basomauthor=D.+Liggittauthor=K.+D.+Eatonauthor=R.+Martinsauthor=J.+T.+Poirierauthor=C.+M.+Rudinauthor=F.+Millettiauthor=W.+Y.+Chengauthor=F.+Mackauthor=D.+MacPherson&title=Targeting+NOTCH+activation+in+small+cell+lung+cancer+through+LSD1+inhibition&doi=10.1126%2Fscisignal.aau2922"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aau2922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aau2922%26sid%3Dliteratum%253Aachs%26aulast%3DAugert%26aufirst%3DA.%26aulast%3DEastwood%26aufirst%3DE.%26aulast%3DIbrahim%26aufirst%3DA.%2BH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DGrunblatt%26aufirst%3DE.%26aulast%3DBasom%26aufirst%3DR.%26aulast%3DLiggitt%26aufirst%3DD.%26aulast%3DEaton%26aufirst%3DK.%2BD.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DJ.%2BT.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DW.%2BY.%26aulast%3DMack%26aufirst%3DF.%26aulast%3DMacPherson%26aufirst%3DD.%26atitle%3DTargeting%2520NOTCH%2520activation%2520in%2520small%2520cell%2520lung%2520cancer%2520through%2520LSD1%2520inhibition%26jtitle%3DSci.%2520Signaling%26date%3D2019%26volume%3D12%26doi%3D10.1126%2Fscisignal.aau2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuyas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumuzio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosch-Barrera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Castillo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encinar, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, J. A.</span></span> <span> </span><span class="NLM_article-title">The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes</span>. <i>Aging</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4794</span>– <span class="NLM_lpage">4814</span>, <span class="refDoi"> DOI: 10.18632/aging.102887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.18632%2Faging.102887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32191225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlansbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=4794-4814&author=E.+Cuyasauthor=J.+Gumuzioauthor=S.+Verduraauthor=J.+Brunetauthor=J.+Bosch-Barreraauthor=B.+Martin-Castilloauthor=T.+Alarconauthor=J.+A.+Encinarauthor=A.+G.+Martinauthor=J.+A.+Menendez&title=The+LSD1+inhibitor+iadademstat+%28ORY-1001%29+targets+SOX2-driven+breast+cancer+stem+cells%3A+a+potential+epigenetic+therapy+in+luminal-B+and+HER2-positive+breast+cancer+subtypes&doi=10.18632%2Faging.102887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes</span></div><div class="casAuthors">Cuyas, Elisabet; Gumuzio, Juan; Verdura, Sara; Brunet, Joan; Bosch-Barrera, Joaquim; Martin-Castillo, Begona; Alarcon, Tomas; Encinar, Jose Antonio; Martin, Angel G.; Menendez, Javier A.</div><div class="citationInfo"><span class="NLM_cas:title">Aging</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4794-4813</span>CODEN:
                <span class="NLM_cas:coden">AGINCN</span>;
        ISSN:<span class="NLM_cas:issn">1945-4589</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">SOX2 is a core pluripotency-assocd. transcription factor causally related to cancer initiation, aggressiveness, and drug resistance by driving the self-renewal and seeding capacity of cancer stem cells (CSC).  Here, we tested the ability of the clin. proven inhibitor of the lysine-specific demethylase 1 (LSD1/KDM1A) iadademstat (ORY-100) to target SOX2-driven CSC in breast cancer.  Iadademstat blocked CSC-driven mammosphere formation in breast cancer cell lines that are dependent on SOX2 expression to maintain their CSC phenotype.  Iadademstat prevented the activation of an LSD1-targeted stemness-specific SOX2 enhancer in CSC-enriched 3-dimensional spheroids.  Using high-throughput transcriptional data available from the METABRIC dataset, high expression of SOX2 was significantly more common in luminal-B and HER2- enriched subtypes according to PAM50 classifier and in IntClust1 (high proliferating luminal-B) and IntClust 5 (luminal-B and HER2-amplified) according to integrative clustering.  Iadademstat significantly reduced mammospheres formation by CSC-like cells from a multidrug-resistant luminal-B breast cancer patient-derived xenograft but not of those from a treatment-na.ovrddot.ive luminal-A patient.  Iadademstat reduced the expression of SOX2 in luminal-B but not in luminal-A mammospheres, likely indicating a selective targeting of SOX2-driven CSC.  The therapeutic relevance of targeting SOX2-driven breast CSC suggests the potential clin. use of iadademstat as an epigenetic therapy in luminal-B and HER2-pos. subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZhqWP3DXGybVg90H21EOLACvtfcHk0lhO3ZeBx_818g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlansbbL&md5=0e96fc883523fb13122888a53382dd91</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.18632%2Faging.102887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Faging.102887%26sid%3Dliteratum%253Aachs%26aulast%3DCuyas%26aufirst%3DE.%26aulast%3DGumuzio%26aufirst%3DJ.%26aulast%3DVerdura%26aufirst%3DS.%26aulast%3DBrunet%26aufirst%3DJ.%26aulast%3DBosch-Barrera%26aufirst%3DJ.%26aulast%3DMartin-Castillo%26aufirst%3DB.%26aulast%3DAlarcon%26aufirst%3DT.%26aulast%3DEncinar%26aufirst%3DJ.%2BA.%26aulast%3DMartin%26aufirst%3DA.%2BG.%26aulast%3DMenendez%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520LSD1%2520inhibitor%2520iadademstat%2520%2528ORY-1001%2529%2520targets%2520SOX2-driven%2520breast%2520cancer%2520stem%2520cells%253A%2520a%2520potential%2520epigenetic%2520therapy%2520in%2520luminal-B%2520and%2520HER2-positive%2520breast%2520cancer%2520subtypes%26jtitle%3DAging%26date%3D2020%26volume%3D12%26spage%3D4794%26epage%3D4814%26doi%3D10.18632%2Faging.102887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2017.09.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28987602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=392-402&author=Y.+C.+Duanauthor=Y.+C.+Maauthor=W.+P.+Qinauthor=L.+N.+Dingauthor=Y.+C.+Zhengauthor=Y.+L.+Zhuauthor=X.+Y.+Zhaiauthor=J.+Yangauthor=C.+Y.+Maauthor=Y.+Y.+Guan&title=Design+and+synthesis+of+tranylcypromine+derivatives+as+novel+LSD1%2FHDACs+dual+inhibitors+for+cancer+treatment&doi=10.1016%2Fj.ejmech.2017.09.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment</span></div><div class="casAuthors">Duan, Ying-Chao; Ma, Yong-Cheng; Qin, Wen-Ping; Ding, Li-Na; Zheng, Yi-Chao; Zhu, Ying-Li; Zhai, Xiao-Yu; Yang, Jing; Ma, Chao-Ya; Guan, Yuan-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">392-402</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) and Histone deacetylases (HDACs) are promising drug targets for cancers.  Recent studies reveal an important functional interplay between LSD1 and HDACs, and there is evidence for the synergistic effect of combined LSD1 and HDAC inhibitors on cancers.  Therefore, development of inhibitors targeting both LSD1 and HDACs might be a promising strategy for epigenetic therapy of cancers.  The authors report herein the synthesis of a series of tranylcypromine derivs. as LSD1/HDACs dual inhibitors.  Most compds. showed potent LSD1 and HDACs inhibitory activity, esp. compd. 7 (N-(7-(hydroxyamino)-7-oxoheptyl)-4-(((phenylcyclopropyl)amino)methyl)benzamide) displayed the most potent inhibitory activity against HDAC1 and HDAC2 with IC50 of 15 nM and 23 nM, as well as potent inhibition against LSD1 with IC50 of 1.20 μM.  Compd. 7 demonstrated stronger anti-proliferative activities than SAHA with IC50 values ranging from 0.81 to 4.28 μM against MGC-803, MCF-7, SW-620 and A-549 human cancer cell lines.  Further mechanistic studies showed that compd. 7 treatment in MGC-803 cells dose-dependently increased cellular H3K4 and H3K9 methylation, as well as H3 acetylation, decreased the mitochondrial membrane potential and induced remarkable apoptosis.  Docking studies showed that compd. 7 can be well docked into the active binding sites of LSD1 and HDAC2.  This finding highlights the potential for the development of LSD1/HDACs dual inhibitors as novel anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr76jU224_UF7Vg90H21EOLACvtfcHk0lgKXsYesvzNug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egsLfJ&md5=82fc575cd2cf9a4b75dae3370b5efd80</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.038%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DY.%2BC.%26aulast%3DQin%26aufirst%3DW.%2BP.%26aulast%3DDing%26aufirst%3DL.%2BN.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DZhu%26aufirst%3DY.%2BL.%26aulast%3DZhai%26aufirst%3DX.%2BY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DC.%2BY.%26aulast%3DGuan%26aufirst%3DY.%2BY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tranylcypromine%2520derivatives%2520as%2520novel%2520LSD1%252FHDACs%2520dual%2520inhibitors%2520for%2520cancer%2520treatment%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D140%26spage%3D392%26epage%3D402%26doi%3D10.1016%2Fj.ejmech.2017.09.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelamegam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricq, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malvaez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span> <span> </span><span class="NLM_article-title">Brain-penetrant LSD1 inhibitors can block memory consolidation</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1021/cn200104y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200104y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVyrs77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=120-128&author=R.+Neelamegamauthor=E.+L.+Ricqauthor=M.+Malvaezauthor=D.+Patnaikauthor=S.+Nortonauthor=S.+M.+Carlinauthor=I.+T.+Hillauthor=M.+A.+Woodauthor=S.+J.+Haggartyauthor=J.+M.+Hooker&title=Brain-penetrant+LSD1+inhibitors+can+block+memory+consolidation&doi=10.1021%2Fcn200104y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-Penetrant LSD1 Inhibitors Can Block Memory Consolidation</span></div><div class="casAuthors">Neelamegam, Ramesh; Ricq, Emily L.; Malvaez, Melissa; Patnaik, Debasis; Norton, Stephanie; Carlin, Stephen M.; Hill, Ian T.; Wood, Marcelo A.; Haggarty, Stephen J.; Hooker, Jacob M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-128</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulation of histone modifications in the brain may represent a new mechanism for brain disorder therapy.  Post-translational modifications of histones regulate gene expression, affecting major cellular processes such as proliferation, differentiation, and function.  An important enzyme involved in one of these histone modifications is lysine specific demethylase 1 (LSD1).  This enzyme is flavin-dependent and exhibits homol. to amine oxidases.  Parnate (2-phenylcyclopropylamine (2-PCPA); tranylcypromine) is a potent inhibitor of monoamine oxidases, and derivs. of 2-PCPA have been used for development of selective LSD1 inhibitors based on the ability to form covalent adducts with FAD.  Here we report the synthesis and in vitro characterization of LSD1 inhibitors that bond covalently to FAD.  The two most potent and selective inhibitors were used to demonstrate brain penetration when administered systemically to rodents.  First, radiosynthesis of a positron-emitting analog was used to obtain preliminary biodistribution data and whole brain time-activity curves.  Second, we demonstrate that this series of LSD1 inhibitors is capable of producing a cognitive effect in a mouse model.  By using a memory formation paradigm, novel object recognition, we show that LSD1 inhibition can abolish long-term memory formation without affecting short-term memory, providing further evidence for the importance of reversible histone methylation in the function of the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRTx9XGRzjgrVg90H21EOLACvtfcHk0li_hgpZW4q0bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVyrs77E&md5=cd365810b397d0ece732ea853a3e93da</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fcn200104y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200104y%26sid%3Dliteratum%253Aachs%26aulast%3DNeelamegam%26aufirst%3DR.%26aulast%3DRicq%26aufirst%3DE.%2BL.%26aulast%3DMalvaez%26aufirst%3DM.%26aulast%3DPatnaik%26aufirst%3DD.%26aulast%3DNorton%26aufirst%3DS.%26aulast%3DCarlin%26aufirst%3DS.%2BM.%26aulast%3DHill%26aufirst%3DI.%2BT.%26aulast%3DWood%26aufirst%3DM.%2BA.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26atitle%3DBrain-penetrant%2520LSD1%2520inhibitors%2520can%2520block%2520memory%2520consolidation%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D120%26epage%3D128%26doi%3D10.1021%2Fcn200104y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jearawiriyapaisarn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trievel, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSimone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavelle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunthararajah, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span> <span> </span><span class="NLM_article-title">The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1182/blood-2015-02-626259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1182%2Fblood-2015-02-626259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=26031919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGqsbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=386-396&author=S.+Cuiauthor=K.+C.+Limauthor=L.+Shiauthor=M.+Leeauthor=N.+Jearawiriyapaisarnauthor=G.+Myersauthor=A.+Campbellauthor=D.+Harroauthor=S.+Iwaseauthor=R.+C.+Trievelauthor=A.+Riversauthor=J.+DeSimoneauthor=D.+Lavelleauthor=Y.+Saunthararajahauthor=J.+D.+Engel&title=The+LSD1+inhibitor+RN-1+induces+fetal+hemoglobin+synthesis+and+reduces+disease+pathology+in+sickle+cell+mice&doi=10.1182%2Fblood-2015-02-626259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice</span></div><div class="casAuthors">Cui, Shuaiying; Lim, Kim-Chew; Shi, Lihong; Lee, Mary; Jearawiriyapaisarn, Natee; Myers, Greggory; Campbell, Andrew; Harro, David; Iwase, Shigeki; Trievel, Raymond C.; Rivers, Angela; DeSimone, Joseph; Lavelle, Donald; Saunthararajah, Yogen; Engel, James Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-396</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Inhibition of lysine-specific demethylase 1 (LSD1) has been shown to induce fetal Hb (HbF) levels in cultured human erythroid cells in vitro.  Here we report the in vivo effects of LSD1 inactivation by a selective and more potent inhibitor, RN-1, in a sickle cell disease (SCD) mouse model.  Compared with untreated animals, RN-1 administration leads to induced HbF synthesis and to increased frequencies of HbF-pos. cells and mature erythrocytes, as well as fewer reticulocytes and sickle cells, in the peripheral blood of treated SCD mice.  In keeping with these observations, histol. analyses of the liver and spleen of treated SCD mice verified that they do not exhibit the necrotic lesions that are usually assocd. with SCD.  These data indicate that RN-1 can effectively induce HbF levels in red blood cells and reduce disease pathol. in SCD mice, and may therefore offer new therapeutic possibilities for treating SCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQhVTwBq84lrVg90H21EOLACvtfcHk0li_hgpZW4q0bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGqsbfM&md5=09823b719e175817dfe3b05a166b49cd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-02-626259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-02-626259%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DK.%2BC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DJearawiriyapaisarn%26aufirst%3DN.%26aulast%3DMyers%26aufirst%3DG.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DHarro%26aufirst%3DD.%26aulast%3DIwase%26aufirst%3DS.%26aulast%3DTrievel%26aufirst%3DR.%2BC.%26aulast%3DRivers%26aufirst%3DA.%26aulast%3DDeSimone%26aufirst%3DJ.%26aulast%3DLavelle%26aufirst%3DD.%26aulast%3DSaunthararajah%26aufirst%3DY.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520LSD1%2520inhibitor%2520RN-1%2520induces%2520fetal%2520hemoglobin%2520synthesis%2520and%2520reduces%2520disease%2520pathology%2520in%2520sickle%2520cell%2520mice%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D386%26epage%3D396%26doi%3D10.1182%2Fblood-2015-02-626259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaitkus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagadeeswaran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouznetsova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSimone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavelle, D.</span></span> <span> </span><span class="NLM_article-title">RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases gamma-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model</span>. <i>Exp. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/j.exphem.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.exphem.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25931013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SgurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=546-53&author=A.+Riversauthor=K.+Vaitkusauthor=M.+A.+Ruizauthor=V.+Ibanezauthor=R.+Jagadeeswaranauthor=T.+Kouznetsovaauthor=J.+DeSimoneauthor=D.+Lavelle&title=RN-1%2C+a+potent+and+selective+lysine-specific+demethylase+1+inhibitor%2C+increases+gamma-globin+expression%2C+F+reticulocytes%2C+and+F+cells+in+a+sickle+cell+disease+mouse+model&doi=10.1016%2Fj.exphem.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model</span></div><div class="casAuthors">Rivers, Angela; Vaitkus, Kestis; Ruiz, Maria Armila; Ibanez, Vinzon; Jagadeeswaran, Ramasamy; Kouznetsova, Tatiana; DeSimone, Joseph; Lavelle, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">546-553.e3</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Increased levels of fetal Hb are assocd. with decreased symptoms and increased lifespan in patients with sickle cell disease (SCD).  Hydroxyurea, the only drug currently approved for SCD, is not effective in a large fraction of patients, and therefore, new agents are urgently needed.  Recently it was found that lysine demethylase 1, an enzyme that removes monomethyl and di-Me residues from the lysine 4 residue of histone H3, is a repressor of γ-globin gene expression.  In this article, we have compared the ability of tranylcypromine (TCP) and a more potent TCP deriv., RN-1, to increase γ-globin expression in cultured baboon erythroid progenitor cells and in the SCD mouse model.  The results indicate that the ability of RN-1 to induce F cells and γ-globin mRNA in SCD mice is similar to that of decitabine, the most powerful fetal Hb-inducing drug known, and greater than that of either TCP or hydroxyurea.  We conclude that RN-1 and other lysine demethylase 1 inhibitors may be promising new γ-globin-inducing agents for the treatment of SCD that warrant further studies in other preclin. models, such as nonhuman primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXFBoMGO2F2rVg90H21EOLACvtfcHk0li_hgpZW4q0bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SgurrN&md5=70d2f9af57d6aa75b69b9739af8c7f69</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.exphem.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exphem.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DRivers%26aufirst%3DA.%26aulast%3DVaitkus%26aufirst%3DK.%26aulast%3DRuiz%26aufirst%3DM.%2BA.%26aulast%3DIbanez%26aufirst%3DV.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DKouznetsova%26aufirst%3DT.%26aulast%3DDeSimone%26aufirst%3DJ.%26aulast%3DLavelle%26aufirst%3DD.%26atitle%3DRN-1%252C%2520a%2520potent%2520and%2520selective%2520lysine-specific%2520demethylase%25201%2520inhibitor%252C%2520increases%2520gamma-globin%2520expression%252C%2520F%2520reticulocytes%252C%2520and%2520F%2520cells%2520in%2520a%2520sickle%2520cell%2520disease%2520mouse%2520model%26jtitle%3DExp.%2520Hematol.%26date%3D2015%26volume%3D43%26spage%3D546%26epage%3D53%26doi%3D10.1016%2Fj.exphem.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed
Khan, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of N-alkylated analogue of NCL1, a selective inhibitor of lysine-specific demethylase 1</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1039/C4MD00330F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1039%2FC4MD00330F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=407-412&author=M.+N.+Ahmed%0AKhanauthor=H.+Tsumotoauthor=Y.+Itohauthor=Y.+Otaauthor=M.+Suzukiauthor=D.+Ogasawaraauthor=H.+Nakagawaauthor=T.+Mizukamiauthor=N.+Miyataauthor=T.+Suzuki&title=Design%2C+synthesis%2C+and+biological+activity+of+N-alkylated+analogue+of+NCL1%2C+a+selective+inhibitor+of+lysine-specific+demethylase+1&doi=10.1039%2FC4MD00330F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological activity of N-alkylated analogue of NCL1, a selective inhibitor of lysine-specific demethylase 1</span></div><div class="casAuthors">Ahmed Khan, Mohammed Naseer; Tsumoto, Hiroki; Itoh, Yukihiro; Ota, Yosuke; Suzuki, Miki; Ogasawara, Daisuke; Nakagawa, Hidehiko; Mizukami, Tamio; Miyata, Naoki; Suzuki, Takayoshi</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-412</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1), the first histone demethylase to be identified, catalyzes specifically the demethylation of the mono- and di-Me groups of histone H3 lysine 4, and its dysregulation is thought to contribute to the development of cancer.  We have recently reported that NCL1 (4) is the first cell-active LSD1-selective inhibitor.  To find LSD1 inhibitors that show higher potency than NCL1 (4), we designed and synthesized an N-alkylated analog of NCL1 (5), and evaluated its biol. activity.  In enzyme assays, compd. 5 was six times more potent than 4, and compd. 5 exhibited cell growth inhibition in cervical cancer HeLa cell line and neuroblastoma SH-SY5Y cell line.  Compd. 5 should be useful as a lead structure for anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRPzAwurHb7bVg90H21EOLACvtfcHk0ljJelNL8-iFmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsLzM&md5=548e783980eb6fa2e152ffa7523e6310</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1039%2FC4MD00330F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00330F%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%2BKhan%26aufirst%3DM.%2BN.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520N-alkylated%2520analogue%2520of%2520NCL1%252C%2520a%2520selective%2520inhibitor%2520of%2520lysine-specific%2520demethylase%25201%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D407%26epage%3D412%26doi%3D10.1039%2FC4MD00330F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairiki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hikichi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span> <span> </span><span class="NLM_article-title">A novel LSD1 inhibitor T-3775440 disrupts GFI1B-containing complex leading to transdifferentiation and impaired growth of AML Cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F1535-7163.MCT-16-0471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27903753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVertr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=273-284&author=Y.+Ishikawaauthor=K.+Gamoauthor=M.+Yabukiauthor=S.+Takagiauthor=K.+Toyoshimaauthor=K.+Nakayamaauthor=A.+Nakayamaauthor=M.+Morimotoauthor=H.+Miyashitaauthor=R.+Dairikiauthor=Y.+Hikichiauthor=N.+Tomitaauthor=D.+Tomitaauthor=S.+Imamuraauthor=M.+Iwataniauthor=Y.+Kamadaauthor=S.+Matsumotoauthor=R.+Haraauthor=T.+Nomuraauthor=K.+Tsuchidaauthor=K.+Nakamura&title=A+novel+LSD1+inhibitor+T-3775440+disrupts+GFI1B-containing+complex+leading+to+transdifferentiation+and+impaired+growth+of+AML+Cells&doi=10.1158%2F1535-7163.MCT-16-0471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells</span></div><div class="casAuthors">Ishikawa, Yoshinori; Gamo, Kanae; Yabuki, Masato; Takagi, Shinji; Toyoshima, Kosei; Nakayama, Kazuhide; Nakayama, Akiko; Morimoto, Megumi; Miyashita, Hitoshi; Dairiki, Ryo; Hikichi, Yukiko; Tomita, Naoki; Tomita, Daisuke; Imamura, Shinichi; Iwatani, Misa; Kamada, Yusuke; Matsumoto, Satoru; Hara, Ryujiro; Nomura, Toshiyuki; Tsuchida, Ken; Nakamura, Kazuhide</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Dysregulation of lysine (K)-specific demethylase 1A (LSD1), also known as KDM1A, has been implicated in the development of various cancers, including leukemia.  Here, we describe the antileukemic activity and mechanism of action of T-3775440, a novel irreversible LSD1 inhibitor.  Cell growth anal. of leukemia cell lines revealed that acute erythroid leukemia (AEL) and acute megakaryoblastic leukemia cells (AMKL) were highly sensitive to this compd.  T-3775440 treatment enforced transdifferentiation of erythroid/megakaryocytic lineages into granulomonocytic-like lineage cells.  Mechanistically, T-3775440 disrupted the interaction between LSD1 and growth factor-independent 1B (GFI1B), a transcription factor crit. for the differentiation processes of erythroid and megakaryocytic lineage cells.  Knockdown of LSD1 and GFI1B recapitulated T-3775440-induced transdifferentiation and cell growth suppression, highlighting the significance of LSD1-GFI1B axis inhibition with regard to the anti-AML effects of T-3775440.  Moreover, T-3775440 exhibited significant antitumor efficacy in AEL and AMKL xenograft models.  Our findings provide a rationale for evaluating LSD1 inhibitors as potential treatments and indicate a novel mechanism of action against AML, particularly AEL and AMKL.  Mol Cancer Ther; 16(2); 273-84. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcxpsluqnf7Vg90H21EOLACvtfcHk0ljJelNL8-iFmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVertr4%253D&md5=2335343b4d5e7bbc197a1d5aec54e3af</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0471%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DGamo%26aufirst%3DK.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DS.%26aulast%3DToyoshima%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DMorimoto%26aufirst%3DM.%26aulast%3DMiyashita%26aufirst%3DH.%26aulast%3DDairiki%26aufirst%3DR.%26aulast%3DHikichi%26aufirst%3DY.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTomita%26aufirst%3DD.%26aulast%3DImamura%26aufirst%3DS.%26aulast%3DIwatani%26aufirst%3DM.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DR.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DTsuchida%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DK.%26atitle%3DA%2520novel%2520LSD1%2520inhibitor%2520T-3775440%2520disrupts%2520GFI1B-containing%2520complex%2520leading%2520to%2520transdifferentiation%2520and%2520impaired%2520growth%2520of%2520AML%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D273%26epage%3D284%26doi%3D10.1158%2F1535-7163.MCT-16-0471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairiki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span> <span> </span><span class="NLM_article-title">Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e377</span> <span class="refDoi"> DOI: 10.1038/oncsis.2017.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Foncsis.2017.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28892104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKltbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&author=Y.+Ishikawaauthor=K.+Nakayamaauthor=M.+Morimotoauthor=A.+Mizutaniauthor=A.+Nakayamaauthor=K.+Toyoshimaauthor=A.+Hayashiauthor=S.+Takagiauthor=R.+Dairikiauthor=H.+Miyashitaauthor=S.+Matsumotoauthor=K.+Gamoauthor=T.+Nomuraauthor=K.+Nakamura&title=Synergistic+anti-AML+effects+of+the+LSD1+inhibitor+T-3775440+and+the+NEDD8-activating+enzyme+inhibitor+pevonedistat+via+transdifferentiation+and+DNA+rereplication&doi=10.1038%2Foncsis.2017.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication</span></div><div class="casAuthors">Ishikawa, Y.; Nakayama, K.; Morimoto, M.; Mizutani, A.; Nakayama, A.; Toyoshima, K.; Hayashi, A.; Takagi, S.; Dairiki, R.; Miyashita, H.; Matsumoto, S.; Gamo, K.; Nomura, T.; Nakamura, K.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e377</span>CODEN:
                <span class="NLM_cas:coden">ONCOCT</span>;
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1A (LSD1, KDM1A) specifically demethylates di- and monomethylated histones H3K4 and K9, resulting in context-dependent transcriptional repression or activation.  We previously identified an irreversible LSD1 inhibitor T-3775440, which exerts antileukemic activities in a subset of acute myeloid leukemia (AML) cell lines by inducing cell transdifferentiation.  The NEDD8-activating enzyme inhibitor pevonedistat (MLN4924, TAK-924) is an investigational drug with antiproliferative activities in AML, and is also reported to induce cell differentiation.  We therefore tested the combination of these two agents in AML models.  The combination treatment resulted in synergistic growth inhibition of AML cells, accompanied by enhanced transdifferentiation of an erythroid leukemia lineage into granulomonocytic-like lineage cells.  In addn., pevonedistat-induced rereplication stress during the S phase was greatly augmented by concomitant treatment with T-3775440, as reflected by the increased induction of apoptosis.  We further demonstrated that the combination treatment was markedly effective in s.c. tumor xenograft models as well as in a disseminated model of AML, leading to tumor eradication or prolonged survival in T-3775440/pevonedistat cotreated mice.  Our findings indicate the therapeutic potential of the combination of LSD1 inhibitors and pevonedistat for the treatment of AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7fhlV7Lk--bVg90H21EOLACvtfcHk0lh17yxbgQcYcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKltbvP&md5=f6b55fdaebb50f359c547677a30b9190</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2017.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2017.76%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DMorimoto%26aufirst%3DM.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DToyoshima%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DA.%26aulast%3DTakagi%26aufirst%3DS.%26aulast%3DDairiki%26aufirst%3DR.%26aulast%3DMiyashita%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DGamo%26aufirst%3DK.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DK.%26atitle%3DSynergistic%2520anti-AML%2520effects%2520of%2520the%2520LSD1%2520inhibitor%2520T-3775440%2520and%2520the%2520NEDD8-activating%2520enzyme%2520inhibitor%2520pevonedistat%2520via%2520transdifferentiation%2520and%2520DNA%2520rereplication%26jtitle%3DOncogenesis%26date%3D2017%26volume%3D6%26doi%3D10.1038%2Foncsis.2017.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5036</span>– <span class="NLM_lpage">5039</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2017.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29037950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5036-5039&author=K.+Sunauthor=J.+D.+Pengauthor=F.+Z.+Suoauthor=T.+Zhangauthor=Y.+D.+Fuauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Discovery+of+tranylcypromine+analogs+with+an+acylhydrazone+substituent+as+LSD1+inactivators%3A+Design%2C+synthesis+and+their+biological+evaluation&doi=10.1016%2Fj.bmcl.2017.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation</span></div><div class="casAuthors">Sun, Kai; Peng, Jia-Di; Suo, Feng-Zhi; Zhang, Ting; Fu, Yun-Dong; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5036-5039</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1), the first identified histone demethylase, plays an important role in epigenetic regulation of gene activation and repression, has been reported to be up-regulated and involved in nos. of solid malignant tumors.  In this study, the authors identified a series of phenylalanyl hydrazones based LSD1 inhibitors, and the most potent one, compd. I, can inactivate LSD1 with IC50 = 91.83 nM.  In cellular level, compd. I can induce the accumulation of CD86 as well as H3K4me2, and inhibit gastric cancer cell proliferation by inactivating LSD1.  The findings indicated that compd. I may serve as a potential leading compd. to target LSD1 overexpressed gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDtZ0bCi6HFLVg90H21EOLACvtfcHk0lh17yxbgQcYcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7F&md5=0af079efb7fb3856f8a67842817e0470</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DJ.%2BD.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DFu%26aufirst%3DY.%2BD.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DDiscovery%2520of%2520tranylcypromine%2520analogs%2520with%2520an%2520acylhydrazone%2520substituent%2520as%2520LSD1%2520inactivators%253A%2520Design%252C%2520synthesis%2520and%2520their%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5036%26epage%3D5039%26doi%3D10.1016%2Fj.bmcl.2017.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengoku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Development and structural evaluation of N-alkylated trans-2-phenylcyclopropylamine-based LSD1 inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">787</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fcmdc.202000014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32166890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFSjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=787&author=H.+Niwaauthor=S.+Satoauthor=N.+Handaauthor=T.+Sengokuauthor=T.+Umeharaauthor=S.+Yokoyama&title=Development+and+structural+evaluation+of+N-alkylated+trans-2-phenylcyclopropylamine-based+LSD1+inhibitors&doi=10.1002%2Fcmdc.202000014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Structural Evaluation of N-Alkylated trans-2-Phenylcyclopropylamine-Based LSD1 Inhibitors</span></div><div class="casAuthors">Niwa, Hideaki; Sato, Shin; Handa, Noriko; Sengoku, Toru; Umehara, Takashi; Yokoyama, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) is a FAD (FAD)-dependent enzyme that catalyzes the demethylation of histone H3 and regulates gene expression.  Because it is implicated in the regulation of diseases such as acute myeloid leukemia, potent LSD1-specific inhibitors have been pursued.  Trans-2-phenylcyclopropylamine (2-PCPA)-based inhibitors featuring substitutions on the amino group have emerged, with sub-micromolar affinities toward LSD1 and high selectivities over monoamine oxidases (MAOs).  We synthesized two N-alkylated 2-PCPA-based LSD1 inhibitors, S2116 and S2157, based on the previously developed S2101.  S2116 and S2157 exhibited enhanced potency for LSD1 by 2.0- to 2.6-fold, as compared with S2101.  In addn., they exhibited improved selectivity over MAOs.  Structural analyses of LSD1 co-crystd. with S2101, S2116, S2157, or another N-alkylated inhibitor (FCPA-MPE) confirmed that the N-substituents enhance the potency of a 2-PCPA-based inhibitor of LSD1, without constituting the adduct formed with FAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6TTnedxbtLVg90H21EOLACvtfcHk0lh17yxbgQcYcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFSjt78%253D&md5=e0b444e8f2ccf027c9a349cb4566ae10</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000014%26sid%3Dliteratum%253Aachs%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DHanda%26aufirst%3DN.%26aulast%3DSengoku%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520structural%2520evaluation%2520of%2520N-alkylated%2520trans-2-phenylcyclopropylamine-based%2520LSD1%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D787%26doi%3D10.1002%2Fcmdc.202000014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinthakindi, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naicker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govender, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvidsson, P. I.</span></span> <span> </span><span class="NLM_article-title">Sulfonimidamides in medicinal and agricultural chemistry</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4100</span>– <span class="NLM_lpage">4109</span>, <span class="refDoi"> DOI: 10.1002/anie.201610456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fanie.201610456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlynu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=4100-4109&author=P.+K.+Chinthakindiauthor=T.+Naickerauthor=N.+Thotaauthor=T.+Govenderauthor=H.+G.+Krugerauthor=P.+I.+Arvidsson&title=Sulfonimidamides+in+medicinal+and+agricultural+chemistry&doi=10.1002%2Fanie.201610456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonimidamides in Medicinal and Agricultural Chemistry</span></div><div class="casAuthors">Chinthakindi, Praveen K.; Naicker, Tricia; Thota, Niranjan; Govender, Thavendran; Kruger, Hendrik G.; Arvidsson, Per I.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4100-4109</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The synthesis and evaluation of structural analogs and isosteres are of central importance in medicinal and agricultural chem.  The sulfonamide functional group represents one of the most important amide isosteres in contemporary drug design, and about 500 such compds. have overcome both the pharmacol. and regulatory hurdles that precede studies in humans.  The mono aza analogs of sulfonamides, i.e., sulfonimidamides, are rapidly gaining popularity as a novel functional group among synthetic chemists involved in the design of biol. active compds. for both pharmaceutical and agrochem. applications.  Herein, we review these recent developments to showcase the promise of this functional group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6zj9KqdepKbVg90H21EOLACvtfcHk0lh17yxbgQcYcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlynu7k%253D&md5=3460c3a7c17bd914174be7c81d645fb0</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fanie.201610456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201610456%26sid%3Dliteratum%253Aachs%26aulast%3DChinthakindi%26aufirst%3DP.%2BK.%26aulast%3DNaicker%26aufirst%3DT.%26aulast%3DThota%26aufirst%3DN.%26aulast%3DGovender%26aufirst%3DT.%26aulast%3DKruger%26aufirst%3DH.%2BG.%26aulast%3DArvidsson%26aufirst%3DP.%2BI.%26atitle%3DSulfonimidamides%2520in%2520medicinal%2520and%2520agricultural%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D4100%26epage%3D4109%26doi%3D10.1002%2Fanie.201610456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, S.</span></span> <span> </span><span class="NLM_article-title">New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">103808</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2020.103808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32334189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotVeksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2020&pages=103808&author=L.+Liangauthor=H.+Wangauthor=Y.+Duauthor=B.+Luoauthor=N.+Mengauthor=M.+Cenauthor=P.+Huangauthor=A.+Ganesanauthor=S.+Wen&title=New+tranylcypromine+derivatives+containing+sulfonamide+motif+as+potent+LSD1+inhibitors+to+target+acute+myeloid+leukemia%3A+Design%2C+synthesis+and+biological+evaluation&doi=10.1016%2Fj.bioorg.2020.103808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation</span></div><div class="casAuthors">Liang, Liyun; Wang, Haiwen; Du, Yongliang; Luo, Bingling; Meng, Ning; Cen, Meifeng; Huang, Peng; Ganesan, A.; Wen, Shijun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103808</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) is frequently elevated in acute myeloid leukemia (AML) and often leads to tumorigenesis.  In recent years, numerous LSD1 inhibitors based on tranylcypromine (TCP) scaffolding have reached clin. trials.  Most TCP derivs. were modified at the amino site of cyclopropane motif.  Herein, we for the first time introduced a sulfonamide group in TCP benzene ring of series a compds. and performed a systematical study on structure and activity relationships by varying sulfonamide groups.  The introduction of sulfonamide significantly increased the targeting capacity of TCP against LSD1.  Moreover, we discovered that the Boc attached LSD1 inhibitors (labeled as series b compds.) substantially improved their anti-proliferation capacity towards AML cells.  The intracellular thermal shift and LC-MS/MS results implied that Boc enhanced the drug lipophilicity and might be removed under the cancerous acidic environment to release the real pharmacophore, evidenced by the fact that a structurally similar but acidic inert pivaloyl to replace Boc dramatically dropped the cellular anti-proliferation effect.  Finally, a benzyl group installed at the amino site to appropriately increase lipophilicity led to trans-4-(2-(benzylamino)-cyclopropyl)-N,N-diethylbenzenesulfonamide a10 that showed better anti-proliferation activity in AML cells and enzymic inhibition against LSD1.  Taken together, our work offers a novel TCP-based structure and provides a prodrug strategy for the discovery of potent LSD1 inhibitors by having appropriate lipophilicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_jMV2UzXfJ7Vg90H21EOLACvtfcHk0ljMlwSdrtPwmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotVeksLg%253D&md5=85e40ad28160195bff91697dd77d62ee</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103808%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DN.%26aulast%3DCen%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DWen%26aufirst%3DS.%26atitle%3DNew%2520tranylcypromine%2520derivatives%2520containing%2520sulfonamide%2520motif%2520as%2520potent%2520LSD1%2520inhibitors%2520to%2520target%2520acute%2520myeloid%2520leukemia%253A%2520Design%252C%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D99%26spage%3D103808%26doi%3D10.1016%2Fj.bioorg.2020.103808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerds, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yacoub, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaczuch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shortt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossetti, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbury, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsoulis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talpaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peppe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rienhoff, H. Y.,  Jr.</span></span> <span> </span><span class="NLM_article-title">A phase 2a study of the LSD1 inhibitor img-7289 (bomedemstat) for the treatment of myelofibrosis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">556</span>, <span class="refDoi"> DOI: 10.1182/blood-2019-123244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1182%2Fblood-2019-123244" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2019&pages=556&author=K.+Pettitauthor=A.+T.+Gerdsauthor=A.+Yacoubauthor=J.+M.+Wattsauthor=M.+Tartaczuchauthor=T.+J.+Bradleyauthor=J.+Shorttauthor=W.+S.+Stevensonauthor=N.+J.+Curtinauthor=J.+M.+Rossettiauthor=K.+Burburyauthor=G.+Natsoulisauthor=A.+Jonesauthor=M.+Talpazauthor=J.+Peppeauthor=D.+M.+Rossauthor=H.+Y.+Rienhoff&title=A+phase+2a+study+of+the+LSD1+inhibitor+img-7289+%28bomedemstat%29+for+the+treatment+of+myelofibrosis&doi=10.1182%2Fblood-2019-123244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1182%2Fblood-2019-123244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2019-123244%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DK.%26aulast%3DGerds%26aufirst%3DA.%2BT.%26aulast%3DYacoub%26aufirst%3DA.%26aulast%3DWatts%26aufirst%3DJ.%2BM.%26aulast%3DTartaczuch%26aufirst%3DM.%26aulast%3DBradley%26aufirst%3DT.%2BJ.%26aulast%3DShortt%26aufirst%3DJ.%26aulast%3DStevenson%26aufirst%3DW.%2BS.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DRossetti%26aufirst%3DJ.%2BM.%26aulast%3DBurbury%26aufirst%3DK.%26aulast%3DNatsoulis%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DPeppe%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DD.%2BM.%26aulast%3DRienhoff%26aufirst%3DH.%2BY.%26atitle%3DA%2520phase%25202a%2520study%2520of%2520the%2520LSD1%2520inhibitor%2520img-7289%2520%2528bomedemstat%2529%2520for%2520the%2520treatment%2520of%2520myelofibrosis%26jtitle%3DBlood%26date%3D2019%26volume%3D134%26spage%3D556%26doi%3D10.1182%2Fblood-2019-123244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jutzi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleppe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staehle, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shank, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya-Feldstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambheer, S. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierks, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rienhoff, H. Y.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahl, H. L.</span></span> <span> </span><span class="NLM_article-title">LSD1 inhibition prolongs survival in mouse models of MPN by selectively targeting the disease clone</span>. <i>Hemasphere</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e54</span> <span class="refDoi"> DOI: 10.1097/HS9.0000000000000054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1097%2FHS9.0000000000000054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31723778" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&author=J.+S.+Jutziauthor=M.+Kleppeauthor=J.+Diasauthor=H.+F.+Staehleauthor=K.+Shankauthor=J.+Teruya-Feldsteinauthor=S.+M.+M.+Gambheerauthor=C.+Dierksauthor=H.+Y.+Rienhoffauthor=R.+L.+Levineauthor=H.+L.+Pahl&title=LSD1+inhibition+prolongs+survival+in+mouse+models+of+MPN+by+selectively+targeting+the+disease+clone&doi=10.1097%2FHS9.0000000000000054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1097%2FHS9.0000000000000054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHS9.0000000000000054%26sid%3Dliteratum%253Aachs%26aulast%3DJutzi%26aufirst%3DJ.%2BS.%26aulast%3DKleppe%26aufirst%3DM.%26aulast%3DDias%26aufirst%3DJ.%26aulast%3DStaehle%26aufirst%3DH.%2BF.%26aulast%3DShank%26aufirst%3DK.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DGambheer%26aufirst%3DS.%2BM.%2BM.%26aulast%3DDierks%26aufirst%3DC.%26aulast%3DRienhoff%26aufirst%3DH.%2BY.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DPahl%26aufirst%3DH.%2BL.%26atitle%3DLSD1%2520inhibition%2520prolongs%2520survival%2520in%2520mouse%2520models%2520of%2520MPN%2520by%2520selectively%2520targeting%2520the%2520disease%2520clone%26jtitle%3DHemasphere%26date%3D2018%26volume%3D2%26doi%3D10.1097%2FHS9.0000000000000054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascaró, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotllant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalcanti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carceller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span> <span> </span><span class="NLM_article-title">P4-404: Ory-2001: An epigenetic drug for the treatment of cognition defects in Alzheimer’s disease and other neurodegenerative disorders</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">P1192</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2016.07.149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.jalz.2016.07.149" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=P1192&author=T.+Maesauthor=C.+Mascar%C3%B3author=D.+Rotllantauthor=F.+Cavalcantiauthor=E.+Carcellerauthor=A.+Ortegaauthor=C.+Molineroauthor=C.+Buesa&title=P4-404%3A+Ory-2001%3A+An+epigenetic+drug+for+the+treatment+of+cognition+defects+in+Alzheimer%E2%80%99s+disease+and+other+neurodegenerative+disorders&doi=10.1016%2Fj.jalz.2016.07.149"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2016.07.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2016.07.149%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DT.%26aulast%3DMascar%25C3%25B3%26aufirst%3DC.%26aulast%3DRotllant%26aufirst%3DD.%26aulast%3DCavalcanti%26aufirst%3DF.%26aulast%3DCarceller%26aufirst%3DE.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DMolinero%26aufirst%3DC.%26aulast%3DBuesa%26aufirst%3DC.%26atitle%3DP4-404%253A%2520Ory-2001%253A%2520An%2520epigenetic%2520drug%2520for%2520the%2520treatment%2520of%2520cognition%2520defects%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520neurodegenerative%2520disorders%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2016%26volume%3D12%26spage%3DP1192%26doi%3D10.1016%2Fj.jalz.2016.07.149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shineman, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillit, H. M.</span></span> <span> </span><span class="NLM_article-title">Meeting report on the Alzheimer’s drug discovery foundation 14th international conference on Alzheimer’s drug discovery</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.1186/alzrt252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1186%2Falzrt252" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=22&author=L.+G.+Friedmanauthor=K.+Priceauthor=R.+F.+Laneauthor=A.+J.+Carmanauthor=P.+A.+Dacksauthor=D.+W.+Shinemanauthor=H.+M.+Fillit&title=Meeting+report+on+the+Alzheimer%E2%80%99s+drug+discovery+foundation+14th+international+conference+on+Alzheimer%E2%80%99s+drug+discovery&doi=10.1186%2Falzrt252"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1186%2Falzrt252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt252%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DL.%2BG.%26aulast%3DPrice%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DR.%2BF.%26aulast%3DCarman%26aufirst%3DA.%2BJ.%26aulast%3DDacks%26aufirst%3DP.%2BA.%26aulast%3DShineman%26aufirst%3DD.%2BW.%26aulast%3DFillit%26aufirst%3DH.%2BM.%26atitle%3DMeeting%2520report%2520on%2520the%2520Alzheimer%25E2%2580%2599s%2520drug%2520discovery%2520foundation%252014th%2520international%2520conference%2520on%2520Alzheimer%25E2%2580%2599s%2520drug%2520discovery%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D22%26doi%3D10.1186%2Falzrt252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascaró, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotllant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griñan-Ferré, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, T.</span></span> <span> </span><span class="NLM_article-title">P4-316: The dual lsd1/maob inhibitor ory2001 prevents the development of the memory deficit in samp8 mice through induction of neuronal plasticity and reduction of neuroinflammation</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">P905</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2015.08.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.jalz.2015.08.146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=P905&author=C.+Buesaauthor=C.+Mascar%C3%B3author=D.+Rotllantauthor=C.+Gri%C3%B1an-Ferr%C3%A9author=M.+Pall%C3%A0sauthor=T.+Maes&title=P4-316%3A+The+dual+lsd1%2Fmaob+inhibitor+ory2001+prevents+the+development+of+the+memory+deficit+in+samp8+mice+through+induction+of+neuronal+plasticity+and+reduction+of+neuroinflammation&doi=10.1016%2Fj.jalz.2015.08.146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.08.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.08.146%26sid%3Dliteratum%253Aachs%26aulast%3DBuesa%26aufirst%3DC.%26aulast%3DMascar%25C3%25B3%26aufirst%3DC.%26aulast%3DRotllant%26aufirst%3DD.%26aulast%3DGri%25C3%25B1an-Ferr%25C3%25A9%26aufirst%3DC.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DMaes%26aufirst%3DT.%26atitle%3DP4-316%253A%2520The%2520dual%2520lsd1%252Fmaob%2520inhibitor%2520ory2001%2520prevents%2520the%2520development%2520of%2520the%2520memory%2520deficit%2520in%2520samp8%2520mice%2520through%2520induction%2520of%2520neuronal%2520plasticity%2520and%2520reduction%2520of%2520neuroinflammation%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3DP905%26doi%3D10.1016%2Fj.jalz.2015.08.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span> <span> </span><span class="NLM_article-title">Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2019.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30713023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=844-847&author=X.+Wangauthor=M.+Suauthor=Y.+Liauthor=T.+Liuauthor=Y.+Wangauthor=Y.+Chenauthor=L.+Tangauthor=Y.+P.+Heauthor=X.+Dingauthor=F.+Yuauthor=J.+Shenauthor=J.+Liauthor=Y.+Zhouauthor=Y.+L.+Chenauthor=B.+Xiong&title=Tranylcypromine+and+6-trifluoroethyl+thienopyrimidine+hybrid+as+LSD1+inhibitor&doi=10.1016%2Fj.bmcl.2019.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor</span></div><div class="casAuthors">Wang, Xiaowen; Su, Mingbo; Li, You; Liu, Tongchao; Wang, Yujie; Chen, Yabing; Tang, Le; He, Yu-Peng; Ding, Xiaoguang; Yu, Fang; Shen, Jingkang; Li, Jia; Zhou, Yubo; Chen, Yue-Lei; Xiong, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">844-847</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tranylcypromine moiety extd. from LSD1 inhibitors and 6-trifluoroethyl thienopyrimidine moiety from menin-MLL1 PPI inhibitors were merged to give new chemotypes for medicinal chem. study.  Among 15 new compds. prepd. in this work, some exhibited nanomolar LSD1 activity and good selectivity over MAO-A/B, low micromolar menin-MLL1 PPI inhibitory activity, as well as submicromolar MV4-11 antiprofilative activities.  Intracellular LSD1 engagement of compds. with higher enzymic and antiproliferative activities was confirmed by CD86 mRNA up-regulation expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKyKovilVyj7Vg90H21EOLACvtfcHk0ljPB1grAXp9MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWnsb8%253D&md5=75190d1e546b766cd00a5cfc29e54644</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DY.%2BP.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DXiong%26aufirst%3DB.%26atitle%3DTranylcypromine%2520and%25206-trifluoroethyl%2520thienopyrimidine%2520hybrid%2520as%2520LSD1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D844%26epage%3D847%26doi%3D10.1016%2Fj.bmcl.2019.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pieroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annunziato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzali, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifiro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costantino, G.</span></span> <span> </span><span class="NLM_article-title">Further insights into the SAR of alpha-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2014.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25585008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFGnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=377-386&author=M.+Pieroniauthor=G.+Annunziatoauthor=E.+Azzaliauthor=P.+Dessantiauthor=C.+Mercurioauthor=G.+Meroniauthor=P.+Trifiroauthor=P.+Vianelloauthor=M.+Villaauthor=C.+Beatoauthor=M.+Varasiauthor=G.+Costantino&title=Further+insights+into+the+SAR+of+alpha-substituted+cyclopropylamine+derivatives+as+inhibitors+of+histone+demethylase+KDM1A&doi=10.1016%2Fj.ejmech.2014.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A</span></div><div class="casAuthors">Pieroni, Marco; Annunziato, Giannamaria; Azzali, Elisa; Dessanti, Paola; Mercurio, Ciro; Meroni, Giuseppe; Trifiro, Paolo; Vianello, Paola; Villa, Manuela; Beato, Claudia; Varasi, Mario; Costantino, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">377-386</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Epigenetics alterations including histone methylation and acetylation, and DNA methylation, are thought to play important roles in the onset and progression of cancer in numerous tumor cell lines.  Lysine-specific demethylase 1 (LSD1 or KDM1A) is highly expressed in different cancer types and inhibiting KDM1A activity seems to have high therapeutic potential in cancer treatment.  In the recent years, several inhibitors of KDM1A have been prepd. and disclosed.  The majority of these derivs. were designed based on the structure of tranylcypromine, as the cyclopropane core is responsible for the covalent interaction between the inhibitor and the catalytic domain of KDM proteins.  In this study, we have further extended the SAR regarding compds. 1a-e, which were recently found to inhibit KDM1A with good activity.  The decoration of the Ph ring at the β-position of the cyclopropane ring with small functional groups, mostly halogenated, and in particular at the meta position, led to a significant improvement of the inhibitory activity against KDM1A, as exemplified by compd. 44a, which has a potency in the low nanomolar range (31 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSQyHWyX2UZLVg90H21EOLACvtfcHk0lhtp7O5aqzhBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFGnuw%253D%253D&md5=76f37a0eeb69d3962a82fd4aab95cc8f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DAnnunziato%26aufirst%3DG.%26aulast%3DAzzali%26aufirst%3DE.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DTrifiro%26aufirst%3DP.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DBeato%26aufirst%3DC.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DCostantino%26aufirst%3DG.%26atitle%3DFurther%2520insights%2520into%2520the%2520SAR%2520of%2520alpha-substituted%2520cyclopropylamine%2520derivatives%2520as%2520inhibitors%2520of%2520histone%2520demethylase%2520KDM1A%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D377%26epage%3D386%26doi%3D10.1016%2Fj.ejmech.2014.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifiro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1A</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2014.08.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25173853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGnsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=352-363&author=P.+Vianelloauthor=O.+A.+Botrugnoauthor=A.+Cappaauthor=G.+Ciossaniauthor=P.+Dessantiauthor=A.+Maiauthor=A.+Matteviauthor=G.+Meroniauthor=S.+Minucciauthor=F.+Thalerauthor=M.+Tortoriciauthor=P.+Trifiroauthor=S.+Valenteauthor=M.+Villaauthor=M.+Varasiauthor=C.+Mercurio&title=Synthesis%2C+biological+activity+and+mechanistic+insights+of+1-substituted+cyclopropylamine+derivatives%3A+a+novel+class+of+irreversible+inhibitors+of+histone+demethylase+KDM1A&doi=10.1016%2Fj.ejmech.2014.08.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: A novel class of irreversible inhibitors of histone demethylase KDM1A</span></div><div class="casAuthors">Vianello, Paola; Botrugno, Oronza A.; Cappa, Anna; Ciossani, Giuseppe; Dessanti, Paola; Mai, Antonello; Mattevi, Andrea; Meroni, Giuseppe; Minucci, Saverio; Thaler, Florian; Tortorici, Marcello; Trifiro, Paolo; Valente, Sergio; Villa, Manuela; Varasi, Mario; Mercurio, Ciro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">352-363</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Histone demethylase KDM1A [i.e., gene LSD1, histone H3 lysine-4 demethylase LSD1] has become an attractive therapeutic target for the treatment of cancer as well as other disorders such as viral infections.  The authors report on the synthesis of compds. derived from the expansion of tranylcypromine as a chem. scaffold for the design of novel demethylase inhibitors.  These compds., which are substituted on the cyclopropyl core moiety, were evaluated for their ability to inhibit KDM1A in vitro as well as to function in cells by modulating the expression of Gfi-1b, a well recognized KDM1A target gene.  The mols. were all found to covalently inhibit KDM1A and to become increasingly selective against human monoamine oxidase MAO A and MAO B through the introduction of bulkier substituents on the cyclopropylamine ring.  Structural and biochem. anal. of selected trans-isomers showed that the two stereoisomers are endowed with similar inhibitory activities against KDM1A, but form different covalent adducts with FAD co-enzyme [i.e., riboflavin 5'-(trihydrogen diphosphate) P'→5'-ester with adenosine, FAD].  The synthesis of the target compds. was achieved using (2S)-2-(phenyl)oxirane, (2R)-2-(phenyl)oxirane, racemic (phenyl)oxirane as starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEJ-thHP_b6rVg90H21EOLACvtfcHk0lhtp7O5aqzhBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGnsrvP&md5=6285108e113c25939e3aa0b1ee5390c6</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.068%26sid%3Dliteratum%253Aachs%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DThaler%26aufirst%3DF.%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DTrifiro%26aufirst%3DP.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3DSynthesis%252C%2520biological%2520activity%2520and%2520mechanistic%2520insights%2520of%25201-substituted%2520cyclopropylamine%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520irreversible%2520inhibitors%2520of%2520histone%2520demethylase%2520KDM1A%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D352%26epage%3D363%26doi%3D10.1016%2Fj.ejmech.2014.08.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borrello, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartels, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benelkebir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Jamal, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duriez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haufe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2099</span>– <span class="NLM_lpage">2101</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2017.03.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28390942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2099-2101&author=M.+T.+Borrelloauthor=B.+Schinorauthor=K.+Bartelsauthor=H.+Benelkebirauthor=S.+Pereiraauthor=W.+T.+Al-Jamalauthor=L.+Douglasauthor=P.+J.+Duriezauthor=G.+Packhamauthor=G.+Haufeauthor=A.+Ganesan&title=Fluorinated+tranylcypromine+analogues+as+inhibitors+of+lysine-specific+demethylase+1+%28LSD1%2C+KDM1A%29&doi=10.1016%2Fj.bmcl.2017.03.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A)</span></div><div class="casAuthors">Borrello, Maria Teresa; Schinor, Benjamin; Bartels, Katharina; Benelkebir, Hanae; Pereira, Sara; Al-Jamal, Wafa T.; Douglas, Leon; Duriez, Patrick J.; Packham, Graham; Haufe, Gunter; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2099-2101</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report a series of tranylcypromine analogs contg. a fluorine in the cyclopropyl ring.  A no. of compds. with addnl. m- or p-substitution of the aryl ring were micromolar inhibitors of the LSD1 enzyme.  In cellular assays, the compds. inhibited the proliferation of acute myeloid leukemia cell lines.  Increased levels of the biomarkers H3K4me2 and CD86 were consistent with LSD1 target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5ZbwPOwT7LVg90H21EOLACvtfcHk0lhHP1NXPu9Fqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOlsr4%253D&md5=aec7b06a5648e828e32f3c1a8b2360e4</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.081%26sid%3Dliteratum%253Aachs%26aulast%3DBorrello%26aufirst%3DM.%2BT.%26aulast%3DSchinor%26aufirst%3DB.%26aulast%3DBartels%26aufirst%3DK.%26aulast%3DBenelkebir%26aufirst%3DH.%26aulast%3DPereira%26aufirst%3DS.%26aulast%3DAl-Jamal%26aufirst%3DW.%2BT.%26aulast%3DDouglas%26aufirst%3DL.%26aulast%3DDuriez%26aufirst%3DP.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DHaufe%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DFluorinated%2520tranylcypromine%2520analogues%2520as%2520inhibitors%2520of%2520lysine-specific%2520demethylase%25201%2520%2528LSD1%252C%2520KDM1A%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2099%26epage%3D2101%26doi%3D10.1016%2Fj.bmcl.2017.03.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Zuffo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrocco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stazi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifiró, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) as orally active antitumor agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyrtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1501-1517&author=P.+Vianelloauthor=O.+A.+Botrugnoauthor=A.+Cappaauthor=R.+Dal+Zuffoauthor=P.+Dessantiauthor=A.+Maiauthor=B.+Marroccoauthor=A.+Matteviauthor=G.+Meroniauthor=S.+Minucciauthor=G.+Staziauthor=F.+Thalerauthor=P.+Trifir%C3%B3author=S.+Valenteauthor=M.+Villaauthor=M.+Varasiauthor=C.+Mercurio&title=Discovery+of+a+novel+inhibitor+of+histone+lysine-specific+demethylase+1A+%28KDM1A%2FLSD1%29+as+orally+active+antitumor+agent&doi=10.1021%2Facs.jmedchem.5b01209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent</span></div><div class="casAuthors">Vianello, Paola; Botrugno, Oronza A.; Cappa, Anna; Dal Zuffo, Roberto; Dessanti, Paola; Mai, Antonello; Marrocco, Biagina; Mattevi, Andrea; Meroni, Giuseppe; Minucci, Saverio; Stazi, Giulia; Thaler, Florian; Trifiro, Paolo; Valente, Sergio; Villa, Manuela; Varasi, Mario; Mercurio, Ciro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1501-1517</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the stereoselective synthesis and biol. activity of a novel series of tranylcypromine (TCPA) derivs, potent inhibitors of KDM1A.  The new compds. strongly inhibit the clonogenic potential of acute leukemia cell lines.  In particular three mols. showing selectivity vs. MAO A and remarkably inhibiting colony formation in THP-1 human leukemia cells, were assessed in mouse for their preliminary pharmacokinetic.  Among them, compds. I and II were further tested in vivo in a murine acute promyelocytic leukemia model, resulting I the most effective.  Its two enantiomers were synthesized: the (1S,2R) enantiomer showed higher activity than its (1R,2S) analog, in both biochem. and cellular assays.  Compd. (1S,2R)-I exhibited in vivo efficacy after oral administration, detg. a 62% increased survival in mouse leukemia model with evidence of KDM1A inhibition.  The biol. profile of compd. (1S,2R)-I supports its further investigation as a cancer therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraSPzAcLQ0u7Vg90H21EOLACvtfcHk0lhHP1NXPu9Fqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyrtbfM&md5=b7df567ef2cf939a1365874fccac9df0</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01209%26sid%3Dliteratum%253Aachs%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DDal%2BZuffo%26aufirst%3DR.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMarrocco%26aufirst%3DB.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DStazi%26aufirst%3DG.%26aulast%3DThaler%26aufirst%3DF.%26aulast%3DTrifir%25C3%25B3%26aufirst%3DP.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520inhibitor%2520of%2520histone%2520lysine-specific%2520demethylase%25201A%2520%2528KDM1A%252FLSD1%2529%2520as%2520orally%2520active%2520antitumor%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1501%26epage%3D1517%26doi%3D10.1021%2Facs.jmedchem.5b01209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunosewoyo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.-F.</span></span> <span> </span><span class="NLM_article-title">Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2017.09.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29031059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GltrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=101-112&author=Y.-Y.+Jiauthor=S.-D.+Linauthor=Y.-J.+Wangauthor=M.-B.+Suauthor=W.+Zhangauthor=H.+Gunosewoyoauthor=F.+Yangauthor=J.+Liauthor=J.+Tangauthor=Y.-B.+Zhouauthor=L.-F.+Yu&title=Tying+up+tranylcypromine%3A+Novel+selective+histone+lysine+specific+demethylase+1+%28LSD1%29+inhibitors&doi=10.1016%2Fj.ejmech.2017.09.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors</span></div><div class="casAuthors">Ji, Yue-Yang; Lin, Sen-Dong; Wang, Yu-Jie; Su, Ming-Bo; Zhang, Wei; Gunosewoyo, Hendra; Yang, Fan; Li, Jia; Tang, Jie; Zhou, Yu-Bo; Yu, Li-Fang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Aberrant expression of lysine specific histone demethylase 1 (LSD1) has been increasingly assocd. with numerous cancer cells and several proof-of-concept studies are strongly suggestive of its potential as a druggable target.  Tranylcypromine (TCP) is an antidepressant originally known to target the monoamine oxidases A and B (MAO-A and MAO-B), which are structurally related to LSD1.  A no. of TCP derivs. have been identified as potent LSD1 inhibitors, with a handful of them currently being tested in clin. trials.  However, thus far the majority of structure-activity relationship studies reported on these TCP derivs. have been mostly limited to the racemates.  In this study, the authors present the SAR data for a novel series of conformationally-restricted TCP-based LSD1 inhibitors, both in their racemic and enantiomerically pure forms.  Compds. I and II were identified as the most potent LSD1 inhibitors within this series, possessing excellent selectivity (>10,000-fold) against MAO-A and MAO-B.  These compds. activated CD86 expression on the human MV4-11 AML cells following 10 days of exposure, accompanied with the apparent cytotoxicity.  Taken together, these findings are consistent with the pharmacol. inhibition of LSD1 and further provide structural insights on the binding modes of these TCP derivs. and their enantiomers at the LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBmzvmFTXrQ7Vg90H21EOLACvtfcHk0lhb0yEwfHhSIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GltrnL&md5=fcef20fb0336c50bfa970fe6ab1a0e55</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.073%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DY.-Y.%26aulast%3DLin%26aufirst%3DS.-D.%26aulast%3DWang%26aufirst%3DY.-J.%26aulast%3DSu%26aufirst%3DM.-B.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.-B.%26aulast%3DYu%26aufirst%3DL.-F.%26atitle%3DTying%2520up%2520tranylcypromine%253A%2520Novel%2520selective%2520histone%2520lysine%2520specific%2520demethylase%25201%2520%2528LSD1%2529%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D141%26spage%3D101%26epage%3D112%26doi%3D10.1016%2Fj.ejmech.2017.09.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunosewoyo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.-F.</span></span> <span> </span><span class="NLM_article-title">Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1676</span>, <span class="refDoi"> DOI: 10.1039/C7RA13097J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1039%2FC7RA13097J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1OjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1666-1676&author=Y.+Shiauthor=Y.-R.+Wuauthor=M.-B.+Suauthor=D.-H.+Shenauthor=H.+Gunosewoyoauthor=F.+Yangauthor=J.+Liauthor=J.+Tangauthor=Y.-B.+Zhouauthor=L.-F.+Yu&title=Novel+spirocyclic+tranylcypromine+derivatives+as+lysine-specific+demethylase+1+%28LSD1%29+inhibitors&doi=10.1039%2FC7RA13097J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors</span></div><div class="casAuthors">Shi, Ying; Wu, Yan-Ran; Su, Ming-Bo; Shen, Dong-Hao; Gunosewoyo, Hendra; Yang, Fan; Li, Jia; Tang, Jie; Zhou, Yu-Bo; Yu, Li-Fang</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1666-1676</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Herein we describe the design, synthesis, and biol. evaluation of a novel series of tranylcypromine-based LSD1 inhibitors via conformational restriction using spiro ring systems.  A simple, direct spirocyclic analog of tranylcypromine (compds. 8a and 8b) was shown to be a 28- to 129-fold more potent inhibitor of LSD1 enzyme compared to tranylcypromine.  Further incorporation of various substituted benzyl groups to the amino group resulted in a suite of 2',3'-dihydrospiro[cyclopropane-1,1'-inden]-2-amines that are potent LSD1 inhibitors with excellent selectivity profiles (e.g.14a, 15b, 16a, 19a and 20b) against closely related enzymes such as MAO-A, MAO-B, and LSD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWzoUiCluAq7Vg90H21EOLACvtfcHk0lhb0yEwfHhSIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1OjtA%253D%253D&md5=127597283f5185a816168b0414f501ef</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1039%2FC7RA13097J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA13097J%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.-R.%26aulast%3DSu%26aufirst%3DM.-B.%26aulast%3DShen%26aufirst%3DD.-H.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.-B.%26aulast%3DYu%26aufirst%3DL.-F.%26atitle%3DNovel%2520spirocyclic%2520tranylcypromine%2520derivatives%2520as%2520lysine-specific%2520demethylase%25201%2520%2528LSD1%2529%2520inhibitors%26jtitle%3DRSC%2520Adv.%26date%3D2018%26volume%3D8%26spage%3D1666%26epage%3D1676%26doi%3D10.1039%2FC7RA13097J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span> <span> </span><span class="NLM_article-title">LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>437</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1038/nature04020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fnature04020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=16079795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFOrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=436-439&author=E.+Metzgerauthor=M.+Wissmannauthor=N.+Yinauthor=J.+M.+Mullerauthor=R.+Schneiderauthor=A.+H.+Petersauthor=T.+Guntherauthor=R.+Buettnerauthor=R.+Schule&title=LSD1+demethylates+repressive+histone+marks+to+promote+androgen-receptor-dependent+transcription&doi=10.1038%2Fnature04020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription</span></div><div class="casAuthors">Metzger, Eric; Wissmann, Melanie; Yin, Na; Mueller, Judith M.; Schneider, Robert; Peters, Antoine H. F. M.; Guenther, Thomas; Buettner, Reinhard; Schuele, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">7057</span>),
    <span class="NLM_cas:pages">436-439</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Gene regulation in eukaryotes requires the coordinate interaction of chromatin-modulating proteins with specific transcription factors such as the androgen receptor.  Gene activation and repression is specifically regulated by histone methylation status at distinct lysine residues.  Here the authors show that lysine-specific demethylase 1 (LSD1; also known as BHC110) co-localizes with the androgen receptor in normal human prostate and prostate tumor.  LSD1 interacts with androgen receptor in vitro and in vivo, and stimulates androgen-receptor-dependent transcription.  Conversely, knockdown of LSD1 protein levels abrogates androgen-induced transcriptional activation and cell proliferation.  Chromatin immunopptn. analyses demonstrate that androgen receptor and LSD1 form chromatin-assocd. complexes in a ligand-dependent manner.  LSD1 relieves repressive histone marks by demethylation of histone H3 at lysine 9 (H3-K9), thereby leading to de-repression of androgen receptor target genes.  Furthermore, the authors identify pargyline as an inhibitor of LSD1.  Pargyline blocks demethylation of H3-K9 by LSD1 and consequently androgen-receptor-dependent transcription.  Thus, modulation of LSD1 activity offers a new strategy to regulate androgen receptor functions.  Here, the authors link demethylation of a repressive histone mark with androgen-receptor-dependent gene activation, thus providing a mechanism by which demethylases control specific gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgFgaYIdjiFbVg90H21EOLACvtfcHk0ljrsoEKvgHrig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFOrtL4%253D&md5=6cac1e6f6c21a80f59de27796cc9ee22</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fnature04020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04020%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DE.%26aulast%3DWissmann%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DN.%26aulast%3DMuller%26aufirst%3DJ.%2BM.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DA.%2BH.%26aulast%3DGunther%26aufirst%3DT.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DSchule%26aufirst%3DR.%26atitle%3DLSD1%2520demethylates%2520repressive%2520histone%2520marks%2520to%2520promote%2520androgen-receptor-dependent%2520transcription%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D436%26epage%3D439%26doi%3D10.1038%2Fnature04020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karakaidos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verigos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magklara, A.</span></span> <span> </span><span class="NLM_article-title">LSD1/KDM1A, a gate-keeper of cancer stemness and a promising therapeutic target</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1821</span>, <span class="refDoi"> DOI: 10.3390/cancers11121821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3390%2Fcancers11121821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXptVyht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1821&author=P.+Karakaidosauthor=J.+Verigosauthor=A.+Magklara&title=LSD1%2FKDM1A%2C+a+gate-keeper+of+cancer+stemness+and+a+promising+therapeutic+target&doi=10.3390%2Fcancers11121821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1/KDM1A, a gate-keeper of cancer stemness and a promising therapeutic target</span></div><div class="casAuthors">Karakaidos, Panagiotis; Verigos, John; Magklara, Angeliki</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1821</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A new exciting area in cancer research is the study of cancer stem cells (CSCs) and the translational implications for putative epigenetic therapies targeted against them.  Accumulating evidence of the effects of epigenetic modulating agents has revealed their dramatic consequences on cellular reprogramming and, particularly, reversing cancer stemness characteristics, such as self-renewal and chemoresistance.  Lysine specific demethylase 1 (LSD1/KDM1A) plays a well-established role in the normal hematopoietic and neuronal stem cells.  Overexpression of LSD1 has been documented in a variety of cancers, where the enzyme is, usually, assocd. with the more aggressive types of the disease.  Interestingly, recent studies have implicated LSD1 in the regulation of the pool of CSCs in different leukemias and solid tumors.  However, the precise mechanisms that LSD1 uses to mediate its effects on cancer stemness are largely unknown.  Herein, we review the literature on LSD1's role in normal and cancer stem cells, highlighting the analogies of its mode of action in the two biol. settings.  Given its potential as a pharmacol. target, we, also, discuss current advances in the design of novel therapeutic regimes in cancer that incorporate LSD1 inhibitors, as well as their future perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyjsYptQmktLVg90H21EOLACvtfcHk0ljrsoEKvgHrig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXptVyht7s%253D&md5=0cef1b5b1817832a8225178244c7c17c</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.3390%2Fcancers11121821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers11121821%26sid%3Dliteratum%253Aachs%26aulast%3DKarakaidos%26aufirst%3DP.%26aulast%3DVerigos%26aufirst%3DJ.%26aulast%3DMagklara%26aufirst%3DA.%26atitle%3DLSD1%252FKDM1A%252C%2520a%2520gate-keeper%2520of%2520cancer%2520stemness%2520and%2520a%2520promising%2520therapeutic%2520target%26jtitle%3DCancers%26date%3D2019%26volume%3D11%26spage%3D1821%26doi%3D10.3390%2Fcancers11121821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stazi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwergel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">LSD1 inhibitors: a patent review (2010–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1517/13543776.2016.1165209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1517%2F13543776.2016.1165209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27019002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFGqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=565-580&author=G.+Staziauthor=C.+Zwergelauthor=S.+Valenteauthor=A.+Mai&title=LSD1+inhibitors%3A+a+patent+review+%282010%E2%80%932015%29&doi=10.1517%2F13543776.2016.1165209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 inhibitors: a patent review (2010-2015)</span></div><div class="casAuthors">Stazi, Giulia; Zwergel, Clemens; Valente, Sergio; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-580</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Lysine demethylase 1 (LSD1) plays an important role in mediating the expression of genes involved in cancer and non-cancer diseases such as viral infections, cardiovascular and neurodegenerative disorders.  It is involved in a no. of processes from adipogenesis to cell adhesion to viral latency, regulating several cell pathways related with proliferation, development, and cell cycle control.  Numerous chem. entities have been studied in recent years and some of them entered the clin. arena.  This review summarizes recent efforts in the drug development of LSD1 inhibitors reported in the patent literature covering the 2010-2015 period, including their potential use as therapeutics in cancerous, neurol., inflammatory, cardiovascular, and viral diseases.  The development of novel potent and selective LSD1 inhibitors is ongoing, in order to improve their potency and selectivity against specific types of cancer or non-cancer diseases.  More in-depth studies are required to assess the role of LSD1 inhibitors in the expression of LSD1 target genes, for a better assessment of the biochem. underlying their efficacy, and to provide evidence for any possible side effects.  Furthermore, an interesting therapeutic approach is the use of LSD1 inhibitors in conjunction with other epidrugs to combine their therapeutic potential, leading to innovative, personalized treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCf5uleaXD27Vg90H21EOLACvtfcHk0ljTDjJCOliq7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFGqs7w%253D&md5=557242114797bc59b35e9f66cec893bf</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1165209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1165209%26sid%3Dliteratum%253Aachs%26aulast%3DStazi%26aufirst%3DG.%26aulast%3DZwergel%26aufirst%3DC.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DLSD1%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D565%26epage%3D580%26doi%3D10.1517%2F13543776.2016.1165209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorna, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theisen, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearss, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vankayalapati, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span> <span> </span><span class="NLM_article-title">High-throughput virtual screening identifies novel N′-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9496</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1021/jm400870h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400870h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyks7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9496-508&author=V.+Sornaauthor=E.+R.+Theisenauthor=B.+Stephensauthor=S.+L.+Warnerauthor=D.+J.+Bearssauthor=H.+Vankayalapatiauthor=S.+Sharma&title=High-throughput+virtual+screening+identifies+novel+N%E2%80%B2-%281-phenylethylidene%29-benzohydrazides+as+potent%2C+specific%2C+and+reversible+LSD1+inhibitors&doi=10.1021%2Fjm400870h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Virtual Screening Identifies Novel N'-(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors</span></div><div class="casAuthors">Sorna, Venkataswamy; Theisen, Emily R.; Stephens, Bret; Warner, Steven L.; Bearss, David J.; Vankayalapati, Hariprasad; Sharma, Sunil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9496-9508</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) plays an important role in regulating histone lysine methylation at residues K4 and K9 on histone H3 and is an attractive therapeutic target in multiple malignancies.  Here we report a structure-based virtual screen of a compd. library contg. ∼2 million small mol. entities.  Computational docking and scoring followed by biochem. screening led to the identification of a novel N'-(1-phenylethylidene)-benzohydrazide series of LSD1 inhibitors with hits showing biochem. IC50s in the 200-400 nM range.  Hit-to-lead optimization and structure-activity relation studies aided in the discovery of compd. (I), with a Ki of 31 nM.  Compd. I is reversible and specific for LSD1 as compared to the monoamine oxidases shows minimal inhibition of CYPs and hERG and inhibits proliferation and survival in several cancer cell lines, including breast and colorectal cancer.  Compd. I may be used to probe LSD1's biol. role in these cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp97P3ef8ur6rVg90H21EOLACvtfcHk0ljTDjJCOliq7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyks7fF&md5=47293fd790c5bc9fd944943ff4b1a58a</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm400870h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400870h%26sid%3Dliteratum%253Aachs%26aulast%3DSorna%26aufirst%3DV.%26aulast%3DTheisen%26aufirst%3DE.%2BR.%26aulast%3DStephens%26aufirst%3DB.%26aulast%3DWarner%26aufirst%3DS.%2BL.%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26aulast%3DVankayalapati%26aufirst%3DH.%26aulast%3DSharma%26aufirst%3DS.%26atitle%3DHigh-throughput%2520virtual%2520screening%2520identifies%2520novel%2520N%25E2%2580%25B2-%25281-phenylethylidene%2529-benzohydrazides%2520as%2520potent%252C%2520specific%252C%2520and%2520reversible%2520LSD1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9496%26epage%3D508%26doi%3D10.1021%2Fjm400870h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D(3) receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4962</span>– <span class="NLM_lpage">4968</span>, <span class="refDoi"> DOI: 10.1021/jm401798r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401798r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4962-4968&author=J.+Chenauthor=B.+Levantauthor=C.+Jiangauthor=T.+M.+Keckauthor=A.+H.+Newmanauthor=S.+Wang&title=Tranylcypromine+substituted+cis-hydroxycyclobutylnaphthamides+as+potent+and+selective+dopamine+D%283%29+receptor+antagonists&doi=10.1021%2Fjm401798r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Chen, Jianyong; Levant, Beth; Jiang, Cheng; Keck, Thomas M.; Newman, Amy Hauck; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4962-4968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a class of potent and selective dopamine D3 receptor antagonists based upon tranylcypromine.  Although tranylcypromine has a low affinity for the rat D3 receptor (Ki = 12.8 μM), our efforts have yielded (1R,2S)-11 (CJ-1882), which has Ki values of 2.7 and 2.8 nM at the rat and human dopamine D3 receptors, resp., and displays resp. selectivities of >10000-fold and 223-fold over the rat and human D2 receptors.  Evaluation in a β-arrestin functional assay showed that (1R,2S)-11 is a potent and competitive antagonist at the human D3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowWudWdAfWgLVg90H21EOLACvtfcHk0liJPk35f4F_YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D&md5=e2ddf0711d00103be281cb043b19ec3a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm401798r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401798r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTranylcypromine%2520substituted%2520cis-hydroxycyclobutylnaphthamides%2520as%2520potent%2520and%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4962%26epage%3D4968%26doi%3D10.1021%2Fjm401798r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2020.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.apsb.2020.02.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=L.+Maauthor=H.+Wangauthor=Y.+Youauthor=C.+Maauthor=Y.+Liuauthor=F.+Yangauthor=Y.+Zhengauthor=H.+Liu&title=Exploration+of+5-cyano-6-phenylpyrimidin+derivatives+containing+an+1%2C2%2C3-triazole+moiety+as+potent+FAD-based+LSD1+inhibitors&doi=10.1016%2Fj.apsb.2020.02.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2020.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2020.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DExploration%2520of%25205-cyano-6-phenylpyrimidin%2520derivatives%2520containing%2520an%25201%252C2%252C3-triazole%2520moiety%2520as%2520potent%2520FAD-based%2520LSD1%2520inhibitors%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2020%26doi%3D10.1016%2Fj.apsb.2020.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, W.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.-W.</span></span> <span> </span><span class="NLM_article-title">Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.04.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2019.04.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31096156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVGisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2019&pages=357-372&author=H.-M.+Liuauthor=F.-Z.+Suoauthor=X.-B.+Liauthor=Y.-H.+Youauthor=C.-T.+Lvauthor=C.-X.+Zhengauthor=G.-C.+Zhangauthor=Y.-J.+Liuauthor=W.-T.+Kangauthor=Y.-C.+Zhengauthor=H.-W.+Xu&title=Discovery+and+synthesis+of+novel+indole+derivatives-containing+3-methylenedihydrofuran-2%283H%29-one+as+irreversible+LSD1+inhibitors&doi=10.1016%2Fj.ejmech.2019.04.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors</span></div><div class="casAuthors">Liu, Hong-Min; Suo, Feng-Zhi; Li, Xiao-Bo; You, Ying-Hua; Lv, Chun-Tao; Zheng, Chen-Xing; Zhang, Guo-Chen; Liu, Yue-Jiao; Kang, Wen-Ting; Zheng, Yi-Chao; Xu, Hai-Wei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">357-372</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of new indole derivs. were designed and synthesized based on a lead compd. obtained by a high-throughput screening with our inhouse compd. library.  Among the synthetic compds., compd. I was characterized as a potent LSD1 inhibitor with an IC50 of 1.230 μM and inhibited the proliferation of THP-1 cells effectively.  And most importantly, this was the first irreversible LSD1 inhibitor that is not derived from monoamine oxidase inhibitors.  Hence, the discovery of compd. I may serve as a proof of concept work for AML treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-rtJCJCweTrVg90H21EOLACvtfcHk0liJPk35f4F_YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVGisr0%253D&md5=4c21ccd38a1bf02c94425b7ee78e550d</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.04.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.04.065%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.-M.%26aulast%3DSuo%26aufirst%3DF.-Z.%26aulast%3DLi%26aufirst%3DX.-B.%26aulast%3DYou%26aufirst%3DY.-H.%26aulast%3DLv%26aufirst%3DC.-T.%26aulast%3DZheng%26aufirst%3DC.-X.%26aulast%3DZhang%26aufirst%3DG.-C.%26aulast%3DLiu%26aufirst%3DY.-J.%26aulast%3DKang%26aufirst%3DW.-T.%26aulast%3DZheng%26aufirst%3DY.-C.%26aulast%3DXu%26aufirst%3DH.-W.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520novel%2520indole%2520derivatives-containing%25203-methylenedihydrofuran-2%25283H%2529-one%2520as%2520irreversible%2520LSD1%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D175%26spage%3D357%26epage%3D372%26doi%3D10.1016%2Fj.ejmech.2019.04.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">6000</span>– <span class="NLM_lpage">6014</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmc.2018.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30448189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1WltrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=6000-6014&author=Y.+Duanauthor=W.+Qinauthor=F.+Suoauthor=X.+Zhaiauthor=Y.+Guanauthor=X.+Wangauthor=Y.+Zhengauthor=H.+Liu&title=Design%2C+synthesis+and+in+vitro+evaluation+of+stilbene+derivatives+as+novel+LSD1+inhibitors+for+AML+therapy&doi=10.1016%2Fj.bmc.2018.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy</span></div><div class="casAuthors">Duan, Yingchao; Qin, Wenping; Suo, Fengzhi; Zhai, Xiaoyu; Guan, Yuanyuan; Wang, Xiaojuan; Zheng, Yichao; Liu, Hongmin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23-24</span>),
    <span class="NLM_cas:pages">6000-6014</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">LSD1 is implicated in a no. of malignancies and has emerged as an exciting target.  As part of our sustained efforts to develop novel reversible LSD1 inhibitors for epigenetic therapy of cancers, in this study, we reported a series of stilbene derivs. and evaluated their LSD1 inhibitory activities, obtaining several compds. as potent LSD1 inhibitors with IC50 values in submicromolar range.  Enzyme kinetics studies and SPR assay suggested that compd. 8c, the most active LSD1 inhibitor (IC50 = 283 nM), potently inhibited LSD1 in a reversible and FAD competitive manner.  Consistent with the kinetics data, mol. docking showed that compd. 8c can be well docked into the FAD binding site of LSD1.  Flow cytometry anal. showed that compd. 8c was capable of up-regulating the expression of the surrogate cellular biomarker CD86 in THP-1 human leukemia cells, suggesting the ability to block LSD1 activity in cells.  Compd. 8c showed good inhibition against THP-1 and MOLM-13 cells with IC50 values of 5.76 and 8.34 μM, resp.  Moreover, compd. 8c significantly inhibited colony formation of THP-1 cells dose dependently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQHvTfU4lSbVg90H21EOLACvtfcHk0lhC8Epa-Erzbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1WltrjJ&md5=989826c422d025071b5533a8be86edae</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DW.%26aulast%3DSuo%26aufirst%3DF.%26aulast%3DZhai%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520stilbene%2520derivatives%2520as%2520novel%2520LSD1%2520inhibitors%2520for%2520AML%2520therapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D6000%26epage%3D6014%26doi%3D10.1016%2Fj.bmc.2018.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine derivatives as novel LSD1 Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjslyju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=384-389&author=Z.+H.+Liauthor=X.+Q.+Liuauthor=P.+F.+Gengauthor=F.+Z.+Suoauthor=J.+L.+Maauthor=B.+Yuauthor=T.+Q.+Zhaoauthor=Z.+Q.+Zhouauthor=C.+X.+Huangauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Discovery+of+%5B1%2C2%2C3%5DTriazolo%5B4%2C5-d%5Dpyrimidine+derivatives+as+novel+LSD1+Inhibitors&doi=10.1021%2Facsmedchemlett.6b00423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Novel LSD1 Inhibitors</span></div><div class="casAuthors">Li, Zhong-Hua; Liu, Xue-Qi; Geng, Peng-Fei; Suo, Feng-Zhi; Ma, Jin-Lian; Yu, Bin; Zhao, Tao-Qian; Zhou, Zhao-Qing; Huang, Chen-Xi; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">384-389</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) plays a pivotal role in regulating the lysine methylation.  The aberrant overexpression of LSD1 was reported to be involved in the progression of certain human malignant tumors.  Abrogation of LSD1 with RNAi or small mol. inhibitors may lead to the inhibition of cancer proliferation and migration.  Herein, a series of [1,2,3]triazolo[4,5-d]pyrimidine derivs. were synthesized and evaluated for their LSD1 inhibitory effects.  The structure-activity relation studies (SARs) were conducted by exploring three regions of this scaffold, leading to the discovery of compd. 27 as potent LSD1 inhibitor (IC50 = 0.564 μM).  Compd. 27 was identified as a reversible LSD1 inhibitor and showed certain selectivity to LSD1 over monoamine oxidase A/B (MAO-A/B).  When MGC-803 cells were treated with compd. 27, the activity of LSD1 can be significantly inhibited, and the cell migration ability was also suppressed.  Docking studies indicated that the hydrogen interaction between the nitrogen atom in the pyridine ring and Met332 could be responsible for the improved activity of 2-thiopyridine series.  The [1,2,3]triazolo[4,5-d]pyrimidine scaffold can be used as the template for designing new LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeTW4tbCivwLVg90H21EOLACvtfcHk0lhC8Epa-Erzbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjslyju74%253D&md5=dc8bb933eebb850e165663d6de2b8270</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00423%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DLiu%26aufirst%3DX.%2BQ.%26aulast%3DGeng%26aufirst%3DP.%2BF.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DT.%2BQ.%26aulast%3DZhou%26aufirst%3DZ.%2BQ.%26aulast%3DHuang%26aufirst%3DC.%2BX.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DDiscovery%2520of%2520%255B1%252C2%252C3%255DTriazolo%255B4%252C5-d%255Dpyrimidine%2520derivatives%2520as%2520novel%2520LSD1%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D384%26epage%3D389%26doi%3D10.1021%2Facsmedchemlett.6b00423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.11.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2016.11.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27888721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGqsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=246-258&author=Y.+C.+Duanauthor=Y.+Y.+Guanauthor=X.+Y.+Zhaiauthor=L.+N.+Dingauthor=W.+P.+Qinauthor=D.+D.+Shenauthor=X.+Q.+Liuauthor=X.+D.+Sunauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Discovery+of+resveratrol+derivatives+as+novel+LSD1+inhibitors%3A+Design%2C+synthesis+and+their+biological+evaluation&doi=10.1016%2Fj.ejmech.2016.11.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation</span></div><div class="casAuthors">Duan, Ying-Chao; Guan, Yuan-Yuan; Zhai, Xiao-Yu; Ding, Li-Na; Qin, Wen-Ping; Shen, Dan-Dan; Liu, Xue-Qi; Sun, Xu-Dong; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">246-258</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Inhibition of lysine-specific demethylase 1 (LSD1) has recently emerged as an attractive therapeutic target for treating cancer and other diseases.  As a continuity of our ongoing effort to identify novel small-mol. LSD1-inhibitors, we designed and synthesized a series of resveratrol derivs., which were shown to be potent inhibitors of LSD1.  Among them, compds. I and II displayed the most potent LSD1-inhibitory activities in enzyme assays, with IC50 values of 121 nM and 123 nM, resp.  Biochem. study and docking anal. indicated that compds. I and II were reversible LSD1 inhibitors.  High content anal. showed that I and II induced a dose-dependent increase of dimethylated Lys4 of histone H3 and had no impact on the expression of LSD1 in MGC-803 cells.  Furthermore, I or II could remarkably increase the mRNA level of CD86, a surrogate cellular biomarker for LSD1 activity, in MGC-803 cells, suggesting that they are likely to exhibit LSD1-inhibitory activities intracellularly.  These findings should encourage further modification of these compds. to produce more potent LSD1 inhibitors with potential anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWLdv3p7rUK7Vg90H21EOLACvtfcHk0lgedfpNFZIqxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGqsrbN&md5=812cb448167dda2f2a2f69b269a4c594</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.11.035%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%2BC.%26aulast%3DGuan%26aufirst%3DY.%2BY.%26aulast%3DZhai%26aufirst%3DX.%2BY.%26aulast%3DDing%26aufirst%3DL.%2BN.%26aulast%3DQin%26aufirst%3DW.%2BP.%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DLiu%26aufirst%3DX.%2BQ.%26aulast%3DSun%26aufirst%3DX.%2BD.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DDiscovery%2520of%2520resveratrol%2520derivatives%2520as%2520novel%2520LSD1%2520inhibitors%253A%2520Design%252C%2520synthesis%2520and%2520their%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D246%26epage%3D258%26doi%3D10.1016%2Fj.ejmech.2016.11.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.11.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2018.11.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30472603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit12ltLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=555-567&author=Q.+S.+Maauthor=Y.+Yaoauthor=Y.+C.+Zhengauthor=S.+Fengauthor=J.+Changauthor=B.+Yuauthor=H.+M.+Liu&title=Ligand-based+design%2C+synthesis+and+biological+evaluation+of+xanthine+derivatives+as+LSD1%2FKDM1A+inhibitors&doi=10.1016%2Fj.ejmech.2018.11.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors</span></div><div class="casAuthors">Ma, Qi-Sheng; Yao, Yongfang; Zheng, Yi-Chao; Feng, Siqi; Chang, Junbiao; Yu, Bin; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">555-567</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Histone lysine specific demethylase 1 (LSD1, KDM1A) has been recognized as an important epigenetic target for disease treatment.  To date, a large no. of LSD1 inhibitors have been developed, some of which are currently being evaluated in clin. trials for the treatment of cancers, virus infection, and neurodegenerative diseases.  In this paper, we for the first time reported the ligand-based design of fragment-like xanthine derivs. as LSD1 inhibitors, of which compd. 4 possessed acceptable pharmacol. inhibition against LSD1 (IC50 = 6.45 μM) and favorable fragment-like nature, and therefore could be used as a promising template to design new LSD1 inhibitors.  Interestingly, compds. 6c and 6i strongly suppressed growth of MGC-803 cells partly dependent on their LSD1 inhibition, and were also found to be able to inhibit BRD4 and IDO1.  The docking studies were performed to rationalize the biochem. potency against LSD1 and to explain the obsd. activity discrepancy.  The proof-of-concept work may provide an example for other natural ligand-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNwIGUA6safrVg90H21EOLACvtfcHk0lhSxIBHcjsWZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit12ltLvO&md5=3b4bd4668111aad864a366d55ab6c777</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.11.035%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%2BS.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DLigand-based%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520xanthine%2520derivatives%2520as%2520LSD1%252FKDM1A%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D162%26spage%3D555%26epage%3D567%26doi%3D10.1016%2Fj.ejmech.2018.11.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1705</span>– <span class="NLM_lpage">1716</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1705-1716&author=L.+Y.+Maauthor=Y.+C.+Zhengauthor=S.+Q.+Wangauthor=B.+Wangauthor=Z.+R.+Wangauthor=L.+P.+Pangauthor=M.+Zhangauthor=J.+W.+Wangauthor=L.+Dingauthor=J.+Liauthor=C.+Wangauthor=B.+Huauthor=Y.+Liuauthor=X.+D.+Zhangauthor=J.+J.+Wangauthor=Z.+J.+Wangauthor=W.+Zhaoauthor=H.+M.+Liu&title=Design%2C+synthesis%2C+and+structure-activity+relationship+of+novel+LSD1+inhibitors+based+on+pyrimidine-thiourea+hybrids+as+potent%2C+orally+active+antitumor+agents&doi=10.1021%2Facs.jmedchem.5b00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship of Novel LSD1 Inhibitors Based on Pyrimidine-Thiourea Hybrids As Potent, Orally Active Antitumor Agents</span></div><div class="casAuthors">Ma, Li-Ying; Zheng, Yi-Chao; Wang, Sai-Qi; Wang, Bo; Wang, Zhi-Ru; Pang, Lu-Ping; Zhang, Miao; Wang, Jun-Wei; Ding, Lina; Li, Juan; Wang, Cong; Hu, Biao; Liu, Ying; Zhang, Xiao-Dan; Wang, Jia-Jia; Wang, Zhi-Jian; Zhao, Wen; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1705-1716</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone lysine specific demethylase 1 (LSD1) was reported to be overexpressed in several human cancers and recognized as a promising anticancer drug target.  In the current study, we designed and synthesized a novel series of pyrimidine-thiourea hybrids and evaluated their potential LSD1 inhibitory effect.  One of the compds., 6b, contg. a terminal alkyne appendage, was shown to be the most potent and selective LSD1 inhibitor in vitro and exhibited strong cytotoxicity against LSD1 overexpressed gastric cancer cells.  Compd. 6b also showed marked inhibition of cell migration and invasion as well as significant in vivo tumor suppressing and antimetastasis role, without significant side effects by oral administration.  Our findings indicate that the pyrimidine-thiourea-based LSD1 inactivator may serve as a leading compd. targeting LSD1 overexpressed cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy8SIAhdqGGbVg90H21EOLACvtfcHk0lhSxIBHcjsWZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyksbw%253D&md5=7256792e23b75e5f26bac47dfa773b11</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00037%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%2BY.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DZ.%2BR.%26aulast%3DPang%26aufirst%3DL.%2BP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%2BD.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DZ.%2BJ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520novel%2520LSD1%2520inhibitors%2520based%2520on%2520pyrimidine-thiourea%2520hybrids%2520as%2520potent%252C%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1705%26epage%3D1716%26doi%3D10.1021%2Facs.jmedchem.5b00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8543</span>– <span class="NLM_lpage">8560</span>, <span class="refDoi"> DOI: 10.1021/jm401002r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401002r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8543-8560&author=Y.+C.+Zhengauthor=Y.+C.+Duanauthor=J.+L.+Maauthor=R.+M.+Xuauthor=X.+Ziauthor=W.+L.+Lvauthor=M.+M.+Wangauthor=X.+W.+Yeauthor=S.+Zhuauthor=D.+Mobleyauthor=Y.+Y.+Zhuauthor=J.+W.+Wangauthor=J.+F.+Liauthor=Z.+R.+Wangauthor=W.+Zhaoauthor=H.+M.+Liu&title=Triazole-dithiocarbamate+based+selective+lysine+specific+demethylase+1+%28LSD1%29+inactivators+inhibit+gastric+cancer+cell+growth%2C+invasion%2C+and+migration&doi=10.1021%2Fjm401002r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Triazole-Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration</span></div><div class="casAuthors">Zheng, Yi-Chao; Duan, Ying-Chao; Ma, Jin-Lian; Xu, Rui-Min; Zi, Xiaolin; Lv, Wen-Lei; Wang, Meng-Meng; Ye, Xian-Wei; Zhu, Shun; Mobley, David; Zhu, Yan-Yan; Wang, Jun-Wei; Li, Jin-Feng; Wang, Zhi-Ru; Zhao, Wen; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8543-8560</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1), the first identified histone demethylase, plays an important role in epigenetic regulation of gene activation and repression.  The up-regulated LSD1's expression has been reported in several malignant tumors.  In the current study, we designed and synthesized five series of 1,2,3-triazole-dithiocarbamate hybrids and screened their inhibitory activity toward LSD1.  We found that some of these compds., esp. compd. (I), exhibited the most specific and robust inhibition of LSD1.  Interestingly, compd. I also showed potent and selective cytotoxicity against LSD1 overexpressing gastric cancer cell lines MGC-803 and HGC-27, as well as marked inhibition of cell migration and invasion, compared to 2-PCPA.  Furthermore, compd. I effectively reduced the tumor growth bared by human gastric cancer cells in vivo with no signs of adverse side effects.  These findings suggested that compd. I deserves further investigation as a lead compd. in the treatment of LSD1 overexpressing gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjGdOvultbebVg90H21EOLACvtfcHk0lhSxIBHcjsWZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nL&md5=4e4594271ff6b62237ff17a87d6f04d8</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm401002r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401002r%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DDuan%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DXu%26aufirst%3DR.%2BM.%26aulast%3DZi%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DW.%2BL.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DYe%26aufirst%3DX.%2BW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DMobley%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DY.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DLi%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DZ.%2BR.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DTriazole-dithiocarbamate%2520based%2520selective%2520lysine%2520specific%2520demethylase%25201%2520%2528LSD1%2529%2520inactivators%2520inhibit%2520gastric%2520cancer%2520cell%2520growth%252C%2520invasion%252C%2520and%2520migration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8543%26epage%3D8560%26doi%3D10.1021%2Fjm401002r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magliulo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messina, S.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">255</span>, <span class="refDoi"> DOI: 10.3389/fonc.2018.00255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3389%2Ffonc.2018.00255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30073149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ks1GqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=255&author=D.+Magliuloauthor=R.+Bernardiauthor=S.+Messina&title=Lysine-specific+demethylase+1A+as+a+promising+target+in+acute+myeloid+leukemia&doi=10.3389%2Ffonc.2018.00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia</span></div><div class="casAuthors">Magliulo Daniela; Magliulo Daniela; Bernardi Rosa; Messina Samantha</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">255</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Acute myeloid leukemia (AML) is a heterogeneous hematopoietic malignancy characterized by the accumulation of incompletely differentiated progenitor cells (blasts) in the bone marrow and blood, and by suppression of normal hematopoiesis.  It has recently become apparent that the AML genome is characterized by recurrent mutations and dysregulations in epigenetic regulators.  These mutations frequently occur before the onset of full blown leukemia, at the pre-leukemic phase, and persist in residual disease that remains after therapeutic intervention, thus suggesting that targeting the AML epigenome may help to eradicate minimal residual disease and prevent relapse.  Within the AML epigenome, lysine-specific demethylase 1 A (LSD1) is a histone demethylase that is found frequently overexpressed, albeit not mutated, in AML.  LSD1 is a required constituent of critical transcription repressor complexes like CoREST and nucleosome remodeling and deacetylase (NuRD), and abrogation of LSD1 expression results in impaired self-renewal and proliferation, and increased differentiation and apoptosis in AML models and primary cells, particularly in AMLs with MLL- and AML1-rearrangements, or erythroid and megakaryoblastic differentiation block.  On this basis, a number of LSD1 inhibitors have been developed in the past decade, and few of them are currently being tested in clinical trials for patients with AML, along with other malignancies.  To date, the most promising application of this therapeutic strategy appears to be combination therapy of LSD1 inhibitors with all-trans retinoic acid (ATRA) to reactivate myeloid differentiation in cells that are not spontaneously susceptible to ATRA treatment.  In this review, we provide an overview of LSD1 function in normal hematopoiesis and leukemia, and of the current clinical application of LSD1 inhibitors for the treatment of patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZvJytNRFkvDC850By6mxpfW6udTcc2eZKgGB3Yw2BObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ks1GqtQ%253D%253D&md5=7aaddbc35e569064c3fa8da358299840</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2018.00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2018.00255%26sid%3Dliteratum%253Aachs%26aulast%3DMagliulo%26aufirst%3DD.%26aulast%3DBernardi%26aufirst%3DR.%26aulast%3DMessina%26aufirst%3DS.%26atitle%3DLysine-specific%2520demethylase%25201A%2520as%2520a%2520promising%2520target%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DFront.%2520Oncol.%26date%3D2018%26volume%3D8%26spage%3D255%26doi%3D10.3389%2Ffonc.2018.00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Baicalin, a natural LSD1 inhibitor</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2016.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2016.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27814566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2016&pages=129-131&author=Y.+C.+Zhengauthor=D.+D.+Shenauthor=M.+Renauthor=X.+Q.+Liuauthor=Z.+R.+Wangauthor=Y.+Liuauthor=Q.+N.+Zhangauthor=L.+J.+Zhaoauthor=L.+J.+Zhaoauthor=J.+L.+Maauthor=B.+Yuauthor=H.+M.+Liu&title=Baicalin%2C+a+natural+LSD1+inhibitor&doi=10.1016%2Fj.bioorg.2016.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Baicalin, a natural LSD1 inhibitor</span></div><div class="casAuthors">Zheng, Yi-Chao; Shen, Dan-Dan; Ren, Meng; Liu, Xue-Qi; Wang, Zhi-Ru; Liu, Ying; Zhang, Qian-Na; Zhao, Li-Juan; Zhao, Li-Jie; Ma, Jin-Lian; Yu, Bin; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129-131</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Baicalin is one of the active ingredients in the skullcap, with a variety of pharmacol. effects, such as blood pressure redn., sedation, liver-protection, gallbladder-protection, antibacteria, and anti-inflammation.  In the study, baicalin was first characterized as a LSD1 inhibitor with an IC50 of 3.01 μM and showed strong LSD1 inhibitory effect in cells.  Baicalin may serve as a template for designing flavone-based LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRTkjAeKcWbVg90H21EOLACvtfcHk0lgN2TAMQfzv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqsbnK&md5=0fef2e4a12b491f203d24f4a23823b80</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2016.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2016.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DRen%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%2BQ.%26aulast%3DWang%26aufirst%3DZ.%2BR.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%2BN.%26aulast%3DZhao%26aufirst%3DL.%2BJ.%26aulast%3DZhao%26aufirst%3DL.%2BJ.%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DBaicalin%252C%2520a%2520natural%2520LSD1%2520inhibitor%26jtitle%3DBioorg.%2520Chem.%26date%3D2016%26volume%3D69%26spage%3D129%26epage%3D131%26doi%3D10.1016%2Fj.bioorg.2016.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Speranzini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrocco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forgione, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forneris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehdipour, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e1601017</span> <span class="refDoi"> DOI: 10.1126/sciadv.1601017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1126%2Fsciadv.1601017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27626075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVWisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&author=V.+Speranziniauthor=D.+Rotiliauthor=G.+Ciossaniauthor=S.+Pilottoauthor=B.+Marroccoauthor=M.+Forgioneauthor=A.+Lucidiauthor=F.+Fornerisauthor=P.+Mehdipourauthor=S.+Velankarauthor=A.+Maiauthor=A.+Mattevi&title=Polymyxins+and+quinazolines+are+LSD1%2FKDM1A+inhibitors+with+unusual+structural+features&doi=10.1126%2Fsciadv.1601017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features</span></div><div class="casAuthors">Speranzini, Valentina; Rotili, Dante; Ciossani, Giuseppe; Pilotto, Simona; Marrocco, Biagina; Forgione, Mariantonietta; Lucidi, Alessia; Forneris, Federico; Mehdipour, Parinaz; Velankar, Sameer; Mai, Antonello; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Science Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1601017/1-e1601017/8</span>CODEN:
                <span class="NLM_cas:coden">SACDAF</span>;
        ISSN:<span class="NLM_cas:issn">2375-2548</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Because of its involvement in the progression of several malignant tumors, the histone lysine-specific demethylase1 (LSD1) has become a prominent drug target in modern medicinal chem. research.  We report on the discoveryof two classes of noncovalent inhibitors displaying unique structural features.  The antibiotics polymyxins bind atthe entrance of the substrate cleft, where their highly charged cyclic moiety interacts with a cluster of pos. charged amino acids.  The same site is occupied by quinazoline-based compds., which were found to inhibit theenzyme through a most peculiar mode because they form a pile of five to seven mols. that obstruct accessto the active center.  These data significantly indicate unpredictable strategies for the development of epigenetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs4C4ugZSy5bVg90H21EOLACvtfcHk0lgN2TAMQfzv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVWisL8%253D&md5=1bb63c0077a5f83a3d270933314b7d9d</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1601017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1601017%26sid%3Dliteratum%253Aachs%26aulast%3DSperanzini%26aufirst%3DV.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DPilotto%26aufirst%3DS.%26aulast%3DMarrocco%26aufirst%3DB.%26aulast%3DForgione%26aufirst%3DM.%26aulast%3DLucidi%26aufirst%3DA.%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DMehdipour%26aufirst%3DP.%26aulast%3DVelankar%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DPolymyxins%2520and%2520quinazolines%2520are%2520LSD1%252FKDM1A%2520inhibitors%2520with%2520unusual%2520structural%2520features%26jtitle%3DSci.%2520Adv.%26date%3D2016%26volume%3D2%26doi%3D10.1126%2Fsciadv.1601017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span> <span> </span><span class="NLM_article-title">Bioactivity evaluation of natural product alpha-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2017.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29274582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWltr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2018&pages=415-419&author=C.+Hanauthor=Z.+Liauthor=J.+Houauthor=Z.+Wangauthor=D.+Xuauthor=G.+Xueauthor=L.+Kong&title=Bioactivity+evaluation+of+natural+product+alpha-mangostin+as+a+novel+xanthone-based+lysine-specific+demethylase+1+inhibitor+to+against+tumor+metastasis&doi=10.1016%2Fj.bioorg.2017.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivity evaluation of natural product α-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis</span></div><div class="casAuthors">Han, Chao; Li, Zhongrui; Hou, Jiqin; Wang, Zhen; Xu, Dingqiao; Xue, Guimin; Kong, Lingyi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">415-419</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1), which has been reported to be overexpressed in several human cancers, has recently emerged as an attractive therapeutic target for treating cancer.  To date, almost all the developed LSD1 inhibitors are chemo-synthesized mols., while α-mangostin is first characterized as xanthone-based natural inhibitor in the current study with IC50 values of 2.81±0.44μM.  Bioactivity study and docking anal. indicated that α-mangostin could inhibit MDA-MB-231 cells migration and evasion through inhibit intracellular LSD1 activity.  These findings provides new mol. skeleton for LSD1 inhibitor study and should encourage further modification of α-mangostin to produce more potent LSD1 inhibitors with potential anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGpOCbxAuNLVg90H21EOLACvtfcHk0lhFaLCpLjdOAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWltr3J&md5=27679988f1a7c98127c71c3799734c5f</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DXue%26aufirst%3DG.%26aulast%3DKong%26aufirst%3DL.%26atitle%3DBioactivity%2520evaluation%2520of%2520natural%2520product%2520alpha-mangostin%2520as%2520a%2520novel%2520xanthone-based%2520lysine-specific%2520demethylase%25201%2520inhibitor%2520to%2520against%2520tumor%2520metastasis%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D76%26spage%3D415%26epage%3D419%26doi%3D10.1016%2Fj.bioorg.2017.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span> <span> </span><span class="NLM_article-title">Bioactivity-guided cut countercurrent chromatography for isolation of lysine-specific demethylase 1 inhibitors from Scutellaria baicalensis Georgi</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1016</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.aca.2018.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.aca.2018.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29534805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFaqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1016&publication_year=2018&pages=59-68&author=C.+Hanauthor=S.+Wangauthor=Z.+Liauthor=C.+Chenauthor=J.+Houauthor=D.+Xuauthor=R.+Wangauthor=Y.+Linauthor=J.+Luoauthor=L.+Kong&title=Bioactivity-guided+cut+countercurrent+chromatography+for+isolation+of+lysine-specific+demethylase+1+inhibitors+from+Scutellaria+baicalensis+Georgi&doi=10.1016%2Fj.aca.2018.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivity-guided cut countercurrent chromatography for isolation of lysine-specific demethylase 1 inhibitors from Scutellaria baicalensis Georgi</span></div><div class="casAuthors">Han, Chao; Wang, Shanshan; Li, Zhongrui; Chen, Chen; Hou, Jiqin; Xu, Dingqiao; Wang, Ruizhi; Lin, Yaolan; Luo, Jianguang; Kong, Lingyi</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-68</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Countercurrent chromatog. (CCC) has gradually become a widely used method for preparative sepn. of bioactive natural mols.  These mols. generally contain distinct scaffolds and characteristics that cannot be readily isolated from plants.  While one-dimensional CCC is typically used for the initial purifn. with insufficiently resolved peaks after locating bioactive components, two-dimensional (2D) or multi-dimensional CCC strategies are employed to improve the resoln. of peaks.  However, these methods usually present certain disadvantages, such as complicated procedures and increased time consumption, exptl. costs, and equipment requirements.  Here, a bioactivity-guided cut CCC strategy was established to isolate lysine-specific demethylase 1 (LSD1) inhibitors from Scutellaria baicalensis Georgi.  Gradient-elution CCC coupled with real-time detection of LSD1 inhibition by the collected fractions was developed.  Next, an online-storage recycling CCC mode was designed to enable the active fractions to be stored in coils, and these active fractions were further sepd. to obtain pure compds. by using sequential recycling elution.  In this strategy, active fractions are first identified, and then pure LSD1 inhibitors are isolated in the 2D CCC mode through continuous sepn. on a single instrument.  By using our bioactivity-guided cut CCC strategy, we successfully isolated six natural LSD1 inhibitors from S. baicalensis Georgi, five of which were identified for the first time as natural LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHMApE4g-b17Vg90H21EOLACvtfcHk0lhFaLCpLjdOAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFaqsbs%253D&md5=862344f018da2cf3a708e3476e5e5d6b</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.aca.2018.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.aca.2018.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DL.%26atitle%3DBioactivity-guided%2520cut%2520countercurrent%2520chromatography%2520for%2520isolation%2520of%2520lysine-specific%2520demethylase%25201%2520inhibitors%2520from%2520Scutellaria%2520baicalensis%2520Georgi%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2018%26volume%3D1016%26spage%3D59%26epage%3D68%26doi%3D10.1016%2Fj.aca.2018.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">126683</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2019.126683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31627991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvF2gsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=126683&author=J.+Wangauthor=X.+Zhangauthor=J.+Yanauthor=W.+Liauthor=Q.+Jiangauthor=X.+Wangauthor=D.+Zhaoauthor=M.+Cheng&title=Design%2C+synthesis+and+biological+evaluation+of+curcumin+analogues+as+novel+LSD1+inhibitors&doi=10.1016%2Fj.bmcl.2019.126683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors</span></div><div class="casAuthors">Wang, Jiming; Zhang, Xiangyu; Yan, Jiangkun; Li, Wei; Jiang, Qinwen; Wang, Xinran; Zhao, Dongmei; Cheng, Maosheng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">126683</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone lysine-specific demethylase 1 (LSD1) was the first discovered histone demethylase.  Inactivating LSD1 or downregulating its expression inhibits cancer-cell development, and thus, it is an attractive mol. target for the development of novel cancer therapeutics.  In this study, we worked on the structural optimization of natural products and identified 30 novel LSD1 inhibitors.  Utilizing a structure-based drug design strategy, we designed and synthesized a series of curcumin analogs that were shown to be potent LSD1 inhibitors in the enzyme assay.  Compd. WB07 (I) displayed the most potent LSD1 inhibitory activity, with an IC50 value of 0.8μM.  Moreover, WA20 (II) showed an anticlonogenic effect on A549 cells with an IC50 value of 4.4μM.  Mol. docking simulations were also carried out, and the results indicated that the inhibitors bound to the protein active site located around the key residues of Asp555 and Asp556.  These findings suggested that compds. II and I are the first curcumin analog-based LSD1 inhibitors with remarkable A549 suppressive activity, providing a novel scaffold for the development of LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTnlsmI6uw3LVg90H21EOLACvtfcHk0lhFaLCpLjdOAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvF2gsrzF&md5=2c6688ce5e03fcaee6f0634423523f41</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126683%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520curcumin%2520analogues%2520as%2520novel%2520LSD1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D126683%26doi%3D10.1016%2Fj.bmcl.2019.126683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Identification and biological evaluation of natural product Biochanin A</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">103674</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2020.103674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32097796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjvVKjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2020&pages=103674&author=L.+Wangauthor=L.+Liauthor=Q.+Hanauthor=X.+Wangauthor=D.+Zhaoauthor=J.+Liu&title=Identification+and+biological+evaluation+of+natural+product+Biochanin+A&doi=10.1016%2Fj.bioorg.2020.103674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biological evaluation of natural product Biochanin A</span></div><div class="casAuthors">Wang, Lei; Li, Lingzhao; Han, Quanxiang; Wang, Xiaofang; Zhao, Di; Liu, Junqi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103674</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Natural products have shown promise for epigenetic modulations and thus are therapeutically potential for cancer prevention and treatment.  In this work, we report the identification of natural product Biochanin A as a new LSD1 inhibitor and further biol. evaluation in gastric MGC-803 cells.  Biochanin A effectively and reversibly inhibited LSD1 (IC50 = 2.95μM) and showed selective inhibition to LSD1 over MAO-A/B.  In gastric MGC-803 cells, Biochanin A induced accumulation of H3K4me1/2, inhibited cell growth moderately (IC50 = 6.77μM), but was less toxic to normal GES-1 (IC50 > 32μM).  Mechanistic studies showed that Biochanin A suppressed colony formation, cell apoptosis, and migration of MGC-803 cells.  This study may help to elucidate the anticancer mechanisms of Biochanin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWmRkIH8HF7Vg90H21EOLACvtfcHk0lh11wDIFrC2tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjvVKjs7c%253D&md5=b0ff6f75858691d6b21d6a4b6d6f3a4e</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103674%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520biological%2520evaluation%2520of%2520natural%2520product%2520Biochanin%2520A%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D97%26spage%3D103674%26doi%3D10.1016%2Fj.bioorg.2020.103674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">103648</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2020.103648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32065882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFajsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2020&pages=103648&author=Z.+R.+Liauthor=F.+Z.+Suoauthor=Y.+J.+Guoauthor=H.+F.+Chengauthor=S.+H.+Niuauthor=D.+D.+Shenauthor=L.+J.+Zhaoauthor=Z.+Z.+Liuauthor=M.+Maaauthor=B.+Yuauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Natural+protoberberine+alkaloids%2C+identified+as+potent+selective+LSD1+inhibitors%2C+induce+AML+cell+differentiation&doi=10.1016%2Fj.bioorg.2020.103648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation</span></div><div class="casAuthors">Li, Zhong-Rui; Suo, Feng-Zhi; Guo, Yan-Jia; Cheng, Hai-Fang; Niu, Sheng-Hui; Shen, Dan-Dan; Zhao, Li-Juan; Liu, Zhen-Zhen; Maa, Mamun; Yu, Bin; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103648</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Natural protoberberine alkaloids were first identified and characterized as potent, selective and cellular active lysine specific demethylase 1 (LSD1) inhibitors.  Due to our study, isoquinoline-based tetracyclic scaffold was identified as the key structural element for their anti-LSD1 activity, subtle changes of substituents attached to the core structure led to dramatic changes of the activity.  Among these protoberberine alkaloids, epiberberine potently inhibited LSD1 (IC50 = 0.14 ± 0.01μM) and was highly selective to LSD1 over MAO-A/B.  Furthermore, epiberberine could induce the expression of CD86, CD11b and CD14 in THP-1 and HL-60 cells, confirming its cellular activity of inducing acute myeloid leukemia (AML) cells differentiation.  Moreover, epiberberine prolonged the survival of THP-1 cells bearing mice and inhibited the growth of AML cells in vivo without obvious global toxicity.  These findings give the potential application of epiberberine in AML treatment, and the isoquinoline-based tetracyclic scaffold could be used for further development of LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3QhTkrzh9qrVg90H21EOLACvtfcHk0lh11wDIFrC2tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFajsr0%253D&md5=4868d9e25f504a93a3c79b01dce5ccc1</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103648%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%2BR.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DGuo%26aufirst%3DY.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BF.%26aulast%3DNiu%26aufirst%3DS.%2BH.%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DZhao%26aufirst%3DL.%2BJ.%26aulast%3DLiu%26aufirst%3DZ.%2BZ.%26aulast%3DMaa%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DNatural%2520protoberberine%2520alkaloids%252C%2520identified%2520as%2520potent%2520selective%2520LSD1%2520inhibitors%252C%2520induce%2520AML%2520cell%2520differentiation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D97%26spage%3D103648%26doi%3D10.1016%2Fj.bioorg.2020.103648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forneris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglioli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Structural basis of LSD1-CoREST selectivity in histone H3 recognition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">20070</span>– <span class="NLM_lpage">20074</span>, <span class="refDoi"> DOI: 10.1074/jbc.C700100200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1074%2Fjbc.C700100200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=17537733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFWntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=20070-20074&author=F.+Fornerisauthor=C.+Bindaauthor=A.+Adamoauthor=E.+Battaglioliauthor=A.+Mattevi&title=Structural+basis+of+LSD1-CoREST+selectivity+in+histone+H3+recognition&doi=10.1074%2Fjbc.C700100200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of LSD1-CoREST Selectivity in Histone H3 Recognition</span></div><div class="casAuthors">Forneris, Federico; Binda, Claudia; Adamo, Antonio; Battaglioli, Elena; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">20070-20074</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Histone demethylase LSD1 regulates transcription by demethylating Lys4 of histone H3.  The crystal structure of the enzyme in complex with CoREST and a substrate-like peptide inhibitor highlights an intricate network of interactions and a folded conformation of the bound peptide.  The core of the peptide structure is formed by Arg2, Gln5, and Ser10, which are engaged in specific intramol. H-bonds.  Several charged side chains on the surface of the substrate-binding pocket establish electrostatic interactions with the peptide.  The three-dimensional structure predicts that methylated Lys4 binds in a solvent inaccessible position in front of the flavin cofactor.  This geometry is fully consistent with the demethylation reaction being catalyzed through a flavin-mediated oxidn. of the substrate amino-Me group.  These features dictate the exquisite substrate specificity of LSD1 and provide a structural framework to explain the fine tuning of its catalytic activity and the active role of CoREST in substrate recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD8PHQpzggArVg90H21EOLACvtfcHk0lh11wDIFrC2tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFWntr0%253D&md5=a8af3e0892441bf3fc64ce80c19d0c3b</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C700100200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C700100200%26sid%3Dliteratum%253Aachs%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DAdamo%26aufirst%3DA.%26aulast%3DBattaglioli%26aufirst%3DE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520of%2520LSD1-CoREST%2520selectivity%2520in%2520histone%2520H3%2520recognition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D20070%26epage%3D20074%26doi%3D10.1074%2Fjbc.C700100200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Molecular mimicry and ligand recognition in binding and catalysis by the histone demethylase LSD1-CoREST complex</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.str.2011.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.str.2011.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=21300290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=212-220&author=R.+Baronauthor=C.+Bindaauthor=M.+Tortoriciauthor=J.+A.+McCammonauthor=A.+Mattevi&title=Molecular+mimicry+and+ligand+recognition+in+binding+and+catalysis+by+the+histone+demethylase+LSD1-CoREST+complex&doi=10.1016%2Fj.str.2011.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mimicry and Ligand Recognition in Binding and Catalysis by the Histone Demethylase LSD1-CoREST Complex</span></div><div class="casAuthors">Baron, Riccardo; Binda, Claudia; Tortorici, Marcello; McCammon, J. Andrew; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-220</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone demethylases LSD1 and LSD2 (KDM1A/B) catalyze the oxidative demethylation of Lys4 of histone H3.  We used mol. dynamics simulations to probe the diffusion of the oxygen substrate.  Oxygen can reach the catalytic center independently from the presence of a bound histone peptide, implying that LSD1 can complete subsequent demethylation cycles without detaching from the nucleosomal particle.  The simulations highlight the role of a strictly conserved active-site Lys residue providing general insight into the enzymic mechanism of oxygen-reacting flavoenzymes.  The crystal structure of LSD1-CoREST bound to a peptide of the transcription factor SNAIL1 unravels a fascinating example of mol. mimicry.  The SNAIL1 N-terminal residues bind to the enzyme active-site cleft, effectively mimicking the H3 tail.  This finding predicts that other members of the SNAIL/Scratch transcription factor family might assoc. to LSD1/2.  The combination of selective histone-modifying activity with the distinct recognition mechanisms underlies the biol. complexity of LSD1/2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGdKxxD93hm7Vg90H21EOLACvtfcHk0lhJ-PxacjM5TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyitL4%253D&md5=61b4d3cf137e45643c3066f3369f18d5</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2011.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2011.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DMolecular%2520mimicry%2520and%2520ligand%2520recognition%2520in%2520binding%2520and%2520catalysis%2520by%2520the%2520histone%2520demethylase%2520LSD1-CoREST%2520complex%26jtitle%3DStructure%26date%3D2011%26volume%3D19%26spage%3D212%26epage%3D220%26doi%3D10.1016%2Fj.str.2011.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talibov, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peintner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geitmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebastiano, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobritzsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danielson, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic peptides uncover a novel binding mode for reversible inhibitors of LSD1</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3979</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/acsomega.9b03493</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b03493" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFansLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=3979-3995&author=J.+Yangauthor=V.+O.+Talibovauthor=S.+Peintnerauthor=C.+Rheeauthor=V.+Poongavanamauthor=M.+Geitmannauthor=M.+R.+Sebastianoauthor=B.+Simonauthor=J.+Hennigauthor=D.+Dobritzschauthor=U.+H.+Danielsonauthor=J.+Kihlberg&title=Macrocyclic+peptides+uncover+a+novel+binding+mode+for+reversible+inhibitors+of+LSD1&doi=10.1021%2Facsomega.9b03493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic Peptides Uncover a Novel Binding Mode for Reversible Inhibitors of LSD1</span></div><div class="casAuthors">Yang, Jie; Talibov, Vladimir O.; Peintner, Stefan; Rhee, Claire; Poongavanam, Vasanthanathan; Geitmann, Matthis; Sebastiano, Matteo Rossi; Simon, Bernd; Hennig, Janosch; Dobritzsch, Doreen; Danielson, U. Helena; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3979-3995</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) is an epigenetic enzyme which regulates the methylation of Lys4 of histone 3 (H3) and is overexpressed in certain cancers.  We used structures of H3 substrate analogs bound to LSD1 to design macrocyclic peptide inhibitors of LSD1.  A linear, Lys4 to Met-substituted, 11-mer (4) was identified as the shortest peptide distinctly interacting with LSD1.  It was evolved into macrocycle 31, which was >40 fold more potent (Ki = 2.3μM) than 4.  Linear and macrocyclic peptides exhibited unexpected differences in structure-activity relationships for interactions with LSD1, indicating that they bind LSD1 differently.  This was confirmed by the crystal structure of 31 in complex with LSD1-CoREST1, which revealed a novel binding mode at the outer rim of the LSD1 active site and without a direct interaction with FAD.  NMR spectroscopy of 31 suggests that macrocyclization restricts its soln. ensemble to conformations that include the one in the cryst. complex.  Our results provide a solid basis for the design of optimized reversible LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSVg23mFeHAbVg90H21EOLACvtfcHk0lhJ-PxacjM5TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFansLc%253D&md5=34987d78346262625897765eefc198cf</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b03493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b03493%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DTalibov%26aufirst%3DV.%2BO.%26aulast%3DPeintner%26aufirst%3DS.%26aulast%3DRhee%26aufirst%3DC.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DGeitmann%26aufirst%3DM.%26aulast%3DSebastiano%26aufirst%3DM.%2BR.%26aulast%3DSimon%26aufirst%3DB.%26aulast%3DHennig%26aufirst%3DJ.%26aulast%3DDobritzsch%26aufirst%3DD.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520peptides%2520uncover%2520a%2520novel%2520binding%2520mode%2520for%2520reversible%2520inhibitors%2520of%2520LSD1%26jtitle%3DACS%2520Omega%26date%3D2020%26volume%3D5%26spage%3D3979%26epage%3D3995%26doi%3D10.1021%2Facsomega.9b03493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of LSD1 for cancer treatment</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3194</span>, <span class="refDoi"> DOI: 10.3390/molecules23123194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3390%2Fmolecules23123194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=3194&author=G.+J.+Yangauthor=P.+M.+Leiauthor=S.+Y.+Wongauthor=D.+L.+Maauthor=C.+H.+Leung&title=Pharmacological+inhibition+of+LSD1+for+cancer+treatment&doi=10.3390%2Fmolecules23123194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of LSD1 for cancer treatment</span></div><div class="casAuthors">Yang, Guan-Jun; Lei, Pui-Man; Wong, Suk-Yu; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3194/1-3194/20</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Lysine-specific demethylase 1A (LSD1, also named KDM1A) is a demethylase that can remove Me groups from histones H3K4me1/2 and H3K9me1/2.  It is aberrantly expressed in many cancers, where it impedes differentiation and contributes to cancer cell proliferation, cell metastasis and invasiveness, and is assocd. with inferior prognosis.  Pharmacol. inhibition of LSD1 has been reported to significantly attenuate tumor progression in vitro and in vivo in a range of solid tumors and acute myeloid leukemia.  This review will present the structural aspects of LSD1, its role in carcinogenesis, a comparison of currently available approaches for screening LSD1 inhibitors, a classification of LSD1 inhibitors, and its potential as a drug target in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSEBy-HsQHlrVg90H21EOLACvtfcHk0lhJ-PxacjM5TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms1yrtb8%253D&md5=87fe2ac11e363e75ac0ef22ff6412d24</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23123194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23123194%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%2BJ.%26aulast%3DLei%26aufirst%3DP.%2BM.%26aulast%3DWong%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DPharmacological%2520inhibition%2520of%2520LSD1%2520for%2520cancer%2520treatment%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D3194%26doi%3D10.3390%2Fmolecules23123194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerneil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niegisch, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the therapeutic potential of the novel isotype specific HDAC Inhibitor 4SC-202 in urothelial carcinoma cell lines</span>. <i>Target Oncol</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1007/s11523-016-0444-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1007%2Fs11523-016-0444-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27250763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FlslWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=783-798&author=M.+Pinkerneilauthor=M.+J.+Hoffmannauthor=H.+Kohlhofauthor=W.+A.+Schulzauthor=G.+Niegisch&title=Evaluation+of+the+therapeutic+potential+of+the+novel+isotype+specific+HDAC+Inhibitor+4SC-202+in+urothelial+carcinoma+cell+lines&doi=10.1007%2Fs11523-016-0444-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines</span></div><div class="casAuthors">Pinkerneil Maria; Hoffmann Michele J; Schulz Wolfgang A; Niegisch Gunter; Kohlhof Hella</div><div class="citationInfo"><span class="NLM_cas:title">Targeted oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">783-798</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Targeting of class I histone deacetylases (HDACs) exerts antineoplastic actions in various cancer types by modulation of transcription, upregulation of tumor suppressors, induction of cell cycle arrest, replication stress and promotion of apoptosis.  Class I HDACs are often deregulated in urothelial cancer. 4SC-202, a novel oral benzamide type HDAC inhibitor (HDACi) specific for class I HDACs HDAC1, HDAC2 and HDAC3 and the histone demethylase LSD1, shows substantial anti-tumor activity in a broad range of cancer cell lines and xenograft tumor models.  AIM:  The aim of this study was to investigate the therapeutic potential of 4SC-202 in urothelial carcinoma (UC) cell lines.  METHODS:  We determined dose response curves of 4SC-202 by MTT assay in seven UC cell lines with distinct HDAC1, HDAC2 and HDAC3 expression profiles.  Cellular effects were further analyzed in VM-CUB1 and UM-UC-3 cells by colony forming assay, caspase-3/7 assay, flow cytometry, senescence assay, LDH release assay, and immunofluorescence staining.  Response markers were followed by quantitative real-time PCR and western blotting.  Treatment with the class I HDAC specific inhibitor SAHA (vorinostat) served as a general control.  RESULTS:  4SC-202 significantly reduced proliferation of all epithelial and mesenchymal UC cell lines (IC50 0.15-0.51 μM), inhibited clonogenic growth and induced caspase activity.  Flow cytometry revealed increased G2/M and subG1 fractions in VM-CUB1 and UM-UC-3 cells.  Both effects were stronger than with SAHA treatment.  CONCLUSION:  Specific pharmacological inhibition of class I HDACs by 4SC-202 impairs UC cell viability, inducing cell cycle disturbances and cell death.  Combined inhibition of HDAC1, HDAC2 and HDAC3 seems to be a promising treatment strategy for UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQWgp4rVh4BHp3bfzSLaX5fW6udTcc2eY6tVSk6USvzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FlslWjsQ%253D%253D&md5=8decc6b1e3ff3d96fc12e0661246fe7c</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1007%2Fs11523-016-0444-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11523-016-0444-7%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerneil%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DM.%2BJ.%26aulast%3DKohlhof%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DW.%2BA.%26aulast%3DNiegisch%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520the%2520therapeutic%2520potential%2520of%2520the%2520novel%2520isotype%2520specific%2520HDAC%2520Inhibitor%25204SC-202%2520in%2520urothelial%2520carcinoma%2520cell%2520lines%26jtitle%3DTarget%2520Oncol%26date%3D2016%26volume%3D11%26spage%3D783%26epage%3D798%26doi%3D10.1007%2Fs11523-016-0444-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zylla, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miskimins, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Puente, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnimpieba, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerli, S. M.</span></span> <span> </span><span class="NLM_article-title">Analysis of dual class I histone deacetylase and lysine demethylase inhibitor domatinostat (4SC-202) on growth and cellular and genomic landscape of atypical teratoid/rhabdoid</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">756</span>, <span class="refDoi"> DOI: 10.3390/cancers12030756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3390%2Fcancers12030756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVShtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=756&author=M.+M.+Hoffmanauthor=J.+S.+Zyllaauthor=S.+Bhattacharyaauthor=K.+Calarauthor=T.+W.+Hartmanauthor=R.+D.+Bhardwajauthor=W.+K.+Miskiminsauthor=P.+de+la+Puenteauthor=E.+Z.+Gnimpiebaauthor=S.+M.+Messerli&title=Analysis+of+dual+class+I+histone+deacetylase+and+lysine+demethylase+inhibitor+domatinostat+%284SC-202%29+on+growth+and+cellular+and+genomic+landscape+of+atypical+teratoid%2Frhabdoid&doi=10.3390%2Fcancers12030756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of dual class I histone deacetylase and lysine demethylase inhibitor domatinostat (4SC-202) on growth and cellular and genomic landscape of atypical teratoid/rhabdoid</span></div><div class="casAuthors">Hoffman, Mariah M.; Zylla, Jessica S.; Bhattacharya, Somshuvra; Calar, Kristin; Hartman, Timothy W.; Bhardwaj, Ratan D.; Miskimins, W. Keith; de la Puente, Pilar; Gnimpieba, Etienne Z.; Messerli, Shanta M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">756</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Central nervous system atypical teratoid/rhabdoid tumors (ATRTs) are rare and aggressive tumors with a very poor prognosis.  Current treatments for ATRT include resection of the tumor, followed by systemic chemotherapy and radiation therapy, which have toxic side effects for young children.  Gene expression analyses of human ATRTs and normal brain samples indicate that ATRTs have aberrant expression of epigenetic markers including class I histone deacetylases (HDAC's) and lysine demethylase (LSD1).  Here, we investigate the effect of a small mol. epigenetic modulator known as Domatinostat (4SC-202), which inhibits both class I HDAC's and Lysine Demethylase (LSD1), on ATRT cell survival and single cell heterogeneity.  Our findings suggest that 4SC-202 is both cytotoxic and cytostatic to ATRT in 2D and 3D scaffold cell culture models and may target cancer stem cells.  Single-cell RNA sequencing data from ATRT-06 spheroids treated with 4SC-202 have a reduced population of cells overexpressing stem cell-related genes, including SOX2.  Flow cytometry and immunofluorescence on 3D ATRT-06 scaffold models support these results suggesting that 4SC-202 reduces expression of cancer stem cell markers SOX2, CD133, and FOXM1.  Drug-induced changes to the systems biol. landscape are also explored by multi-omics enrichment analyses.  In summary, our data indicate that 4SC-202 has both cytotoxic and cytostatic effects on ATRT, targets specific cell sub-populations, including those with cancer stem-like features, and is an important potential cancer therapeutic to be investigated in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ0LyYtW0QabVg90H21EOLACvtfcHk0lhvLRsDQlcGxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVShtr3M&md5=26d4293a3e4025eda9745e8099460f26</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.3390%2Fcancers12030756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers12030756%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DM.%2BM.%26aulast%3DZylla%26aufirst%3DJ.%2BS.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DCalar%26aufirst%3DK.%26aulast%3DHartman%26aufirst%3DT.%2BW.%26aulast%3DBhardwaj%26aufirst%3DR.%2BD.%26aulast%3DMiskimins%26aufirst%3DW.%2BK.%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DP.%26aulast%3DGnimpieba%26aufirst%3DE.%2BZ.%26aulast%3DMesserli%26aufirst%3DS.%2BM.%26atitle%3DAnalysis%2520of%2520dual%2520class%2520I%2520histone%2520deacetylase%2520and%2520lysine%2520demethylase%2520inhibitor%2520domatinostat%2520%25284SC-202%2529%2520on%2520growth%2520and%2520cellular%2520and%2520genomic%2520landscape%2520of%2520atypical%2520teratoid%252Frhabdoid%26jtitle%3DCancers%26date%3D2020%26volume%3D12%26spage%3D756%26doi%3D10.3390%2Fcancers12030756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFleur, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Carvalho, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.05.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.cell.2018.05.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29937226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFymsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2018&pages=549-563&author=W.+Shengauthor=M.+W.+LaFleurauthor=T.+H.+Nguyenauthor=S.+Chenauthor=A.+Chakravarthyauthor=J.+R.+Conwayauthor=Y.+Liauthor=H.+Chenauthor=H.+Yangauthor=P.+H.+Hsuauthor=E.+M.+Van+Allenauthor=G.+J.+Freemanauthor=D.+D.+De+Carvalhoauthor=H.+H.+Heauthor=A.+H.+Sharpeauthor=Y.+Shi&title=LSD1+ablation+stimulates+anti-tumor+immunity+and+enables+checkpoint+blockade&doi=10.1016%2Fj.cell.2018.05.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade</span></div><div class="casAuthors">Sheng, Wanqiang; LaFleur, Martin W.; Nguyen, Thao H.; Chen, Sujun; Chakravarthy, Ankur; Conway, Jake Ryan; Li, Ying; Chen, Hao; Yang, Henry; Hsu, Pang-Hung; Van Allen, Eliezer M.; Freeman, Gordon J.; De Carvalho, Daniel D.; He, Housheng Hansen; Sharpe, Arlene H.; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">549-563.e19</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Chromatin regulators play a broad role in regulating gene expression and, when gone awry, can lead to cancer.  Here, we demonstrate that ablation of the histone demethylase LSD1 in cancer cells increases repetitive element expression, including endogenous retroviral elements (ERVs), and decreases expression of RNA-induced silencing complex (RISC) components.  Significantly, this leads to double-stranded RNA (dsRNA) stress and activation of type 1 interferon, which stimulates anti-tumor T cell immunity and restrains tumor growth.  Furthermore, LSD1 depletion enhances tumor immunogenicity and T cell infiltration in poorly immunogenic tumors and elicits significant responses of checkpoint blockade-refractory mouse melanoma to anti-PD-1 therapy.  Consistently, TCGA data anal. shows an inverse correlation between LSD1 expression and CD8+ T cell infiltration in various human cancers.  Our study identifies LSD1 as a potent inhibitor of anti-tumor immunity and responsiveness to immunotherapy and suggests LSD1 inhibition combined with PD-(L)1 blockade as a novel cancer treatment strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE26ECJjxIc7Vg90H21EOLACvtfcHk0lhvLRsDQlcGxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFymsrbE&md5=4f113b8f2b641165dc35dc7aa7da4fe8</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.05.052%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DW.%26aulast%3DLaFleur%26aufirst%3DM.%2BW.%26aulast%3DNguyen%26aufirst%3DT.%2BH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChakravarthy%26aufirst%3DA.%26aulast%3DConway%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHsu%26aufirst%3DP.%2BH.%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DFreeman%26aufirst%3DG.%2BJ.%26aulast%3DDe%2BCarvalho%26aufirst%3DD.%2BD.%26aulast%3DHe%26aufirst%3DH.%2BH.%26aulast%3DSharpe%26aufirst%3DA.%2BH.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DLSD1%2520ablation%2520stimulates%2520anti-tumor%2520immunity%2520and%2520enables%2520checkpoint%2520blockade%26jtitle%3DCell%26date%3D2018%26volume%3D174%26spage%3D549%26epage%3D563%26doi%3D10.1016%2Fj.cell.2018.05.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinyard, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegenfeld, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterbury, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedy, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosavi, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senzer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinello, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liau, B. B.</span></span> <span> </span><span class="NLM_article-title">CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/s41589-019-0263-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fs41589-019-0263-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30992567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXos12gsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=529-539&author=M.+E.+Vinyardauthor=C.+Suauthor=A.+P.+Siegenfeldauthor=A.+L.+Waterburyauthor=A.+M.+Freedyauthor=P.+M.+Gosaviauthor=Y.+Parkauthor=E.+E.+Kwanauthor=B.+D.+Senzerauthor=J.+G.+Doenchauthor=D.+E.+Bauerauthor=L.+Pinelloauthor=B.+B.+Liau&title=CRISPR-suppressor+scanning+reveals+a+nonenzymatic+role+of+LSD1+in+AML&doi=10.1038%2Fs41589-019-0263-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML</span></div><div class="casAuthors">Vinyard, Michael E.; Su, Cindy; Siegenfeld, Allison P.; Waterbury, Amanda L.; Freedy, Allyson M.; Gosavi, Pallavi M.; Park, Yongho; Kwan, Eugene E.; Senzer, Benjamin D.; Doench, John G.; Bauer, Daniel E.; Pinello, Luca; Liau, Brian B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">529-539</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Understanding the mechanism of small mols. is a crit. challenge in chem. biol. and drug discovery.  Medicinal chem. is essential for elucidating drug mechanism, enabling variation of small mol. structure to gain structure-activity relationships (SARs).  However, the development of complementary approaches that systematically vary target protein structure could provide equally informative SARs for investigating drug mechanism and protein function.  Here we explore the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chem. inhibitors in the context of acute myeloid leukemia (AML).  Through this approach, termed CRISPR-suppressor scanning, we elucidate drug mechanism of action by showing that LSD1 enzyme activity is not required for AML survival and that LSD1 inhibitors instead function by disrupting interactions between LSD1 and the transcription factor GFI1B on chromatin.  Our studies clarify how LSD1 inhibitors mechanistically operate in AML and demonstrate how CRISPR-suppressor scanning can uncover novel aspects of target biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoekAhOtw79I7Vg90H21EOLACvtfcHk0liDCT41qa2zuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXos12gsb4%253D&md5=49115c4d215f413dfe6f3f45abd6bfd2</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1038%2Fs41589-019-0263-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-019-0263-0%26sid%3Dliteratum%253Aachs%26aulast%3DVinyard%26aufirst%3DM.%2BE.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DSiegenfeld%26aufirst%3DA.%2BP.%26aulast%3DWaterbury%26aufirst%3DA.%2BL.%26aulast%3DFreedy%26aufirst%3DA.%2BM.%26aulast%3DGosavi%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DKwan%26aufirst%3DE.%2BE.%26aulast%3DSenzer%26aufirst%3DB.%2BD.%26aulast%3DDoench%26aufirst%3DJ.%2BG.%26aulast%3DBauer%26aufirst%3DD.%2BE.%26aulast%3DPinello%26aufirst%3DL.%26aulast%3DLiau%26aufirst%3DB.%2BB.%26atitle%3DCRISPR-suppressor%2520scanning%2520reveals%2520a%2520nonenzymatic%2520role%2520of%2520LSD1%2520in%2520AML%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26spage%3D529%26epage%3D539%26doi%3D10.1038%2Fs41589-019-0263-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">12311</span>– <span class="NLM_lpage">12320</span>, <span class="refDoi"> DOI: 10.1073/pnas.1902012116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1902012116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31152129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFyktr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=12311-12320&author=H.+Lanauthor=M.+Tanauthor=Q.+Zhangauthor=F.+Yangauthor=S.+Wangauthor=H.+Liauthor=X.+Xiongauthor=Y.+Sun&title=LSD1+destabilizes+FBXW7+and+abrogates+FBXW7+functions+independent+of+its+demethylase+activity&doi=10.1073%2Fpnas.1902012116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity</span></div><div class="casAuthors">Lan, Huiyin; Tan, Mingjia; Zhang, Qiang; Yang, Fei; Wang, Siyuan; Li, Hua; Xiong, Xiufang; Sun, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">12311-12320</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">FBXW7 acts as a typical tumor suppressor, with loss-of-function alterations in human cancers, by promoting ubiquitylation and degrdn. of many oncoproteins.  Lysine-specific demethylase 1 (LSD1) is a well-characterized histone demethylase.  Whether LSD1 has demethylase-independent activity remains elusive.  Here we report that LSD1 directly binds to FBXW7 to destabilize FBXW7 independent of its demethylase activity.  Specifically, LSD1 is a pseudosubstrate of FBXW7 and LSD-FBXW7 binding does not trigger LSD1 ubiquitylation, but instead promotes FBXW7 self-ubiquitylation by preventing FBXW7 dimerization.  The self-ubiquitylated FBXW7 is subjected to degrdn. by proteasome as well as lysosome in a manner dependent on autophagy protein p62/SQSTM1.  Biol., LSD1 destabilizes FBXW7 to abrogate its functions in growth suppression, nonhomologous end-joining repair, and radioprotection.  Collectively, our study revealed a previously unknown activity of LSD1, which likely contributes to its oncogenic function.  Targeting LSD1 protein, not only its demethylase activity, might be a unique approach for LSD1-based drug discovery for anticancer application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNb1Flt8cl9LVg90H21EOLACvtfcHk0liDCT41qa2zuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFyktr3M&md5=d67de38a5b9ea4eef7bf0a81cb7f4e0a</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1902012116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1902012116%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DLSD1%2520destabilizes%2520FBXW7%2520and%2520abrogates%2520FBXW7%2520functions%2520independent%2520of%2520its%2520demethylase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D12311%26epage%3D12320%26doi%3D10.1073%2Fpnas.1902012116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span> <span> </span><span class="NLM_article-title">LSD1: A single target to combat lineage plasticity in lethal prostate cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">4530</span>– <span class="NLM_lpage">4531</span>, <span class="refDoi"> DOI: 10.1073/pnas.1804205115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1804205115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29666280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGhtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=4530-4531&author=L.+Ellisauthor=M.+Loda&title=LSD1%3A+A+single+target+to+combat+lineage+plasticity+in+lethal+prostate+cancer&doi=10.1073%2Fpnas.1804205115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1: a single target to combat lineage plasticity in lethal prostate cancer</span></div><div class="casAuthors">Ellis, Leigh; Loda, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4530-4531</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostate cancer initiation and progression to a lethal metastatic castration-resistant (mCRPC) phenotype remains largely dependent on the function of the androgen receptor.  Recently, however, more potent androgen-deprivation therapy (ADT) regimens that target the AR and the androgen biosynthesis pathways have led to the emergence, in a subset of cases, of resistance mechanisms independent of AR activity (CRPCAI).  The lysine-specific demethylase 1(LSD1) is a regulator of gene expression in stem cells.  Prior literature demonstrated that LSD1 acts by demethylation of both H3K4me1/2 and H3K9me1/2, providing dual functionality of gene repression and activation,resp.  The latter includes AR target genes, suggesting a functional role for LSD1 in androgen-sensitive disease.  In this review with commentary we provide recent data on what governs the emergence of lineage plasticity and ADT resistance, and novel therapeutic targets to treat this lethal phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFAp3OS8nbLVg90H21EOLACvtfcHk0liDCT41qa2zuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGhtb7K&md5=bc7b1e2d1f4ea6c1ca52162ca75bb380</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1804205115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1804205115%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DLoda%26aufirst%3DM.%26atitle%3DLSD1%253A%2520A%2520single%2520target%2520to%2520combat%2520lineage%2520plasticity%2520in%2520lethal%2520prostate%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3D4530%26epage%3D4531%26doi%3D10.1073%2Fpnas.1804205115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehrawat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankhead, A.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWeeney, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartzman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urrutia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallakury, B. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Eeden, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alumkal, J. J.</span></span> <span> </span><span class="NLM_article-title">LSD1 activates a lethal prostate cancer gene network independently of its demethylase function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E4179</span>– <span class="NLM_lpage">E4188</span>, <span class="refDoi"> DOI: 10.1073/pnas.1719168115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1719168115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29581250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGht7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E4179-E4188&author=A.+Sehrawatauthor=L.+Gaoauthor=Y.+Wangauthor=A.+Bankheadauthor=S.+K.+McWeeneyauthor=C.+J.+Kingauthor=J.+Schwartzmanauthor=J.+Urrutiaauthor=W.+H.+Bissonauthor=D.+J.+Colemanauthor=S.+K.+Joshiauthor=D.+H.+Kimauthor=D.+A.+Sampsonauthor=S.+Weinmannauthor=B.+V.+S.+Kallakuryauthor=D.+L.+Berryauthor=R.+Haqueauthor=S.+K.+Van+Den+Eedenauthor=S.+Sharmaauthor=J.+Bearssauthor=T.+M.+Beerauthor=G.+V.+Thomasauthor=L.+M.+Heiserauthor=J.+J.+Alumkal&title=LSD1+activates+a+lethal+prostate+cancer+gene+network+independently+of+its+demethylase+function&doi=10.1073%2Fpnas.1719168115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 activates a lethal prostate cancer gene network independently of its demethylase function</span></div><div class="casAuthors">Sehrawat, Archana; Gao, Lina; Wang, Yuliang; Bankhead, Armand, III; McWeeney, Shannon K.; King, Carly J.; Schwartzman, Jacob; Urrutia, Joshua; Bisson, William H.; Coleman, Daniel J.; Joshi, Sunil K.; Kim, Dae-Hwan; Sampson, David A.; Weinmann, Sheila; Kallakury, Bhaskar V. S.; Berry, Deborah L.; Haque, Reina; Van Den Eeden, Stephen K.; Sharma, Sunil; Bearss, Jared; Beer, Tomasz M.; Thomas, George V.; Heiser, Laura M.; Alumkal, Joshi J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">E4179-E4188</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Medical castration that interferes with androgen receptor (AR) function is the principal treatment for advanced prostate cancer.  However, clin. progression is universal, and tumors with AR-independent resistance mechanisms appear to be increasing in frequency.  Consequently, there is an urgent need to develop new treatments targeting mol. pathways enriched in lethal prostate cancer.  Lysine-specific demethylase 1 (LSD1) is a histone demethylase and an important regulator of gene expression.  Here, we show that LSD1 promotes the survival of prostate cancer cells, including those that are castration-resistant, independently of its demethylase function and of the AR.  Importantly, this effect is explained in part by activation of a lethal prostate cancer gene network in collaboration with LSD1's binding protein, ZNF217.  Finally, that a small-mol. LSD1 inhibitor-SP-2509-blocks important demethylase-independent functions and suppresses castration-resistant prostate cancer cell viability demonstrates the potential of LSD1 inhibition in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG9LmMzLAzw7Vg90H21EOLACvtfcHk0lhbzrV0241rlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGht7bJ&md5=3cc0558c15fe5496e7cdd9dc737c0780</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1719168115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1719168115%26sid%3Dliteratum%253Aachs%26aulast%3DSehrawat%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBankhead%26aufirst%3DA.%26aulast%3DMcWeeney%26aufirst%3DS.%2BK.%26aulast%3DKing%26aufirst%3DC.%2BJ.%26aulast%3DSchwartzman%26aufirst%3DJ.%26aulast%3DUrrutia%26aufirst%3DJ.%26aulast%3DBisson%26aufirst%3DW.%2BH.%26aulast%3DColeman%26aufirst%3DD.%2BJ.%26aulast%3DJoshi%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DSampson%26aufirst%3DD.%2BA.%26aulast%3DWeinmann%26aufirst%3DS.%26aulast%3DKallakury%26aufirst%3DB.%2BV.%2BS.%26aulast%3DBerry%26aufirst%3DD.%2BL.%26aulast%3DHaque%26aufirst%3DR.%26aulast%3DVan%2BDen%2BEeden%26aufirst%3DS.%2BK.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DBearss%26aufirst%3DJ.%26aulast%3DBeer%26aufirst%3DT.%2BM.%26aulast%3DThomas%26aufirst%3DG.%2BV.%26aulast%3DHeiser%26aufirst%3DL.%2BM.%26aulast%3DAlumkal%26aufirst%3DJ.%2BJ.%26atitle%3DLSD1%2520activates%2520a%2520lethal%2520prostate%2520cancer%2520gene%2520network%2520independently%2520of%2520its%2520demethylase%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE4179%26epage%3DE4188%26doi%3D10.1073%2Fpnas.1719168115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, H.</span></span> <span> </span><span class="NLM_article-title">Biological roles of LSD1 beyond its demethylase activity</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3350</span>, <span class="refDoi"> DOI: 10.1007/s00018-020-03489-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1007%2Fs00018-020-03489-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32193608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1Grsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2020&pages=3341-3350&author=F.+Guauthor=Y.+Linauthor=Z.+Wangauthor=X.+Wuauthor=Z.+Yeauthor=Y.+Wangauthor=H.+Lan&title=Biological+roles+of+LSD1+beyond+its+demethylase+activity&doi=10.1007%2Fs00018-020-03489-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Biological roles of LSD1 beyond its demethylase activity</span></div><div class="casAuthors">Gu, Feiying; Lin, Yuxin; Wang, Zhun; Wu, Xiaoxin; Ye, Zhenyue; Wang, Yuezhen; Lan, Huiyin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3341-3350</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Abstr.: It is well-established that Lysine-specific demethylase 1 (LSD1, also known as KDM1A) roles as a lysine demethylase canonically acting on H3K4me1/2 and H3K9me1/2 for regulating gene expression.  Though the discovery of non-histone substrates methylated by LSD1 has largely expanded the functions of LSD1 as a typical demethylase, recent groundbreaking studies unveiled its non-catalytic functions as a second life for this demethylase.  We and others found that LSD1 is implicated in the interaction with a line of proteins to exhibit addnl. non-canonical functions in a demethylase-independent manner.  Here, we present an integrated overview of these recent literatures charging LSD1 with unforeseen functions to re-evaluate and summarize its non-catalytic biol. roles beyond the current understanding of its demethylase activity.  Given LSD1 is reported to be ubiquitously overexpressed in a variety of tumors, it has been generally considered as an innovative target for cancer therapy.  We anticipate that these non-canonical functions of LSD1 will arouse the consideration that extending the LSD1-based drug discovery to targeting LSD1 protein interactions non-catalytically, not only its demethylase activity, may be a novel strategy for cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeSPlo5zskFLVg90H21EOLACvtfcHk0lhbzrV0241rlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1Grsb4%253D&md5=50d0f7b94c7ed1512766c271c7879a73</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs00018-020-03489-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-020-03489-9%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DH.%26atitle%3DBiological%2520roles%2520of%2520LSD1%2520beyond%2520its%2520demethylase%2520activity%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2020%26volume%3D77%26spage%3D3341%26epage%3D3350%26doi%3D10.1007%2Fs00018-020-03489-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romo-Morales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aladowicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, J. M.</span></span> <span> </span><span class="NLM_article-title">Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy</span>. <i>Pediatr. Blood Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>66</i></span>, <span class="NLM_elocation-id">e27888</span> <span class="refDoi"> DOI: 10.1002/pbc.27888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fpbc.27888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31207107" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2019&author=A.+Romo-Moralesauthor=E.+Aladowiczauthor=J.+Blaggauthor=S.+A.+Gatzauthor=J.+M.+Shipley&title=Catalytic+inhibition+of+KDM1A+in+Ewing+sarcoma+is+insufficient+as+a+therapeutic+strategy&doi=10.1002%2Fpbc.27888"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1002%2Fpbc.27888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.27888%26sid%3Dliteratum%253Aachs%26aulast%3DRomo-Morales%26aufirst%3DA.%26aulast%3DAladowicz%26aufirst%3DE.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DGatz%26aufirst%3DS.%2BA.%26aulast%3DShipley%26aufirst%3DJ.%2BM.%26atitle%3DCatalytic%2520inhibition%2520of%2520KDM1A%2520in%2520Ewing%2520sarcoma%2520is%2520insufficient%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2019%26volume%3D66%26doi%3D10.1002%2Fpbc.27888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sonnemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauterjung, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, J. F.</span></span> <span> </span><span class="NLM_article-title">LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells</span>. <i>Br. J. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1111/bjh.14983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1111%2Fbjh.14983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29205263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC1M3nvFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2018&pages=494-497&author=J.+Sonnemannauthor=M.+Zimmermannauthor=C.+Marxauthor=F.+Ebertauthor=S.+Beckerauthor=M.+L.+Lauterjungauthor=J.+F.+Beck&title=LSD1+%28KDM1A%29-independent+effects+of+the+LSD1+inhibitor+SP2509+in+cancer+cells&doi=10.1111%2Fbjh.14983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells</span></div><div class="casAuthors">Sonnemann Jurgen; Zimmermann Miriam; Ebert Franziska; Becker Sabine; Lauterjung Marie-Luise; Beck James F; Sonnemann Jurgen; Zimmermann Miriam; Ebert Franziska; Becker Sabine; Marx Christian</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">494-497</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgjJY71tdjTSCEBeYuoi7AfW6udTcc2ebxnuFrIP7wgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3nvFGgsQ%253D%253D&md5=7c590c5ff28614d7dba0892e76fd6cec</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1111%2Fbjh.14983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjh.14983%26sid%3Dliteratum%253Aachs%26aulast%3DSonnemann%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DM.%26aulast%3DMarx%26aufirst%3DC.%26aulast%3DEbert%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DLauterjung%26aufirst%3DM.%2BL.%26aulast%3DBeck%26aufirst%3DJ.%2BF.%26atitle%3DLSD1%2520%2528KDM1A%2529-independent%2520effects%2520of%2520the%2520LSD1%2520inhibitor%2520SP2509%2520in%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2018%26volume%3D183%26spage%3D494%26epage%3D497%26doi%3D10.1111%2Fbjh.14983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yi Zhang, Deqin Rong, Bingbing Li, <span class="NLM_string-name hlFld-ContribAuthor">Yuanxiang Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 7900-7925. <a href="https://doi.org/10.1021/acs.jmedchem.0c02055" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BEpigenetic%252BRegulators%252Bwith%252BCovalent%252BSmall-Molecule%252BInhibitors%26aulast%3DZhang%26aufirst%3DYi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26112020%26date%3D18022021%26volume%3D64%26issue%3D12%26spage%3D7900%26epage%3D7925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xing-Jie Dai, Ying Liu, Lei-Peng Xue, Xiao-Peng Xiong, Ying Zhou, Yi-Chao Zheng, <span class="NLM_string-name hlFld-ContribAuthor">Hong-Min Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2466-2488. <a href="https://doi.org/10.1021/acs.jmedchem.0c02176" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02176%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DReversible%252BLysine%252BSpecific%252BDemethylase%252B1%252B%252528LSD1%252529%252BInhibitors%25253A%252BA%252BPromising%252BWrench%252Bto%252BImpair%252BLSD1%26aulast%3DDai%26aufirst%3DXing-Jie%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D16122020%26date%3D23022021%26volume%3D64%26issue%3D5%26spage%3D2466%26epage%3D2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Chao  Duan</span>, <span class="hlFld-ContribAuthor ">Shao-Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Shi</span>, <span class="hlFld-ContribAuthor ">Lin-Feng  Jin</span>, <span class="hlFld-ContribAuthor ">Tong  Yu</span>, <span class="hlFld-ContribAuthor ">Yu  Song</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113588. <a href="https://doi.org/10.1016/j.ejmech.2021.113588" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113588%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bof%252Bdual%252Binhibitors%252Btargeting%252Bcrosstalk%252Bbetween%252Bhistone%252Bepigenetic%252Bmodulators%252Bfor%252Bcancer%252Btherapy%26aulast%3DDuan%26aufirst%3DYing-Chao%26date%3D2021%26volume%3D222%26spage%3D113588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Chao  Duan</span>, <span class="hlFld-ContribAuthor ">Lin-Feng  Jin</span>, <span class="hlFld-ContribAuthor ">Hong-Mei  Ren</span>, <span class="hlFld-ContribAuthor ">Shao-Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Yue-Jiao  Liu</span>, <span class="hlFld-ContribAuthor ">Yong-Tao  Xu</span>, <span class="hlFld-ContribAuthor ">Zi-Hao  He</span>, <span class="hlFld-ContribAuthor ">Yu  Song</span>, <span class="hlFld-ContribAuthor ">Hang  Yuan</span>, <span class="hlFld-ContribAuthor ">Shu-Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113453. <a href="https://doi.org/10.1016/j.ejmech.2021.113453" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113453%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bdual%252Binhibitors%252Btargeting%252Blysine%252Bspecific%252Bdemethylase%252B1%252B%252528LSD1%252529%252Band%252Bhistone%252Bdeacetylases%252B%252528HDAC%252529%252Bfor%252Btreatment%252Bof%252Bgastric%252Bcancer%26aulast%3DDuan%26aufirst%3DYing-Chao%26date%3D2021%26volume%3D220%26spage%3D113453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongtao  Xu</span>, <span class="hlFld-ContribAuthor ">Yunlong  Gao</span>, <span class="hlFld-ContribAuthor ">Min  Yang</span>, <span class="hlFld-ContribAuthor ">Meiting  Wang</span>, <span class="hlFld-ContribAuthor ">Jiarui  Lu</span>, <span class="hlFld-ContribAuthor ">Ziqing  Wu</span>, <span class="hlFld-ContribAuthor ">Junqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yi  Yu</span>, <span class="hlFld-ContribAuthor ">Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Zongya  Zhao</span>, <span class="hlFld-ContribAuthor ">Qinghe  Gao</span>, <span class="hlFld-ContribAuthor ">Yingchao  Duan</span>, <span class="hlFld-ContribAuthor ">Di  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Design and identification of two novel resveratrol derivatives as potential LSD1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.4155/fmc-2021-0105" title="DOI URL">https://doi.org/10.4155/fmc-2021-0105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2021-0105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2021-0105%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bidentification%252Bof%252Btwo%252Bnovel%252Bresveratrol%252Bderivatives%252Bas%252Bpotential%252BLSD1%252Binhibitors%26aulast%3DXu%26aufirst%3DYongtao%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Di  Che</span>, <span class="hlFld-ContribAuthor ">Mingshuo  Wang</span>, <span class="hlFld-ContribAuthor ">Juan  Sun</span>, <span class="hlFld-ContribAuthor ">Bo  Li</span>, <span class="hlFld-ContribAuthor ">Tao  Xu</span>, <span class="hlFld-ContribAuthor ">Yuxiong  Lu</span>, <span class="hlFld-ContribAuthor ">Haiyan  Pan</span>, <span class="hlFld-ContribAuthor ">Zhaoliang  Lu</span>, <span class="hlFld-ContribAuthor ">Xiaoqiong  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">KRT6A Promotes Lung Cancer Cell Growth and Invasion Through MYC-Regulated Pentose Phosphate Pathway. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fcell.2021.694071" title="DOI URL">https://doi.org/10.3389/fcell.2021.694071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2021.694071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2021.694071%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DKRT6A%252BPromotes%252BLung%252BCancer%252BCell%252BGrowth%252Band%252BInvasion%252BThrough%252BMYC-Regulated%252BPentose%252BPhosphate%252BPathway%26aulast%3DChe%26aufirst%3DDi%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Jie  Huang</span>, <span class="hlFld-ContribAuthor ">Jia-Wen  Guo</span>, <span class="hlFld-ContribAuthor ">Yun-Dong  Fu</span>, <span class="hlFld-ContribAuthor ">Ya-Zhen  You</span>, <span class="hlFld-ContribAuthor ">Wen-Yu  Xu</span>, <span class="hlFld-ContribAuthor ">Ting-Yu  Song</span>, <span class="hlFld-ContribAuthor ">Ran  Li</span>, <span class="hlFld-ContribAuthor ">Zi-Tong  Chen</span>, <span class="hlFld-ContribAuthor ">Li-Hua  Huang</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new tranylcypromine derivatives as highly potent LSD1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>41 </em>, 127993. <a href="https://doi.org/10.1016/j.bmcl.2021.127993" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127993</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127993%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnew%252Btranylcypromine%252Bderivatives%252Bas%252Bhighly%252Bpotent%252BLSD1%252Binhibitors%26aulast%3DHuang%26aufirst%3DMing-Jie%26date%3D2021%26volume%3D41%26spage%3D127993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peizhi  Ma</span>, <span class="hlFld-ContribAuthor ">Gang  Jia</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Monobenzone, a Novel and Potent KDM1A Inhibitor, Suppresses Migration of Gastric Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.640949" title="DOI URL">https://doi.org/10.3389/fphar.2021.640949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.640949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.640949%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DMonobenzone%25252C%252Ba%252BNovel%252Band%252BPotent%252BKDM1A%252BInhibitor%25252C%252BSuppresses%252BMigration%252Bof%252BGastric%252BCancer%252BCells%26aulast%3DMa%26aufirst%3DPeizhi%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Jun  Fu</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Annual review of LSD1/KDM1A inhibitors in 2020. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113254. <a href="https://doi.org/10.1016/j.ejmech.2021.113254" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113254%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnnual%252Breview%252Bof%252BLSD1%25252FKDM1A%252Binhibitors%252Bin%252B2020%26aulast%3DFu%26aufirst%3DDong-Jun%26date%3D2021%26volume%3D214%26spage%3D113254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yin  Sun</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Wang</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Tongchao  Liu</span>, <span class="hlFld-ContribAuthor ">Yue-Lei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Divalent tranylcypromine derivative as lysine-specific demethylase 1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 421-428. <a href="https://doi.org/10.1007/s00044-020-02689-z" title="DOI URL">https://doi.org/10.1007/s00044-020-02689-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02689-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02689-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDivalent%252Btranylcypromine%252Bderivative%252Bas%252Blysine-specific%252Bdemethylase%252B1%252Binhibitor%26aulast%3DSun%26aufirst%3DYin%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D421%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structural basis for designing novel TCP-based LSD1 inhibitors. (A) Catalytic mechanism of LSD1. (B) Mechanism of LSD1 inhibition by forming the covalent TCP–FAD adducts. (C) Cocrystal structure of TCP–FAD adduct in LSD1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds substituted on the phenyl of TCP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds substituted on the amino of TCP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Miscellaneous substituted TCP-based compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compounds substituted on the cyclopropyl core of TCP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/medium/jm0c00919_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Conformationally constrained TCP-based compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00919/20201203/images/large/jm0c00919_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00919&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 132 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gelato, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischle, W.</span></span> <span> </span><span class="NLM_article-title">Role of histone modifications in defining chromatin structure and function</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1515/BC.2008.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1515%2FBC.2008.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18225984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFait7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=353-363&author=K.+A.+Gelatoauthor=W.+Fischle&title=Role+of+histone+modifications+in+defining+chromatin+structure+and+function&doi=10.1515%2FBC.2008.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of histone modifications in defining chromatin structure and function</span></div><div class="casAuthors">Gelato, Kathy A.; Fischle, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-363</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Chromosomes in eukaryotic cell nuclei are not uniformly organized, but rather contain distinct chromatin elements, with each state having a defined biochem. structure and biol. function.  These are recognizable by their distinct architectures and mol. components, which can change in response to cellular stimuli or metabolic requirements.  Chromatin elements are characterized by the fundamental histone and DNA components, as well as other assocd. non-histone proteins and factors.  Post-translational modifications of histones in particular often correlate with a specific chromatin structure and function.  Patterns of histone modifications are implicated as having a role in directing the level of chromatin compaction, as well as playing roles in multiple functional pathways directing the readout of distinct regions of the genome.  Here, the authors review the properties of various chromatin elements and the apparent links of histone modifications with chromatin organization and functional output.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm8YRKkBO4w7Vg90H21EOLACvtfcHk0lgmHn-mXjau5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFait7s%253D&md5=14b1db5766047ab8201007c5cde0405d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1515%2FBC.2008.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2008.048%26sid%3Dliteratum%253Aachs%26aulast%3DGelato%26aufirst%3DK.%2BA.%26aulast%3DFischle%26aufirst%3DW.%26atitle%3DRole%2520of%2520histone%2520modifications%2520in%2520defining%2520chromatin%2520structure%2520and%2520function%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26spage%3D353%26epage%3D363%26doi%3D10.1515%2FBC.2008.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whetstine, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casero, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Histone demethylation mediated by the nuclear amine oxidase homolog LSD1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.cell.2004.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=15620353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2004&pages=941-953&author=Y.+Shiauthor=F.+Lanauthor=C.+Matsonauthor=P.+Mulliganauthor=J.+R.+Whetstineauthor=P.+A.+Coleauthor=R.+A.+Caseroauthor=Y.+Shi&title=Histone+demethylation+mediated+by+the+nuclear+amine+oxidase+homolog+LSD1&doi=10.1016%2Fj.cell.2004.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Histone demethylation mediated by the nuclear amine oxidase homolog LSD1</span></div><div class="casAuthors">Shi, Yujiang; Lan, Fei; Matson, Caitlin; Mulligan, Peter; Whetstine, Johnathan R.; Cole, Philip A.; Casero, Robert A.; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-953</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Posttranslational modifications of histone N-terminal tails impact chromatin structure and gene transcription.  While the extent of histone acetylation is detd. by both acetyltransferases and deacetylases, it has been unclear whether histone methylation is also regulated by enzymes with opposing activities.  Here, we provide evidence that LSD1 (KIAA0601), a nuclear homolog of amine oxidases, functions as a histone demethylase and transcriptional corepressor.  LSD1 specifically demethylates histone H3 lysine 4, which is linked to active transcription.  Lysine demethylation occurs via an oxidn. reaction that generates formaldehyde.  Importantly, RNAi inhibition of LSD1 causes an increase in H3 lysine 4 methylation and concomitant derepression of target genes, suggesting that LSD1 represses transcription via histone demethylation.  The results thus identify a histone demethylase conserved from S. pombe to human and reveal dynamic regulation of histone methylation by both histone methylases and demethylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXHr-8kwGdXrVg90H21EOLACvtfcHk0ljQPeMLhlxujw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlSitg%253D%253D&md5=3474569204255e90a832667ba654748b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DMatson%26aufirst%3DC.%26aulast%3DMulligan%26aufirst%3DP.%26aulast%3DWhetstine%26aufirst%3DJ.%2BR.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DCasero%26aufirst%3DR.%2BA.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DHistone%2520demethylation%2520mediated%2520by%2520the%2520nuclear%2520amine%2520oxidase%2520homolog%2520LSD1%26jtitle%3DCell%26date%3D2004%26volume%3D119%26spage%3D941%26epage%3D953%26doi%3D10.1016%2Fj.cell.2004.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurash, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1038/ng.268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fng.268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=19098913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=125-129&author=J.+Wangauthor=S.+Heviauthor=J.+K.+Kurashauthor=H.+Leiauthor=F.+Gayauthor=J.+Bajkoauthor=H.+Suauthor=W.+Sunauthor=H.+Changauthor=G.+Xuauthor=F.+Gaudetauthor=E.+Liauthor=T.+Chen&title=The+lysine+demethylase+LSD1+%28KDM1%29+is+required+for+maintenance+of+global+DNA+methylation&doi=10.1038%2Fng.268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation</span></div><div class="casAuthors">Wang, Jing; Hevi, Sarah; Kurash, Julia K.; Lei, Hong; Gay, Frederique; Bajko, Jeffrey; Su, Hui; Sun, Weitao; Chang, Hua; Xu, Guoliang; Gaudet, Francois; Li, En; Chen, Taiping</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-129</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone methylation and DNA methylation cooperatively regulate chromatin structure and gene activity.  How these two systems coordinate with each other remains unclear.  Here we study the biol. function of lysine-specific demethylase 1 (LSD1, also known as KDM1 and AOF2), which has been shown to demethylate histone H3 on lysine 4 (H3K4) and lysine 9 (H3K9).  We show that LSD1 is required for gastrulation during mouse embryogenesis.  Notably, targeted deletion of the gene encoding LSD1 (namely, Aof2) in embryonic stem (ES) cells induces progressive loss of DNA methylation.  This loss correlates with a decrease in DNA methyltransferase 1 (Dnmt1) protein, as a result of reduced Dnmt1 stability.  Dnmt1 protein is methylated in vivo, and its methylation is enhanced in the absence of LSD1.  Furthermore, Dnmt1 can be methylated by Set7/9 (also known as KMT7) and demethylated by LSD1 in vitro.  Our findings suggest that LSD1 demethylates and stabilizes Dnmt1, thus providing a previously unknown mechanistic link between the histone and DNA methylation systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSJgebl5_48LVg90H21EOLACvtfcHk0ljQPeMLhlxujw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajtbbK&md5=37722ddd4564a79a0cd1c7b148c370d8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fng.268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.268%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHevi%26aufirst%3DS.%26aulast%3DKurash%26aufirst%3DJ.%2BK.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DGay%26aufirst%3DF.%26aulast%3DBajko%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DGaudet%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DThe%2520lysine%2520demethylase%2520LSD1%2520%2528KDM1%2529%2520is%2520required%2520for%2520maintenance%2520of%2520global%2520DNA%2520methylation%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D125%26epage%3D129%26doi%3D10.1038%2Fng.268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espejo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opravil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiekhattar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedford, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenuwein, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. L.</span></span> <span> </span><span class="NLM_article-title">p53 is regulated by the lysine demethylase LSD1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1038/nature06092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fnature06092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=17805299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFWrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2007&pages=105-108&author=J.+Huangauthor=R.+Senguptaauthor=A.+B.+Espejoauthor=M.+G.+Leeauthor=J.+A.+Dorseyauthor=M.+Richterauthor=S.+Opravilauthor=R.+Shiekhattarauthor=M.+T.+Bedfordauthor=T.+Jenuweinauthor=S.+L.+Berger&title=p53+is+regulated+by+the+lysine+demethylase+LSD1&doi=10.1038%2Fnature06092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">p53 is regulated by the lysine demethylase LSD1</span></div><div class="casAuthors">Huang, Jing; Sengupta, Roopsha; Espejo, Alexsandra B.; Lee, Min Gyu; Dorsey, Jean A.; Richter, Mario; Opravil, Susanne; Shiekhattar, Ramin; Bedford, Mark T.; Jenuwein, Thomas; Berger, Shelley L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">7158</span>),
    <span class="NLM_cas:pages">105-108</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P53, the tumor suppressor and transcriptional activator, is regulated by numerous post-translational modifications, including lysine methylation.  Histone lysine methylation has recently been shown to be reversible; however, it is not known whether non-histone proteins are substrates for demethylation.  Here we show that, in human cells, the histone lysine-specific demethylase LSD1 (refs. 3, 4) interacts with p53 to repress p53-mediated transcriptional activation and to inhibit the role of p53 in promoting apoptosis.  We find that, in vitro, LSD1 removes both monomethylation (K370me1) and dimethylation (K370me2) at K370, a previously identified Smyd2-dependent monomethylation site.  However, in vivo, LSD1 shows a strong preference to reverse K370me2, which is performed by a distinct, but unknown, methyltransferase.  Our results indicate that K370me2 has a different role in regulating p53 from that of K370me1: K370me1 represses p53 function, whereas K370me2 promotes assocn. with the coactivator 53BP1 (p53-binding protein 1) through tandem Tudor domains in 53BP1.  Further, LSD1 represses p53 function through the inhibition of interaction of p53 with 53BP1.  These observations show that p53 is dynamically regulated by lysine methylation and demethylation and that the methylation status at a single lysine residue confers distinct regulatory output.  Lysine methylation therefore provides similar regulatory complexity for non-histone proteins and for histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ggpbeqDqsbVg90H21EOLACvtfcHk0lhJEHcRcENBeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFWrs7w%253D&md5=8bf23f859f97d21bf7008a6d6e1c4946</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature06092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06092%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSengupta%26aufirst%3DR.%26aulast%3DEspejo%26aufirst%3DA.%2BB.%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DDorsey%26aufirst%3DJ.%2BA.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DOpravil%26aufirst%3DS.%26aulast%3DShiekhattar%26aufirst%3DR.%26aulast%3DBedford%26aufirst%3DM.%2BT.%26aulast%3DJenuwein%26aufirst%3DT.%26aulast%3DBerger%26aufirst%3DS.%2BL.%26atitle%3Dp53%2520is%2520regulated%2520by%2520the%2520lysine%2520demethylase%2520LSD1%26jtitle%3DNature%26date%3D2007%26volume%3D449%26spage%3D105%26epage%3D108%26doi%3D10.1038%2Fnature06092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohmae, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokawa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurash, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamoto, R.</span></span> <span> </span><span class="NLM_article-title">Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-2446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F0008-5472.CAN-10-2446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=21115810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=655-660&author=H.+S.+Choauthor=T.+Suzukiauthor=N.+Dohmaeauthor=S.+Hayamiauthor=M.+Unokiauthor=M.+Yoshimatsuauthor=G.+Toyokawaauthor=M.+Takawaauthor=T.+Chenauthor=J.+K.+Kurashauthor=H.+I.+Fieldauthor=B.+A.+Ponderauthor=Y.+Nakamuraauthor=R.+Hamamoto&title=Demethylation+of+RB+regulator+MYPT1+by+histone+demethylase+LSD1+promotes+cell+cycle+progression+in+cancer+cells&doi=10.1158%2F0008-5472.CAN-10-2446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Demethylation of RB Regulator MYPT1 by Histone Demethylase LSD1 Promotes Cell Cycle Progression in Cancer Cells</span></div><div class="casAuthors">Cho, Hyun-Soo; Suzuki, Takehiro; Dohmae, Naoshi; Hayami, Shinya; Unoki, Motoko; Yoshimatsu, Masanori; Toyokawa, Gouji; Takawa, Masashi; Chen, Taiping; Kurash, Julia K.; Field, Helen I.; Ponder, Bruce A. J.; Nakamura, Yusuke; Hamamoto, Ryuji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">655-660</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Histone demethylase LSD1 (also known as KDM1 and AOF2) is active in various cancer cells, but its biol. significance in human carcinogenesis is unexplored.  In this study, we explored hypothesized interactions between LSD1 and MYPT1, a known regulator of RB1 phosphorylation.  We found that MYPT1 was methylated in vitro and in vivo by histone lysine methyltransferase SETD7 and demethylated by LSD1, identifying Lys 442 of MYPT1 as a target for methylation/demethylation by these enzymes.  LSD1 silencing increased MYPT1 protein levels, decreasing the steady state level of phosphorylated RB1 (Ser 807/811) and reducing E2F activity.  MYPT1 methylation status influenced the affinity of MYPT1 for the ubiquitin-proteasome pathway of protein turnover.  MYPT1 was unstable in murine cells deficient in SETD7, supporting the concept that MYPT1 protein stability is physiol. regulated by methylation status.  LSD1 overexpression could activate RB1 phosphorylation by inducing a destabilization of MYPT1 protein.  Taken together, our results comprise a novel cell cycle regulatory mechanism mediated by methylation/demethylation dynamics, and they reveal the significance of LSD1 overexpression in human carcinogenesis.  Cancer Res; 71(3); 655-60.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh4fxBs2QNSrVg90H21EOLACvtfcHk0lhJEHcRcENBeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCis7c%253D&md5=4812d562b79453755b7c2eb8f74cc3eb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-2446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-2446%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DHayami%26aufirst%3DS.%26aulast%3DUnoki%26aufirst%3DM.%26aulast%3DYoshimatsu%26aufirst%3DM.%26aulast%3DToyokawa%26aufirst%3DG.%26aulast%3DTakawa%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DKurash%26aufirst%3DJ.%2BK.%26aulast%3DField%26aufirst%3DH.%2BI.%26aulast%3DPonder%26aufirst%3DB.%2BA.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DHamamoto%26aufirst%3DR.%26atitle%3DDemethylation%2520of%2520RB%2520regulator%2520MYPT1%2520by%2520histone%2520demethylase%2520LSD1%2520promotes%2520cell%2520cycle%2520progression%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D655%26epage%3D660%26doi%3D10.1158%2F0008-5472.CAN-10-2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talianidis, I.</span></span> <span> </span><span class="NLM_article-title">Lysine methylation regulates E2F1-induced cell death</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.molcel.2010.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=20603083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFejs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=152-160&author=H.+Kontakiauthor=I.+Talianidis&title=Lysine+methylation+regulates+E2F1-induced+cell+death&doi=10.1016%2Fj.molcel.2010.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine methylation regulates E2F1-induced cell death</span></div><div class="casAuthors">Kontaki, Haroula; Talianidis, Iannis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-160</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone-modifying enzymes can regulate DNA damage-induced apoptosis through modulation of p53 function.  Here, we show that, in p53-deficient tumor cells, Set9 and LSD1 regulate DNA damage-induced cell death in a manner opposite to that obsd. in p53+/+ cells, via modulation of E2F1 stabilization.  Set9 methylates E2F1 at lysine-185, which prevents E2F1 accumulation during DNA damage and activation of its proapoptotic target gene p73.  This Me mark is removed by LSD1, which is required for E2F1 stabilization and apoptotic function.  The mol. mechanism involves cross-talks between Lys methylation and other covalent modifications that affect E2F1 stability.  Methylation at Lys-185 inhibits acetylation and phosphorylation at distant positions and, in parallel, stimulates ubiquitination and degrdn. of the protein.  The findings illustrate that the function of methyltransferases can have opposing biol. outcomes depending on the specificity of transcription factor targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXEj98lICfQ7Vg90H21EOLACvtfcHk0ligMlCAyPoESQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFejs7w%253D&md5=12b34f33cde33be3f37a53f8115aecde</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DKontaki%26aufirst%3DH.%26aulast%3DTalianidis%26aufirst%3DI.%26atitle%3DLysine%2520methylation%2520regulates%2520E2F1-induced%2520cell%2520death%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D39%26spage%3D152%26epage%3D160%26doi%3D10.1016%2Fj.molcel.2010.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chance, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, G. R.</span></span> <span> </span><span class="NLM_article-title">Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">21499</span>– <span class="NLM_lpage">21504</span>, <span class="refDoi"> DOI: 10.1073/pnas.1016147107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1016147107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=21098664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WisL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=21499-21504&author=J.+Yangauthor=J.+Huangauthor=M.+Dasguptaauthor=N.+Searsauthor=M.+Miyagiauthor=B.+Wangauthor=M.+R.+Chanceauthor=X.+Chenauthor=Y.+Duauthor=Y.+Wangauthor=L.+Anauthor=Q.+Wangauthor=T.+Luauthor=X.+Zhangauthor=Z.+Wangauthor=G.+R.+Stark&title=Reversible+methylation+of+promoter-bound+STAT3+by+histone-modifying+enzymes&doi=10.1073%2Fpnas.1016147107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes</span></div><div class="casAuthors">Yang, Jinbo; Huang, Jing; Dasgupta, Maupali; Sears, Nathan; Miyagi, Masaru; Wang, Benlian; Chance, Mark R.; Chen, Xing; Du, Yuping; Wang, Yuxin; An, Lizhe; Wang, Qin; Lu, Tao; Zhang, Xiaodong; Wang, Zhenghe; Stark, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">21499-21504, S21499/1-S21499/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Following its tyrosine phosphorylation, STAT3 is methylated on K140 by the histone Me transferase SET9 and demethylated by LSD1 when it is bound to a subset of the promoters that it activates.  Methylation of K140 is a neg. regulatory event, because its blockade greatly increases the steady-state amt. of activated STAT3 and the expression of many (i.e., SOCS3) but not all (i.e., CD14) STAT3 target genes.  Biol. relevance is shown by the observation that overexpression of SOCS3 when K140 cannot be methylated blocks the ability of cells to activate STAT3 in response to IL-6.  K140 methylation does not occur with mutants of STAT3 that do not enter nuclei or bind to DNA.  Following treatment with IL-6, events at the SOCS3 promoter occur in an ordered sequence, as shown by chromatin immunopptns.  Y705-phosphoryl-STAT3 binds first and S727 is then phosphorylated, followed by the coincident binding of SET9 and dimethylation of K140, and lastly by the binding of LSD1.  We conclude that the lysine methylation of promoter-bound STAT3 leads to biol. important down-regulation of the dependent responses and that SET9, which is known to help provide an activating methylation mark to H3K4, is recruited to the newly activated SOCS3 promoter by STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTNJmJCGOKwbVg90H21EOLACvtfcHk0ligMlCAyPoESQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WisL%252FM&md5=255afed29b2b72fde8e2baf3d09a85dd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1016147107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1016147107%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDasgupta%26aufirst%3DM.%26aulast%3DSears%26aufirst%3DN.%26aulast%3DMiyagi%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DChance%26aufirst%3DM.%2BR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DStark%26aufirst%3DG.%2BR.%26atitle%3DReversible%2520methylation%2520of%2520promoter-bound%2520STAT3%2520by%2520histone-modifying%2520enzymes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D21499%26epage%3D21504%26doi%3D10.1073%2Fpnas.1016147107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croce, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, G.</span></span> <span> </span><span class="NLM_article-title">LSD1 demethylates HIF1alpha to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5512</span>– <span class="NLM_lpage">5521</span>, <span class="refDoi"> DOI: 10.1038/onc.2017.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fonc.2017.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28534506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyltLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=5512-5521&author=J.+Y.+Leeauthor=J.+H.+Parkauthor=H.+J.+Choiauthor=H.+Y.+Wonauthor=H.+S.+Jooauthor=D.+H.+Shinauthor=M.+K.+Parkauthor=B.+Hanauthor=K.+P.+Kimauthor=T.+J.+Leeauthor=C.+M.+Croceauthor=G.+Kong&title=LSD1+demethylates+HIF1alpha+to+inhibit+hydroxylation+and+ubiquitin-mediated+degradation+in+tumor+angiogenesis&doi=10.1038%2Fonc.2017.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis</span></div><div class="casAuthors">Lee, J-Y.; Park, J-H.; Choi, H-J.; Won, H-Y.; Joo, H-s; Shin, D-H.; Park, M. K.; Han, B.; Kim, K. P.; Lee, T. J.; Croce, C. M.; Kong, G.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5512-5521</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1), which has been considered as a potential therapeutic target in human cancer, has been known to regulate many biol. functions through its non-histone substrates.  Although LSD1-induced hypoxia-inducible factor alpha (HIF1α) demethylation has recently been proposed, the effect of LSD1 on the relationship between HIF1α post-translational modifications (PTMs) and HIF1α-induced tumor angiogenesis remains to be elucidated.  Here, we identify a new methylation site of the HIF1α protein antagonized by LSD1 and the interplay between HIF1α protein methylation and other PTMs in regulating tumor angiogenesis.  LSD1 demethylates HIF1α at lysine (K) 391, which protects HIF1α against ubiquitin-mediated protein degrdn.  LSD1 also directly suppresses PHD2-induced HIF1α hydroxylation, which has a mutually dependent interplay with Set9-mediated HIF1α methylation.  Moreover, the HIF1α acetylation that occurs in a HIF1α methylation-dependent manner is inhibited by the LSD1/NuRD complex.  HIF1α stabilized by LSD1 cooperates with CBP and MTA1 to enhance vascular endothelial growth factor (VEGF)-induced tumor angiogenesis.  Thus, LSD1 is a key regulator of HIF1α/VEGF-mediated tumor angiogenesis by antagonizing the crosstalk between PTMs involving HIF1α protein degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtgPa519Y26LVg90H21EOLACvtfcHk0ligMlCAyPoESQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyltLvP&md5=99c96e8bcb4b3616e89961facf9602ea</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fonc.2017.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2017.158%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DWon%26aufirst%3DH.%2BY.%26aulast%3DJoo%26aufirst%3DH.%2BS.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DPark%26aufirst%3DM.%2BK.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DK.%2BP.%26aulast%3DLee%26aufirst%3DT.%2BJ.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DKong%26aufirst%3DG.%26atitle%3DLSD1%2520demethylates%2520HIF1alpha%2520to%2520inhibit%2520hydroxylation%2520and%2520ubiquitin-mediated%2520degradation%2520in%2520tumor%2520angiogenesis%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D5512%26epage%3D5521%26doi%3D10.1038%2Fonc.2017.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirfel, J.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1093%2Fcarcin%2Fbgp324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=20042638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFGmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=512-520&author=S.+Limauthor=A.+Janzerauthor=A.+Beckerauthor=A.+Zimmerauthor=R.+Schuleauthor=R.+Buettnerauthor=J.+Kirfel&title=Lysine-specific+demethylase+1+%28LSD1%29+is+highly+expressed+in+ER-negative+breast+cancers+and+a+biomarker+predicting+aggressive+biology&doi=10.1093%2Fcarcin%2Fbgp324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology</span></div><div class="casAuthors">Lim, Soyoung; Janzer, Andreas; Becker, Astrid; Zimmer, Andreas; Schuele, Roland; Buettner, Reinhard; Kirfel, Jutta</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">512-520</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Breast carcinogenesis is a multistep process involving both genetic and epigenetic changes.  Since epigenetic changes like histone modifications are potentially reversible processes, much effort has been directed toward understanding this mechanism with the goal of finding novel therapies as well as more refined diagnostic and prognostic tools in breast cancer.  Lysine-specific demethylase 1 (LSD1) plays a key role in the regulation of gene expression by removing the Me groups from methylated lysine 4 of histone H3 and lysine 9 of histone H3.  LSD1 is essential for mammalian development and involved in many biol. processes.  Considering recent evidence that LSD1 is involved in carcinogenesis, we investigated the role of LSD1 in breast cancer.  Therefore, we developed an ELISA to det. LSD1 protein levels in tissue specimens of breast cancer and measured very high LSD1 levels in estrogen receptor (ER)-neg. tumors.  Pharmacol. LSD1 inhibition resulted in growth inhibition of breast cancer cells.  Knockdown of LSD1 using small interfering RNA approach induced regulation of several proliferation-assocd. genes like p21, ERBB2 and CCNA2.  Addnl., we found that LSD1 is recruited to the promoters of these genes.  In summary, our data indicate that LSD1 may provide a predictive marker for aggressive biol. and a novel attractive therapeutic target for treatment of ER-neg. breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeX6QvvaygFLVg90H21EOLACvtfcHk0ljWCN1hfj6xsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFGmsrw%253D&md5=b94c60b52c6a440d71cdf5a8007ea97b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp324%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%26aulast%3DJanzer%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DKirfel%26aufirst%3DJ.%26atitle%3DLysine-specific%2520demethylase%25201%2520%2528LSD1%2529%2520is%2520highly%2520expressed%2520in%2520ER-negative%2520breast%2520cancers%2520and%2520a%2520biomarker%2520predicting%2520aggressive%2520biology%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D512%26epage%3D520%26doi%3D10.1093%2Fcarcin%2Fbgp324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span> <span> </span><span class="NLM_article-title">LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.cell.2009.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=19703393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCjs73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2009&pages=660-672&author=Y.+Wangauthor=H.+Zhangauthor=Y.+Chenauthor=Y.+Sunauthor=F.+Yangauthor=W.+Yuauthor=J.+Liangauthor=L.+Sunauthor=X.+Yangauthor=L.+Shiauthor=R.+Liauthor=Y.+Liauthor=Y.+Zhangauthor=Q.+Liauthor=X.+Yiauthor=Y.+Shang&title=LSD1+is+a+subunit+of+the+NuRD+complex+and+targets+the+metastasis+programs+in+breast+cancer&doi=10.1016%2Fj.cell.2009.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer</span></div><div class="casAuthors">Wang, Yan; Zhang, Hua; Chen, Yupeng; Sun, Yimin; Yang, Fen; Yu, Wenhua; Liang, Jing; Sun, Luyang; Yang, Xiaohan; Shi, Lei; Li, Ruifang; Li, Yanyan; Zhang, Yu; Li, Qian; Yi, Xia; Shang, Yongfeng</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) exerts pathway-specific activity in animal development and has been linked to several high-risk cancers.  Here, we report that LSD1 is an integral component of the Mi-2/nucleosome remodeling and deacetylase (NuRD) complex.  Transcriptional target anal. revealed that the LSD1/NuRD complexes regulate several cellular signaling pathways including TGFβ1 signaling pathway that are critically involved in cell proliferation, survival, and epithelial-to-mesenchymal transition.  We demonstrated that LSD1 inhibits the invasion of breast cancer cells in vitro and suppresses breast cancer metastatic potential in vivo.  We found that LSD1 is downregulated in breast carcinomas and that its level of expression is neg. correlated with that of TGFβ1.  Our data provide a mol. basis for the interplay of histone demethylation and deacetylation in chromatin remodeling.  By enlisting LSD1, the NuRD complex expands its chromatin remodeling capacity to include ATPase, histone deacetylase, and histone demethylase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngSfM5Ree9LVg90H21EOLACvtfcHk0ljWCN1hfj6xsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCjs73F&md5=5b62ee7d574671b5cda39a2d173b8491</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYi%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DY.%26atitle%3DLSD1%2520is%2520a%2520subunit%2520of%2520the%2520NuRD%2520complex%2520and%2520targets%2520the%2520metastasis%2520programs%2520in%2520breast%2520cancer%26jtitle%3DCell%26date%3D2009%26volume%3D138%26spage%3D660%26epage%3D672%26doi%3D10.1016%2Fj.cell.2009.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrichs, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koster, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versteeg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajtler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein-Hitpass, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhfittig-Kulle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schüle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirfel, J.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2071</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-1735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F0008-5472.CAN-08-1735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=19223552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFSruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2065-2071&author=J.+H.+Schulteauthor=S.+Limauthor=A.+Schrammauthor=N.+Friedrichsauthor=J.+Kosterauthor=R.+Versteegauthor=I.+Oraauthor=K.+Pajtlerauthor=L.+Klein-Hitpassauthor=S.+Kuhfittig-Kulleauthor=E.+Metzgerauthor=R.+Sch%C3%BCleauthor=A.+Eggertauthor=R.+Buettnerauthor=J.+Kirfel&title=Lysine-specific+demethylase+1+is+strongly+expressed+in+poorly+differentiated+neuroblastoma%3A+implications+for+therapy&doi=10.1158%2F0008-5472.CAN-08-1735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: Implications for therapy</span></div><div class="casAuthors">Schulte, Johannes H.; Lim, Soyoung; Schramm, Alexander; Friedrichs, Nicolaus; Koster, Jan; Versteeg, Rogier; Ora, Ingrid; Pajtler, Kristian; Klein-Hitpass, Ludger; Kuhfittig-Kulle, Steffi; Metzger, Eric; Schuele, Roland; Eggert, Angelika; Buettner, Reinhard; Kirfel, Jutta</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2065-2071</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant epigenetic changes in DNA methylation and histone acetylation are hallmarks of most cancers, whereas histone methylation was previously considered to be irreversible and less versatile.  Recently, several histone demethylases were identified catalyzing the removal of Me groups from histone H3 lysine residues and thereby influencing gene expression.  Neuroblastomas continue to remain a clin. challenge despite advances in multimodal therapy.  Here, we address the functional significance of the chromatin-modifying enzyme lysine-specific demethylase 1 (LSD1) in neuroblastoma.  LSD1 expression correlated with adverse outcome and was inversely correlated with differentiation in neuroblastic tumors.  Differentiation of neuroblastoma cells resulted in down-regulation of LSD1.  Small interfering RNA-mediated knockdown of LSD1 decreased cellular growth, induced expression of differentiation-assocd. genes, and increased target gene-specific H3K4 methylation.  Moreover, LSD1 inhibition using monoamine oxidase inhibitors resulted in an increase of global H3K4 methylation and growth inhibition of neuroblastoma cells in vitro.  Finally, targeting LSD1 reduced neuroblastoma xenograft growth in vivo.  Here, we provide the first evidence that a histone demethylase, LSD1, is involved in maintaining the undifferentiated, malignant phenotype of neuroblastoma cells.  We show that inhibition of LSD1 reprograms the transcriptome of neuroblastoma cells and inhibits neuroblastoma xenograft growth.  Our results suggest that targeting histone demethylases may provide a novel option for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjmZreB7Q67Vg90H21EOLACvtfcHk0lhHwmtIuHidMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFSruro%253D&md5=4118d7f651c8abf8c32e296cc0030656</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-1735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-1735%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DJ.%2BH.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DSchramm%26aufirst%3DA.%26aulast%3DFriedrichs%26aufirst%3DN.%26aulast%3DKoster%26aufirst%3DJ.%26aulast%3DVersteeg%26aufirst%3DR.%26aulast%3DOra%26aufirst%3DI.%26aulast%3DPajtler%26aufirst%3DK.%26aulast%3DKlein-Hitpass%26aufirst%3DL.%26aulast%3DKuhfittig-Kulle%26aufirst%3DS.%26aulast%3DMetzger%26aufirst%3DE.%26aulast%3DSch%25C3%25BCle%26aufirst%3DR.%26aulast%3DEggert%26aufirst%3DA.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DKirfel%26aufirst%3DJ.%26atitle%3DLysine-specific%2520demethylase%25201%2520is%2520strongly%2520expressed%2520in%2520poorly%2520differentiated%2520neuroblastoma%253A%2520implications%2520for%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D2065%26epage%3D2071%26doi%3D10.1158%2F0008-5472.CAN-08-1735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takezawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, S.</span></span> <span> </span><span class="NLM_article-title">Transrepressive function of TLX requires the histone demethylase LSD1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3995</span>– <span class="NLM_lpage">4003</span>, <span class="refDoi"> DOI: 10.1128/MCB.02030-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1128%2FMCB.02030-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18391013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFanu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3995-4003&author=A.+Yokoyamaauthor=S.+Takezawaauthor=R.+Schuleauthor=H.+Kitagawaauthor=S.+Kato&title=Transrepressive+function+of+TLX+requires+the+histone+demethylase+LSD1&doi=10.1128%2FMCB.02030-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Transrepressive function of TLX requires the histone demethylase LSD1</span></div><div class="casAuthors">Yokoyama, Atsushi; Takezawa, Shinichiro; Schule, Roland; Kitagawa, Hirochika; Kato, Shigeaki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3995-4003</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">TLX is an orphan nuclear receptor (also called NR2E1) that regulates the expression of target genes by functioning as a constitutive transrepressor.  The physiol. significance of TLX in the cytodifferentiation of neural cells in the brain is known.  However, the corepressors supporting the transrepressive function of TLX have yet to be identified.  In this report, Y79 retinoblastoma cells were subjected to biochem. techniques to purify proteins that interact with TLX, and we identified LSD1 (also called KDM1), which appears to form a complex with CoREST and histone deacetylase 1.  LSD1 interacted with TLX directly through its SWIRM and amine oxidase domains.  LSD1 potentiated the transrepressive function of TLX through its histone demethylase activity as detd. by a luciferase assay using a genomically integrated reporter gene.  LSD1 and TLX were recruited to a TLX-binding site in the PTEN gene promoter, accompanied by the demethylation of H3K4me2 and deacetylation of H3.  Knockdown of either TLX or LSD1 derepressed expression of the endogenous PTEN gene and inhibited cell proliferation of Y79 cells.  Thus, the present study suggests that LSD1 is a prime corepressor for TLX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_Td2RFe3A7Vg90H21EOLACvtfcHk0ljQM4eahtKvPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFanu74%253D&md5=a415eb96d627b7b5de33d2341ea578ed</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.02030-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.02030-07%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DA.%26aulast%3DTakezawa%26aufirst%3DS.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DKitagawa%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DS.%26atitle%3DTransrepressive%2520function%2520of%2520TLX%2520requires%2520the%2520histone%2520demethylase%2520LSD1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D3995%26epage%3D4003%26doi%3D10.1128%2FMCB.02030-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jandausch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forne, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirfel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span> <span> </span><span class="NLM_article-title">Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">2704</span>– <span class="NLM_lpage">2709</span>, <span class="refDoi"> DOI: 10.1002/ijc.27555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fijc.27555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=22447389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlSis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=2704-2709&author=D.+Willmannauthor=S.+Limauthor=S.+Wetzelauthor=E.+Metzgerauthor=A.+Jandauschauthor=W.+Wilkauthor=M.+Jungauthor=I.+Forneauthor=A.+Imhofauthor=A.+Janzerauthor=J.+Kirfelauthor=H.+Waldmannauthor=R.+Schuleauthor=R.+Buettner&title=Impairment+of+prostate+cancer+cell+growth+by+a+selective+and+reversible+lysine-specific+demethylase+1+inhibitor&doi=10.1002%2Fijc.27555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor</span></div><div class="casAuthors">Willmann, Dominica; Lim, Soyoung; Wetzel, Stefan; Metzger, Eric; Jandausch, Anett; Wilk, Wolfram; Jung, Manfred; Forne, Ignasi; Imhof, Axel; Janzer, Andreas; Kirfel, Jutta; Waldmann, Herbert; Schuele, Roland; Buettner, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2704-2709</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Post-translational modifications of histones by chromatin modifying enzymes regulate chromatin structure and gene expression.  As deregulation of histone modifications contributes to cancer progression, inhibition of chromatin modifying enzymes such as histone demethylases is an attractive therapeutic strategy to impair cancer growth.  Lysine-specific demethylase 1 (LSD1) removes mono- and di-Me marks from lysine 4 or 9 of histone H3.  LSD1 in assocn. with the androgen receptor (AR) controls androgen-dependent gene expression and prostate tumor cell proliferation, thus highlighting LSD1 as a drug target.  By combining protein structure similarity clustering and in vitro screening, we identified Namoline, a γ-pyrone, as a novel, selective and reversible LSD1 inhibitor.  Namoline blocks LSD1 demethylase activity in vitro and in vivo.  Inhibition of LSD1 by Namoline leads to silencing of AR-regulated gene expression and severely impairs androgen-dependent proliferation in vitro and in vivo.  Thus, Namoline is a novel promising starting compd. for the development of therapeutics to treat androgen-dependent prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKxYi0f1zoOrVg90H21EOLACvtfcHk0ljQM4eahtKvPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlSis78%253D&md5=3104057823357b199b635e1a22071b2a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fijc.27555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27555%26sid%3Dliteratum%253Aachs%26aulast%3DWillmann%26aufirst%3DD.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DMetzger%26aufirst%3DE.%26aulast%3DJandausch%26aufirst%3DA.%26aulast%3DWilk%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DForne%26aufirst%3DI.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DJanzer%26aufirst%3DA.%26aulast%3DKirfel%26aufirst%3DJ.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DBuettner%26aufirst%3DR.%26atitle%3DImpairment%2520of%2520prostate%2520cancer%2520cell%2520growth%2520by%2520a%2520selective%2520and%2520reversible%2520lysine-specific%2520demethylase%25201%2520inhibitor%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D131%26spage%3D2704%26epage%3D2709%26doi%3D10.1002%2Fijc.27555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helczynski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudas, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mongan, N. P.</span></span> <span> </span><span class="NLM_article-title">The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2013.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.molonc.2013.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=23384557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVGnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=555-566&author=V.+Kashyapauthor=S.+Ahmadauthor=E.+M.+Nilssonauthor=L.+Helczynskiauthor=S.+Kennaauthor=J.+L.+Perssonauthor=L.+J.+Gudasauthor=N.+P.+Mongan&title=The+lysine+specific+demethylase-1+%28LSD1%2FKDM1A%29+regulates+VEGF-A+expression+in+prostate+cancer&doi=10.1016%2Fj.molonc.2013.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer</span></div><div class="casAuthors">Kashyap, Vasundhra; Ahmad, Shafqat; Nilsson, Emeli M.; Helczynski, Leszek; Kenna, Sinead; Persson, Jenny Liao; Gudas, Lorraine J.; Mongan, Nigel P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">555-566</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-7891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recurrent prostate cancer remains a major clin. challenge.  The lysine specific demethylase-1 (LSD1/KDM1A), together with the JmjC domain-contg. JMJD2A and JMJD2C proteins, have emerged as crit. regulators of histone lysine methylation.  The LSD1-JMJD2 complex functions as a transcriptional co-regulator of hormone activated androgen and estrogen receptors at specific gene promoters.  LSD1 also regulates DNA methylation and p53 function.  LSD1 is overexpressed in numerous cancers including prostate cancer through an unknown mechanism.  We investigated expression of the LSD1 and JMJD2A in malignant human prostate specimens.  We correlated LSD1 and JMJD2A expression with known mediators of prostate cancer progression: VEGF-A and cyclin A1.  We show that elevated expression of LSD1, but not JMJD2A, correlates with prostate cancer recurrence and with increased VEGF-A expression.  We show that functional depletion of LSD1 expression using siRNA in prostate cancer cells decreases VEGF-A and blocks androgen induced VEGF-A, PSA and Tmprss2 expression.  We demonstrate that pharmacol. inhibition of LSD1 reduces proliferation of both androgen dependent (LnCaP) and independent cell lines (LnCaP: C42, PC3).  We show a direct mechanistic link between LSD1 over-expression and increased activity of pro-angiogenic pathways.  New therapies targeting LSD1 activity should be useful in the treatment of hormone dependent and independent prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy47FR2bqB4LVg90H21EOLACvtfcHk0ljQM4eahtKvPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVGnurw%253D&md5=a77d7c25e03a603046e30cdc1c092c98</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2013.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2013.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DKashyap%26aufirst%3DV.%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DE.%2BM.%26aulast%3DHelczynski%26aufirst%3DL.%26aulast%3DKenna%26aufirst%3DS.%26aulast%3DPersson%26aufirst%3DJ.%2BL.%26aulast%3DGudas%26aufirst%3DL.%2BJ.%26aulast%3DMongan%26aufirst%3DN.%2BP.%26atitle%3DThe%2520lysine%2520specific%2520demethylase-1%2520%2528LSD1%252FKDM1A%2529%2520regulates%2520VEGF-A%2520expression%2520in%2520prostate%2520cancer%26jtitle%3DMol.%2520Oncol.%26date%3D2013%26volume%3D7%26spage%3D555%26epage%3D566%26doi%3D10.1016%2Fj.molonc.2013.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ketscher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jilg, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span> <span> </span><span class="NLM_article-title">LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e120</span> <span class="refDoi"> DOI: 10.1038/oncsis.2014.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Foncsis.2014.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25285406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSrtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&author=A.+Ketscherauthor=C.+A.+Jilgauthor=D.+Willmannauthor=B.+Hummelauthor=A.+Imhofauthor=V.+Russelerauthor=S.+Holzauthor=E.+Metzgerauthor=J.+M.+Mullerauthor=R.+Schule&title=LSD1+controls+metastasis+of+androgen-independent+prostate+cancer+cells+through+PXN+and+LPAR6&doi=10.1038%2Foncsis.2014.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6</span></div><div class="casAuthors">Ketscher, A.; Jilg, C. A.; Willmann, D.; Hummel, B.; Imhof, A.; Ruesseler, V.; Hoelz, S.; Metzger, E.; Mueller, J. M.; Schuele, R.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e120</span>CODEN:
                <span class="NLM_cas:coden">ONCOCT</span>;
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) was shown to control gene expression and cell proliferation of androgen-dependent prostate cancer (PCa) cells, whereas the role of LSD1 in androgen-independent metastatic prostate cancer remains elusive.  Here, we show that depletion of LSD1 leads to increased migration and invasion of androgen-independent PCa cells.  Transcriptome and cistrome analyses reveal that LSD1 regulates expression of lysophosphatidic acid receptor 6 (LPAR6) and cytoskeletal genes including the focal adhesion adaptor protein paxillin (PXN).  Enhanced LPAR6 signalling upon LSD1 depletion promotes migration with concomitant phosphorylation of PXN.  In mice LPAR6 overexpression enhances, whereas knockdown of LPAR6 abolishes metastasis of androgen-independent PCa cells.  Taken together, we uncover a novel mechanism of how LSD1 controls metastasis and identify LPAR6 as a promising therapeutic target to treat metastatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0AuIBVSe1xrVg90H21EOLACvtfcHk0ljyz4gKv_8v3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSrtrnJ&md5=9dbae5b23a0744f6f2df84dc9d3af7d0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2014.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2014.34%26sid%3Dliteratum%253Aachs%26aulast%3DKetscher%26aufirst%3DA.%26aulast%3DJilg%26aufirst%3DC.%2BA.%26aulast%3DWillmann%26aufirst%3DD.%26aulast%3DHummel%26aufirst%3DB.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DRusseler%26aufirst%3DV.%26aulast%3DHolz%26aufirst%3DS.%26aulast%3DMetzger%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DJ.%2BM.%26aulast%3DSchule%26aufirst%3DR.%26atitle%3DLSD1%2520controls%2520metastasis%2520of%2520androgen-independent%2520prostate%2520cancer%2520cells%2520through%2520PXN%2520and%2520LPAR6%26jtitle%3DOncogenesis%26date%3D2014%26volume%3D3%26doi%3D10.1038%2Foncsis.2014.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Irreversible LSD1 Inhibitors: Application of tranylcypromine and its derivatives in cancer treatment</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2179</span>– <span class="NLM_lpage">2188</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160216154042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.2174%2F1568026616666160216154042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=26881714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVahtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2179-2188&author=Y.+C.+Zhengauthor=B.+Yuauthor=G.+Z.+Jiangauthor=X.+J.+Fengauthor=P.+X.+Heauthor=X.+Y.+Chuauthor=W.+Zhaoauthor=H.+M.+Liu&title=Irreversible+LSD1+Inhibitors%3A+Application+of+tranylcypromine+and+its+derivatives+in+cancer+treatment&doi=10.2174%2F1568026616666160216154042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment</span></div><div class="casAuthors">Zheng, Yi C.; Yu, Bin; Jiang, Guo Z.; Feng, Xue J.; He, Peng X.; Chu, Xiao Y.; Zhao, Wen; Liu, Hong M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2179-2188</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Due to the increasing costs and time consuming for new drug discovery, a large no. of pharmaceutical firms have chosen to modify the existing drug mols. for repositioning candidates with new or improved properties, esp. those with severe adverse effects, thereby accelerating the drug discovery process.  Such strategy has witnessed its success with several examples reported.  As the first identified histone lysine specific demethylase, lysine specific demethylase 1 (LSD1) is classified as a member of monoamine oxidase (MAO) superfamily, and specifically removes mono- and dimethylated histone 3 lysine 4 (H3K4) and H3 lysine 9 (H3K9).  It has been reported that LSD1 and its downstream targets are involved in cancer cell growth and metastasis.  Meanwhile, it is overexpressed in a variety of tumor cells.  Inactivating LSD1 specifically inhibits tumor progression and metastasis.  Hence, LSD1 inhibition may represent a new and promising direction in anti-cancer drug discovery.  Based on the structure and cofactor of LSD1, some clin. applied MAO inhibitors have been identified as LSD1 inactivators.  Among them, tranylcypromine presented the most potency against LSD1 and its derivs. were further developed by medicinal chemists in order to develop potent and selective LSD1 inhibitors.  Currently, a no. of tranylcypromine based LSD1 inhibitors have been developed and two of them, ORY-1001 and GSK2879552, are in clin. trials for cancer treatment.  This review highlights recent advances in the repurposing of tranylcypromine and its derivs. as irreversible LSD1 inhibitors for cancer treatment, which are conventionally used for the treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjwBd-ReWHu7Vg90H21EOLACvtfcHk0lisWbYCf5h3LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVahtb8%253D&md5=81b0fdfba4e6cea3636b70de73c246ce</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160216154042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160216154042%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DG.%2BZ.%26aulast%3DFeng%26aufirst%3DX.%2BJ.%26aulast%3DHe%26aufirst%3DP.%2BX.%26aulast%3DChu%26aufirst%3DX.%2BY.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DIrreversible%2520LSD1%2520Inhibitors%253A%2520Application%2520of%2520tranylcypromine%2520and%2520its%2520derivatives%2520in%2520cancer%2520treatment%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2179%26epage%3D2188%26doi%3D10.2174%2F1568026616666160216154042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Recent progress in histone demethylase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01758</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyrtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1308-1329&author=T.+E.+McAllisterauthor=K.+S.+Englandauthor=R.+J.+Hopkinsonauthor=P.+E.+Brennanauthor=A.+Kawamuraauthor=C.+J.+Schofield&title=Recent+progress+in+histone+demethylase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in Histone Demethylase Inhibitors</span></div><div class="casAuthors">McAllister, Tom E.; England, Katherine S.; Hopkinson, Richard J.; Brennan, Paul E.; Kawamura, Akane; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1308-1329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is increasing interest in targeting histone N-methyl-lysine demethylases (KDMs) with small mols. both for the generation of probes for target exploration and for therapeutic purposes.  Here we update on previous reviews on the inhibition of the lysine-specific demethylases (LSDs or KDM1s) and JmjC families of N-methyl-lysine demethylases (JmjC KDMs, KDM2-7), focusing on the academic and patent literature from 2014 to date.  We also highlight recent biochem., biol., and structural studies which are relevant to KDM inhibitor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWx0bnBT9cDrVg90H21EOLACvtfcHk0lisWbYCf5h3LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyrtbfE&md5=f744b65af58dff765cdab8f9fea85310</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01758%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DT.%2BE.%26aulast%3DEngland%26aufirst%3DK.%2BS.%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DRecent%2520progress%2520in%2520histone%2520demethylase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1308%26epage%3D1329%26doi%3D10.1021%2Facs.jmedchem.5b01758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-M.</span></span> <span> </span><span class="NLM_article-title">Pharmacoepigenetics of LSD1 inhibitors in cancer</span>. <i>Pharmacoepigenetics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-813939-4.00014-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2FB978-0-12-813939-4.00014-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=523-530&author=B.+Yuauthor=H.-M.+Liu&title=Pharmacoepigenetics+of+LSD1+inhibitors+in+cancer&doi=10.1016%2FB978-0-12-813939-4.00014-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-813939-4.00014-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-813939-4.00014-0%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.-M.%26atitle%3DPharmacoepigenetics%2520of%2520LSD1%2520inhibitors%2520in%2520cancer%26jtitle%3DPharmacoepigenetics%26date%3D2019%26volume%3D10%26spage%3D523%26epage%3D530%26doi%3D10.1016%2FB978-0-12-813939-4.00014-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">Advances toward LSD1 inhibitors for cancer therapy</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1227</span>– <span class="NLM_lpage">1242</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.4155%2Ffmc-2017-0068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28722477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2qsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1227-1242&author=X.+Fuauthor=P.+Zhangauthor=B.+Yu&title=Advances+toward+LSD1+inhibitors+for+cancer+therapy&doi=10.4155%2Ffmc-2017-0068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Advances toward LSD1 inhibitors for cancer therapy</span></div><div class="casAuthors">Fu, Xiaoli; Zhang, Peng; Yu, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1227-1242</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  LSD1 has become an important biol. validated epigenetic target for cancer therapy since its identification in 2004.  LSD1 mediates many cellular signaling pathways and is involved in the initiation and development of cancers.  Aberrant overexpression of LSD1 has been obsd. in different types of cancers, and inactivation by small mols. suppresses cancer cell differentiation, proliferation, invasion and migration.  To date, a large no. of LSD1 inhibitors have been reported, RG6016, GSK-2879552, INCB059872, IMG-7289 and CC-90011 are currently undergoing clin. assessment for the treatment of acute myeloid leukemia, small-cell lung cancer, etc.  In this review, we briefly highlight recent advances of LSD1 inhibitors mainly covering the literatures from 2015 to 2017 and tentatively propose our perspectives on the design of new LSD1 inhibitors for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlJAzt51S4crVg90H21EOLACvtfcHk0lhPXshdpN_yiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2qsLbK&md5=182f10eb7a2aea7b5c13f50f84f44c20</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0068%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DB.%26atitle%3DAdvances%2520toward%2520LSD1%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1227%26epage%3D1242%26doi%3D10.4155%2Ffmc-2017-0068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">LSD1/KDM1A inhibitors in clinical trials: advances and prospects</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">129</span>, <span class="refDoi"> DOI: 10.1186/s13045-019-0811-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1186%2Fs13045-019-0811-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31801559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BB3MfmsFylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=129&author=Y.+Fangauthor=G.+Liaoauthor=B.+Yu&title=LSD1%2FKDM1A+inhibitors+in+clinical+trials%3A+advances+and+prospects&doi=10.1186%2Fs13045-019-0811-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1/KDM1A inhibitors in clinical trials: advances and prospects</span></div><div class="casAuthors">Fang Yuan; Liao Guochao; Yu Bin; Yu Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hematology & oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Histone demethylase LSD1 plays key roles during carcinogenesis, targeting LSD1 is becoming an emerging option for the treatment of cancers.  Numerous LSD1 inhibitors have been reported to date, some of them such as TCP, ORY-1001, GSK-2879552, IMG-7289, INCB059872, CC-90011, and ORY-2001 currently undergo clinical assessment for cancer therapy, particularly for small lung cancer cells (SCLC) and acute myeloid leukemia (AML).  This review is to provide a comprehensive overview of LSD1 inhibitors in clinical trials including molecular mechanistic studies, clinical efficacy, adverse drug reactions, and PD/PK studies and offer prospects in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbk3-5OqEjmWlSCSgBhwJFfW6udTcc2eYqShm5nEnqyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MfmsFylsg%253D%253D&md5=112299f15281667341a55dea57f6c83b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1186%2Fs13045-019-0811-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13045-019-0811-9%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DB.%26atitle%3DLSD1%252FKDM1A%2520inhibitors%2520in%2520clinical%2520trials%253A%2520advances%2520and%2520prospects%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2019%26volume%3D12%26spage%3D129%26doi%3D10.1186%2Fs13045-019-0811-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC-803</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">4957</span>– <span class="NLM_lpage">4966</span>, <span class="refDoi"> DOI: 10.1002/jcb.26741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fjcb.26741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29384217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFWru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2018&pages=4957-4966&author=J.+L.+Maauthor=T.+Zhangauthor=F.+Z.+Suoauthor=J.+Changauthor=X.+B.+Wanauthor=X.+J.+Fengauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Lysine-specific+demethylase+1+activation+by+vitamin+B2+attenuates+efficacy+of+apatinib+for+proliferation+and+migration+of+gastric+cancer+cell+MGC-803&doi=10.1002%2Fjcb.26741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC-803</span></div><div class="casAuthors">Ma, Jin-Lian; Zhang, Ting; Suo, Feng-Zhi; Chang, Jiao; Wan, Xiang-Bin; Feng, Xue-Jian; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4957-4966</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">B vitamins play an essential role in the biosynthesis of nucleotides, replication of DNA, supply of methyl-groups, growth and repair of cells, aberrancies of which have all been implicated in carcinogenesis.  Although the potential role of vitamin B in relation to the risk of cancer, including breast, and colorectal cancer, has been investigated in several observational studies, the mechanism of action is still unclear.  In this study, vitamin B2 exhibited efficient activation of LSD1 by occupying the active sites where FAD stands.  Interestingly, vitamin B2 significantly downregulated expression of CD86, a sensitive surrogate biomarker of LSD1 inhibition, and showed marked activation of gastric cancer cell migration and invasion.  Meanwhile, vitamin B2 induced activation of LSD1 may attenuate the proliferation inhibition, and anti-migration effects of apatinib in gastric cancer cells.  These findings suggested that vitamin B supplementation may interfere with the efficacy of apatinib in patients with gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtbNe934XbYrVg90H21EOLACvtfcHk0lhPXshdpN_yiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFWru7g%253D&md5=880045a3371a40e61de59ee0416e438f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fjcb.26741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.26741%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DX.%2BB.%26aulast%3DFeng%26aufirst%3DX.%2BJ.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DLysine-specific%2520demethylase%25201%2520activation%2520by%2520vitamin%2520B2%2520attenuates%2520efficacy%2520of%2520apatinib%2520for%2520proliferation%2520and%2520migration%2520of%2520gastric%2520cancer%2520cell%2520MGC-803%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2018%26volume%3D119%26spage%3D4957%26epage%3D4966%26doi%3D10.1002%2Fjcb.26741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaniskan, H. Ü.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of protein methyltransferases and demethylases</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">989</span>– <span class="NLM_lpage">1068</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00801</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00801" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslynsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2018&pages=989-1068&author=H.+%C3%9C.+Kaniskanauthor=M.+L.+Martiniauthor=J.+Jin&title=Inhibitors+of+protein+methyltransferases+and+demethylases&doi=10.1021%2Facs.chemrev.6b00801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Protein Methyltransferases and Demethylases</span></div><div class="casAuthors">Kaniskan, H. Umit; Martini, Michael L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">989-1068</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Post-translational modifications of histones by protein methyltransferases (PMTs) and histone demethylases (KDMs) play an important role in the regulation of gene expression and transcription and are implicated in cancer and many other diseases.  Many of these enzymes also target various nonhistone proteins impacting numerous crucial biol. pathways.  Given their key biol. functions and implications in human diseases, there has been a growing interest in assessing these enzymes as potential therapeutic targets.  Consequently, discovering and developing inhibitors of these enzymes has become a very active and fast-growing research area over the past decade.  In this review, the authors cover the discovery, characterization, and biol. application of inhibitors of PMTs and KDMs with emphasis on key advancements in the field.  The authors also discuss challenges, opportunities, and future directions in this emerging, exciting research field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJYjiYtw_n4rVg90H21EOLACvtfcHk0liCx9bn5ExU4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslynsL8%253D&md5=1ed520c6b0c42d2aa8a7f66b0a2d4e40</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00801%26sid%3Dliteratum%253Aachs%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259C.%26aulast%3DMartini%26aufirst%3DM.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520protein%2520methyltransferases%2520and%2520demethylases%26jtitle%3DChem.%2520Rev.%26date%3D2018%26volume%3D118%26spage%3D989%26epage%3D1068%26doi%3D10.1021%2Facs.chemrev.6b00801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span> <span> </span><span class="NLM_article-title">Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases</span>. <i>Epigenetics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1080/15592294.2017.1290032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1080%2F15592294.2017.1290032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28277979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC1czks1GitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=340-352&author=H.+Niwaauthor=T.+Umehara&title=Structural+insight+into+inhibitors+of+flavin+adenine+dinucleotide-dependent+lysine+demethylases&doi=10.1080%2F15592294.2017.1290032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases</span></div><div class="casAuthors">Niwa Hideaki; Umehara Takashi; Umehara Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Epigenetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">340-352</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Until 2004, many researchers believed that protein methylation in eukaryotic cells was an irreversible reaction.  However, the discovery of lysine-specific demethylase 1 in 2004 drastically changed this view and the concept of chromatin regulation.  Since then, the enzymes responsible for lysine demethylation and their cellular substrates, biological significance, and selective regulation have become major research topics in epigenetics and chromatin biology.  Many cell-permeable inhibitors for lysine demethylases have been developed, including both target-specific and nonspecific inhibitors.  Structural understanding of how these inhibitors bind to lysine demethylases is crucial both for validation of the inhibitors as chemical probes and for the rational design of more potent, target-specific inhibitors.  This review focuses on published small-molecule inhibitors targeted at the two flavin adenine dinucleotide-dependent lysine demethylases, lysine-specific demethylases 1 and 2, and how the inhibitors interact with the tertiary structures of the enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyKG85Hfra9xjv2lLSLOxFfW6udTcc2eYFnCP8dYWH0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czks1GitA%253D%253D&md5=31f93c2cc7909c4197f5892f7f04af9d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1080%2F15592294.2017.1290032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15592294.2017.1290032%26sid%3Dliteratum%253Aachs%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DUmehara%26aufirst%3DT.%26atitle%3DStructural%2520insight%2520into%2520inhibitors%2520of%2520flavin%2520adenine%2520dinucleotide-dependent%2520lysine%2520demethylases%26jtitle%3DEpigenetics%26date%3D2017%26volume%3D12%26spage%3D340%26epage%3D352%26doi%3D10.1080%2F15592294.2017.1290032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">An overview on screening methods for lysine specific demethylase 1 (LSD1) Inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2496</span>– <span class="NLM_lpage">2504</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170509114321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.2174%2F0929867324666170509114321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28486922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFantbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=2496-2504&author=Y.+C.+Zhengauthor=J.+Changauthor=T.+Zhangauthor=F.+Z.+Suoauthor=X.+B.+Chenauthor=Y.+Liuauthor=B.+Zhaoauthor=B.+Yuauthor=H.+M.+Liu&title=An+overview+on+screening+methods+for+lysine+specific+demethylase+1+%28LSD1%29+Inhibitors&doi=10.2174%2F0929867324666170509114321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors</span></div><div class="casAuthors">Zheng, Yi-Chao; Chang, Jiao; Zhang, Ting; Suo, Feng-Zhi; Chen, Xiao-Bing; Liu, Ying; Zhao, Bing; Yu, Bin; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2496-2504</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: In the past few years, great of attention has been paid to the identification and characterization of selective and potent inhibitors of the first identified histone demethylase LSD1, which may erase mono- and di-methylated histone 3 lysine 4 and 9.  As the aberrant overexpression of LSD1 is involved in various pathol. processes, esp. cancer, obtaining selective and potent LSD1 inhibitors has emerged as a crucial issue in medicinal chem. research.  Method: Until now, several LSD1 inhibitor screening models have been established, including enzyme coupled assay, LC-MS based assay, and FRET based assay.  Nevertheless, due to some special instrument requirement and addnl. costs of LC-MS and FRET, the enzyme coupled assay is the most widely applied method for LSD1 inhibitor screening.  Result: We summarized and compared several reported in vitro LSD1 inhibitor screening models.  Each of them has distinct advantages and disadvantages, and none of these methods is perfect.  In order to exclude the false pos. results, at least one addnl. method should be applied to screen LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJeShKTm7x6rVg90H21EOLACvtfcHk0liCx9bn5ExU4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFantbfM&md5=f95a9271848abfd32fa42d9f09205dad</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170509114321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170509114321%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DChen%26aufirst%3DX.%2BB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DAn%2520overview%2520on%2520screening%2520methods%2520for%2520lysine%2520specific%2520demethylase%25201%2520%2528LSD1%2529%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26spage%3D2496%26epage%3D2504%26doi%3D10.2174%2F0929867324666170509114321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Writers and erasers of histone lysine methylation with clinically applied modulators: promising target for cancer therapy</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5943</span>– <span class="NLM_lpage">5947</span>, <span class="refDoi"> DOI: 10.2174/1381612822666160715125417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.2174%2F1381612822666160715125417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27426130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1emsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=5943-5947&author=Y.+C.+Zhengauthor=J.+L.+Maauthor=Y.+Liuauthor=H.+M.+Liu&title=Writers+and+erasers+of+histone+lysine+methylation+with+clinically+applied+modulators%3A+promising+target+for+cancer+therapy&doi=10.2174%2F1381612822666160715125417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy</span></div><div class="casAuthors">Zheng, Yi-Chao; Ma, Jin-Lian; Liu, Ying; Liu, Hong M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5943-5947</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Histone lysine methylation can be modified by various writers and erasers.  Different from other epigenetic modifications, mono-, di, and tri- methylation distinctly modulate chromatin structure and thereby contribute to the regulation of DNA-based nuclear processes such as transcription, replication and repair on their target genes depending on different sites.  Modulators with opposing catalytic activities dynamically and precisely control levels of histone lysine methylation, and individual enzymes within these families have become candidate oncol. targets in recent years.  Until now, plenty of medicinal chemists try to pursue potent and selective inhibitor for KMTs and KDMs in order to have the potential anti-cancer agent, and several of the inhibitors have already enrolled in clinic.  Here, we discuss three histone lysine methylation modulators with their inhibitors in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlmyIdpVVQYrVg90H21EOLACvtfcHk0lh3rr4l74ISKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1emsQ%253D%253D&md5=0c5ad31f6629b4699bfea1a515d0bdf9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F1381612822666160715125417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612822666160715125417%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DWriters%2520and%2520erasers%2520of%2520histone%2520lysine%2520methylation%2520with%2520clinically%2520applied%2520modulators%253A%2520promising%2520target%2520for%2520cancer%2520therapy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2016%26volume%3D22%26spage%3D5943%26epage%3D5947%26doi%3D10.2174%2F1381612822666160715125417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirapu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estiarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guibourt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdones, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lufino, M. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somervaille, T. C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willekens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valls, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fyfe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Palomino, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span> <span> </span><span class="NLM_article-title">ORY-1001, a potent and selective covalent KDM1A Inhibitor, for the treatment of acute leukemia</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ccell.2018.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29502954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsl2ktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=495-511&author=T.+Maesauthor=C.+Mascaroauthor=I.+Tirapuauthor=A.+Estiarteauthor=F.+Ciceriauthor=S.+Lunardiauthor=N.+Guibourtauthor=A.+Perdonesauthor=M.+M.+P.+Lufinoauthor=T.+C.+P.+Somervailleauthor=D.+H.+Wisemanauthor=C.+Duyauthor=A.+Melnickauthor=C.+Willekensauthor=A.+Ortegaauthor=M.+Martinellauthor=N.+Vallsauthor=G.+Kurzauthor=M.+Fyfeauthor=J.+C.+Castro-Palominoauthor=C.+Buesa&title=ORY-1001%2C+a+potent+and+selective+covalent+KDM1A+Inhibitor%2C+for+the+treatment+of+acute+leukemia&doi=10.1016%2Fj.ccell.2018.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia</span></div><div class="casAuthors">Maes, Tamara; Mascaro, Cristina; Tirapu, Inigo; Estiarte, Angels; Ciceri, Filippo; Lunardi, Serena; Guibourt, Nathalie; Perdones, Alvaro; Lufino, Michele M. P.; Somervaille, Tim C. P.; Wiseman, Dan H.; Duy, Cihangir; Melnick, Ari; Willekens, Christophe; Ortega, Alberto; Martinell, Marc; Valls, Nuria; Kurz, Guido; Fyfe, Matthew; Castro-Palomino, Julio Cesar; Buesa, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-511.e12</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The lysine-specific demethylase KDM1A is a key regulator of stem cell potential in acute myeloid leukemia (AML).  ORY-1001 is a highly potent and selective KDM1A inhibitor that induces H3K4me2 accumulation on KDM1A target genes, blast differentiation, and redn. of leukemic stem cell capacity in AML.  ORY-1001 exhibits potent synergy with std.-of-care drugs and selective epigenetic inhibitors, reduces growth of an AML xenograft model, and extends survival in a mouse PDX (patient-derived xenograft) model of T cell acute leukemia.  Surrogate pharmacodynamic biomarkers developed based on expression changes in leukemia cell lines were translated to samples from patients treated with ORY-1001.  ORY-1001 is a selective KDM1A inhibitor in clin. trials and is currently being evaluated in patients with leukemia and solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb2QFk3s8-eLVg90H21EOLACvtfcHk0lh3rr4l74ISKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsl2ktL8%253D&md5=68f69ade1b0110f3e0adf0173326e9b7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DT.%26aulast%3DMascaro%26aufirst%3DC.%26aulast%3DTirapu%26aufirst%3DI.%26aulast%3DEstiarte%26aufirst%3DA.%26aulast%3DCiceri%26aufirst%3DF.%26aulast%3DLunardi%26aufirst%3DS.%26aulast%3DGuibourt%26aufirst%3DN.%26aulast%3DPerdones%26aufirst%3DA.%26aulast%3DLufino%26aufirst%3DM.%2BM.%2BP.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26aulast%3DWiseman%26aufirst%3DD.%2BH.%26aulast%3DDuy%26aufirst%3DC.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DWillekens%26aufirst%3DC.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DMartinell%26aufirst%3DM.%26aulast%3DValls%26aufirst%3DN.%26aulast%3DKurz%26aufirst%3DG.%26aulast%3DFyfe%26aufirst%3DM.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DBuesa%26aufirst%3DC.%26atitle%3DORY-1001%252C%2520a%2520potent%2520and%2520selective%2520covalent%2520KDM1A%2520Inhibitor%252C%2520for%2520the%2520treatment%2520of%2520acute%2520leukemia%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26spage%3D495%26epage%3D511%26doi%3D10.1016%2Fj.ccell.2018.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitheman, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federowicz, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Aller, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butticello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnette, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degenhardt, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappalardi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouthamel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span> <span> </span><span class="NLM_article-title">A DNA Hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ccell.2015.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=26175415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Grt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=57-69&author=H.+P.+Mohammadauthor=K.+N.+Smithemanauthor=C.+D.+Kamatauthor=D.+Soongauthor=K.+E.+Federowiczauthor=G.+S.+Van+Allerauthor=J.+L.+Schneckauthor=J.+D.+Carsonauthor=Y.+Liuauthor=M.+Butticelloauthor=W.+G.+Bonnetteauthor=S.+A.+Gormanauthor=Y.+Degenhardtauthor=Y.+Baiauthor=M.+T.+McCabeauthor=M.+B.+Pappalardiauthor=J.+Kasparecauthor=X.+Tianauthor=K.+C.+McNultyauthor=M.+Rouseauthor=P.+McDevittauthor=T.+Hoauthor=M.+Crouthamelauthor=T.+K.+Hartauthor=N.+O.+Conchaauthor=C.+F.+McHughauthor=W.+H.+Millerauthor=D.+Dhanakauthor=P.+J.+Tumminoauthor=C.+L.+Carpenterauthor=N.+W.+Johnsonauthor=C.+L.+Hannauthor=R.+G.+Kruger&title=A+DNA+Hypomethylation+signature+predicts+antitumor+activity+of+LSD1+inhibitors+in+SCLC&doi=10.1016%2Fj.ccell.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC</span></div><div class="casAuthors">Mohammad, Helai P.; Smitheman, Kimberly N.; Kamat, Chandrashekhar D.; Soong, David; Federowicz, Kelly E.; Van Aller, Glenn S.; Schneck, Jess L.; Carson, Jeffrey D.; Liu, Yan; Butticello, Michael; Bonnette, William G.; Gorman, Shelby A.; Degenhardt, Yan; Bai, Yuchen; McCabe, Michael T.; Pappalardi, Melissa B.; Kasparec, Jiri; Tian, Xinrong; McNulty, Kenneth C.; Rouse, Meagan; McDevitt, Patrick; Ho, Thau; Crouthamel, Michelle; Hart, Timothy K.; Concha, Nestor O.; McHugh, Charles F.; Miller, William H.; Dhanak, Dashyant; Tummino, Peter J.; Carpenter, Christopher L.; Johnson, Neil W.; Hann, Christine L.; Kruger, Ryan G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Epigenetic dysregulation has emerged as an important mechanism in cancer.  Alterations in epigenetic machinery have become a major focus for targeted therapies.  The current report describes the discovery and biol. activity of a cyclopropylamine contg. inhibitor of Lysine Demethylase 1 (LSD1), GSK2879552.  This small mol. is a potent, selective, orally bioavailable, mechanism-based irreversible inactivator of LSD1.  A proliferation screen of cell lines representing a no. of tumor types indicated that small cell lung carcinoma (SCLC) is sensitive to LSD1 inhibition.  The subset of SCLC lines and primary samples that undergo growth inhibition in response to GSK2879552 exhibit DNA hypomethylation of a signature set of probes, suggesting this may be used as a predictive biomarker of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppluiM41UspbVg90H21EOLACvtfcHk0lh3fPx9Idm98w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Grt7fJ&md5=863924e99fa3576dc1c67824b45462f8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DH.%2BP.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DKamat%26aufirst%3DC.%2BD.%26aulast%3DSoong%26aufirst%3DD.%26aulast%3DFederowicz%26aufirst%3DK.%2BE.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DSchneck%26aufirst%3DJ.%2BL.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DButticello%26aufirst%3DM.%26aulast%3DBonnette%26aufirst%3DW.%2BG.%26aulast%3DGorman%26aufirst%3DS.%2BA.%26aulast%3DDegenhardt%26aufirst%3DY.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DPappalardi%26aufirst%3DM.%2BB.%26aulast%3DKasparec%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DMcNulty%26aufirst%3DK.%2BC.%26aulast%3DRouse%26aufirst%3DM.%26aulast%3DMcDevitt%26aufirst%3DP.%26aulast%3DHo%26aufirst%3DT.%26aulast%3DCrouthamel%26aufirst%3DM.%26aulast%3DHart%26aufirst%3DT.%2BK.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCarpenter%26aufirst%3DC.%2BL.%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26aulast%3DHann%26aufirst%3DC.%2BL.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26atitle%3DA%2520DNA%2520Hypomethylation%2520signature%2520predicts%2520antitumor%2520activity%2520of%2520LSD1%2520inhibitors%2520in%2520SCLC%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D28%26spage%3D57%26epage%3D69%26doi%3D10.1016%2Fj.ccell.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitheman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R.</span></span> <span> </span><span class="NLM_article-title">212 Novel anti-tumor activity of targeted LSD1 inhibition by GSK2879552</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">72</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(14)70338-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2FS0959-8049%2814%2970338-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=72&author=H.+Mohammadauthor=K.+Smithemanauthor=G.+van+Allerauthor=M.+Cusanauthor=S.+Kamatauthor=Y.+Liuauthor=N.+Johnsonauthor=C.+Hannauthor=S.+Armstrongauthor=R.+Kruger&title=212+Novel+anti-tumor+activity+of+targeted+LSD1+inhibition+by+GSK2879552&doi=10.1016%2FS0959-8049%2814%2970338-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2814%2970338-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252814%252970338-7%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DH.%26aulast%3DSmitheman%26aufirst%3DK.%26aulast%3Dvan%2BAller%26aufirst%3DG.%26aulast%3DCusan%26aufirst%3DM.%26aulast%3DKamat%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DN.%26aulast%3DHann%26aufirst%3DC.%26aulast%3DArmstrong%26aufirst%3DS.%26aulast%3DKruger%26aufirst%3DR.%26atitle%3D212%2520Novel%2520anti-tumor%2520activity%2520of%2520targeted%2520LSD1%2520inhibition%2520by%2520GSK2879552%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2014%26volume%3D50%26spage%3D72%26doi%3D10.1016%2FS0959-8049%2814%2970338-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostalik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B.</span></span> <span> </span><span class="NLM_article-title">Abstract 4704: The evaluation of INCB059872, an FAD-directed inhibitor of LSD1, in preclinical models of human small cell lung cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4704</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-4704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F1538-7445.AM2016-4704" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4704&author=S.+H.+Leeauthor=X.+M.+Liuauthor=M.+Diamondauthor=V.+Dostalikauthor=M.+Favataauthor=C.+Heauthor=L.+Wuauthor=R.+Wynnauthor=W.+Yaoauthor=G.+Hollisauthor=R.+Huberauthor=P.+Scherleauthor=B.+Ruggeri&title=Abstract+4704%3A+The+evaluation+of+INCB059872%2C+an+FAD-directed+inhibitor+of+LSD1%2C+in+preclinical+models+of+human+small+cell+lung+cancer&doi=10.1158%2F1538-7445.AM2016-4704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-4704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-4704%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DX.%2BM.%26aulast%3DDiamond%26aufirst%3DM.%26aulast%3DDostalik%26aufirst%3DV.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26aulast%3DRuggeri%26aufirst%3DB.%26atitle%3DAbstract%25204704%253A%2520The%2520evaluation%2520of%2520INCB059872%252C%2520an%2520FAD-directed%2520inhibitor%2520of%2520LSD1%252C%2520in%2520preclinical%2520models%2520of%2520human%2520small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4704%26doi%3D10.1158%2F1538-7445.AM2016-4704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostalik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margulis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P.</span></span> <span> </span><span class="NLM_article-title">Abstract 4712: Discovery of INCB059872, a novel FAD-directed LSD1 inhibitor that is effective in preclinical models of human and murine AML</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4712</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-4712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F1538-7445.AM2016-4712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4712&author=S.+H.+Leeauthor=M.+Stubbsauthor=X.+M.+Liuauthor=M.+Diamondauthor=V.+Dostalikauthor=M.+Yeauthor=Y.+Loauthor=M.+Favataauthor=G.+Yangauthor=K.+Gallagherauthor=L.+Leffetauthor=C.+Heauthor=L.+Wuauthor=A.+Margulisauthor=M.+Covingtonauthor=R.+Wynnauthor=W.+Yaoauthor=G.+Hollisauthor=R.+Huberauthor=B.+Ruggeriauthor=P.+Scherle&title=Abstract+4712%3A+Discovery+of+INCB059872%2C+a+novel+FAD-directed+LSD1+inhibitor+that+is+effective+in+preclinical+models+of+human+and+murine+AML&doi=10.1158%2F1538-7445.AM2016-4712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-4712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-4712%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%2BM.%26aulast%3DDiamond%26aufirst%3DM.%26aulast%3DDostalik%26aufirst%3DV.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DGallagher%26aufirst%3DK.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DMargulis%26aufirst%3DA.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DScherle%26aufirst%3DP.%26atitle%3DAbstract%25204712%253A%2520Discovery%2520of%2520INCB059872%252C%2520a%2520novel%2520FAD-directed%2520LSD1%2520inhibitor%2520that%2520is%2520effective%2520in%2520preclinical%2520models%2520of%2520human%2520and%2520murine%2520AML%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4712%26doi%3D10.1158%2F1538-7445.AM2016-4712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romussi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brambillasca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cera, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Zuffo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifirò, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vultaggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecatiello, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasqualato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, C. W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of reversible inhibitors of KDM1A efficacious in acute myeloid leukemia models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">754</span>– <span class="NLM_lpage">759</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00604</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivFyisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=754-759&author=A.+Romussiauthor=A.+Cappaauthor=P.+Vianelloauthor=S.+Brambillascaauthor=M.+R.+Ceraauthor=R.+Dal+Zuffoauthor=G.+Fag%C3%A0author=R.+Fattoriauthor=L.+Morettiauthor=P.+Trifir%C3%B2author=M.+Villaauthor=S.+Vultaggioauthor=V.+Cecatielloauthor=S.+Pasqualatoauthor=G.+Dondioauthor=C.+W.+E.+Soauthor=S.+Minucciauthor=L.+Sartoriauthor=M.+Varasiauthor=C.+Mercurio&title=Discovery+of+reversible+inhibitors+of+KDM1A+efficacious+in+acute+myeloid+leukemia+models&doi=10.1021%2Facsmedchemlett.9b00604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models</span></div><div class="casAuthors">Romussi, Alessia; Cappa, Anna; Vianello, Paola; Brambillasca, Silvia; Cera, Maria Rosaria; Dal Zuffo, Roberto; Faga, Giovanni; Fattori, Raimondo; Moretti, Loris; Trifiro, Paolo; Villa, Manuela; Vultaggio, Stefania; Cecatiello, Valentina; Pasqualato, Sebastiano; Dondio, Giulio; So, Chi Wai Eric; Minucci, Saverio; Sartori, Luca; Varasi, Mario; Mercurio, Ciro</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">754-759</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1 or KDM1A) is a FAD-dependent enzyme that acts as a transcription corepressor or coactivator by regulating the methylation status of histone H3 lysines K4 and K9, resp.  KDM1A represents an attractive target for cancer therapy.  While, in the past, the main medicinal chem. strategy toward KDM1A inhibition was based on the optimization of ligands that irreversibly bind the FAD cofactor within the enzyme catalytic site, we and others have also identified reversible inhibitors.  Herein we reported the discovery of 5-imidazolylthieno[3,2-b]pyrroles, a new series of KDM1A inhibitors endowed with picomolar inhibitory potency, active in cells and efficacious after oral administration in murine leukemia models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiYpo0iHtNZLVg90H21EOLACvtfcHk0ljfpSUHm3B0kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivFyisL0%253D&md5=638d1b2f8653b1fa53f8d6278e297553</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00604%26sid%3Dliteratum%253Aachs%26aulast%3DRomussi%26aufirst%3DA.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DBrambillasca%26aufirst%3DS.%26aulast%3DCera%26aufirst%3DM.%2BR.%26aulast%3DDal%2BZuffo%26aufirst%3DR.%26aulast%3DFag%25C3%25A0%26aufirst%3DG.%26aulast%3DFattori%26aufirst%3DR.%26aulast%3DMoretti%26aufirst%3DL.%26aulast%3DTrifir%25C3%25B2%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DVultaggio%26aufirst%3DS.%26aulast%3DCecatiello%26aufirst%3DV.%26aulast%3DPasqualato%26aufirst%3DS.%26aulast%3DDondio%26aufirst%3DG.%26aulast%3DSo%26aufirst%3DC.%2BW.%2BE.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DSartori%26aufirst%3DL.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520reversible%2520inhibitors%2520of%2520KDM1A%2520efficacious%2520in%2520acute%2520myeloid%2520leukemia%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D754%26epage%3D759%26doi%3D10.1021%2Facsmedchemlett.9b00604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy</span>. <i>Epigenomics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.2217/epi-2015-0002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.2217%2Fepi-2015-0002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27102879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XotVSrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=651-666&author=Y.+C.+Zhengauthor=B.+Yuauthor=Z.+S.+Chenauthor=Y.+Liuauthor=H.+M.+Liu&title=TCPs%3A+privileged+scaffolds+for+identifying+potent+LSD1+inhibitors+for+cancer+therapy&doi=10.2217%2Fepi-2015-0002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy</span></div><div class="casAuthors">Zheng, Yi-Chao; Yu, Bin; Chen, Zhe-Sheng; Liu, Ying; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Epigenomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">651-666</span>CODEN:
                <span class="NLM_cas:coden">EPIGC7</span>;
        ISSN:<span class="NLM_cas:issn">1750-192X</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the first lysine-specific demethylase (KDM), lysine-specific demethylase 1 (LSD1), was characterized in 2004, several families of KDMs have been identified.  LSD1 can specifically demethylate H3K4me1/2, H3K9me1/2 as well as some nonhistone substrates.  It has been demonstrated to be an oncogene as well as a drug target.  Hence, tens of small-mol. LSD1 inhibitors have been designed, synthesized and applied for cancer treatment.  However, the two LSD1 inhibitors that have been advanced into early phase clin. trials are trans-2-phenylcyclopropylamine (TCP) derivs., which indicate that TCP is a druggable scaffold for LSD1 inhibitor.  Here, we review the design, synthesis and properties of reported TCP-based LSD1 inhibitors as well as their biol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtSkXNPl_7LVg90H21EOLACvtfcHk0ljfpSUHm3B0kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotVSrsrs%253D&md5=6f8021101929c931a6769dce538010c2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2217%2Fepi-2015-0002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fepi-2015-0002%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DTCPs%253A%2520privileged%2520scaffolds%2520for%2520identifying%2520potent%2520LSD1%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DEpigenomics%26date%3D2016%26volume%3D8%26spage%3D651%26epage%3D666%26doi%3D10.2217%2Fepi-2015-0002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culhane, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalili, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">8058</span>– <span class="NLM_lpage">8065</span>, <span class="refDoi"> DOI: 10.1021/bi700664y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi700664y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsVKmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=8058-8065&author=M.+Yangauthor=J.+C.+Culhaneauthor=L.+M.+Szewczukauthor=P.+Jaliliauthor=H.+L.+Ballauthor=M.+Machiusauthor=P.+A.+Coleauthor=H.+Yu&title=Structural+basis+for+the+inhibition+of+the+LSD1+histone+demethylase+by+the+antidepressant+trans-2-phenylcyclopropylamine&doi=10.1021%2Fbi700664y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Inhibition of the LSD1 Histone Demethylase by the Antidepressant trans-2-Phenylcyclopropylamine</span></div><div class="casAuthors">Yang, Maojun; Culhane, Jeffrey C.; Szewczuk, Lawrence M.; Jalili, Pegah; Ball, Haydn L.; Machius, Mischa; Cole, Philip A.; Yu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">8058-8065</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone modifications, such as acetylation and methylation, are important epigenetic marks that regulate diverse biol. processes that use chromatin as the template, including transcription.  Dysregulation of histone acetylation and methylation leads to the silencing of tumor suppressor genes and contributes to cancer progression.  Inhibitors of enzymes that catalyze the addn. and removal of these epigenetic marks thus have therapeutic potential for treating cancer.  Lysine-specific demethylase 1 (LSD1) is the first discovered histone lysine demethylase and with the help of its cofactor CoREST, specifically demethylates mono- and dimethylated histone H3 lysine 4 (H3-K4), thus repressing transcription.  Because LSD1 belongs to the family of FAD (FAD)-dependent amine oxidases, certain inhibitors of monoamine oxidases (MAOs), including the clin. used antidepressant trans-2-phenylcyclopropylamine (PCPA; tranylcypromine; Parnate), are also capable of inhibiting LSD1.  In this study, we have further measured the kinetic parameters of the inhibition of LSD1 by PCPA and detd. the crystal structure of LSD1-CoREST in the presence of PCPA.  Our structural and mass spectrometry analyses are consistent with PCPA forming a covalent adduct with FAD in LSD1 that is distinct from the FAD-PCPA adduct of MAO B.  The structure also reveals that the Ph ring of the FAD-PCPA adduct in LSD1 does not form extensive interactions with active-site residues.  This study thus provides the basis for designing more potent inhibitors of LSD1 that contain substitutions on the Ph ring of PCPA to fully engage neighboring residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLqcLmzpB1S7Vg90H21EOLACvtfcHk0ljj4L6yuPj3zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsVKmsr8%253D&md5=e11fe93832d46962b6c4848f682042d2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi700664y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700664y%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DCulhane%26aufirst%3DJ.%2BC.%26aulast%3DSzewczuk%26aufirst%3DL.%2BM.%26aulast%3DJalili%26aufirst%3DP.%26aulast%3DBall%26aufirst%3DH.%2BL.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520the%2520LSD1%2520histone%2520demethylase%2520by%2520the%2520antidepressant%2520trans-2-phenylcyclopropylamine%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D8058%26epage%3D8065%26doi%3D10.1021%2Fbi700664y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengoku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuzawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25Å</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2007.11.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bbrc.2007.11.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18039463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOktr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2008&pages=15-22&author=S.+Mimasuauthor=T.+Sengokuauthor=S.+Fukuzawaauthor=T.+Umeharaauthor=S.+Yokoyama&title=Crystal+structure+of+histone+demethylase+LSD1+and+tranylcypromine+at+2.25%C3%85&doi=10.1016%2Fj.bbrc.2007.11.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 Å</span></div><div class="casAuthors">Mimasu, Shinya; Sengoku, Toru; Fukuzawa, Seketsu; Umehara, Takashi; Yokoyama, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Transcriptional activity and chromatin structure accessibility are correlated with the methylation of specific histone residues.  Lysine-specific demethylase 1 (LSD1) is the 1st discovered histone demethylase, which demethylates Lys-4 or Lys-9 of histone H3, using FAD.  Among the known monoamine oxidase inhibitors, tranylcypromine (Parnate) showed the most potent inhibitory effect on LSD1.  Recently, the crystal structure of LSD1 and tranylcypromine was solved at 2.75 Å, revealing a 5-membered ring fused to the flavin of LSD1.  Here, the authors refined the crystal structure of the LSD1-tranylcypromine complex to 2.25 Å.  The 5-membered ring model did not fit completely with the electron d., giving Rwork/R free values of 0.226/0.254.  On the other hand, the N(5) adduct gave the lowest Rwork/Rfree values of 0.218/0.248, among the tested models.  These results imply that the LSD1-tranylcypromine complex is not completely composed of the 5-membered adduct, but partially contains an intermediate, such as the N(5) adduct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo__1EoL6D_NLVg90H21EOLACvtfcHk0lgP4c39O98g1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOktr7P&md5=b2f5185385eca05415fa4f3efcd64bdf</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2007.11.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2007.11.066%26sid%3Dliteratum%253Aachs%26aulast%3DMimasu%26aufirst%3DS.%26aulast%3DSengoku%26aufirst%3DT.%26aulast%3DFukuzawa%26aufirst%3DS.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520histone%2520demethylase%2520LSD1%2520and%2520tranylcypromine%2520at%25202.25%25C3%2585%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D366%26spage%3D15%26epage%3D22%26doi%3D10.1016%2Fj.bbrc.2007.11.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanenghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karytinos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forneris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tardugno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">6827</span>– <span class="NLM_lpage">6833</span>, <span class="refDoi"> DOI: 10.1021/ja101557k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja101557k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=6827-6833&author=C.+Bindaauthor=S.+Valenteauthor=M.+Romanenghiauthor=S.+Pilottoauthor=R.+Cirilliauthor=A.+Karytinosauthor=G.+Ciossaniauthor=O.+A.+Botrugnoauthor=F.+Fornerisauthor=M.+Tardugnoauthor=D.+E.+Edmondsonauthor=S.+Minucciauthor=A.+Matteviauthor=A.+Mai&title=Biochemical%2C+structural%2C+and+biological+evaluation+of+tranylcypromine+derivatives+as+inhibitors+of+histone+demethylases+LSD1+and+LSD2&doi=10.1021%2Fja101557k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2</span></div><div class="casAuthors">Binda, Claudia; Valente, Sergio; Romanenghi, Mauro; Pilotto, Simona; Cirilli, Roberto; Karytinos, Aristotele; Ciossani, Giuseppe; Botrugno, Oronza A.; Forneris, Federico; Tardugno, Maria; Edmondson, Dale E.; Minucci, Saverio; Mattevi, Andrea; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6827-6833</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">LSD1 and LSD2 histone demethylases are implicated in a no. of physiol. and pathol. processes, ranging from tumorigenesis to herpes virus infection.  A comprehensive structural, biochem., and cellular study is presented here to probe the potential of these enzymes for epigenetic therapies.  This approach employs tranylcypromine as a chem. scaffold for the design of novel demethylase inhibitors.  This drug is a clin. validated antidepressant known to target monoamine oxidases A and B.  These two flavoenzymes are structurally related to LSD1 and LSD2.  Mechanistic and crystallog. studies of tranylcypromine inhibition reveal a lack of selectivity and differing covalent modifications of the FAD cofactor depending on the enantiomeric form.  These findings are pharmacol. relevant, since tranylcypromine is currently administered as a racemic mixt.  A large set of tranylcypromine analogs were synthesized and screened for inhibitory activities.  We found that the common evolutionary origin of LSD and MAO enzymes, despite their unrelated functions and substrate specificities, is reflected in related ligand-binding properties.  A few compds. with partial enzyme selectivity were identified.  The biol. activity of one of these new inhibitors was evaluated with a cellular model of acute promyelocytic leukemia chosen since its pathogenesis includes aberrant activities of several chromatin modifiers.  Marked effects on cell differentiation and an unprecedented synergistic activity with antileukemia drugs were obsd.  These data demonstrate that these LSD1/2 inhibitors are of potential relevance for the treatment of promyelocytic leukemia and, more generally, as tools to alter chromatin state with promise of a block of tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH4F9uwn5Jx7Vg90H21EOLACvtfcHk0lgP4c39O98g1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChur0%253D&md5=d6b28616bbb0455e139625fdb43696d3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fja101557k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja101557k%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DRomanenghi%26aufirst%3DM.%26aulast%3DPilotto%26aufirst%3DS.%26aulast%3DCirilli%26aufirst%3DR.%26aulast%3DKarytinos%26aufirst%3DA.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DTardugno%26aufirst%3DM.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520structural%252C%2520and%2520biological%2520evaluation%2520of%2520tranylcypromine%2520derivatives%2520as%2520inhibitors%2520of%2520histone%2520demethylases%2520LSD1%2520and%2520LSD2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D6827%26epage%3D6833%26doi%3D10.1021%2Fja101557k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiekhattar, R.</span></span> <span> </span><span class="NLM_article-title">Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2006.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.chembiol.2006.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=16793513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=563-567&author=M.+G.+Leeauthor=C.+Wynderauthor=D.+M.+Schmidtauthor=D.+G.+McCaffertyauthor=R.+Shiekhattar&title=Histone+H3+lysine+4+demethylation+is+a+target+of+nonselective+antidepressive+medications&doi=10.1016%2Fj.chembiol.2006.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive Medications</span></div><div class="casAuthors">Lee, Min Gyu; Wynder, Christopher; Schmidt, Dawn M.; McCafferty, Dewey G.; Shiekhattar, Ramin</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">563-567</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Demethylation of histone H3 lysine 4 is carried out by BHC110/LSD1, an enzyme with close homol. to monoamine oxidases (MAO).  Monoamine oxidase A or B are frequent targets of selective and nonselective small mol. inhibitors used for treatment of depression.  Here the authors show that in contrast to selective monoamine oxidase inhibitors such as pargyline, nonselective monoamine oxidase inhibitors potently inhibit nucleosomal demethylation of histone H3 lysine 4.  Tranylcypromine (brand name Parnate) displayed the best inhibitory activity with an IC50 of less than 2 μM.  Treatment of P19 embryonal carcinoma cells with tranylcypromine resulted in global increase in H3K4 methylation as well as transcriptional derepression of two BHC110 target genes, Egr1 and the pluripotent stem cell marker Oct4.  These results attest to the effectiveness of tranylcypromine as a small mol. inhibitor of histone demethylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpatbgTiqG1Y7Vg90H21EOLACvtfcHk0lj26SV8zS-mBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGqs7k%253D&md5=4a877937287bada8b6e885638926bff2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DWynder%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DD.%2BM.%26aulast%3DMcCafferty%26aufirst%3DD.%2BG.%26aulast%3DShiekhattar%26aufirst%3DR.%26atitle%3DHistone%2520H3%2520lysine%25204%2520demethylation%2520is%2520a%2520target%2520of%2520nonselective%2520antidepressive%2520medications%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D563%26epage%3D567%26doi%3D10.1016%2Fj.chembiol.2006.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, D. G.</span></span> <span> </span><span class="NLM_article-title">Trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4408</span>– <span class="NLM_lpage">4416</span>, <span class="refDoi"> DOI: 10.1021/bi0618621</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0618621" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivF2jsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=4408-4416&author=D.+M.+Schmidtauthor=D.+G.+McCafferty&title=Trans-2-Phenylcyclopropylamine+is+a+mechanism-based+inactivator+of+the+histone+demethylase+LSD1&doi=10.1021%2Fbi0618621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1</span></div><div class="casAuthors">Schmidt, Dawn M. Z.; McCafferty, Dewey G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4408-4416</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The catalytic domain of the flavin-dependent human histone demethylase, lysine-specific demethylase 1 (LSD1), belongs to the family of amine oxidases including polyamine oxidase and monoamine oxidase (MAO).  The authors previously assessed MAO inhibitors (MAOIs) for their ability to inhibit the reaction catalyzed by LSD1, demonstrating that trans-2-phenylcyclopropylamine (2-PCPA; tranylcypromine, Parnate) was the most potent inhibitor with respect to LSD1.  Here, the authors showed that 2-PCPA was a time-dependent, mechanism-based irreversible inhibitor of LSD1 with a Ki of 242 μM and a kinact of 0.0106 s-1.  2-PCPA showed limited selectivity for human MAOs vs. LSD1, with kinact/Ki values only 16-fold and 2.4-fold higher for MAO B and MAO A, resp.  Profiles of LSD1 activity and inactivation by 2-PCPA as a function of pH were consistent with a mechanism of inactivation dependent upon enzyme catalysis.  Mass spectrometry supported a role for FAD as the site of covalent modification by 2-PCPA.  These results will provide a foundation for the design of cyclopropylamine-based inhibitors that are selective for LSD1 to probe its role in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVK59U7IsBvbVg90H21EOLACvtfcHk0lj26SV8zS-mBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivF2jsr0%253D&md5=02925342b86c7dbfb5f1a99fa5264adc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fbi0618621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0618621%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DD.%2BM.%26aulast%3DMcCafferty%26aufirst%3DD.%2BG.%26atitle%3DTrans-2-Phenylcyclopropylamine%2520is%2520a%2520mechanism-based%2520inactivator%2520of%2520the%2520histone%2520demethylase%2520LSD1%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D4408%26epage%3D4416%26doi%3D10.1021%2Fbi0618621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besenbeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenk, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mundmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gothert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noppeney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schliemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikesch, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornhauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serve, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platzbecker, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foerster, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burhenne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haefeli, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabst, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Tidow, C.</span></span>; <span class="NLM_contrib-group">Study Alliance Leukemia</span> <span> </span><span class="NLM_article-title">A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1038/s41375-020-0892-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fs41375-020-0892-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32561840" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=M.+Wassauthor=S.+Gollnerauthor=B.+Besenbeckauthor=R.+F.+Schlenkauthor=P.+Mundmannauthor=J.+R.+Gothertauthor=R.+Noppeneyauthor=C.+Schliemannauthor=J.+H.+Mikeschauthor=G.+Lenzauthor=M.+Dugasauthor=M.+Wermkeauthor=C.+Rolligauthor=M.+Bornhauserauthor=H.+Serveauthor=U.+Platzbeckerauthor=K.+I.+Foersterauthor=J.+Burhenneauthor=W.+E.+Haefeliauthor=L.+P.+Mullerauthor=M.+Binderauthor=C.+Pabstauthor=C.+Muller-Tidowauthor=Study+Alliance+Leukemia&title=A+proof+of+concept+phase+I%2FII+pilot+trial+of+LSD1+inhibition+by+tranylcypromine+combined+with+ATRA+in+refractory%2Frelapsed+AML+patients+not+eligible+for+intensive+therapy&doi=10.1038%2Fs41375-020-0892-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fs41375-020-0892-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41375-020-0892-z%26sid%3Dliteratum%253Aachs%26aulast%3DWass%26aufirst%3DM.%26aulast%3DGollner%26aufirst%3DS.%26aulast%3DBesenbeck%26aufirst%3DB.%26aulast%3DSchlenk%26aufirst%3DR.%2BF.%26aulast%3DMundmann%26aufirst%3DP.%26aulast%3DGothert%26aufirst%3DJ.%2BR.%26aulast%3DNoppeney%26aufirst%3DR.%26aulast%3DSchliemann%26aufirst%3DC.%26aulast%3DMikesch%26aufirst%3DJ.%2BH.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DDugas%26aufirst%3DM.%26aulast%3DWermke%26aufirst%3DM.%26aulast%3DRollig%26aufirst%3DC.%26aulast%3DBornhauser%26aufirst%3DM.%26aulast%3DServe%26aufirst%3DH.%26aulast%3DPlatzbecker%26aufirst%3DU.%26aulast%3DFoerster%26aufirst%3DK.%2BI.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DHaefeli%26aufirst%3DW.%2BE.%26aulast%3DMuller%26aufirst%3DL.%2BP.%26aulast%3DBinder%26aufirst%3DM.%26aulast%3DPabst%26aufirst%3DC.%26aulast%3DMuller-Tidow%26aufirst%3DC.%26aulast%3D%26atitle%3DA%2520proof%2520of%2520concept%2520phase%2520I%252FII%2520pilot%2520trial%2520of%2520LSD1%2520inhibition%2520by%2520tranylcypromine%2520combined%2520with%2520ATRA%2520in%2520refractory%252Frelapsed%2520AML%2520patients%2520not%2520eligible%2520for%2520intensive%2520therapy%26jtitle%3DLeukemia%26date%3D2020%26doi%3D10.1038%2Fs41375-020-0892-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">538</span>, <span class="refDoi"> DOI: 10.1038/s41416-019-0680-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fs41416-019-0680-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31848446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWks77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2020&pages=528-538&author=W.+Zhangauthor=J.+Chengauthor=P.+Diaoauthor=D.+Wangauthor=W.+Zhangauthor=H.+Jiangauthor=Y.+Wang&title=Therapeutically+targeting+head+and+neck+squamous+cell+carcinoma+through+synergistic+inhibition+of+LSD1+and+JMJD3+by+TCP+and+GSK-J1&doi=10.1038%2Fs41416-019-0680-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1</span></div><div class="casAuthors">Zhang, Wei; Cheng, Jie; Diao, Pengfei; Wang, Dongmiao; Jiang, Hongbing; Wang, Yanling</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">528-538</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: The histone demethylase LSD1 is a key mediator driving tumorigenesis, which holds potential as a promising therapeutic target.  However, treatment with LSD1 inhibitors alone failed to result in complete cancer regression.  Methods: The synergistic effects of TCP (a LSD1 inhibitor) and GSK-J1 (a JMJD3 inhibitor) against HNSCC were detd. in vitro and in preclin. animal models.  Genes modulated by chem. agents or siRNAs in HNSCC cells were identified by RNA-seq and further functionally interrogated by bioinformatics approach.  Integrative siRNA-mediated gene knockdown, rescue expt. and ChIP-qPCR assays were utilized to characterize the mediators underlying the therapeutic effects conferred by TCP and GSK-J1.  Results: Treatment with TCP and GSK-J1 impaired cell proliferation, induced apoptosis and senescence in vitro, which were largely recapitulated by simultaneous LSD1 and JMJD3 knockdown.  Combinational treatment inhibited tumor growth and progression in vivo.  Differentially expressed genes modulated by TCP and GSK-J1 were significantly enriched in cell proliferation, apoptosis and cancer-related pathways.  SPP1 was identified as the mediator of synergy underlying the pro-apoptosis effects conferred by TCP and GSK-J1.  Co-upregulation of LSD1 and JMJD3 assocd. with worse prognosis in patients with HNSCC.  Conclusions: Our findings revealed a novel therapeutic strategy of simultaneous LSD1 and JMJD3 inhibition against HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2WLQcQJoPeLVg90H21EOLACvtfcHk0lguCUqZup-jUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWks77I&md5=ffcf18ad231f5d499c2b116239629163</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fs41416-019-0680-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-019-0680-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DDiao%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DTherapeutically%2520targeting%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%2520through%2520synergistic%2520inhibition%2520of%2520LSD1%2520and%2520JMJD3%2520by%2520TCP%2520and%2520GSK-J1%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2020%26volume%3D122%26spage%3D528%26epage%3D538%26doi%3D10.1038%2Fs41416-019-0680-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gooden, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabadi, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, D. G.</span></span> <span> </span><span class="NLM_article-title">Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3047</span>– <span class="NLM_lpage">3051</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2008.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18242989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3047-3051&author=D.+M.+Goodenauthor=D.+M.+Schmidtauthor=J.+A.+Pollockauthor=A.+M.+Kabadiauthor=D.+G.+McCafferty&title=Facile+synthesis+of+substituted+trans-2-arylcyclopropylamine+inhibitors+of+the+human+histone+demethylase+LSD1+and+monoamine+oxidases+A+and+B&doi=10.1016%2Fj.bmcl.2008.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B</span></div><div class="casAuthors">Gooden, David M.; Schmidt, Dawn M. Z.; Pollock, Julie A.; Kabadi, Ami M.; McCafferty, Dewey G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3047-3051</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A facile synthetic route to substituted trans-2-arylcyclopropylamines was developed to provide access to mechanism-based inhibitors of the human flavoenzyme oxidase lysine-specific histone demethylase LSD1 and related enzyme family members such as monoamine oxidases A and B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojt7YjHKC3yrVg90H21EOLACvtfcHk0lguCUqZup-jUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVagurs%253D&md5=2459dcb4cde160186fc17c09258c5906</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DGooden%26aufirst%3DD.%2BM.%26aulast%3DSchmidt%26aufirst%3DD.%2BM.%26aulast%3DPollock%26aufirst%3DJ.%2BA.%26aulast%3DKabadi%26aufirst%3DA.%2BM.%26aulast%3DMcCafferty%26aufirst%3DD.%2BG.%26atitle%3DFacile%2520synthesis%2520of%2520substituted%2520trans-2-arylcyclopropylamine%2520inhibitors%2520of%2520the%2520human%2520histone%2520demethylase%2520LSD1%2520and%2520monoamine%2520oxidases%2520A%2520and%2520B%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3047%26epage%3D3051%26doi%3D10.1016%2Fj.bmcl.2008.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culhane, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gocke, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigam, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span> <span> </span><span class="NLM_article-title">Structural basis of histone demethylation by LSD1 revealed by suicide inactivation</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/nsmb1255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fnsmb1255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=17529991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVyjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=535-539&author=M.+Yangauthor=J.+C.+Culhaneauthor=L.+M.+Szewczukauthor=C.+B.+Gockeauthor=C.+A.+Brautigamauthor=D.+R.+Tomchickauthor=M.+Machiusauthor=P.+A.+Coleauthor=H.+Yu&title=Structural+basis+of+histone+demethylation+by+LSD1+revealed+by+suicide+inactivation&doi=10.1038%2Fnsmb1255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of histone demethylation by LSD1 revealed by suicide inactivation</span></div><div class="casAuthors">Yang, Maojun; Culhane, Jeffrey C.; Szewczuk, Lawrence M.; Gocke, Christian B.; Brautigam, Chad A.; Tomchick, Diana R.; Machius, Mischa; Cole, Philip A.; Yu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">535-539</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone methylation regulates diverse chromatin-templated processes, including transcription.  The recent discovery of the first histone lysine-specific demethylase (LSD1) has changed the long-held view that histone methylation is a permanent epigenetic mark.  LSD1 is a FAD-dependent amine oxidase that demethylates histone H3 Lys4 (H3-K4).  However, the mechanism by which LSD1 achieves its substrate specificity is unclear.  We report the crystal structure of human LSD1 with a propargylamine-derivatized H3 peptide covalently tethered to FAD.  H3 adopts three consecutive γ-turns, enabling an ideal side chain spacing that places its N terminus into an anionic pocket and positions methyl-Lys4 near FAD for catalysis.  The LSD1 active site cannot productively accommodate more than three residues on the N-terminal side of the methyllysine, explaining its H3-K4 specificity.  The unusual backbone conformation of LSD1-bound H3 suggests a strategy for designing potent LSD1 inhibitors with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocskIRV1aPVbVg90H21EOLACvtfcHk0lh3fysh37QDAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVyjtbs%253D&md5=51ba4fc92701ed0952d3f37e11ecda00</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1255%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DCulhane%26aufirst%3DJ.%2BC.%26aulast%3DSzewczuk%26aufirst%3DL.%2BM.%26aulast%3DGocke%26aufirst%3DC.%2BB.%26aulast%3DBrautigam%26aufirst%3DC.%2BA.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520of%2520histone%2520demethylation%2520by%2520LSD1%2520revealed%2520by%2520suicide%2520inactivation%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D535%26epage%3D539%26doi%3D10.1038%2Fnsmb1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span> <span> </span><span class="NLM_article-title">Identification of cell-active lysine specific demethylase 1-selective inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">17536</span>– <span class="NLM_lpage">17537</span>, <span class="refDoi"> DOI: 10.1021/ja907055q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja907055q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17536-17537&author=R.+Uedaauthor=T.+Suzukiauthor=K.+Minoauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyata&title=Identification+of+cell-active+lysine+specific+demethylase+1-selective+inhibitors&doi=10.1021%2Fja907055q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of cell-active lysine specific demethylase 1-selective inhibitors</span></div><div class="casAuthors">Ueda, Rie; Suzuki, Takayoshi; Mino, Koshiki; Tsumoto, Hiroki; Nakagawa, Hidehiko; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">17536-17537</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) plays a key role in the regulation of gene expression by removing the Me groups from methylated Lys4 of histone H3 (H3K4).  Here we report the identification of the first small-mol. LSD1-selective inhibitors.  These inhibitors show in vivo H3K4-methylating activity and antiproliferative activity and should be useful as lead structures for anticancer drugs and as tools for studying the biol. roles of LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH7uDFiErmKbVg90H21EOLACvtfcHk0lh3fysh37QDAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtbzO&md5=243e81a1d8d8cb3747f8307d5f42cd29</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja907055q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja907055q%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520cell-active%2520lysine%2520specific%2520demethylase%25201-selective%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D17536%26epage%3D17537%26doi%3D10.1021%2Fja907055q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukihara, T.</span></span> <span> </span><span class="NLM_article-title">Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates/inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">5739</span>– <span class="NLM_lpage">5744</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710626105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.0710626105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=18391214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.+Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+of+human+monoamine+oxidase+A+at+2.2-A+resolution%3A+the+control+of+opening+the+entry+for+substrates%2Finhibitors&doi=10.1073%2Fpnas.0710626105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors</span></div><div class="casAuthors">Son, Se-Young; Mat, Jichun; Kondou, Youhei; Yoshimura, Masato; Yamashita, Eiki; Tsukihara, Tomitake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5744</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial outer membrane-anchored monoamine oxidase (MAO) is a biochem. important flavoenzyme that catalyzes the deamination of biogenic and xenobiotic amines.  Its 2 subtypes, MAOA and MAOB, are linked to several psychiatric disorders and therefore are interesting targets for drug design.  To understand the relation between structure and function of this enzyme, the authors extended their previously reported low-resoln. rat MAOA structure to the high-resoln. wild-type and G110A mutant structures of human MAOA complexed with the reversible inhibitor, harmine, at 2.2 and 2.17 Å, resp.  The high-resoln. MAOA structures were similar to those of rat MAOA and human MAOB, but different from the known structure of human MAOA, specifically regarding residues 108-118 and 210-216, which surround the substrate/inhibitor cavity.  The results confirmed that the inhibitor selectivity of MAOA and MAOB is caused by the structural differences arising from Ile-335 in MAOA vs. Tyr-326 in MAOB.  The structures exhibited a C-terminal transmembrane helix with clear electron d., as is also seen in rat MAOA.  Mutations on one residue of loop 108-118, Gly-110, which is far from the active center but close to the membrane surface, caused the solubilized enzyme to undergo a dramatic drop in activity, but have less effect when the enzyme was anchored in the membrane.  These results suggest that the flexibility of loop 108-118, facilitated by anchoring the enzyme into the membrane, is essential for controlling substrate access to the active site.  The authors report on the observation of the structure-function relation between a transmembrane helical anchor and an extra-membrane domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdm8Cs1NxHxLVg90H21EOLACvtfcHk0lh3fysh37QDAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D&md5=7443fe77547220547312f7259df590df</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710626105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710626105%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520of%2520human%2520monoamine%2520oxidase%2520A%2520at%25202.2-A%2520resolution%253A%2520the%2520control%2520of%2520opening%2520the%2520entry%2520for%2520substrates%252Finhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744%26doi%3D10.1073%2Fpnas.0710626105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restelli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">9750</span>– <span class="NLM_lpage">9755</span>, <span class="refDoi"> DOI: 10.1073/pnas.1633804100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1633804100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=12913124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVejt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=9750-9755&author=C.+Bindaauthor=M.+Liauthor=F.+Hubalekauthor=N.+Restelliauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Insights+into+the+mode+of+inhibition+of+human+mitochondrial+monoamine+oxidase+B+from+high-resolution+crystal+structures&doi=10.1073%2Fpnas.1633804100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures</span></div><div class="casAuthors">Binda, Claudia; Li, Min; Hubalek, Frantisek; Restelli, Nadia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9750-9755</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO-B) is an outer mitochondrial membrane-bound enzyme that catalyzes the oxidative deamination of arylalkylamine neurotransmitters and has been a target for a no. of clin. used drug inhibitors.  The 1.7-Å structure of the reversible isatin-MAO-B complex has been detd.; it forms a basis for the interpretation of the enzyme's structure when bound to either reversible or irreversible inhibitors.  1,4-Diphenyl-2-butene is found to be a reversible MAO-B inhibitor, which occupies both the entrance and substrate cavity space in the enzyme.  Comparison of these two structures identifies Ile-199 as a "gate" between the two cavities.  Rotation of the side chain allows for either sepn. or fusion of the two cavities.  Inhibition of the enzyme with N-(2-aminoethyl)-p-chlorobenzamide results in the formation of a covalent N(5) flavin adduct with the Ph ring of the inhibitor occupying a position in the catalytic site overlapping that of isatin.  Inhibition of MAO-B with the clin. used trans-2-phenylcyclopropylamine results in the formation of a covalent C(4a) flavin adduct with an opened cyclopropyl ring and the Ph ring in a parallel orientation to the flavin.  The peptide bond between the flavin-substituted Cys-397 and Tyr-398 is in a cis conformation, which allows the proper orientation of the phenolic ring of Tyr-398 in the active site.  The flavin ring exists in a twisted nonplanar conformation, which is obsd. in the oxidized form as well as in both the N(5) and the C(4a) adducts.  An immobile water mol. is H-bonded to Lys-296 and to the N(5) of the flavin as obsd. in other flavin-dependent amine oxidases.  The active site cavities are highly apolar; however, hydrophilic areas exist near the flavin and direct the amine moiety of the substrate for binding and catalysis.  Small conformational changes are obsd. on comparison of the different inhibitor-enzyme complexes.  Future MAO-B drug design will need to consider "induced fit" contributions as an element in ligand-enzyme interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0K1SiYQtmN7Vg90H21EOLACvtfcHk0lgbnYS7smUeSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVejt7c%253D&md5=41ecf51fec3d1c4c811dc716c43beda5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1633804100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1633804100%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DRestelli%26aufirst%3DN.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DInsights%2520into%2520the%2520mode%2520of%2520inhibition%2520of%2520human%2520mitochondrial%2520monoamine%2520oxidase%2520B%2520from%2520high-resolution%2520crystal%2520structures%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D9750%26epage%3D9755%26doi%3D10.1073%2Fpnas.1633804100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cortez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekmal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Aguayo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Berestein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadlamudi, R. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer</span>. <i>Breast Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">R108</span>, <span class="refDoi"> DOI: 10.1186/bcr3229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1186%2Fbcr3229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=22812534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlyqtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R108&author=V.+Cortezauthor=M.+Mannauthor=S.+Tekmalauthor=T.+Suzukiauthor=N.+Miyataauthor=C.+Rodriguez-Aguayoauthor=G.+Lopez-Beresteinauthor=A.+K.+Soodauthor=R.+K.+Vadlamudi&title=Targeting+the+PELP1-KDM1+axis+as+a+potential+therapeutic+strategy+for+breast+cancer&doi=10.1186%2Fbcr3229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer</span></div><div class="casAuthors">Cortez, Valerie; Mann, Monica; Tekmal, Seshidhar; Suzuki, Takayoshi; Miyata, Naoki; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K.; Vadlamudi, Ratna K.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">R108</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: The estrogen receptor (ER) co-regulator proline glutamic acid and leucine-rich protein 1 (PELP1) is a proto-oncogene that modulates epigenetic changes on ER target gene promoters via interactions with lysine-specific histone demethylase 1 (KDM1).  In this study, we assessed the therapeutic potential of targeting the PELP1-KDM1 axis in vivo using liposomal (1,2-dioleoyl-sn-glycero-3-phosphatidylcholine; DOPC) siRNA to downregulate PELP1 expression and KDM1 inhibitors, pargyline and N-((1S)-3-(3-(trans-2-aminocyclopropyl)phenoxy)-1-(benzylcarbamoyl)propyl)benzamide using preclin. models.  Methods: Preclin. xenograft models were used to test the efficacy of drugs in vivo.  Ki-67 and terminal deoxynucleotidyl transferase dUTP nick end-labeling immunohistochem. anal. of epigenetic markers was performed on tumor tissues.  The in vitro effect of PELP1-KDM axis blockers was tested using proliferation, reporter gene, chromatin immunopptn. and real-time RT-PCR assays.  The efficacy of the KDM1 targeting drugs alone or in combination with letrozole and tamoxifen was tested using therapy-resistant model cells.  Results: Treatment of ER-pos. xenograft-based breast tumors with PELP1-siRNA-DOPC or pargyline reduced tumor vol. by 58.6% and 62%, resp.  In a postmenopausal model, in which tumor growth is stimulated solely by local estrogen synthesis, daily pargyline treatment reduced tumor vol. by 78%.  Immunohistochem. anal. of excised tumors revealed a combined decrease in cellular proliferation, induction of apoptosis and upregulation of inhibitory epigenetic modifications.  Pharmacol. inhibition of KDM1 in vitro increased inhibitory histone mark dimethylation of histone H3 at lysine 9 (H3K9me2) and decreased histone activation mark acetylation of H3K9 (H3K9Ac) on ER target gene promoters.  Combining KDM1 targeting drugs with current endocrine therapies substantially impeded growth and restored sensitivity of therapy-resistant breast cancer cells to treatment.  Conclusion: Our results suggest inhibition of PELP1-KDM1-mediated histone modifications as a potential therapeutic strategy for blocking breast cancer progression and therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQDxZ2Mh92HLVg90H21EOLACvtfcHk0lhVLG-h8rYF3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlyqtb3L&md5=19fe4fcd0f366188f7a32196ec6592d5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2Fbcr3229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr3229%26sid%3Dliteratum%253Aachs%26aulast%3DCortez%26aufirst%3DV.%26aulast%3DMann%26aufirst%3DM.%26aulast%3DTekmal%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DRodriguez-Aguayo%26aufirst%3DC.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DVadlamudi%26aufirst%3DR.%2BK.%26atitle%3DTargeting%2520the%2520PELP1-KDM1%2520axis%2520as%2520a%2520potential%2520therapeutic%2520strategy%2520for%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2012%26volume%3D14%26spage%3DR108%26doi%3D10.1186%2Fbcr3229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Etani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki-Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span> <span> </span><span class="NLM_article-title">NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2865</span>– <span class="NLM_lpage">2878</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.18632%2Foncotarget.3067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25605246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC2MvnvF2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2865-2878&author=T.+Etaniauthor=T.+Suzukiauthor=T.+Naikiauthor=A.+Naiki-Itoauthor=R.+Andoauthor=K.+Iidaauthor=N.+Kawaiauthor=K.+Tozawaauthor=N.+Miyataauthor=K.+Kohriauthor=S.+Takahashi&title=NCL1%2C+a+highly+selective+lysine-specific+demethylase+1+inhibitor%2C+suppresses+prostate+cancer+without+adverse+effect&doi=10.18632%2Foncotarget.3067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect</span></div><div class="casAuthors">Etani Toshiki; Naiki Taku; Ando Ryosuke; Iida Keitaro; Kawai Noriyasu; Tozawa Keiichi; Kohri Kenjiro; Suzuki Takayoshi; Naiki-Ito Aya; Takahashi Satoru; Miyata Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2865-78</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Herein, we investigated therapeutic potential of a novel histone lysine demethylase 1 (LSD1) inhibitor, NCL1, in prostate cancer.  Hormone-sensitive prostate cancer cells, (LNCaP) and castration resistant cancer cells (PC3 and PCai1) were treated with NCL1, and LSD1 expression and cell viability were assessed.  Prostate cancer cells showed strong LSD1 expression, and cell viability was decreased by NCL1.  ChIP analysis showed that NCL1 induced H3K9me2 accumulation at the promoters of androgen-responsive genes.  NCL1 also induced G1 cell cycle arrest and apoptosis.  In addition, autophagosomes and autolysosomes were induced by NCL1 treatment in LNCaP.  Furthermore, LC3-II expression was significantly increased by NCL1 and chloroquine.  In mice injected subcutaneously with PCai1 and intraperitoneally with NCL1, tumor volume was reduced with no adverse effects in NCL1-treated mice.  Finally, LSD1 expression in human cancer specimens was significantly higher than that in normal prostate glands.  In conclusion, NCL1 effectively suppressed prostate cancer growth without adverse events.  We suggest that NCL1 is a potential therapeutic agent for hormone-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9hizy4Ezi3IvKgEt20y1XfW6udTcc2eYcwAvNQvWeW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvnvF2qsQ%253D%253D&md5=6845c5c712fb2ca8ee06c0e31780ca67</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3067%26sid%3Dliteratum%253Aachs%26aulast%3DEtani%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNaiki%26aufirst%3DT.%26aulast%3DNaiki-Ito%26aufirst%3DA.%26aulast%3DAndo%26aufirst%3DR.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DKawai%26aufirst%3DN.%26aulast%3DTozawa%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DKohri%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DS.%26atitle%3DNCL1%252C%2520a%2520highly%2520selective%2520lysine-specific%2520demethylase%25201%2520inhibitor%252C%2520suppresses%2520prostate%2520cancer%2520without%2520adverse%2520effect%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D2865%26epage%3D2878%26doi%3D10.18632%2Foncotarget.3067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Etani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki-Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayasu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span> <span> </span><span class="NLM_article-title">NCL1, A highly selective lysine-specific demethylase 1 inhibitor, suppresses castration-resistant prostate cancer growth via regulation of apoptosis and autophagy</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">442</span>, <span class="refDoi"> DOI: 10.3390/jcm8040442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3390%2Fjcm8040442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitl2qtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=442&author=T.+Etaniauthor=T.+Naikiauthor=A.+Naiki-Itoauthor=T.+Suzukiauthor=K.+Iidaauthor=S.+Nozakiauthor=H.+Katoauthor=Y.+Nagayasuauthor=S.+Suzukiauthor=N.+Kawaiauthor=T.+Yasuiauthor=S.+Takahashi&title=NCL1%2C+A+highly+selective+lysine-specific+demethylase+1+inhibitor%2C+suppresses+castration-resistant+prostate+cancer+growth+via+regulation+of+apoptosis+and+autophagy&doi=10.3390%2Fjcm8040442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses castration-resistant prostate cancer growth via regulation of apoptosis and autophagy</span></div><div class="casAuthors">Etani, Toshiki; Naiki, Taku; Naiki-Ito, Aya; Suzuki, Takayoshi; Iida, Keitaro; Nozaki, Satoshi; Kato, Hiroyuki; Nagayasu, Yuko; Suzuki, Shugo; Kawai, Noriyasu; Yasui, Takahiro; Takahashi, Satoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Recent studies have shown that epigenetic alterations lead to oncogenic activation, thus indicating that these are therapeutic targets.  Herein, we analyzed the efficacy and therapeutic potential of our developed histone lysine demethylase 1 (LSD1) inhibitor, NCL1, in castration-resistant prostate cancer (CRPC).  The CRPC cell lines 22Rv1, PC3, and PCai1CS were treated with NCL1, and LSD1 expression and cell viability were assessed.  The epigenetic effects and mechanisms of NCL1 were also evaluated.  CRPC cells showed strong LSD1 expression, and cell viability was decreased by NCL1 in a dose-dependent manner.  Chromatin immunopptn. anal. indicated that NCL1 induced histone H3 lysine 9 dimethylation accumulation at promoters of P21.  As shown by Western blot and flow cytometry analyses, NCL1 also dose-dependently induced caspase-dependent apoptosis.  The stimulation of autophagy was obsd. in NCL1-treated 22Rv1 cells by transmission electron microscopy and LysoTracker anal.  Furthermore, WST-8 assay revealed that the anti-tumor effect of NCL1 was reinforced when autophagy was inhibited by chloroquine in 22Rv1 cells.  Combination index anal. revealed that a concurrent use of these drugs had a synergistic effect.  In ex vivo anal., castrated nude mice were injected s.c. with PCai1 cells and i.p. with NCL1.  Tumor vol. was found to be reduced with no adverse effects in NCL1-treated mice compared with controls.  Finally, immunohistochem. anal. using consecutive human specimens in pre- and post-androgen deprivation therapy demonstrated that LSD1 expression levels in CRPC, including neuroendocrine differentiation cases, were very high, and identical to levels obsd. in previously examd. prostate biopsy specimens.  NCL1 effectively suppressed prostate cancer growth in vitro and ex vivo without adverse events via the regulation of apoptosis and autophagy, suggesting that NCL1 is a potential therapeutic agent for CRPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyWK5Bza-8FLVg90H21EOLACvtfcHk0lhVLG-h8rYF3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitl2qtLrF&md5=759b1216a71d0288917314af1f725f89</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fjcm8040442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm8040442%26sid%3Dliteratum%253Aachs%26aulast%3DEtani%26aufirst%3DT.%26aulast%3DNaiki%26aufirst%3DT.%26aulast%3DNaiki-Ito%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DNozaki%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DNagayasu%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DKawai%26aufirst%3DN.%26aulast%3DYasui%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26atitle%3DNCL1%252C%2520A%2520highly%2520selective%2520lysine-specific%2520demethylase%25201%2520inhibitor%252C%2520suppresses%2520castration-resistant%2520prostate%2520cancer%2520growth%2520via%2520regulation%2520of%2520apoptosis%2520and%2520autophagy%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D442%26doi%3D10.3390%2Fjcm8040442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sareddy, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanadhapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surapaneni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadlamudi, R. K.</span></span> <span> </span><span class="NLM_article-title">Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2423</span>– <span class="NLM_lpage">2434</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fonc.2016.395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27893719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCnu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=2423-2434&author=G.+R.+Sareddyauthor=S.+Viswanadhapalliauthor=P.+Surapaneniauthor=T.+Suzukiauthor=A.+Brennerauthor=R.+K.+Vadlamudi&title=Novel+KDM1A+inhibitors+induce+differentiation+and+apoptosis+of+glioma+stem+cells+via+unfolded+protein+response+pathway&doi=10.1038%2Fonc.2016.395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway</span></div><div class="casAuthors">Sareddy, G. R.; Viswanadhapalli, S.; Surapaneni, P.; Suzuki, T.; Brenner, A.; Vadlamudi, R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2423-2434</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glioma stem cells (GSCs) have a central role in glioblastoma (GBM) development and chemo/radiation resistance, and their elimination is crit. for the development of efficient therapeutic strategies.  Recently, we showed that lysine demethylase KDM1A is overexpressed in GBM.  In the present study, we detd. whether KDM1A modulates GSCs stemness and differentiation and tested the utility of two novel KDM1A-specific inhibitors (NCL-1 and NCD-38) to promote differentiation and apoptosis of GSCs.  The efficacy of KDM1A targeting drugs was tested on purified GSCs isolated from established and patient-derived GBMs using both in vitro assays and in vivo orthotopic preclin. models.  Our results suggested that KDM1A is highly expressed in GSCs and knockdown of KDM1A using shRNA-reduced GSCs stemness and induced the differentiation.  Pharmacol. inhibition of KDM1A using NCL-1 and NCD-38 significantly reduced the cell viability, neurosphere formation and induced apoptosis of GSCs with little effect on differentiated cells.  In preclin. studies using orthotopic models, NCL-1 and NCD-38 significantly reduced GSCs-driven tumor progression and improved mice survival.  RNA-sequencing anal. showed that KDM1A inhibitors modulate several pathways related to stemness, differentiation and apoptosis.  Mechanistic studies showed that KDM1A inhibitors induce activation of the unfolded protein response (UPR) pathway.  These results strongly suggest that selective targeting of KDM1A using NCL-1 and NCD-38 is a promising therapeutic strategy for elimination of GSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDjv7Rh1PPRbVg90H21EOLACvtfcHk0ljtownqZOR4nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCnu7vK&md5=f8e7736d039b748021ea639aca1d8a98</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.395%26sid%3Dliteratum%253Aachs%26aulast%3DSareddy%26aufirst%3DG.%2BR.%26aulast%3DViswanadhapalli%26aufirst%3DS.%26aulast%3DSurapaneni%26aufirst%3DP.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DBrenner%26aufirst%3DA.%26aulast%3DVadlamudi%26aufirst%3DR.%2BK.%26atitle%3DNovel%2520KDM1A%2520inhibitors%2520induce%2520differentiation%2520and%2520apoptosis%2520of%2520glioma%2520stem%2520cells%2520via%2520unfolded%2520protein%2520response%2520pathway%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D2423%26epage%3D2434%26doi%3D10.1038%2Fonc.2016.395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sareddy, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonugunta, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brann, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadlamudi, R. K.</span></span> <span> </span><span class="NLM_article-title">KDM1 is a novel therapeutic target for the treatment of gliomas</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.18632%2Foncotarget.725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=23248157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC3s3isl2qtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=18-28&author=G.+R.+Sareddyauthor=B.+C.+Nairauthor=S.+K.+Krishnanauthor=V.+K.+Gonuguntaauthor=Q.+G.+Zhangauthor=T.+Suzukiauthor=N.+Miyataauthor=A.+J.+Brennerauthor=D.+W.+Brannauthor=R.+K.+Vadlamudi&title=KDM1+is+a+novel+therapeutic+target+for+the+treatment+of+gliomas&doi=10.18632%2Foncotarget.725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">KDM1 is a novel therapeutic target for the treatment of gliomas</span></div><div class="casAuthors">Sareddy Gangadhara R; Nair Binoj C; Krishnan Samaya K; Gonugunta Vijay K; Zhang Quan-guang; Suzuki Takayoshi; Miyata Naoki; Brenner Andrew J; Brann Darrell W; Vadlamudi Ratna K</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioma development is a multistep process, involving alterations in genetic and epigenetic mechanisms.  Understanding the mechanisms and enzymes that promote epigenetic changes in gliomas are urgently needed to identify novel therapeutic targets.  We examined the role of histone demethylase KDM1 in glioma progression.  KDM1 was overexpressed in gliomas and its expression positively correlated with histological malignancy.  Knockdown of KDM1 expression or its pharmacological inhibition using pargyline or NCL-1 significantly reduced the proliferation of glioma cells.  Inhibition of KDM1 promoted up regulation of the p53 target genes p21 and PUMA.  Patient-derived primary GBM cells expressed high levels of KDM1 and pharmacological inhibition of KDM1 decreased their proliferation.  Further, KDM1 inhibition reduced the expression of stemness markers CD133 and nestin in GBM cells.  Mouse xenograft assays revealed that inhibition of KDM1 significantly reduced glioma xenograft tumor growth.  Inhibition of KDM1 increased levels of H3K4-me2 and H3K9-Ac histone modifications, reduced H3K9-me2 modification and promoted expression of p53 target genes (p21 and PUMA), leading to apoptosis of glioma xenograft tumors.  Our results suggest that KDM1 is overexpressed in gliomas and could be a potential therapeutic target for the treatment of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTF-mJUXmh8xNenUz0lpNqnfW6udTcc2ea7xoPF6z5Icrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3isl2qtQ%253D%253D&md5=43e27a0248dd0fc5e9cce613c589ec28</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.725%26sid%3Dliteratum%253Aachs%26aulast%3DSareddy%26aufirst%3DG.%2BR.%26aulast%3DNair%26aufirst%3DB.%2BC.%26aulast%3DKrishnan%26aufirst%3DS.%2BK.%26aulast%3DGonugunta%26aufirst%3DV.%2BK.%26aulast%3DZhang%26aufirst%3DQ.%2BG.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DBrenner%26aufirst%3DA.%2BJ.%26aulast%3DBrann%26aufirst%3DD.%2BW.%26aulast%3DVadlamudi%26aufirst%3DR.%2BK.%26atitle%3DKDM1%2520is%2520a%2520novel%2520therapeutic%2520target%2520for%2520the%2520treatment%2520of%2520gliomas%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D18%26epage%3D28%26doi%3D10.18632%2Foncotarget.725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki-Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, T.</span></span> <span> </span><span class="NLM_article-title">Mp38-08 Selective lysine specific demethylase 1 inhibitor, Ncl1, could cause testicular toxicity via the regulation of apoptosis</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">e572</span>, <span class="refDoi"> DOI: 10.1097/JU.0000000000000887.08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1097%2FJU.0000000000000887.08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2020&pages=e572&author=S.+Nozakiauthor=T.+Naikiauthor=S.+Iwatsukiauthor=A.+Naiki-Itoauthor=T.+Takedaauthor=T.+Etaniauthor=S.+Kurokawaauthor=S.+Takahashiauthor=Y.+Umemotoauthor=T.+Yasui&title=Mp38-08+Selective+lysine+specific+demethylase+1+inhibitor%2C+Ncl1%2C+could+cause+testicular+toxicity+via+the+regulation+of+apoptosis&doi=10.1097%2FJU.0000000000000887.08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1097%2FJU.0000000000000887.08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJU.0000000000000887.08%26sid%3Dliteratum%253Aachs%26aulast%3DNozaki%26aufirst%3DS.%26aulast%3DNaiki%26aufirst%3DT.%26aulast%3DIwatsuki%26aufirst%3DS.%26aulast%3DNaiki-Ito%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DT.%26aulast%3DEtani%26aufirst%3DT.%26aulast%3DKurokawa%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DUmemoto%26aufirst%3DY.%26aulast%3DYasui%26aufirst%3DT.%26atitle%3DMp38-08%2520Selective%2520lysine%2520specific%2520demethylase%25201%2520inhibitor%252C%2520Ncl1%252C%2520could%2520cause%2520testicular%2520toxicity%2520via%2520the%2520regulation%2520of%2520apoptosis%26jtitle%3DJ.%2520Urol.%26date%3D2020%26volume%3D203%26spage%3De572%26doi%3D10.1097%2FJU.0000000000000887.08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umezawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6494</span>– <span class="NLM_lpage">6503</span>, <span class="refDoi"> DOI: 10.1021/bi100299r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi100299r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFCmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6494-6503&author=S.+Mimasuauthor=N.+Umezawaauthor=S.+Satoauthor=T.+Higuchiauthor=T.+Umeharaauthor=S.+Yokoyama&title=Structurally+designed+trans-2-phenylcyclopropylamine+derivatives+potently+inhibit+histone+demethylase+LSD1%2FKDM1&doi=10.1021%2Fbi100299r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structurally Designed trans-2-Phenylcyclopropylamine Derivatives Potently Inhibit Histone Demethylase LSD1/KDM1</span></div><div class="casAuthors">Mimasu, Shinya; Umezawa, Naoki; Sato, Shin; Higuchi, Tsunehiko; Umehara, Takashi; Yokoyama, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">6494-6503</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1/KDM1) demethylates histone H3, in addn. to tumor suppressor p53 and DNA methyltransferase 1 (Dnmt1), thus regulating eukaryotic gene expression by altering chromatin structure.  Specific inhibitors of LSD1 are desired as anticancer agents, because LSD1 aberrations are assocd. with several cancers, and LSD1 inhibition restores the expression of abnormally silenced genes in cancerous cells.  In this study, we designed and synthesized several candidate compds. to inhibit LSD1, based on the structures of LSD1 and monoamine oxidase B (MAO-B), in complex with an antidepressant tranylcypromine (2-PCPA) deriv.  Compd. S2101 exhibited stronger LSD1 inhibition than tranylcypromine and the known small LSD1 inhibitors in LSD1 demethylation assays, with a kinact/KI value of 4560 M-1 s-1.  In comparison with tranylcypromine, the compd. displayed weaker inhibition to the monoamine oxidases.  The inhibition modes of the two 2-PCPA derivs., 2-PFPA and S1201, were identified by detn. of the inhibitor-bound LSD1 structures, which revealed the enhanced stability of the inhibitor-FAD adducts by their interactions with the surrounding LSD1 residues.  These mols. are potential pharmaceutical candidates for cancer or latent virus infection, as well as research tools for LSD1-related biol. investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIFRdqSvmn97Vg90H21EOLACvtfcHk0lidTbgXklPDgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFCmur8%253D&md5=26732b0cd1928d44263f8bb8790ace54</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbi100299r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi100299r%26sid%3Dliteratum%253Aachs%26aulast%3DMimasu%26aufirst%3DS.%26aulast%3DUmezawa%26aufirst%3DN.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DHiguchi%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DStructurally%2520designed%2520trans-2-phenylcyclopropylamine%2520derivatives%2520potently%2520inhibit%2520histone%2520demethylase%2520LSD1%252FKDM1%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D6494%26epage%3D6503%26doi%3D10.1021%2Fbi100299r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fioravanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mautone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Bello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corinti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwergel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vultaggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Tranylcypromine-based LSD1 inhibitors: structure-activity relationships, antiproliferative effects in leukemia, and gene target modulation</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">658</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fcmdc.201900730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32003940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtVehs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=643-658&author=R.+Fioravantiauthor=A.+Romanelliauthor=N.+Mautoneauthor=E.+Di+Belloauthor=A.+Rovereauthor=D.+Corintiauthor=C.+Zwergelauthor=S.+Valenteauthor=D.+Rotiliauthor=O.+A.+Botrugnoauthor=P.+Dessantiauthor=S.+Vultaggioauthor=P.+Vianelloauthor=A.+Cappaauthor=C.+Bindaauthor=A.+Matteviauthor=S.+Minucciauthor=C.+Mercurioauthor=M.+Varasiauthor=A.+Mai&title=Tranylcypromine-based+LSD1+inhibitors%3A+structure-activity+relationships%2C+antiproliferative+effects+in+leukemia%2C+and+gene+target+modulation&doi=10.1002%2Fcmdc.201900730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation</span></div><div class="casAuthors">Fioravanti, Rossella; Romanelli, Annalisa; Mautone, Nicola; Di Bello, Elisabetta; Rovere, Annarita; Corinti, Davide; Zwergel, Clemens; Valente, Sergio; Rotili, Dante; Botrugno, Oronza A.; Dessanti, Paola; Vultaggio, Stefania; Vianello, Paola; Cappa, Anna; Binda, Claudia; Mattevi, Andrea; Minucci, Saverio; Mercurio, Ciro; Varasi, Mario; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">643-658</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Abstr.: LSD1 is a lysine demethylase highly involved in initiation and development of cancer.  To design highly effective covalent inhibitors, a strategy is to fill its large catalytic cleft by designing tranylcypromine (TCP) analogs decorated with long, hindered substituents.  We prepd. three series of TCP analogs, carrying aroyl- and arylacetylamino (1 a-h), Z-amino acylamino (2 a-o), or double-substituted benzamide (3 a-n) residues at the C4 or C3 position of the Ph ring.  Further fragments obtained by chem. manipulation applied on the TCP scaffold (compds. 4 a-i) were also prepd.  When tested against LSD1, most of 1 and 3 exhibited IC50 values in the low nanomolar range, with 1 e and 3 a,d,f,g being also the most selective respect to monoamine oxidases.  In MV4-11 AML and NB4 APL cells compds. 3 were the most potent, displaying up to sub-micromolar cell growth inhibition against both cell lines (3 a) or against NB4 cells (3 c).  The most potent compds. in cellular assays were also able to induce the expression of LSD1 target genes, such as GFI-1b, ITGAM, and KCTD12, as functional read-out for LSD1 inhibition.  Mouse and human intrinsic clearance data highlighted the high metabolic stability of compds. 3 a, 3 d and 3 g.  Further studies will be performed on the new compds. 3 a and 3 c to assess their anticancer potential in different cancer contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXz4wd2RgF17Vg90H21EOLACvtfcHk0lidTbgXklPDgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtVehs74%253D&md5=31e9e04ed0a7264b19204019273b37c4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900730%26sid%3Dliteratum%253Aachs%26aulast%3DFioravanti%26aufirst%3DR.%26aulast%3DRomanelli%26aufirst%3DA.%26aulast%3DMautone%26aufirst%3DN.%26aulast%3DDi%2BBello%26aufirst%3DE.%26aulast%3DRovere%26aufirst%3DA.%26aulast%3DCorinti%26aufirst%3DD.%26aulast%3DZwergel%26aufirst%3DC.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DVultaggio%26aufirst%3DS.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DTranylcypromine-based%2520LSD1%2520inhibitors%253A%2520structure-activity%2520relationships%252C%2520antiproliferative%2520effects%2520in%2520leukemia%252C%2520and%2520gene%2520target%2520modulation%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D643%26epage%3D658%26doi%3D10.1002%2Fcmdc.201900730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benelkebir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duriez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulleid, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabb, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3709</span>– <span class="NLM_lpage">3716</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmc.2011.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=21382717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVyju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3709-3716&author=H.+Benelkebirauthor=C.+Hodgkinsonauthor=P.+J.+Duriezauthor=A.+L.+Haydenauthor=R.+A.+Bulleidauthor=S.+J.+Crabbauthor=G.+Packhamauthor=A.+Ganesan&title=Enantioselective+synthesis+of+tranylcypromine+analogues+as+lysine+demethylase+%28LSD1%29+inhibitors&doi=10.1016%2Fj.bmc.2011.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors</span></div><div class="casAuthors">Benelkebir, Hanae; Hodgkinson, Christopher; Duriez, Patrick J.; Hayden, Annette L.; Bulleid, Rosemary A.; Crabb, Simon J.; Packham, Graham; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3709-3716</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Asym. cyclopropanation of styrenes by tert-Bu diazoacetate followed by ester hydrolysis and Curtius rearrangement gave a series of tranylcypromine analogs as single enantiomers.  The o-, m-, and p-bromo analogs were all more active than tranylcypromine in a LSD1 enzyme assay.  The m- and p-bromo analogs were micromolar growth inhibitors of the LNCaP prostate cancer cell line as were the corresponding biphenyl analogs prepd. from the bromide by Suzuki crosscoupling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuHGveNGE6AbVg90H21EOLACvtfcHk0lidTbgXklPDgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVyju7s%253D&md5=a8517cf8753c76b1403b6354977fc2a2</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DBenelkebir%26aufirst%3DH.%26aulast%3DHodgkinson%26aufirst%3DC.%26aulast%3DDuriez%26aufirst%3DP.%2BJ.%26aulast%3DHayden%26aufirst%3DA.%2BL.%26aulast%3DBulleid%26aufirst%3DR.%2BA.%26aulast%3DCrabb%26aufirst%3DS.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DEnantioselective%2520synthesis%2520of%2520tranylcypromine%2520analogues%2520as%2520lysine%2520demethylase%2520%2528LSD1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3709%26epage%3D3716%26doi%3D10.1016%2Fj.bmc.2011.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stazi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Pyrrole- and indole-containing tranylcypromine derivatives as novel lysine-specific demethylase 1 inhibitors active on cancer cells</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1039/C4MD00507D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1039%2FC4MD00507D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=665-670&author=V.+Rodriguezauthor=S.+Valenteauthor=S.+Rovidaauthor=D.+Rotiliauthor=G.+Staziauthor=A.+Lucidiauthor=G.+Ciossaniauthor=A.+Matteviauthor=O.+A.+Botrugnoauthor=P.+Dessantiauthor=C.+Mercurioauthor=P.+Vianelloauthor=S.+Minucciauthor=M.+Varasiauthor=A.+Mai&title=Pyrrole-+and+indole-containing+tranylcypromine+derivatives+as+novel+lysine-specific+demethylase+1+inhibitors+active+on+cancer+cells&doi=10.1039%2FC4MD00507D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrole- and indole-containing tranylcypromine derivatives as novel lysine-specific demethylase 1 inhibitors active on cancer cells</span></div><div class="casAuthors">Rodriguez, Veronica; Valente, Sergio; Rovida, Stefano; Rotili, Dante; Stazi, Giulia; Lucidi, Alessia; Ciossani, Giuseppe; Mattevi, Andrea; Botrugno, Oronza A.; Dessanti, Paola; Mercurio, Ciro; Vianello, Paola; Minucci, Saverio; Varasi, Mario; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">665-670</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">On the basis of previous research showing the capability of N-carbobenzyloxy-(Z-)amino acid-tranylcypromine (-TCPA) derivs. to inhibit LSD1, we inserted at the 4-amino-TCPA moiety first a Z-Pro (9) and a Z-Gly (10) residue and then, after the encouraging data obtained for 9, a pyrrole and an indole ring in which the relative N1 position carried a acetophenone, a N-phenyl/benzylacetamide, or a Z chain (11a-f and 12a-f, resp.).  In both series, the Z-pyrrole and indole derivs. 11e, f and 12e, f displayed high LSD1 inhibitory activity.  The compds. are able to inhibit LSD1 in NB4 cells, increasing the expression of two related genes, GFI-1b and ITGAM, and to induce cell growth arrest in the AML MB4-11 and APL NB4 cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOllVHCuR7lLVg90H21EOLACvtfcHk0lj9cmND8Ex34Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrtb%252FN&md5=5ed5d4a172f787639bd9f4f84065c880</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1039%2FC4MD00507D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00507D%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DV.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DRovida%26aufirst%3DS.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DStazi%26aufirst%3DG.%26aulast%3DLucidi%26aufirst%3DA.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DPyrrole-%2520and%2520indole-containing%2520tranylcypromine%2520derivatives%2520as%2520novel%2520lysine-specific%2520demethylase%25201%2520inhibitors%2520active%2520on%2520cancer%2520cells%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D665%26epage%3D670%26doi%3D10.1039%2FC4MD00507D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, L.</span>; <span class="NLM_string-name">Benelkebir, H.</span>; <span class="NLM_string-name">Ganesan, P.</span>; <span class="NLM_string-name">Duriez, P. J.</span>; <span class="NLM_string-name">Packham, G.</span>; <span class="NLM_string-name">Crabb, S.</span>; <span class="NLM_string-name">Bailey, S.</span>; <span class="NLM_string-name">Bowles, K.</span>; <span class="NLM_string-name">Rushworth, S.</span>; <span class="NLM_string-name">Shafat, M.</span>; <span class="NLM_string-name">Tam, C. H.</span>; <span class="NLM_string-name">Borrello, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of carboxamides tranylcypromine analogues as LSD1 (KDM1A) inhibitors for AML</span>.  <i>ChemRxiv</i> <span class="NLM_year">2020</span>, <a href="https://chemrxiv.org/articles/preprint/Synthesis_of_Carboxamides_Tranylcypromine_Analogues_as_LSD1_KDM1A_Inhibitors_for_AML/11860824/1" class="extLink">10.26434/chemrxiv.11860824</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=L.+Douglas&author=H.+Benelkebir&author=P.+Ganesan&author=P.+J.+Duriez&author=G.+Packham&author=S.+Crabb&author=S.+Bailey&author=K.+Bowles&author=S.+Rushworth&author=M.+Shafat&author=C.+H.+Tam&author=T.+Borrello&title=Synthesis+of+carboxamides+tranylcypromine+analogues+as+LSD1+%28KDM1A%29+inhibitors+for+AML"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DL.%26atitle%3DSynthesis%2520of%2520carboxamides%2520tranylcypromine%2520analogues%2520as%2520LSD1%2520%2528KDM1A%2529%2520inhibitors%2520for%2520AML%26jtitle%3DChemRxiv%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrocco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yapp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1021/jm4012802</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012802" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=42-55&author=D.+Rotiliauthor=S.+Tomassiauthor=M.+Conteauthor=R.+Benedettiauthor=M.+Tortoriciauthor=G.+Ciossaniauthor=S.+Valenteauthor=B.+Marroccoauthor=D.+Labellaauthor=E.+Novellinoauthor=A.+Matteviauthor=L.+Altucciauthor=A.+Tumberauthor=C.+Yappauthor=O.+N.+Kingauthor=R.+J.+Hopkinsonauthor=A.+Kawamuraauthor=C.+J.+Schofieldauthor=A.+Mai&title=Pan-histone+demethylase+inhibitors+simultaneously+targeting+Jumonji+C+and+lysine-specific+demethylases+display+high+anticancer+activities&doi=10.1021%2Fjm4012802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities</span></div><div class="casAuthors">Rotili, Dante; Tomassi, Stefano; Conte, Mariarosaria; Benedetti, Rosaria; Tortorici, Marcello; Ciossani, Giuseppe; Valente, Sergio; Marrocco, Biagina; Labella, Donatella; Novellino, Ettore; Mattevi, Andrea; Altucci, Lucia; Tumber, Anthony; Yapp, Clarence; King, Oliver N. F.; Hopkinson, Richard J.; Kawamura, Akane; Schofield, Christopher J.; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-55</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In prostate cancer, two different types of histone lysine demethylases (KDM), LSD1/KDM1 and JMJD2/KDM4, are coexpressed and colocalize with the androgen receptor.  We designed and synthesized hybrid LSD1/JmjC or "pan-KDM" inhibitors by coupling the skeleton of tranylcypromine, a known LSD1 inhibitor, with 4-carboxy-4'-carbomethoxy-2,2'-bipyridine or 5-carboxy-8-hydroxyquinoline , two 2-oxoglutarate competitive templates developed for JmjC inhibition.  Hybrid compds. are able to simultaneously target both KDM families and have been validated as potential antitumor agents in cells.  Among them,two compds. increase H3K4 and H3K9 methylation levels in cells and cause growth arrest and substantial apoptosis in LNCaP prostate and HCT116 colon cancer cells.  When tested in non-cancer mesenchymal progenitor (MePR) cells, two compds. induced little and no apoptosis, resp., thus showing cancer-selective inhibiting action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-XAvtMSKOmLVg90H21EOLACvtfcHk0lj-tIe-wb-bKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltL7P&md5=9dbdf51a5c6b9b2881da746eb3955e90</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm4012802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012802%26sid%3Dliteratum%253Aachs%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DConte%26aufirst%3DM.%26aulast%3DBenedetti%26aufirst%3DR.%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DMarrocco%26aufirst%3DB.%26aulast%3DLabella%26aufirst%3DD.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DKing%26aufirst%3DO.%2BN.%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DPan-histone%2520demethylase%2520inhibitors%2520simultaneously%2520targeting%2520Jumonji%2520C%2520and%2520lysine-specific%2520demethylases%2520display%2520high%2520anticancer%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D42%26epage%3D55%26doi%3D10.1021%2Fjm4012802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Regulation of LSD1 histone demethylase activity by its associated factors</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2005.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.molcel.2005.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=16140033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyhtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=857-864&author=Y.-J.+Shiauthor=C.+Matsonauthor=F.+Lanauthor=S.+Iwaseauthor=T.+Babaauthor=Y.+Shi&title=Regulation+of+LSD1+histone+demethylase+activity+by+its+associated+factors&doi=10.1016%2Fj.molcel.2005.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of LSD1 histone demethylase activity by its associated factors</span></div><div class="casAuthors">Shi, Yu-Jiang; Matson, Caitlin; Lan, Fei; Iwase, Shigeki; Baba, Tadashi; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">857-864</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">LSD1 is a recently identified human lysine (K)-specific histone demethylase.  LSD1 is assocd. with HDAC1/2, with CoREST, a SANT domain-contg. corepressor, and with BHC80, a PHD domain-contg. protein, among others.  We show that CoREST confers on LSD1 the ability to demethylate nucleosomal substrates and that it protects LSD1 from proteasomal degrdn. in vivo.  We find hyperacetylated nucleosomes less susceptible to CoREST/LSD1-mediated demethylation, suggesting that hypoacetylated nucleosomes may be the preferred physiol. substrates.  This raises the possibility that histone deacetylases and LSD1 may collaborate to generate a repressive chromatin environment.  Consistent with this model, TSA treatment results in derepression of LSD1 target genes.  While CoREST pos. regulates LSD1 function, BHC80 inhibits CoREST/LSD1-mediated demethylation in vitro and may therefore confer neg. regulation.  Taken together, these findings suggest that LSD1-mediated histone demethylation is regulated dynamically in vivo.  This is expected to have profound effects on gene expression under both physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraharVnxcaMLVg90H21EOLACvtfcHk0lj-tIe-wb-bKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyhtbzK&md5=34ba238112151c6596dd6f6c7caa043e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.-J.%26aulast%3DMatson%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DIwase%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRegulation%2520of%2520LSD1%2520histone%2520demethylase%2520activity%2520by%2520its%2520associated%2520factors%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D857%26epage%3D864%26doi%3D10.1016%2Fj.molcel.2005.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">A systematic review of histone lysine-specific demethylase 1 and its inhibitors</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1071</span>, <span class="refDoi"> DOI: 10.1002/med.21350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fmed.21350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yqtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1032-1071&author=Y.+C.+Zhengauthor=J.+Maauthor=Z.+Wangauthor=J.+Liauthor=B.+Jiangauthor=W.+Zhouauthor=X.+Shiauthor=X.+Wangauthor=W.+Zhaoauthor=H.+M.+Liu&title=A+systematic+review+of+histone+lysine-specific+demethylase+1+and+its+inhibitors&doi=10.1002%2Fmed.21350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors</span></div><div class="casAuthors">Zheng, Yi-Chao; Ma, Jinlian; Wang, Zhiru; Li, Jinfeng; Jiang, Bailing; Zhou, Wenjuan; Shi, Xiaojing; Wang, Xixin; Zhao, Wen; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1032-1071</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Histone lysine-specific demethylase 1 (LSD1) is the first discovered and reported histone demethylase by Dr. Shi Yang's group in 2004.  It is classified as a member of amine oxidase superfamily, the common feature of which is using the FAD (FAD) as its cofactor.  Since it is located in cell nucleus and acts as a histone methylation eraser, LSD1 specifically removes mono- or dimethylated histone H3 lysine 4 (H3K4) and H3 lysine 9 (H3K9) through formaldehyde-generating oxidn.  It has been indicated that LSD1 and its downstream targets are involved in a wide range of biol. courses, including embryonic development and tumor-cell growth and metastasis.  LSD1 has been reported to be overexpressed in variety of tumors.  Inactivating LSD1 or downregulating its expression inhibits cancer-cell development.  LSD1 targeting inhibitors may represent a new insight in anticancer drug discovery.  This review summarizes recent studies about LSD1 and mainly focuses on the basic physiol. function of LSD1 and its involved mechanisms in pathophysiol. conditions, as well as the development of LSD1 inhibitors as potential anticancer therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7JXHHRI-QAbVg90H21EOLACvtfcHk0lj-tIe-wb-bKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yqtrfN&md5=43b875856c2fe9f7a02857e7d6de73e6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fmed.21350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21350%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DA%2520systematic%2520review%2520of%2520histone%2520lysine-specific%2520demethylase%25201%2520and%2520its%2520inhibitors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2015%26volume%3D35%26spage%3D1032%26epage%3D1071%26doi%3D10.1002%2Fmed.21350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adejola, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusevich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeliazkov, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy Burman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eroglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proby, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwabe, J. W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alani, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">53</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02242-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fs41467-017-02242-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29302039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC1MznsFKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=53&author=J.+H.+Kalinauthor=M.+Wuauthor=A.+V.+Gomezauthor=Y.+Songauthor=J.+Dasauthor=D.+Haywardauthor=N.+Adejolaauthor=M.+Wuauthor=I.+Panovaauthor=H.+J.+Chungauthor=E.+Kimauthor=H.+J.+Robertsauthor=J.+M.+Robertsauthor=P.+Prusevichauthor=J.+R.+Jeliazkovauthor=S.+S.+Roy+Burmanauthor=L.+Fairallauthor=C.+Milanoauthor=A.+Erogluauthor=C.+M.+Probyauthor=A.+T.+Dinkova-Kostovaauthor=W.+W.+Hancockauthor=J.+J.+Grayauthor=J.+E.+Bradnerauthor=S.+Valenteauthor=A.+Maiauthor=N.+M.+Andersauthor=M.+A.+Rudekauthor=Y.+Huauthor=B.+Ryuauthor=J.+W.+R.+Schwabeauthor=A.+Matteviauthor=R.+M.+Alaniauthor=P.+A.+Cole&title=Targeting+the+CoREST+complex+with+dual+histone+deacetylase+and+demethylase+inhibitors&doi=10.1038%2Fs41467-017-02242-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors</span></div><div class="casAuthors">Kalin Jay H; Wu Mingxuan; Cole Philip A; Kalin Jay H; Das Jayanta; Hayward Dawn; Adejola Nkosi; Wu Mingxuan; Prusevich Polina; Eroglu Abdulkerim; Dinkova-Kostova Albena T; Cole Philip A; Wu Muzhou; Panova Izabela; Chung Hye Jin; Kim Edward; Roberts Holly J; Ryu Byungwoo; Alani Rhoda M; Gomez Andrea V; Mattevi Andrea; Song Yun; Fairall Louise; Milano Charles; Schwabe John W R; Roberts Justin M; Bradner James E; Jeliazkov Jeliazko R; Gray Jeffrey J; Roy Burman Shourya S; Gray Jeffrey J; Proby Charlotte M; Dinkova-Kostova Albena T; Hancock Wayne W; Gray Jeffrey J; Anders Nicole M; Rudek Michelle A; Valente Sergio; Mai Antonello; Hu Yong</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Here we report corin, a synthetic hybrid agent derived from the class I HDAC inhibitor (entinostat) and an LSD1 inhibitor (tranylcypromine analog).  Enzymologic analysis reveals that corin potently targets the CoREST complex and shows more sustained inhibition of CoREST complex HDAC activity compared with entinostat.  Cell-based experiments demonstrate that corin exhibits a superior anti-proliferative profile against several melanoma lines and cutaneous squamous cell carcinoma lines compared to its parent monofunctional inhibitors but is less toxic to melanocytes and keratinocytes.  CoREST knockdown, gene expression, and ChIP studies suggest that corin's favorable pharmacologic effects may rely on an intact CoREST complex.  Corin was also effective in slowing tumor growth in a melanoma mouse xenograft model.  These studies highlight the promise of a new class of two-pronged hybrid agents that may show preferential targeting of particular epigenetic regulatory complexes and offer unique therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6q8vQkB-NEHl8icjszYl0fW6udTcc2eZD72DHFPabvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MznsFKiug%253D%253D&md5=83e70e824d89f6148286a69ae2868731</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02242-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02242-4%26sid%3Dliteratum%253Aachs%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DA.%2BV.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DHayward%26aufirst%3DD.%26aulast%3DAdejola%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DPanova%26aufirst%3DI.%26aulast%3DChung%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DH.%2BJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DPrusevich%26aufirst%3DP.%26aulast%3DJeliazkov%26aufirst%3DJ.%2BR.%26aulast%3DRoy%2BBurman%26aufirst%3DS.%2BS.%26aulast%3DFairall%26aufirst%3DL.%26aulast%3DMilano%26aufirst%3DC.%26aulast%3DEroglu%26aufirst%3DA.%26aulast%3DProby%26aufirst%3DC.%2BM.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DGray%26aufirst%3DJ.%2BJ.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DAnders%26aufirst%3DN.%2BM.%26aulast%3DRudek%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DRyu%26aufirst%3DB.%26aulast%3DSchwabe%26aufirst%3DJ.%2BW.%2BR.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DAlani%26aufirst%3DR.%2BM.%26aulast%3DCole%26aufirst%3DP.%2BA.%26atitle%3DTargeting%2520the%2520CoREST%2520complex%2520with%2520dual%2520histone%2520deacetylase%2520and%2520demethylase%2520inhibitors%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D53%26doi%3D10.1038%2Fs41467-017-02242-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastas, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zee, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrescu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nocco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonal, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suva, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filbin, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2019.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ccell.2019.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31631026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVSlsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=528-544&author=J.+N.+Anastasauthor=B.+M.+Zeeauthor=J.+H.+Kalinauthor=M.+Kimauthor=R.+Guoauthor=S.+Alexandrescuauthor=M.+A.+Blancoauthor=S.+Gieraauthor=S.+M.+Gillespieauthor=J.+Dasauthor=M.+Wuauthor=S.+Noccoauthor=D.+M.+Bonalauthor=Q.-D.+Nguyenauthor=M.+L.+Suvaauthor=B.+E.+Bernsteinauthor=R.+Alaniauthor=T.+R.+Golubauthor=P.+A.+Coleauthor=M.+G.+Filbinauthor=Y.+Shi&title=Re-programing+chromatin+with+a+bifunctional+LSD1%2FHDAC+inhibitor+induces+therapeutic+differentiation+in+DIPG&doi=10.1016%2Fj.ccell.2019.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG</span></div><div class="casAuthors">Anastas, Jamie N.; Zee, Barry M.; Kalin, Jay H.; Kim, Mirhee; Guo, Robyn; Alexandrescu, Sanda; Blanco, Mario Andres; Giera, Stefanie; Gillespie, Shawn M.; Das, Jayanta; Wu, Muzhou; Nocco, Sarah; Bonal, Dennis M.; Nguyen, Quang-De; Suva, Mario L.; Bernstein, Bradley E.; Alani, Rhoda; Golub, Todd R.; Cole, Philip A.; Filbin, Mariella G.; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">528-544.e10</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">H3K27M mutations resulting in epigenetic dysfunction are frequently obsd. in diffuse intrinsic pontine glioma (DIPGs), an incurable pediatric cancer.  We conduct a CRISPR screen revealing that knockout of KDM1A encoding lysine-specific demethylase 1 (LSD1) sensitizes DIPG cells to histone deacetylase (HDAC) inhibitors.  Consistently, Corin, a bifunctional inhibitor of HDACs and LSD1, potently inhibits DIPG growth in vitro and in xenografts.  Mechanistically, Corin increases H3K27me3 levels suppressed by H3K27M histones, and simultaneously increases HDAC-targeted H3K27ac and LSD1-targeted H3K4me1 at differentiation-assocd. genes.  Corin treatment induces cell death, cell-cycle arrest, and a cellular differentiation phenotype and drives transcriptional changes correlating with increased survival time in DIPG patients.  These data suggest a strategy for treating DIPG by simultaneously inhibiting LSD1 and HDACs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHX1Q6HDJoobVg90H21EOLACvtfcHk0lgHVoixV1Hkgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVSlsr%252FL&md5=32c4c2c7f032812a95d424b19ca7039e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2019.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2019.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DAnastas%26aufirst%3DJ.%2BN.%26aulast%3DZee%26aufirst%3DB.%2BM.%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DAlexandrescu%26aufirst%3DS.%26aulast%3DBlanco%26aufirst%3DM.%2BA.%26aulast%3DGiera%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DS.%2BM.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DNocco%26aufirst%3DS.%26aulast%3DBonal%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DQ.-D.%26aulast%3DSuva%26aufirst%3DM.%2BL.%26aulast%3DBernstein%26aufirst%3DB.%2BE.%26aulast%3DAlani%26aufirst%3DR.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DFilbin%26aufirst%3DM.%2BG.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRe-programing%2520chromatin%2520with%2520a%2520bifunctional%2520LSD1%252FHDAC%2520inhibitor%2520induces%2520therapeutic%2520differentiation%2520in%2520DIPG%26jtitle%3DCancer%2520Cell%26date%3D2019%26volume%3D36%26spage%3D528%26epage%3D544%26doi%3D10.1016%2Fj.ccell.2019.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turrini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catanzaro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimognari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span> <span> </span><span class="NLM_article-title">Novel polyamine-based histone deacetylases-lysine demethylase 1 dual binding inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1001</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.02.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2018.02.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29496367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsF2ktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1001-1004&author=A.+Milelliauthor=C.+Marchettiauthor=E.+Turriniauthor=E.+Catanzaroauthor=R.+Mazzoneauthor=D.+Tomaselliauthor=C.+Fimognariauthor=V.+Tumiattiauthor=A.+Minarini&title=Novel+polyamine-based+histone+deacetylases-lysine+demethylase+1+dual+binding+inhibitors&doi=10.1016%2Fj.bmcl.2018.02.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors</span></div><div class="casAuthors">Milelli, Andrea; Marchetti, Chiara; Turrini, Eleonora; Catanzaro, Elena; Mazzone, Roberta; Tomaselli, Daniela; Fimognari, Carmela; Tumiatti, Vincenzo; Minarini, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1001-1004</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Epigenetic modulators Histone deacetylases (HDACs) and Lysine demethylase (LSD1) are validated targets for anticancer therapy.  Both HDAC1/2 and LSD1 are found in assocn. with the repressor protein Co-REST in a transcriptional corepressor complex, which is responsible for gene silencing.  Combined modulation of both targets results in a synergistic antiproliferative activity.  In the present investigation, the authors report about the design and synthesis of a series of polyamine-based HDACs-LSD1 dual binding inhibitors obtained by coupling Vorinostat and Tranylcypromine.  Compd. I emerged as the most promising of the synthesized series, showing good inhibitory activity towards HDAC1 and LSD1 either in vitro and in cell-based assay (Ki = 42.52±8.94 nM and IC50 = 3.85 μM, resp.).  Furthermore, at 70.0 μM compd. I induced a more pronounced cytotoxic effect than Vorinostat (68.6% vs. 56.6% of dead cells) in MCF7 cancer cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT9vK3NTBBprVg90H21EOLACvtfcHk0lhT1oD5StbcEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsF2ktL4%253D&md5=3821c6837a93fc19c03e6f3cb5ea848f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.02.034%26sid%3Dliteratum%253Aachs%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DTurrini%26aufirst%3DE.%26aulast%3DCatanzaro%26aufirst%3DE.%26aulast%3DMazzone%26aufirst%3DR.%26aulast%3DTomaselli%26aufirst%3DD.%26aulast%3DFimognari%26aufirst%3DC.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMinarini%26aufirst%3DA.%26atitle%3DNovel%2520polyamine-based%2520histone%2520deacetylases-lysine%2520demethylase%25201%2520dual%2520binding%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D1001%26epage%3D1004%26doi%3D10.1016%2Fj.bmcl.2018.02.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasinghe, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woster, P. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1021/ml4002997</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4002997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=29-33&author=I.+R.+Kumarasingheauthor=P.+M.+Woster&title=Synthesis+and+evaluation+of+novel+cyclic+Peptide+inhibitors+of+lysine-specific+demethylase+1&doi=10.1021%2Fml4002997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Novel Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1</span></div><div class="casAuthors">Kumarasinghe, Isuru R.; Woster, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) selectively removes Me groups from mono- and dimethylated histone 3 lysine 4 (H3K4), resulting in gene silencing.  LSD1 is overexpressed in many human cancers, resulting in aberrant silencing of tumor suppressor genes.  Thus, LSD1 is a validated target for the discovery of antitumor agents.  Using a ligand-based approach, the authors designed and synthesized a series of cyclic and linear peptides that are effective inhibitors of LSD1.  Linear peptide 7 and cyclic peptide 9 inhibited LSD1 in vitro by 91 and 94%, resp., at a concn. of 10 μM.  Compd. 9 was a potent LSD1 inhibitor (IC50 = 2.1 μM; Ki = 385 nM) and had moderate antitumor activity in the MCF-7 and Calu-6 cell lines in vitro.  Importantly, 9 is significantly more stable to hydrolysis in rat plasma than the linear analog 7.  The cyclic peptides described herein represent important lead structures in the search for inhibitors of flavin-dependent histone demethylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZKg9n5W93bVg90H21EOLACvtfcHk0lhT1oD5StbcEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrsr3F&md5=65810b4100bf4fb4fb10c204e77f88a0</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fml4002997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4002997%26sid%3Dliteratum%253Aachs%26aulast%3DKumarasinghe%26aufirst%3DI.%2BR.%26aulast%3DWoster%26aufirst%3DP.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520cyclic%2520Peptide%2520inhibitors%2520of%2520lysine-specific%2520demethylase%25201%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D29%26epage%3D33%26doi%3D10.1021%2Fml4002997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrello, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tardugno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellore, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabb, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1677</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1021/cb4001926</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4001926" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1677-1682&author=M.+Tortoriciauthor=M.+T.+Borrelloauthor=M.+Tardugnoauthor=L.+R.+Chiarelliauthor=S.+Pilottoauthor=G.+Ciossaniauthor=N.+A.+Velloreauthor=S.+G.+Baileyauthor=J.+Cowanauthor=M.+O%E2%80%99Connellauthor=S.+J.+Crabbauthor=G.+Packhamauthor=A.+Maiauthor=R.+Baronauthor=A.+Ganesanauthor=A.+Mattevi&title=Protein+recognition+by+short+peptide+reversible+inhibitors+of+the+chromatin-modifying+LSD1%2FCoREST+lysine+demethylase&doi=10.1021%2Fcb4001926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylase</span></div><div class="casAuthors">Tortorici, Marcello; Borrello, Maria Teresa; Tardugno, Maria; Chiarelli, Laurent R.; Pilotto, Simona; Ciossani, Giuseppe; Vellore, Nadeem A.; Bailey, Sarah G.; Cowan, Jonathan; O'Connell, Maria; Crabb, Simon J.; Packham, Graham; Mai, Antonello; Baron, Riccardo; Ganesan, A.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1677-1682</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The combinatorial assembly of protein complexes is at the heart of chromatin biol.  Lysine demethylase LSD1(KDM1A)/CoREST beautifully exemplifies this concept.  The active site of the enzyme tightly assocs. to the N-terminal domain of transcription factors of the SNAIL1 family, which therefore can competitively inhibit the binding of the N-terminal tail of the histone substrate.  Our enzymic, crystallog., spectroscopic, and computational studies reveal that LSD1/CoREST can bind to a hexapeptide derived from the SNAIL sequence through recognition of a pos. charged α-helical turn that forms upon binding to the enzyme.  Variations in sequence and length of this six amino acid ligand modulate affinities enabling the same binding site to differentially interact with proteins that exert distinct biol. functions.  The discovered short peptide inhibitors exhibit antiproliferative activities and lay the foundation for the development of peptidomimetic small mol. inhibitors of LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7SufQOwK-y7Vg90H21EOLACvtfcHk0lhT1oD5StbcEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVCmt7g%253D&md5=a8479b513e392e8acb78979e116dcffa</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fcb4001926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4001926%26sid%3Dliteratum%253Aachs%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DBorrello%26aufirst%3DM.%2BT.%26aulast%3DTardugno%26aufirst%3DM.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DPilotto%26aufirst%3DS.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DVellore%26aufirst%3DN.%2BA.%26aulast%3DBailey%26aufirst%3DS.%2BG.%26aulast%3DCowan%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DM.%26aulast%3DCrabb%26aufirst%3DS.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DProtein%2520recognition%2520by%2520short%2520peptide%2520reversible%2520inhibitors%2520of%2520the%2520chromatin-modifying%2520LSD1%252FCoREST%2520lysine%2520demethylase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1677%26epage%3D1682%26doi%3D10.1021%2Fcb4001926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuhara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">8620</span>– <span class="NLM_lpage">8624</span>, <span class="refDoi"> DOI: 10.1002/anie.201303999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fanie.201303999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGrsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=8620-8624&author=D.+Ogasawaraauthor=Y.+Itohauthor=H.+Tsumotoauthor=T.+Kakizawaauthor=K.+Minoauthor=K.+Fukuharaauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyataauthor=T.+Suzuki&title=Lysine-specific+demethylase+1-selective+inactivators%3A+protein-targeted+drug+delivery+mechanism&doi=10.1002%2Fanie.201303999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-specific demethylase 1-selective inactivators: Protein-targeted drug delivery mechanism</span></div><div class="casAuthors">Ogasawara, Daisuke; Itoh, Yukihiro; Tsumoto, Hiroki; Kakizawa, Taeko; Mino, Koshiki; Fukuhara, Kiyoshi; Nakagawa, Hidehiko; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio; Miyata, Naoki; Suzuki, Takayoshi</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">8620-8624</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of novel LSD1 (LSD1 = lysine-specific demethylase) inactivators based on new concept of LSD1-targeted PCPA (PCPA = trans-2-phenylcyclopropylamine) delivery have been designed.  This concept was tested with peptide 1a [1a = (ART-X-QTARKSTGGKAPRKQLA)] X = (I) and confirmed that 1a does indeed inhibit LSD1 selectively and efficiently by delivering PCPA directly to the LSD1 active site.  The enzyme is then inactivated by FAD-PCPA adduct formation, as in the case of PCPA itself.  This strategy could be applied to the design of nonpeptide, small-mol. LSD1 inactivators.  Mechanistic studies and biol. evaluations revealed that these small-mol. compds. are potent LSD1-selective inactivators (comparable to peptide 1a) in enzyme assays, and they also exhibit potent cell growth inhibitory activities against cancer cell lines.  This is the first time that a drug-carrier-type system has been employed to target a specific mol.  These novel LSD1-selective inactivators are considered to be candidates for anticancer agents, as well as bioprobes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqQOLhLwmv9rVg90H21EOLACvtfcHk0lg4vmJXZ_tSfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGrsbnF&md5=71bd05a50aeb73431444f2588fba2dac</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fanie.201303999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201303999%26sid%3Dliteratum%253Aachs%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DKakizawa%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DFukuhara%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DLysine-specific%2520demethylase%25201-selective%2520inactivators%253A%2520protein-targeted%2520drug%2520delivery%2520mechanism%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D8620%26epage%3D8624%26doi%3D10.1002%2Fanie.201303999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kakizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span> <span> </span><span class="NLM_article-title">Histone H3 peptide based LSD1-selective inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1925</span>– <span class="NLM_lpage">1928</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2015.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25827526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1925-1928&author=T.+Kakizawaauthor=Y.+Otaauthor=Y.+Itohauthor=H.+Tsumotoauthor=T.+Suzuki&title=Histone+H3+peptide+based+LSD1-selective+inhibitors&doi=10.1016%2Fj.bmcl.2015.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Histone H3 peptide based LSD1-selective inhibitors</span></div><div class="casAuthors">Kakizawa, Taeko; Ota, Yosuke; Itoh, Yukihiro; Tsumoto, Hiroki; Suzuki, Takayoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1925-1928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of candidates for the histone H3 peptide based LSD1-selective inhibitor were designed and synthesized.  Among peptides, ART-X-QTARKSTGGKAPRKQLA and ARTKQTAR-X-STGGKAPRKQLA [X = substituted with phenylcyclopropylamine, 5-dihydro-1H-pyrrole and 1,2,3,6-tetrahydropyridine lysine (I), (II) and (III)].  Peptide ART-I-QTARKSTGGKAPRKQLA, which has a phenylcyclopropylamine (PCPA) moiety at Lys-4 of the 21 amino acid residues of histone H3, was the most potent LSD1-selective inhibitor.  Truncation studies of peptide ART-I-QTARKSTGGKAPRKQLA revealed the significance of the peptide sequence length.  These findings will be useful for the further development of histone H3 peptide based LSD1-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxO8fMkITrQ7Vg90H21EOLACvtfcHk0lg4vmJXZ_tSfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgs7Y%253D&md5=1ea3add93c3eaa8a367433a6ddcb4dd9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DKakizawa%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DHistone%2520H3%2520peptide%2520based%2520LSD1-selective%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1925%26epage%3D1928%26doi%3D10.1016%2Fj.bmcl.2015.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis, LSD1 inhibitory activity, and LSD1 binding model of optically pure lysine-PCPA conjugates</span>. <i>Comput. Struct. Biotechnol. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e201402002</span> <span class="refDoi"> DOI: 10.5936/csbj.201402002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.5936%2Fcsbj.201402002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=24757500" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=Y.+Itohauthor=D.+Ogasawaraauthor=Y.+Otaauthor=T.+Mizukamiauthor=T.+Suzuki&title=Synthesis%2C+LSD1+inhibitory+activity%2C+and+LSD1+binding+model+of+optically+pure+lysine-PCPA+conjugates&doi=10.5936%2Fcsbj.201402002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.5936%2Fcsbj.201402002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5936%252Fcsbj.201402002%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520LSD1%2520inhibitory%2520activity%252C%2520and%2520LSD1%2520binding%2520model%2520of%2520optically%2520pure%2520lysine-PCPA%2520conjugates%26jtitle%3DComput.%2520Struct.%2520Biotechnol.%2520J.%26date%3D2014%26volume%3D9%26doi%3D10.5936%2Fcsbj.201402002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Etani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, T.</span></span> <span> </span><span class="NLM_article-title">Mp11-03 Novel selective lysine-specific demethylase 1 inhibitors suppress testicular tumor cell proliferation</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>203</i></span>, <span class="NLM_elocation-id">e135</span> <span class="refDoi"> DOI: 10.1097/JU.0000000000000831.03</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1097%2FJU.0000000000000831.03" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2020&author=T.+Etaniauthor=T.+Naikiauthor=S.+Nozakiauthor=T.+Nagaiauthor=K.+Iidaauthor=R.+Andoauthor=N.+Kawaiauthor=S.+Takahashiauthor=T.+Suzukiauthor=T.+Yasui&title=Mp11-03+Novel+selective+lysine-specific+demethylase+1+inhibitors+suppress+testicular+tumor+cell+proliferation&doi=10.1097%2FJU.0000000000000831.03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1097%2FJU.0000000000000831.03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJU.0000000000000831.03%26sid%3Dliteratum%253Aachs%26aulast%3DEtani%26aufirst%3DT.%26aulast%3DNaiki%26aufirst%3DT.%26aulast%3DNozaki%26aufirst%3DS.%26aulast%3DNagai%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DR.%26aulast%3DKawai%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYasui%26aufirst%3DT.%26atitle%3DMp11-03%2520Novel%2520selective%2520lysine-specific%2520demethylase%25201%2520inhibitors%2520suppress%2520testicular%2520tumor%2520cell%2520proliferation%26jtitle%3DJ.%2520Urol.%26date%3D2020%26volume%3D203%26doi%3D10.1097%2FJU.0000000000000831.03" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz-Fincke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greve, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubbert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludeke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity studies on N-substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2017.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29247860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFyju7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2018&pages=52-67&author=J.+Schulz-Finckeauthor=M.+Hauauthor=J.+Barthauthor=D.+Robaaauthor=D.+Willmannauthor=A.+Kurnerauthor=J.+Haasauthor=G.+Greveauthor=T.+Haydnauthor=S.+Fuldaauthor=M.+Lubbertauthor=S.+Ludekeauthor=T.+Bergauthor=W.+Sipplauthor=R.+Schuleauthor=M.+Jung&title=Structure-activity+studies+on+N-substituted+tranylcypromine+derivatives+lead+to+selective+inhibitors+of+lysine+specific+demethylase+1+%28LSD1%29+and+potent+inducers+of+leukemic+cell+differentiation&doi=10.1016%2Fj.ejmech.2017.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation</span></div><div class="casAuthors">Schulz-Fincke, Johannes; Hau, Mirjam; Barth, Jessica; Robaa, Dina; Willmann, Dominica; Kuerner, Andreas; Haas, Julian; Greve, Gabriele; Haydn, Tinka; Fulda, Simone; Luebbert, Michael; Luedeke, Steffen; Berg, Tobias; Sippl, Wolfgang; Schuele, Roland; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-67</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">FAD-dependent lysine-specific demethylase 1 (LSD1) is overexpressed or deregulated in many cancers such as AML and prostate cancer and hence is a promising anticancer target with first inhibitors in clin. trials.  Clin. candidates are N-substituted derivs. of the dual LSD1-/monoamine oxidase-inhibitor tranylcypromine (2-PCPA) with a basic amine function in the N-substituent.  These derivs. are selective over monoamine oxidases.  So far, only very limited information on structure-activity studies about this important class of LSD1 inhibitors is published in peer reviewed journals.  Here, we show that N-substituted 2-PCPA derivs. without a basic function or even a polar group are still potent inhibitors of LSD1 in vitro and effectively inhibit colony formation of leukemic cells in culture.  Yet, these lipophilic inhibitors also block the structurally related monoamine oxidases (MAO-A and MAO-B), which may be of interest for the treatment of neurodegenerative disorders, but this property is undesired for applications in cancer treatment.  The introduction of a polar, non-basic function led to optimized structures that retain potent LSD1 inhibitors but exhibit selectivity over MAOs and are highly potent in the suppression of colony formation of cultured leukemic cells.  Cellular target engagement is shown via a Cellular Thermal Shift Assay (CETSA) for LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS7XCIKeZiVrVg90H21EOLACvtfcHk0lg1smJj9eqt5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFyju7zN&md5=f9460e47baf69fb33d4e314564591bd4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz-Fincke%26aufirst%3DJ.%26aulast%3DHau%26aufirst%3DM.%26aulast%3DBarth%26aufirst%3DJ.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DWillmann%26aufirst%3DD.%26aulast%3DKurner%26aufirst%3DA.%26aulast%3DHaas%26aufirst%3DJ.%26aulast%3DGreve%26aufirst%3DG.%26aulast%3DHaydn%26aufirst%3DT.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DLubbert%26aufirst%3DM.%26aulast%3DLudeke%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DStructure-activity%2520studies%2520on%2520N-substituted%2520tranylcypromine%2520derivatives%2520lead%2520to%2520selective%2520inhibitors%2520of%2520lysine%2520specific%2520demethylase%25201%2520%2528LSD1%2529%2520and%2520potent%2520inducers%2520of%2520leukemic%2520cell%2520differentiation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D144%26spage%3D52%26epage%3D67%26doi%3D10.1016%2Fj.ejmech.2017.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somervaille, T. C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arevalo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xaus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, R.</span></span> <span> </span><span class="NLM_article-title">Iadademstat shows efficacy in elderly AML patients in combination with azacitidine. Alice Trial</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">3839</span>– <span class="NLM_lpage">3839</span>, <span class="refDoi"> DOI: 10.1182/blood-2019-125121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1182%2Fblood-2019-125121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2019&pages=3839-3839&author=C.+Buesaauthor=T.+C.+P.+Somervailleauthor=M.+Arevaloauthor=J.+Xausauthor=S.+Gutierrezauthor=R.+Bullock&title=Iadademstat+shows+efficacy+in+elderly+AML+patients+in+combination+with+azacitidine.+Alice+Trial&doi=10.1182%2Fblood-2019-125121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1182%2Fblood-2019-125121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2019-125121%26sid%3Dliteratum%253Aachs%26aulast%3DBuesa%26aufirst%3DC.%26aulast%3DSomervaille%26aufirst%3DT.%2BC.%2BP.%26aulast%3DArevalo%26aufirst%3DM.%26aulast%3DXaus%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DS.%26aulast%3DBullock%26aufirst%3DR.%26atitle%3DIadademstat%2520shows%2520efficacy%2520in%2520elderly%2520AML%2520patients%2520in%2520combination%2520with%2520azacitidine.%2520Alice%2520Trial%26jtitle%3DBlood%26date%3D2019%26volume%3D134%26spage%3D3839%26epage%3D3839%26doi%3D10.1182%2Fblood-2019-125121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carceller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span> <span> </span><span class="NLM_article-title">Advances in the development of histone lysine demethylase inhibitors</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.coph.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=26057211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1Slt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=52-60&author=T.+Maesauthor=E.+Carcellerauthor=J.+Salasauthor=A.+Ortegaauthor=C.+Buesa&title=Advances+in+the+development+of+histone+lysine+demethylase+inhibitors&doi=10.1016%2Fj.coph.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the development of histone lysine demethylase inhibitors</span></div><div class="casAuthors">Maes, Tamara; Carceller, Elena; Salas, Jordi; Ortega, Alberto; Buesa, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-60</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The covalent modification of histones is closely assocd. with regulation of gene transcription.  Chromatin modifications have been suggested to represent an epigenetic code that is dynamically 'written' and 'erased' by specialized proteins, and 'read', or interpreted, by proteins that translate the code into gene expression changes.  Initially thought to be an irreversible process, histone methylation is now known to be reversed by demethylases, FAD dependent amineoxidases and by iron(II)-alpha-ketoglutarate dependent deoxygenases of the Jumonji family.  Altered histone demethylase activities have been assocd. with human disease, including cancer.  The first wave of novel investigational drugs directed against KDM1A has recently entered the clinic, and the first specific inhibitor targeting a Jumonji KDM is advancing in preclin. regulatory studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCr97IlCYFrVg90H21EOLACvtfcHk0lg1smJj9eqt5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1Slt7o%253D&md5=02e8a5f8d426743be1eb209c329bd3ed</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DT.%26aulast%3DCarceller%26aufirst%3DE.%26aulast%3DSalas%26aufirst%3DJ.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DBuesa%26aufirst%3DC.%26atitle%3DAdvances%2520in%2520the%2520development%2520of%2520histone%2520lysine%2520demethylase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2015%26volume%3D23%26spage%3D52%26epage%3D60%26doi%3D10.1016%2Fj.coph.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bose, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konopleva, M. Y.</span></span> <span> </span><span class="NLM_article-title">ORY-1001: Overcoming the differentiation block in AML</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ccell.2018.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29533778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksVent7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=342-343&author=P.+Boseauthor=M.+Y.+Konopleva&title=ORY-1001%3A+Overcoming+the+differentiation+block+in+AML&doi=10.1016%2Fj.ccell.2018.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">ORY-1001: Overcoming the Differentiation Block in AML</span></div><div class="casAuthors">Bose, Prithviraj; Konopleva, Marina Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-343</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In this issue of Cancer Cell, Maes and colleagues report in vitro and in vivo findings with ORY-1001-an oral, highly potent and selective covalent small-mol. inhibitor of lysine-specific demethylase 1 (LSD1)-in development for acute myeloid leukemia (AML), as well as correlative data from two AML patients receiving ORY-1001.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHnFqnbjs2W7Vg90H21EOLACvtfcHk0lg1smJj9eqt5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksVent7s%253D&md5=cf628b6d2e99903626cedc4b497aacdb</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DP.%26aulast%3DKonopleva%26aufirst%3DM.%2BY.%26atitle%3DORY-1001%253A%2520Overcoming%2520the%2520differentiation%2520block%2520in%2520AML%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26spage%3D342%26epage%3D343%26doi%3D10.1016%2Fj.ccell.2018.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mill, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNardo, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthakur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadia, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K. N.</span></span> <span> </span><span class="NLM_article-title">Synergistic pre-clinical activity of targeted inhibition of KDM1A and BET proteins against human AML blast progenitor cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">3930</span>– <span class="NLM_lpage">3930</span>, <span class="refDoi"> DOI: 10.1182/blood-2018-99-114198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1182%2Fblood-2018-99-114198" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2018&pages=3930-3930&author=W.+Fiskusauthor=C.+P.+Millauthor=R.+Soldiauthor=R.+Hanauthor=D.+T.+Saenzauthor=A.+J.+Nowakauthor=B.+Sunauthor=D.+N.+Saenzauthor=C.+D.+DiNardoauthor=G.+Borthakurauthor=T.+M.+Kadiaauthor=W.+Jinauthor=T.+Ganeshauthor=V.+Raoauthor=J.+D.+Khouryauthor=S.+Sharmaauthor=K.+N.+Bhalla&title=Synergistic+pre-clinical+activity+of+targeted+inhibition+of+KDM1A+and+BET+proteins+against+human+AML+blast+progenitor+cells&doi=10.1182%2Fblood-2018-99-114198"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1182%2Fblood-2018-99-114198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2018-99-114198%26sid%3Dliteratum%253Aachs%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DMill%26aufirst%3DC.%2BP.%26aulast%3DSoldi%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DR.%26aulast%3DSaenz%26aufirst%3DD.%2BT.%26aulast%3DNowak%26aufirst%3DA.%2BJ.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DSaenz%26aufirst%3DD.%2BN.%26aulast%3DDiNardo%26aufirst%3DC.%2BD.%26aulast%3DBorthakur%26aufirst%3DG.%26aulast%3DKadia%26aufirst%3DT.%2BM.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DRao%26aufirst%3DV.%26aulast%3DKhoury%26aufirst%3DJ.%2BD.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26atitle%3DSynergistic%2520pre-clinical%2520activity%2520of%2520targeted%2520inhibition%2520of%2520KDM1A%2520and%2520BET%2520proteins%2520against%2520human%2520AML%2520blast%2520progenitor%2520cells%26jtitle%3DBlood%26date%3D2018%26volume%3D132%26spage%3D3930%26epage%3D3930%26doi%3D10.1182%2Fblood-2018-99-114198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Augert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunblatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liggitt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacPherson, D.</span></span> <span> </span><span class="NLM_article-title">Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">eaau2922</span> <span class="refDoi"> DOI: 10.1126/scisignal.aau2922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1126%2Fscisignal.aau2922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30723171" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&author=A.+Augertauthor=E.+Eastwoodauthor=A.+H.+Ibrahimauthor=N.+Wuauthor=E.+Grunblattauthor=R.+Basomauthor=D.+Liggittauthor=K.+D.+Eatonauthor=R.+Martinsauthor=J.+T.+Poirierauthor=C.+M.+Rudinauthor=F.+Millettiauthor=W.+Y.+Chengauthor=F.+Mackauthor=D.+MacPherson&title=Targeting+NOTCH+activation+in+small+cell+lung+cancer+through+LSD1+inhibition&doi=10.1126%2Fscisignal.aau2922"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aau2922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aau2922%26sid%3Dliteratum%253Aachs%26aulast%3DAugert%26aufirst%3DA.%26aulast%3DEastwood%26aufirst%3DE.%26aulast%3DIbrahim%26aufirst%3DA.%2BH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DGrunblatt%26aufirst%3DE.%26aulast%3DBasom%26aufirst%3DR.%26aulast%3DLiggitt%26aufirst%3DD.%26aulast%3DEaton%26aufirst%3DK.%2BD.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DJ.%2BT.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DW.%2BY.%26aulast%3DMack%26aufirst%3DF.%26aulast%3DMacPherson%26aufirst%3DD.%26atitle%3DTargeting%2520NOTCH%2520activation%2520in%2520small%2520cell%2520lung%2520cancer%2520through%2520LSD1%2520inhibition%26jtitle%3DSci.%2520Signaling%26date%3D2019%26volume%3D12%26doi%3D10.1126%2Fscisignal.aau2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuyas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumuzio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosch-Barrera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Castillo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encinar, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, J. A.</span></span> <span> </span><span class="NLM_article-title">The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes</span>. <i>Aging</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4794</span>– <span class="NLM_lpage">4814</span>, <span class="refDoi"> DOI: 10.18632/aging.102887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.18632%2Faging.102887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32191225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlansbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=4794-4814&author=E.+Cuyasauthor=J.+Gumuzioauthor=S.+Verduraauthor=J.+Brunetauthor=J.+Bosch-Barreraauthor=B.+Martin-Castilloauthor=T.+Alarconauthor=J.+A.+Encinarauthor=A.+G.+Martinauthor=J.+A.+Menendez&title=The+LSD1+inhibitor+iadademstat+%28ORY-1001%29+targets+SOX2-driven+breast+cancer+stem+cells%3A+a+potential+epigenetic+therapy+in+luminal-B+and+HER2-positive+breast+cancer+subtypes&doi=10.18632%2Faging.102887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes</span></div><div class="casAuthors">Cuyas, Elisabet; Gumuzio, Juan; Verdura, Sara; Brunet, Joan; Bosch-Barrera, Joaquim; Martin-Castillo, Begona; Alarcon, Tomas; Encinar, Jose Antonio; Martin, Angel G.; Menendez, Javier A.</div><div class="citationInfo"><span class="NLM_cas:title">Aging</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4794-4813</span>CODEN:
                <span class="NLM_cas:coden">AGINCN</span>;
        ISSN:<span class="NLM_cas:issn">1945-4589</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">SOX2 is a core pluripotency-assocd. transcription factor causally related to cancer initiation, aggressiveness, and drug resistance by driving the self-renewal and seeding capacity of cancer stem cells (CSC).  Here, we tested the ability of the clin. proven inhibitor of the lysine-specific demethylase 1 (LSD1/KDM1A) iadademstat (ORY-100) to target SOX2-driven CSC in breast cancer.  Iadademstat blocked CSC-driven mammosphere formation in breast cancer cell lines that are dependent on SOX2 expression to maintain their CSC phenotype.  Iadademstat prevented the activation of an LSD1-targeted stemness-specific SOX2 enhancer in CSC-enriched 3-dimensional spheroids.  Using high-throughput transcriptional data available from the METABRIC dataset, high expression of SOX2 was significantly more common in luminal-B and HER2- enriched subtypes according to PAM50 classifier and in IntClust1 (high proliferating luminal-B) and IntClust 5 (luminal-B and HER2-amplified) according to integrative clustering.  Iadademstat significantly reduced mammospheres formation by CSC-like cells from a multidrug-resistant luminal-B breast cancer patient-derived xenograft but not of those from a treatment-na.ovrddot.ive luminal-A patient.  Iadademstat reduced the expression of SOX2 in luminal-B but not in luminal-A mammospheres, likely indicating a selective targeting of SOX2-driven CSC.  The therapeutic relevance of targeting SOX2-driven breast CSC suggests the potential clin. use of iadademstat as an epigenetic therapy in luminal-B and HER2-pos. subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZhqWP3DXGybVg90H21EOLACvtfcHk0lhivAYL5yCwwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlansbbL&md5=0e96fc883523fb13122888a53382dd91</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.18632%2Faging.102887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Faging.102887%26sid%3Dliteratum%253Aachs%26aulast%3DCuyas%26aufirst%3DE.%26aulast%3DGumuzio%26aufirst%3DJ.%26aulast%3DVerdura%26aufirst%3DS.%26aulast%3DBrunet%26aufirst%3DJ.%26aulast%3DBosch-Barrera%26aufirst%3DJ.%26aulast%3DMartin-Castillo%26aufirst%3DB.%26aulast%3DAlarcon%26aufirst%3DT.%26aulast%3DEncinar%26aufirst%3DJ.%2BA.%26aulast%3DMartin%26aufirst%3DA.%2BG.%26aulast%3DMenendez%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520LSD1%2520inhibitor%2520iadademstat%2520%2528ORY-1001%2529%2520targets%2520SOX2-driven%2520breast%2520cancer%2520stem%2520cells%253A%2520a%2520potential%2520epigenetic%2520therapy%2520in%2520luminal-B%2520and%2520HER2-positive%2520breast%2520cancer%2520subtypes%26jtitle%3DAging%26date%3D2020%26volume%3D12%26spage%3D4794%26epage%3D4814%26doi%3D10.18632%2Faging.102887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2017.09.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28987602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=392-402&author=Y.+C.+Duanauthor=Y.+C.+Maauthor=W.+P.+Qinauthor=L.+N.+Dingauthor=Y.+C.+Zhengauthor=Y.+L.+Zhuauthor=X.+Y.+Zhaiauthor=J.+Yangauthor=C.+Y.+Maauthor=Y.+Y.+Guan&title=Design+and+synthesis+of+tranylcypromine+derivatives+as+novel+LSD1%2FHDACs+dual+inhibitors+for+cancer+treatment&doi=10.1016%2Fj.ejmech.2017.09.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment</span></div><div class="casAuthors">Duan, Ying-Chao; Ma, Yong-Cheng; Qin, Wen-Ping; Ding, Li-Na; Zheng, Yi-Chao; Zhu, Ying-Li; Zhai, Xiao-Yu; Yang, Jing; Ma, Chao-Ya; Guan, Yuan-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">392-402</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) and Histone deacetylases (HDACs) are promising drug targets for cancers.  Recent studies reveal an important functional interplay between LSD1 and HDACs, and there is evidence for the synergistic effect of combined LSD1 and HDAC inhibitors on cancers.  Therefore, development of inhibitors targeting both LSD1 and HDACs might be a promising strategy for epigenetic therapy of cancers.  The authors report herein the synthesis of a series of tranylcypromine derivs. as LSD1/HDACs dual inhibitors.  Most compds. showed potent LSD1 and HDACs inhibitory activity, esp. compd. 7 (N-(7-(hydroxyamino)-7-oxoheptyl)-4-(((phenylcyclopropyl)amino)methyl)benzamide) displayed the most potent inhibitory activity against HDAC1 and HDAC2 with IC50 of 15 nM and 23 nM, as well as potent inhibition against LSD1 with IC50 of 1.20 μM.  Compd. 7 demonstrated stronger anti-proliferative activities than SAHA with IC50 values ranging from 0.81 to 4.28 μM against MGC-803, MCF-7, SW-620 and A-549 human cancer cell lines.  Further mechanistic studies showed that compd. 7 treatment in MGC-803 cells dose-dependently increased cellular H3K4 and H3K9 methylation, as well as H3 acetylation, decreased the mitochondrial membrane potential and induced remarkable apoptosis.  Docking studies showed that compd. 7 can be well docked into the active binding sites of LSD1 and HDAC2.  This finding highlights the potential for the development of LSD1/HDACs dual inhibitors as novel anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr76jU224_UF7Vg90H21EOLACvtfcHk0lhivAYL5yCwwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egsLfJ&md5=82fc575cd2cf9a4b75dae3370b5efd80</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.038%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DY.%2BC.%26aulast%3DQin%26aufirst%3DW.%2BP.%26aulast%3DDing%26aufirst%3DL.%2BN.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DZhu%26aufirst%3DY.%2BL.%26aulast%3DZhai%26aufirst%3DX.%2BY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DC.%2BY.%26aulast%3DGuan%26aufirst%3DY.%2BY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tranylcypromine%2520derivatives%2520as%2520novel%2520LSD1%252FHDACs%2520dual%2520inhibitors%2520for%2520cancer%2520treatment%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D140%26spage%3D392%26epage%3D402%26doi%3D10.1016%2Fj.ejmech.2017.09.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelamegam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricq, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malvaez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span> <span> </span><span class="NLM_article-title">Brain-penetrant LSD1 inhibitors can block memory consolidation</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1021/cn200104y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200104y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVyrs77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=120-128&author=R.+Neelamegamauthor=E.+L.+Ricqauthor=M.+Malvaezauthor=D.+Patnaikauthor=S.+Nortonauthor=S.+M.+Carlinauthor=I.+T.+Hillauthor=M.+A.+Woodauthor=S.+J.+Haggartyauthor=J.+M.+Hooker&title=Brain-penetrant+LSD1+inhibitors+can+block+memory+consolidation&doi=10.1021%2Fcn200104y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-Penetrant LSD1 Inhibitors Can Block Memory Consolidation</span></div><div class="casAuthors">Neelamegam, Ramesh; Ricq, Emily L.; Malvaez, Melissa; Patnaik, Debasis; Norton, Stephanie; Carlin, Stephen M.; Hill, Ian T.; Wood, Marcelo A.; Haggarty, Stephen J.; Hooker, Jacob M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-128</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulation of histone modifications in the brain may represent a new mechanism for brain disorder therapy.  Post-translational modifications of histones regulate gene expression, affecting major cellular processes such as proliferation, differentiation, and function.  An important enzyme involved in one of these histone modifications is lysine specific demethylase 1 (LSD1).  This enzyme is flavin-dependent and exhibits homol. to amine oxidases.  Parnate (2-phenylcyclopropylamine (2-PCPA); tranylcypromine) is a potent inhibitor of monoamine oxidases, and derivs. of 2-PCPA have been used for development of selective LSD1 inhibitors based on the ability to form covalent adducts with FAD.  Here we report the synthesis and in vitro characterization of LSD1 inhibitors that bond covalently to FAD.  The two most potent and selective inhibitors were used to demonstrate brain penetration when administered systemically to rodents.  First, radiosynthesis of a positron-emitting analog was used to obtain preliminary biodistribution data and whole brain time-activity curves.  Second, we demonstrate that this series of LSD1 inhibitors is capable of producing a cognitive effect in a mouse model.  By using a memory formation paradigm, novel object recognition, we show that LSD1 inhibition can abolish long-term memory formation without affecting short-term memory, providing further evidence for the importance of reversible histone methylation in the function of the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRTx9XGRzjgrVg90H21EOLACvtfcHk0lgbBEanlONKIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVyrs77E&md5=cd365810b397d0ece732ea853a3e93da</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fcn200104y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200104y%26sid%3Dliteratum%253Aachs%26aulast%3DNeelamegam%26aufirst%3DR.%26aulast%3DRicq%26aufirst%3DE.%2BL.%26aulast%3DMalvaez%26aufirst%3DM.%26aulast%3DPatnaik%26aufirst%3DD.%26aulast%3DNorton%26aufirst%3DS.%26aulast%3DCarlin%26aufirst%3DS.%2BM.%26aulast%3DHill%26aufirst%3DI.%2BT.%26aulast%3DWood%26aufirst%3DM.%2BA.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26atitle%3DBrain-penetrant%2520LSD1%2520inhibitors%2520can%2520block%2520memory%2520consolidation%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D120%26epage%3D128%26doi%3D10.1021%2Fcn200104y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jearawiriyapaisarn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trievel, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSimone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavelle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunthararajah, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span> <span> </span><span class="NLM_article-title">The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1182/blood-2015-02-626259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1182%2Fblood-2015-02-626259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=26031919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGqsbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=386-396&author=S.+Cuiauthor=K.+C.+Limauthor=L.+Shiauthor=M.+Leeauthor=N.+Jearawiriyapaisarnauthor=G.+Myersauthor=A.+Campbellauthor=D.+Harroauthor=S.+Iwaseauthor=R.+C.+Trievelauthor=A.+Riversauthor=J.+DeSimoneauthor=D.+Lavelleauthor=Y.+Saunthararajahauthor=J.+D.+Engel&title=The+LSD1+inhibitor+RN-1+induces+fetal+hemoglobin+synthesis+and+reduces+disease+pathology+in+sickle+cell+mice&doi=10.1182%2Fblood-2015-02-626259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice</span></div><div class="casAuthors">Cui, Shuaiying; Lim, Kim-Chew; Shi, Lihong; Lee, Mary; Jearawiriyapaisarn, Natee; Myers, Greggory; Campbell, Andrew; Harro, David; Iwase, Shigeki; Trievel, Raymond C.; Rivers, Angela; DeSimone, Joseph; Lavelle, Donald; Saunthararajah, Yogen; Engel, James Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-396</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Inhibition of lysine-specific demethylase 1 (LSD1) has been shown to induce fetal Hb (HbF) levels in cultured human erythroid cells in vitro.  Here we report the in vivo effects of LSD1 inactivation by a selective and more potent inhibitor, RN-1, in a sickle cell disease (SCD) mouse model.  Compared with untreated animals, RN-1 administration leads to induced HbF synthesis and to increased frequencies of HbF-pos. cells and mature erythrocytes, as well as fewer reticulocytes and sickle cells, in the peripheral blood of treated SCD mice.  In keeping with these observations, histol. analyses of the liver and spleen of treated SCD mice verified that they do not exhibit the necrotic lesions that are usually assocd. with SCD.  These data indicate that RN-1 can effectively induce HbF levels in red blood cells and reduce disease pathol. in SCD mice, and may therefore offer new therapeutic possibilities for treating SCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQhVTwBq84lrVg90H21EOLACvtfcHk0lgbBEanlONKIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGqsbfM&md5=09823b719e175817dfe3b05a166b49cd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-02-626259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-02-626259%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DK.%2BC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DJearawiriyapaisarn%26aufirst%3DN.%26aulast%3DMyers%26aufirst%3DG.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DHarro%26aufirst%3DD.%26aulast%3DIwase%26aufirst%3DS.%26aulast%3DTrievel%26aufirst%3DR.%2BC.%26aulast%3DRivers%26aufirst%3DA.%26aulast%3DDeSimone%26aufirst%3DJ.%26aulast%3DLavelle%26aufirst%3DD.%26aulast%3DSaunthararajah%26aufirst%3DY.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520LSD1%2520inhibitor%2520RN-1%2520induces%2520fetal%2520hemoglobin%2520synthesis%2520and%2520reduces%2520disease%2520pathology%2520in%2520sickle%2520cell%2520mice%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D386%26epage%3D396%26doi%3D10.1182%2Fblood-2015-02-626259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaitkus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagadeeswaran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouznetsova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSimone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavelle, D.</span></span> <span> </span><span class="NLM_article-title">RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases gamma-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model</span>. <i>Exp. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/j.exphem.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.exphem.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25931013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SgurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=546-53&author=A.+Riversauthor=K.+Vaitkusauthor=M.+A.+Ruizauthor=V.+Ibanezauthor=R.+Jagadeeswaranauthor=T.+Kouznetsovaauthor=J.+DeSimoneauthor=D.+Lavelle&title=RN-1%2C+a+potent+and+selective+lysine-specific+demethylase+1+inhibitor%2C+increases+gamma-globin+expression%2C+F+reticulocytes%2C+and+F+cells+in+a+sickle+cell+disease+mouse+model&doi=10.1016%2Fj.exphem.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model</span></div><div class="casAuthors">Rivers, Angela; Vaitkus, Kestis; Ruiz, Maria Armila; Ibanez, Vinzon; Jagadeeswaran, Ramasamy; Kouznetsova, Tatiana; DeSimone, Joseph; Lavelle, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">546-553.e3</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Increased levels of fetal Hb are assocd. with decreased symptoms and increased lifespan in patients with sickle cell disease (SCD).  Hydroxyurea, the only drug currently approved for SCD, is not effective in a large fraction of patients, and therefore, new agents are urgently needed.  Recently it was found that lysine demethylase 1, an enzyme that removes monomethyl and di-Me residues from the lysine 4 residue of histone H3, is a repressor of γ-globin gene expression.  In this article, we have compared the ability of tranylcypromine (TCP) and a more potent TCP deriv., RN-1, to increase γ-globin expression in cultured baboon erythroid progenitor cells and in the SCD mouse model.  The results indicate that the ability of RN-1 to induce F cells and γ-globin mRNA in SCD mice is similar to that of decitabine, the most powerful fetal Hb-inducing drug known, and greater than that of either TCP or hydroxyurea.  We conclude that RN-1 and other lysine demethylase 1 inhibitors may be promising new γ-globin-inducing agents for the treatment of SCD that warrant further studies in other preclin. models, such as nonhuman primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXFBoMGO2F2rVg90H21EOLACvtfcHk0lgbBEanlONKIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SgurrN&md5=70d2f9af57d6aa75b69b9739af8c7f69</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.exphem.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exphem.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DRivers%26aufirst%3DA.%26aulast%3DVaitkus%26aufirst%3DK.%26aulast%3DRuiz%26aufirst%3DM.%2BA.%26aulast%3DIbanez%26aufirst%3DV.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DKouznetsova%26aufirst%3DT.%26aulast%3DDeSimone%26aufirst%3DJ.%26aulast%3DLavelle%26aufirst%3DD.%26atitle%3DRN-1%252C%2520a%2520potent%2520and%2520selective%2520lysine-specific%2520demethylase%25201%2520inhibitor%252C%2520increases%2520gamma-globin%2520expression%252C%2520F%2520reticulocytes%252C%2520and%2520F%2520cells%2520in%2520a%2520sickle%2520cell%2520disease%2520mouse%2520model%26jtitle%3DExp.%2520Hematol.%26date%3D2015%26volume%3D43%26spage%3D546%26epage%3D53%26doi%3D10.1016%2Fj.exphem.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed
Khan, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of N-alkylated analogue of NCL1, a selective inhibitor of lysine-specific demethylase 1</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1039/C4MD00330F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1039%2FC4MD00330F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=407-412&author=M.+N.+Ahmed%0AKhanauthor=H.+Tsumotoauthor=Y.+Itohauthor=Y.+Otaauthor=M.+Suzukiauthor=D.+Ogasawaraauthor=H.+Nakagawaauthor=T.+Mizukamiauthor=N.+Miyataauthor=T.+Suzuki&title=Design%2C+synthesis%2C+and+biological+activity+of+N-alkylated+analogue+of+NCL1%2C+a+selective+inhibitor+of+lysine-specific+demethylase+1&doi=10.1039%2FC4MD00330F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological activity of N-alkylated analogue of NCL1, a selective inhibitor of lysine-specific demethylase 1</span></div><div class="casAuthors">Ahmed Khan, Mohammed Naseer; Tsumoto, Hiroki; Itoh, Yukihiro; Ota, Yosuke; Suzuki, Miki; Ogasawara, Daisuke; Nakagawa, Hidehiko; Mizukami, Tamio; Miyata, Naoki; Suzuki, Takayoshi</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-412</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1), the first histone demethylase to be identified, catalyzes specifically the demethylation of the mono- and di-Me groups of histone H3 lysine 4, and its dysregulation is thought to contribute to the development of cancer.  We have recently reported that NCL1 (4) is the first cell-active LSD1-selective inhibitor.  To find LSD1 inhibitors that show higher potency than NCL1 (4), we designed and synthesized an N-alkylated analog of NCL1 (5), and evaluated its biol. activity.  In enzyme assays, compd. 5 was six times more potent than 4, and compd. 5 exhibited cell growth inhibition in cervical cancer HeLa cell line and neuroblastoma SH-SY5Y cell line.  Compd. 5 should be useful as a lead structure for anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRPzAwurHb7bVg90H21EOLACvtfcHk0liE9OoWxOTglw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsLzM&md5=548e783980eb6fa2e152ffa7523e6310</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1039%2FC4MD00330F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00330F%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%2BKhan%26aufirst%3DM.%2BN.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520N-alkylated%2520analogue%2520of%2520NCL1%252C%2520a%2520selective%2520inhibitor%2520of%2520lysine-specific%2520demethylase%25201%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D407%26epage%3D412%26doi%3D10.1039%2FC4MD00330F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairiki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hikichi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span> <span> </span><span class="NLM_article-title">A novel LSD1 inhibitor T-3775440 disrupts GFI1B-containing complex leading to transdifferentiation and impaired growth of AML Cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1158%2F1535-7163.MCT-16-0471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27903753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVertr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=273-284&author=Y.+Ishikawaauthor=K.+Gamoauthor=M.+Yabukiauthor=S.+Takagiauthor=K.+Toyoshimaauthor=K.+Nakayamaauthor=A.+Nakayamaauthor=M.+Morimotoauthor=H.+Miyashitaauthor=R.+Dairikiauthor=Y.+Hikichiauthor=N.+Tomitaauthor=D.+Tomitaauthor=S.+Imamuraauthor=M.+Iwataniauthor=Y.+Kamadaauthor=S.+Matsumotoauthor=R.+Haraauthor=T.+Nomuraauthor=K.+Tsuchidaauthor=K.+Nakamura&title=A+novel+LSD1+inhibitor+T-3775440+disrupts+GFI1B-containing+complex+leading+to+transdifferentiation+and+impaired+growth+of+AML+Cells&doi=10.1158%2F1535-7163.MCT-16-0471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells</span></div><div class="casAuthors">Ishikawa, Yoshinori; Gamo, Kanae; Yabuki, Masato; Takagi, Shinji; Toyoshima, Kosei; Nakayama, Kazuhide; Nakayama, Akiko; Morimoto, Megumi; Miyashita, Hitoshi; Dairiki, Ryo; Hikichi, Yukiko; Tomita, Naoki; Tomita, Daisuke; Imamura, Shinichi; Iwatani, Misa; Kamada, Yusuke; Matsumoto, Satoru; Hara, Ryujiro; Nomura, Toshiyuki; Tsuchida, Ken; Nakamura, Kazuhide</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Dysregulation of lysine (K)-specific demethylase 1A (LSD1), also known as KDM1A, has been implicated in the development of various cancers, including leukemia.  Here, we describe the antileukemic activity and mechanism of action of T-3775440, a novel irreversible LSD1 inhibitor.  Cell growth anal. of leukemia cell lines revealed that acute erythroid leukemia (AEL) and acute megakaryoblastic leukemia cells (AMKL) were highly sensitive to this compd.  T-3775440 treatment enforced transdifferentiation of erythroid/megakaryocytic lineages into granulomonocytic-like lineage cells.  Mechanistically, T-3775440 disrupted the interaction between LSD1 and growth factor-independent 1B (GFI1B), a transcription factor crit. for the differentiation processes of erythroid and megakaryocytic lineage cells.  Knockdown of LSD1 and GFI1B recapitulated T-3775440-induced transdifferentiation and cell growth suppression, highlighting the significance of LSD1-GFI1B axis inhibition with regard to the anti-AML effects of T-3775440.  Moreover, T-3775440 exhibited significant antitumor efficacy in AEL and AMKL xenograft models.  Our findings provide a rationale for evaluating LSD1 inhibitors as potential treatments and indicate a novel mechanism of action against AML, particularly AEL and AMKL.  Mol Cancer Ther; 16(2); 273-84. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcxpsluqnf7Vg90H21EOLACvtfcHk0liE9OoWxOTglw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVertr4%253D&md5=2335343b4d5e7bbc197a1d5aec54e3af</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0471%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DGamo%26aufirst%3DK.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DS.%26aulast%3DToyoshima%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DMorimoto%26aufirst%3DM.%26aulast%3DMiyashita%26aufirst%3DH.%26aulast%3DDairiki%26aufirst%3DR.%26aulast%3DHikichi%26aufirst%3DY.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTomita%26aufirst%3DD.%26aulast%3DImamura%26aufirst%3DS.%26aulast%3DIwatani%26aufirst%3DM.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DR.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DTsuchida%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DK.%26atitle%3DA%2520novel%2520LSD1%2520inhibitor%2520T-3775440%2520disrupts%2520GFI1B-containing%2520complex%2520leading%2520to%2520transdifferentiation%2520and%2520impaired%2520growth%2520of%2520AML%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D273%26epage%3D284%26doi%3D10.1158%2F1535-7163.MCT-16-0471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairiki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span> <span> </span><span class="NLM_article-title">Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e377</span> <span class="refDoi"> DOI: 10.1038/oncsis.2017.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Foncsis.2017.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28892104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKltbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&author=Y.+Ishikawaauthor=K.+Nakayamaauthor=M.+Morimotoauthor=A.+Mizutaniauthor=A.+Nakayamaauthor=K.+Toyoshimaauthor=A.+Hayashiauthor=S.+Takagiauthor=R.+Dairikiauthor=H.+Miyashitaauthor=S.+Matsumotoauthor=K.+Gamoauthor=T.+Nomuraauthor=K.+Nakamura&title=Synergistic+anti-AML+effects+of+the+LSD1+inhibitor+T-3775440+and+the+NEDD8-activating+enzyme+inhibitor+pevonedistat+via+transdifferentiation+and+DNA+rereplication&doi=10.1038%2Foncsis.2017.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication</span></div><div class="casAuthors">Ishikawa, Y.; Nakayama, K.; Morimoto, M.; Mizutani, A.; Nakayama, A.; Toyoshima, K.; Hayashi, A.; Takagi, S.; Dairiki, R.; Miyashita, H.; Matsumoto, S.; Gamo, K.; Nomura, T.; Nakamura, K.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e377</span>CODEN:
                <span class="NLM_cas:coden">ONCOCT</span>;
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1A (LSD1, KDM1A) specifically demethylates di- and monomethylated histones H3K4 and K9, resulting in context-dependent transcriptional repression or activation.  We previously identified an irreversible LSD1 inhibitor T-3775440, which exerts antileukemic activities in a subset of acute myeloid leukemia (AML) cell lines by inducing cell transdifferentiation.  The NEDD8-activating enzyme inhibitor pevonedistat (MLN4924, TAK-924) is an investigational drug with antiproliferative activities in AML, and is also reported to induce cell differentiation.  We therefore tested the combination of these two agents in AML models.  The combination treatment resulted in synergistic growth inhibition of AML cells, accompanied by enhanced transdifferentiation of an erythroid leukemia lineage into granulomonocytic-like lineage cells.  In addn., pevonedistat-induced rereplication stress during the S phase was greatly augmented by concomitant treatment with T-3775440, as reflected by the increased induction of apoptosis.  We further demonstrated that the combination treatment was markedly effective in s.c. tumor xenograft models as well as in a disseminated model of AML, leading to tumor eradication or prolonged survival in T-3775440/pevonedistat cotreated mice.  Our findings indicate the therapeutic potential of the combination of LSD1 inhibitors and pevonedistat for the treatment of AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7fhlV7Lk--bVg90H21EOLACvtfcHk0ljvYVS6Y7iGsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKltbvP&md5=f6b55fdaebb50f359c547677a30b9190</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2017.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2017.76%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DMorimoto%26aufirst%3DM.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DToyoshima%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DA.%26aulast%3DTakagi%26aufirst%3DS.%26aulast%3DDairiki%26aufirst%3DR.%26aulast%3DMiyashita%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DGamo%26aufirst%3DK.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DK.%26atitle%3DSynergistic%2520anti-AML%2520effects%2520of%2520the%2520LSD1%2520inhibitor%2520T-3775440%2520and%2520the%2520NEDD8-activating%2520enzyme%2520inhibitor%2520pevonedistat%2520via%2520transdifferentiation%2520and%2520DNA%2520rereplication%26jtitle%3DOncogenesis%26date%3D2017%26volume%3D6%26doi%3D10.1038%2Foncsis.2017.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5036</span>– <span class="NLM_lpage">5039</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2017.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29037950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5036-5039&author=K.+Sunauthor=J.+D.+Pengauthor=F.+Z.+Suoauthor=T.+Zhangauthor=Y.+D.+Fuauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Discovery+of+tranylcypromine+analogs+with+an+acylhydrazone+substituent+as+LSD1+inactivators%3A+Design%2C+synthesis+and+their+biological+evaluation&doi=10.1016%2Fj.bmcl.2017.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation</span></div><div class="casAuthors">Sun, Kai; Peng, Jia-Di; Suo, Feng-Zhi; Zhang, Ting; Fu, Yun-Dong; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5036-5039</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1), the first identified histone demethylase, plays an important role in epigenetic regulation of gene activation and repression, has been reported to be up-regulated and involved in nos. of solid malignant tumors.  In this study, the authors identified a series of phenylalanyl hydrazones based LSD1 inhibitors, and the most potent one, compd. I, can inactivate LSD1 with IC50 = 91.83 nM.  In cellular level, compd. I can induce the accumulation of CD86 as well as H3K4me2, and inhibit gastric cancer cell proliferation by inactivating LSD1.  The findings indicated that compd. I may serve as a potential leading compd. to target LSD1 overexpressed gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDtZ0bCi6HFLVg90H21EOLACvtfcHk0ljvYVS6Y7iGsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7F&md5=0af079efb7fb3856f8a67842817e0470</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DJ.%2BD.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DFu%26aufirst%3DY.%2BD.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DDiscovery%2520of%2520tranylcypromine%2520analogs%2520with%2520an%2520acylhydrazone%2520substituent%2520as%2520LSD1%2520inactivators%253A%2520Design%252C%2520synthesis%2520and%2520their%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5036%26epage%3D5039%26doi%3D10.1016%2Fj.bmcl.2017.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengoku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Development and structural evaluation of N-alkylated trans-2-phenylcyclopropylamine-based LSD1 inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">787</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fcmdc.202000014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32166890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFSjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=787&author=H.+Niwaauthor=S.+Satoauthor=N.+Handaauthor=T.+Sengokuauthor=T.+Umeharaauthor=S.+Yokoyama&title=Development+and+structural+evaluation+of+N-alkylated+trans-2-phenylcyclopropylamine-based+LSD1+inhibitors&doi=10.1002%2Fcmdc.202000014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Structural Evaluation of N-Alkylated trans-2-Phenylcyclopropylamine-Based LSD1 Inhibitors</span></div><div class="casAuthors">Niwa, Hideaki; Sato, Shin; Handa, Noriko; Sengoku, Toru; Umehara, Takashi; Yokoyama, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) is a FAD (FAD)-dependent enzyme that catalyzes the demethylation of histone H3 and regulates gene expression.  Because it is implicated in the regulation of diseases such as acute myeloid leukemia, potent LSD1-specific inhibitors have been pursued.  Trans-2-phenylcyclopropylamine (2-PCPA)-based inhibitors featuring substitutions on the amino group have emerged, with sub-micromolar affinities toward LSD1 and high selectivities over monoamine oxidases (MAOs).  We synthesized two N-alkylated 2-PCPA-based LSD1 inhibitors, S2116 and S2157, based on the previously developed S2101.  S2116 and S2157 exhibited enhanced potency for LSD1 by 2.0- to 2.6-fold, as compared with S2101.  In addn., they exhibited improved selectivity over MAOs.  Structural analyses of LSD1 co-crystd. with S2101, S2116, S2157, or another N-alkylated inhibitor (FCPA-MPE) confirmed that the N-substituents enhance the potency of a 2-PCPA-based inhibitor of LSD1, without constituting the adduct formed with FAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6TTnedxbtLVg90H21EOLACvtfcHk0ljvYVS6Y7iGsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFSjt78%253D&md5=e0b444e8f2ccf027c9a349cb4566ae10</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000014%26sid%3Dliteratum%253Aachs%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DHanda%26aufirst%3DN.%26aulast%3DSengoku%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520structural%2520evaluation%2520of%2520N-alkylated%2520trans-2-phenylcyclopropylamine-based%2520LSD1%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D787%26doi%3D10.1002%2Fcmdc.202000014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinthakindi, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naicker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govender, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvidsson, P. I.</span></span> <span> </span><span class="NLM_article-title">Sulfonimidamides in medicinal and agricultural chemistry</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4100</span>– <span class="NLM_lpage">4109</span>, <span class="refDoi"> DOI: 10.1002/anie.201610456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fanie.201610456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlynu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=4100-4109&author=P.+K.+Chinthakindiauthor=T.+Naickerauthor=N.+Thotaauthor=T.+Govenderauthor=H.+G.+Krugerauthor=P.+I.+Arvidsson&title=Sulfonimidamides+in+medicinal+and+agricultural+chemistry&doi=10.1002%2Fanie.201610456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonimidamides in Medicinal and Agricultural Chemistry</span></div><div class="casAuthors">Chinthakindi, Praveen K.; Naicker, Tricia; Thota, Niranjan; Govender, Thavendran; Kruger, Hendrik G.; Arvidsson, Per I.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4100-4109</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The synthesis and evaluation of structural analogs and isosteres are of central importance in medicinal and agricultural chem.  The sulfonamide functional group represents one of the most important amide isosteres in contemporary drug design, and about 500 such compds. have overcome both the pharmacol. and regulatory hurdles that precede studies in humans.  The mono aza analogs of sulfonamides, i.e., sulfonimidamides, are rapidly gaining popularity as a novel functional group among synthetic chemists involved in the design of biol. active compds. for both pharmaceutical and agrochem. applications.  Herein, we review these recent developments to showcase the promise of this functional group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6zj9KqdepKbVg90H21EOLACvtfcHk0lj0JiCrbZmzCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlynu7k%253D&md5=3460c3a7c17bd914174be7c81d645fb0</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fanie.201610456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201610456%26sid%3Dliteratum%253Aachs%26aulast%3DChinthakindi%26aufirst%3DP.%2BK.%26aulast%3DNaicker%26aufirst%3DT.%26aulast%3DThota%26aufirst%3DN.%26aulast%3DGovender%26aufirst%3DT.%26aulast%3DKruger%26aufirst%3DH.%2BG.%26aulast%3DArvidsson%26aufirst%3DP.%2BI.%26atitle%3DSulfonimidamides%2520in%2520medicinal%2520and%2520agricultural%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D4100%26epage%3D4109%26doi%3D10.1002%2Fanie.201610456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, S.</span></span> <span> </span><span class="NLM_article-title">New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">103808</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2020.103808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32334189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotVeksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2020&pages=103808&author=L.+Liangauthor=H.+Wangauthor=Y.+Duauthor=B.+Luoauthor=N.+Mengauthor=M.+Cenauthor=P.+Huangauthor=A.+Ganesanauthor=S.+Wen&title=New+tranylcypromine+derivatives+containing+sulfonamide+motif+as+potent+LSD1+inhibitors+to+target+acute+myeloid+leukemia%3A+Design%2C+synthesis+and+biological+evaluation&doi=10.1016%2Fj.bioorg.2020.103808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation</span></div><div class="casAuthors">Liang, Liyun; Wang, Haiwen; Du, Yongliang; Luo, Bingling; Meng, Ning; Cen, Meifeng; Huang, Peng; Ganesan, A.; Wen, Shijun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103808</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) is frequently elevated in acute myeloid leukemia (AML) and often leads to tumorigenesis.  In recent years, numerous LSD1 inhibitors based on tranylcypromine (TCP) scaffolding have reached clin. trials.  Most TCP derivs. were modified at the amino site of cyclopropane motif.  Herein, we for the first time introduced a sulfonamide group in TCP benzene ring of series a compds. and performed a systematical study on structure and activity relationships by varying sulfonamide groups.  The introduction of sulfonamide significantly increased the targeting capacity of TCP against LSD1.  Moreover, we discovered that the Boc attached LSD1 inhibitors (labeled as series b compds.) substantially improved their anti-proliferation capacity towards AML cells.  The intracellular thermal shift and LC-MS/MS results implied that Boc enhanced the drug lipophilicity and might be removed under the cancerous acidic environment to release the real pharmacophore, evidenced by the fact that a structurally similar but acidic inert pivaloyl to replace Boc dramatically dropped the cellular anti-proliferation effect.  Finally, a benzyl group installed at the amino site to appropriately increase lipophilicity led to trans-4-(2-(benzylamino)-cyclopropyl)-N,N-diethylbenzenesulfonamide a10 that showed better anti-proliferation activity in AML cells and enzymic inhibition against LSD1.  Taken together, our work offers a novel TCP-based structure and provides a prodrug strategy for the discovery of potent LSD1 inhibitors by having appropriate lipophilicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_jMV2UzXfJ7Vg90H21EOLACvtfcHk0lj0JiCrbZmzCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotVeksLg%253D&md5=85e40ad28160195bff91697dd77d62ee</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103808%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DN.%26aulast%3DCen%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DWen%26aufirst%3DS.%26atitle%3DNew%2520tranylcypromine%2520derivatives%2520containing%2520sulfonamide%2520motif%2520as%2520potent%2520LSD1%2520inhibitors%2520to%2520target%2520acute%2520myeloid%2520leukemia%253A%2520Design%252C%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D99%26spage%3D103808%26doi%3D10.1016%2Fj.bioorg.2020.103808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerds, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yacoub, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaczuch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shortt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossetti, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbury, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsoulis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talpaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peppe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rienhoff, H. Y.,  Jr.</span></span> <span> </span><span class="NLM_article-title">A phase 2a study of the LSD1 inhibitor img-7289 (bomedemstat) for the treatment of myelofibrosis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">556</span>, <span class="refDoi"> DOI: 10.1182/blood-2019-123244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1182%2Fblood-2019-123244" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2019&pages=556&author=K.+Pettitauthor=A.+T.+Gerdsauthor=A.+Yacoubauthor=J.+M.+Wattsauthor=M.+Tartaczuchauthor=T.+J.+Bradleyauthor=J.+Shorttauthor=W.+S.+Stevensonauthor=N.+J.+Curtinauthor=J.+M.+Rossettiauthor=K.+Burburyauthor=G.+Natsoulisauthor=A.+Jonesauthor=M.+Talpazauthor=J.+Peppeauthor=D.+M.+Rossauthor=H.+Y.+Rienhoff&title=A+phase+2a+study+of+the+LSD1+inhibitor+img-7289+%28bomedemstat%29+for+the+treatment+of+myelofibrosis&doi=10.1182%2Fblood-2019-123244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1182%2Fblood-2019-123244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2019-123244%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DK.%26aulast%3DGerds%26aufirst%3DA.%2BT.%26aulast%3DYacoub%26aufirst%3DA.%26aulast%3DWatts%26aufirst%3DJ.%2BM.%26aulast%3DTartaczuch%26aufirst%3DM.%26aulast%3DBradley%26aufirst%3DT.%2BJ.%26aulast%3DShortt%26aufirst%3DJ.%26aulast%3DStevenson%26aufirst%3DW.%2BS.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DRossetti%26aufirst%3DJ.%2BM.%26aulast%3DBurbury%26aufirst%3DK.%26aulast%3DNatsoulis%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DPeppe%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DD.%2BM.%26aulast%3DRienhoff%26aufirst%3DH.%2BY.%26atitle%3DA%2520phase%25202a%2520study%2520of%2520the%2520LSD1%2520inhibitor%2520img-7289%2520%2528bomedemstat%2529%2520for%2520the%2520treatment%2520of%2520myelofibrosis%26jtitle%3DBlood%26date%3D2019%26volume%3D134%26spage%3D556%26doi%3D10.1182%2Fblood-2019-123244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jutzi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleppe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staehle, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shank, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya-Feldstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambheer, S. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierks, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rienhoff, H. Y.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahl, H. L.</span></span> <span> </span><span class="NLM_article-title">LSD1 inhibition prolongs survival in mouse models of MPN by selectively targeting the disease clone</span>. <i>Hemasphere</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e54</span> <span class="refDoi"> DOI: 10.1097/HS9.0000000000000054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1097%2FHS9.0000000000000054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31723778" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&author=J.+S.+Jutziauthor=M.+Kleppeauthor=J.+Diasauthor=H.+F.+Staehleauthor=K.+Shankauthor=J.+Teruya-Feldsteinauthor=S.+M.+M.+Gambheerauthor=C.+Dierksauthor=H.+Y.+Rienhoffauthor=R.+L.+Levineauthor=H.+L.+Pahl&title=LSD1+inhibition+prolongs+survival+in+mouse+models+of+MPN+by+selectively+targeting+the+disease+clone&doi=10.1097%2FHS9.0000000000000054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1097%2FHS9.0000000000000054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHS9.0000000000000054%26sid%3Dliteratum%253Aachs%26aulast%3DJutzi%26aufirst%3DJ.%2BS.%26aulast%3DKleppe%26aufirst%3DM.%26aulast%3DDias%26aufirst%3DJ.%26aulast%3DStaehle%26aufirst%3DH.%2BF.%26aulast%3DShank%26aufirst%3DK.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DGambheer%26aufirst%3DS.%2BM.%2BM.%26aulast%3DDierks%26aufirst%3DC.%26aulast%3DRienhoff%26aufirst%3DH.%2BY.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DPahl%26aufirst%3DH.%2BL.%26atitle%3DLSD1%2520inhibition%2520prolongs%2520survival%2520in%2520mouse%2520models%2520of%2520MPN%2520by%2520selectively%2520targeting%2520the%2520disease%2520clone%26jtitle%3DHemasphere%26date%3D2018%26volume%3D2%26doi%3D10.1097%2FHS9.0000000000000054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascaró, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotllant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalcanti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carceller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span> <span> </span><span class="NLM_article-title">P4-404: Ory-2001: An epigenetic drug for the treatment of cognition defects in Alzheimer’s disease and other neurodegenerative disorders</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">P1192</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2016.07.149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.jalz.2016.07.149" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=P1192&author=T.+Maesauthor=C.+Mascar%C3%B3author=D.+Rotllantauthor=F.+Cavalcantiauthor=E.+Carcellerauthor=A.+Ortegaauthor=C.+Molineroauthor=C.+Buesa&title=P4-404%3A+Ory-2001%3A+An+epigenetic+drug+for+the+treatment+of+cognition+defects+in+Alzheimer%E2%80%99s+disease+and+other+neurodegenerative+disorders&doi=10.1016%2Fj.jalz.2016.07.149"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2016.07.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2016.07.149%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DT.%26aulast%3DMascar%25C3%25B3%26aufirst%3DC.%26aulast%3DRotllant%26aufirst%3DD.%26aulast%3DCavalcanti%26aufirst%3DF.%26aulast%3DCarceller%26aufirst%3DE.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DMolinero%26aufirst%3DC.%26aulast%3DBuesa%26aufirst%3DC.%26atitle%3DP4-404%253A%2520Ory-2001%253A%2520An%2520epigenetic%2520drug%2520for%2520the%2520treatment%2520of%2520cognition%2520defects%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520neurodegenerative%2520disorders%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2016%26volume%3D12%26spage%3DP1192%26doi%3D10.1016%2Fj.jalz.2016.07.149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shineman, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillit, H. M.</span></span> <span> </span><span class="NLM_article-title">Meeting report on the Alzheimer’s drug discovery foundation 14th international conference on Alzheimer’s drug discovery</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.1186/alzrt252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1186%2Falzrt252" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=22&author=L.+G.+Friedmanauthor=K.+Priceauthor=R.+F.+Laneauthor=A.+J.+Carmanauthor=P.+A.+Dacksauthor=D.+W.+Shinemanauthor=H.+M.+Fillit&title=Meeting+report+on+the+Alzheimer%E2%80%99s+drug+discovery+foundation+14th+international+conference+on+Alzheimer%E2%80%99s+drug+discovery&doi=10.1186%2Falzrt252"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1186%2Falzrt252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt252%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DL.%2BG.%26aulast%3DPrice%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DR.%2BF.%26aulast%3DCarman%26aufirst%3DA.%2BJ.%26aulast%3DDacks%26aufirst%3DP.%2BA.%26aulast%3DShineman%26aufirst%3DD.%2BW.%26aulast%3DFillit%26aufirst%3DH.%2BM.%26atitle%3DMeeting%2520report%2520on%2520the%2520Alzheimer%25E2%2580%2599s%2520drug%2520discovery%2520foundation%252014th%2520international%2520conference%2520on%2520Alzheimer%25E2%2580%2599s%2520drug%2520discovery%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D22%26doi%3D10.1186%2Falzrt252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buesa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascaró, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotllant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griñan-Ferré, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, T.</span></span> <span> </span><span class="NLM_article-title">P4-316: The dual lsd1/maob inhibitor ory2001 prevents the development of the memory deficit in samp8 mice through induction of neuronal plasticity and reduction of neuroinflammation</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">P905</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2015.08.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.jalz.2015.08.146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=P905&author=C.+Buesaauthor=C.+Mascar%C3%B3author=D.+Rotllantauthor=C.+Gri%C3%B1an-Ferr%C3%A9author=M.+Pall%C3%A0sauthor=T.+Maes&title=P4-316%3A+The+dual+lsd1%2Fmaob+inhibitor+ory2001+prevents+the+development+of+the+memory+deficit+in+samp8+mice+through+induction+of+neuronal+plasticity+and+reduction+of+neuroinflammation&doi=10.1016%2Fj.jalz.2015.08.146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.08.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.08.146%26sid%3Dliteratum%253Aachs%26aulast%3DBuesa%26aufirst%3DC.%26aulast%3DMascar%25C3%25B3%26aufirst%3DC.%26aulast%3DRotllant%26aufirst%3DD.%26aulast%3DGri%25C3%25B1an-Ferr%25C3%25A9%26aufirst%3DC.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DMaes%26aufirst%3DT.%26atitle%3DP4-316%253A%2520The%2520dual%2520lsd1%252Fmaob%2520inhibitor%2520ory2001%2520prevents%2520the%2520development%2520of%2520the%2520memory%2520deficit%2520in%2520samp8%2520mice%2520through%2520induction%2520of%2520neuronal%2520plasticity%2520and%2520reduction%2520of%2520neuroinflammation%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3DP905%26doi%3D10.1016%2Fj.jalz.2015.08.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span> <span> </span><span class="NLM_article-title">Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2019.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30713023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=844-847&author=X.+Wangauthor=M.+Suauthor=Y.+Liauthor=T.+Liuauthor=Y.+Wangauthor=Y.+Chenauthor=L.+Tangauthor=Y.+P.+Heauthor=X.+Dingauthor=F.+Yuauthor=J.+Shenauthor=J.+Liauthor=Y.+Zhouauthor=Y.+L.+Chenauthor=B.+Xiong&title=Tranylcypromine+and+6-trifluoroethyl+thienopyrimidine+hybrid+as+LSD1+inhibitor&doi=10.1016%2Fj.bmcl.2019.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor</span></div><div class="casAuthors">Wang, Xiaowen; Su, Mingbo; Li, You; Liu, Tongchao; Wang, Yujie; Chen, Yabing; Tang, Le; He, Yu-Peng; Ding, Xiaoguang; Yu, Fang; Shen, Jingkang; Li, Jia; Zhou, Yubo; Chen, Yue-Lei; Xiong, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">844-847</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tranylcypromine moiety extd. from LSD1 inhibitors and 6-trifluoroethyl thienopyrimidine moiety from menin-MLL1 PPI inhibitors were merged to give new chemotypes for medicinal chem. study.  Among 15 new compds. prepd. in this work, some exhibited nanomolar LSD1 activity and good selectivity over MAO-A/B, low micromolar menin-MLL1 PPI inhibitory activity, as well as submicromolar MV4-11 antiprofilative activities.  Intracellular LSD1 engagement of compds. with higher enzymic and antiproliferative activities was confirmed by CD86 mRNA up-regulation expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKyKovilVyj7Vg90H21EOLACvtfcHk0liDzEnTF7c_YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWnsb8%253D&md5=75190d1e546b766cd00a5cfc29e54644</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DY.%2BP.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DXiong%26aufirst%3DB.%26atitle%3DTranylcypromine%2520and%25206-trifluoroethyl%2520thienopyrimidine%2520hybrid%2520as%2520LSD1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D844%26epage%3D847%26doi%3D10.1016%2Fj.bmcl.2019.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pieroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annunziato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzali, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifiro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costantino, G.</span></span> <span> </span><span class="NLM_article-title">Further insights into the SAR of alpha-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2014.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25585008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFGnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=377-386&author=M.+Pieroniauthor=G.+Annunziatoauthor=E.+Azzaliauthor=P.+Dessantiauthor=C.+Mercurioauthor=G.+Meroniauthor=P.+Trifiroauthor=P.+Vianelloauthor=M.+Villaauthor=C.+Beatoauthor=M.+Varasiauthor=G.+Costantino&title=Further+insights+into+the+SAR+of+alpha-substituted+cyclopropylamine+derivatives+as+inhibitors+of+histone+demethylase+KDM1A&doi=10.1016%2Fj.ejmech.2014.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A</span></div><div class="casAuthors">Pieroni, Marco; Annunziato, Giannamaria; Azzali, Elisa; Dessanti, Paola; Mercurio, Ciro; Meroni, Giuseppe; Trifiro, Paolo; Vianello, Paola; Villa, Manuela; Beato, Claudia; Varasi, Mario; Costantino, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">377-386</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Epigenetics alterations including histone methylation and acetylation, and DNA methylation, are thought to play important roles in the onset and progression of cancer in numerous tumor cell lines.  Lysine-specific demethylase 1 (LSD1 or KDM1A) is highly expressed in different cancer types and inhibiting KDM1A activity seems to have high therapeutic potential in cancer treatment.  In the recent years, several inhibitors of KDM1A have been prepd. and disclosed.  The majority of these derivs. were designed based on the structure of tranylcypromine, as the cyclopropane core is responsible for the covalent interaction between the inhibitor and the catalytic domain of KDM proteins.  In this study, we have further extended the SAR regarding compds. 1a-e, which were recently found to inhibit KDM1A with good activity.  The decoration of the Ph ring at the β-position of the cyclopropane ring with small functional groups, mostly halogenated, and in particular at the meta position, led to a significant improvement of the inhibitory activity against KDM1A, as exemplified by compd. 44a, which has a potency in the low nanomolar range (31 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSQyHWyX2UZLVg90H21EOLACvtfcHk0liDzEnTF7c_YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFGnuw%253D%253D&md5=76f37a0eeb69d3962a82fd4aab95cc8f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DAnnunziato%26aufirst%3DG.%26aulast%3DAzzali%26aufirst%3DE.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DTrifiro%26aufirst%3DP.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DBeato%26aufirst%3DC.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DCostantino%26aufirst%3DG.%26atitle%3DFurther%2520insights%2520into%2520the%2520SAR%2520of%2520alpha-substituted%2520cyclopropylamine%2520derivatives%2520as%2520inhibitors%2520of%2520histone%2520demethylase%2520KDM1A%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D377%26epage%3D386%26doi%3D10.1016%2Fj.ejmech.2014.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifiro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1A</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2014.08.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=25173853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGnsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=352-363&author=P.+Vianelloauthor=O.+A.+Botrugnoauthor=A.+Cappaauthor=G.+Ciossaniauthor=P.+Dessantiauthor=A.+Maiauthor=A.+Matteviauthor=G.+Meroniauthor=S.+Minucciauthor=F.+Thalerauthor=M.+Tortoriciauthor=P.+Trifiroauthor=S.+Valenteauthor=M.+Villaauthor=M.+Varasiauthor=C.+Mercurio&title=Synthesis%2C+biological+activity+and+mechanistic+insights+of+1-substituted+cyclopropylamine+derivatives%3A+a+novel+class+of+irreversible+inhibitors+of+histone+demethylase+KDM1A&doi=10.1016%2Fj.ejmech.2014.08.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: A novel class of irreversible inhibitors of histone demethylase KDM1A</span></div><div class="casAuthors">Vianello, Paola; Botrugno, Oronza A.; Cappa, Anna; Ciossani, Giuseppe; Dessanti, Paola; Mai, Antonello; Mattevi, Andrea; Meroni, Giuseppe; Minucci, Saverio; Thaler, Florian; Tortorici, Marcello; Trifiro, Paolo; Valente, Sergio; Villa, Manuela; Varasi, Mario; Mercurio, Ciro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">352-363</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Histone demethylase KDM1A [i.e., gene LSD1, histone H3 lysine-4 demethylase LSD1] has become an attractive therapeutic target for the treatment of cancer as well as other disorders such as viral infections.  The authors report on the synthesis of compds. derived from the expansion of tranylcypromine as a chem. scaffold for the design of novel demethylase inhibitors.  These compds., which are substituted on the cyclopropyl core moiety, were evaluated for their ability to inhibit KDM1A in vitro as well as to function in cells by modulating the expression of Gfi-1b, a well recognized KDM1A target gene.  The mols. were all found to covalently inhibit KDM1A and to become increasingly selective against human monoamine oxidase MAO A and MAO B through the introduction of bulkier substituents on the cyclopropylamine ring.  Structural and biochem. anal. of selected trans-isomers showed that the two stereoisomers are endowed with similar inhibitory activities against KDM1A, but form different covalent adducts with FAD co-enzyme [i.e., riboflavin 5'-(trihydrogen diphosphate) P'→5'-ester with adenosine, FAD].  The synthesis of the target compds. was achieved using (2S)-2-(phenyl)oxirane, (2R)-2-(phenyl)oxirane, racemic (phenyl)oxirane as starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEJ-thHP_b6rVg90H21EOLACvtfcHk0lixNlvH_v6Niw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGnsrvP&md5=6285108e113c25939e3aa0b1ee5390c6</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.068%26sid%3Dliteratum%253Aachs%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DThaler%26aufirst%3DF.%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DTrifiro%26aufirst%3DP.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3DSynthesis%252C%2520biological%2520activity%2520and%2520mechanistic%2520insights%2520of%25201-substituted%2520cyclopropylamine%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520irreversible%2520inhibitors%2520of%2520histone%2520demethylase%2520KDM1A%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D352%26epage%3D363%26doi%3D10.1016%2Fj.ejmech.2014.08.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borrello, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartels, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benelkebir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Jamal, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duriez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haufe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2099</span>– <span class="NLM_lpage">2101</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2017.03.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=28390942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2099-2101&author=M.+T.+Borrelloauthor=B.+Schinorauthor=K.+Bartelsauthor=H.+Benelkebirauthor=S.+Pereiraauthor=W.+T.+Al-Jamalauthor=L.+Douglasauthor=P.+J.+Duriezauthor=G.+Packhamauthor=G.+Haufeauthor=A.+Ganesan&title=Fluorinated+tranylcypromine+analogues+as+inhibitors+of+lysine-specific+demethylase+1+%28LSD1%2C+KDM1A%29&doi=10.1016%2Fj.bmcl.2017.03.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A)</span></div><div class="casAuthors">Borrello, Maria Teresa; Schinor, Benjamin; Bartels, Katharina; Benelkebir, Hanae; Pereira, Sara; Al-Jamal, Wafa T.; Douglas, Leon; Duriez, Patrick J.; Packham, Graham; Haufe, Gunter; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2099-2101</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report a series of tranylcypromine analogs contg. a fluorine in the cyclopropyl ring.  A no. of compds. with addnl. m- or p-substitution of the aryl ring were micromolar inhibitors of the LSD1 enzyme.  In cellular assays, the compds. inhibited the proliferation of acute myeloid leukemia cell lines.  Increased levels of the biomarkers H3K4me2 and CD86 were consistent with LSD1 target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5ZbwPOwT7LVg90H21EOLACvtfcHk0lixNlvH_v6Niw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOlsr4%253D&md5=aec7b06a5648e828e32f3c1a8b2360e4</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.081%26sid%3Dliteratum%253Aachs%26aulast%3DBorrello%26aufirst%3DM.%2BT.%26aulast%3DSchinor%26aufirst%3DB.%26aulast%3DBartels%26aufirst%3DK.%26aulast%3DBenelkebir%26aufirst%3DH.%26aulast%3DPereira%26aufirst%3DS.%26aulast%3DAl-Jamal%26aufirst%3DW.%2BT.%26aulast%3DDouglas%26aufirst%3DL.%26aulast%3DDuriez%26aufirst%3DP.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DHaufe%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DFluorinated%2520tranylcypromine%2520analogues%2520as%2520inhibitors%2520of%2520lysine-specific%2520demethylase%25201%2520%2528LSD1%252C%2520KDM1A%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2099%26epage%3D2101%26doi%3D10.1016%2Fj.bmcl.2017.03.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrugno, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Zuffo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessanti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrocco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stazi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifiró, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) as orally active antitumor agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyrtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1501-1517&author=P.+Vianelloauthor=O.+A.+Botrugnoauthor=A.+Cappaauthor=R.+Dal+Zuffoauthor=P.+Dessantiauthor=A.+Maiauthor=B.+Marroccoauthor=A.+Matteviauthor=G.+Meroniauthor=S.+Minucciauthor=G.+Staziauthor=F.+Thalerauthor=P.+Trifir%C3%B3author=S.+Valenteauthor=M.+Villaauthor=M.+Varasiauthor=C.+Mercurio&title=Discovery+of+a+novel+inhibitor+of+histone+lysine-specific+demethylase+1A+%28KDM1A%2FLSD1%29+as+orally+active+antitumor+agent&doi=10.1021%2Facs.jmedchem.5b01209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent</span></div><div class="casAuthors">Vianello, Paola; Botrugno, Oronza A.; Cappa, Anna; Dal Zuffo, Roberto; Dessanti, Paola; Mai, Antonello; Marrocco, Biagina; Mattevi, Andrea; Meroni, Giuseppe; Minucci, Saverio; Stazi, Giulia; Thaler, Florian; Trifiro, Paolo; Valente, Sergio; Villa, Manuela; Varasi, Mario; Mercurio, Ciro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1501-1517</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the stereoselective synthesis and biol. activity of a novel series of tranylcypromine (TCPA) derivs, potent inhibitors of KDM1A.  The new compds. strongly inhibit the clonogenic potential of acute leukemia cell lines.  In particular three mols. showing selectivity vs. MAO A and remarkably inhibiting colony formation in THP-1 human leukemia cells, were assessed in mouse for their preliminary pharmacokinetic.  Among them, compds. I and II were further tested in vivo in a murine acute promyelocytic leukemia model, resulting I the most effective.  Its two enantiomers were synthesized: the (1S,2R) enantiomer showed higher activity than its (1R,2S) analog, in both biochem. and cellular assays.  Compd. (1S,2R)-I exhibited in vivo efficacy after oral administration, detg. a 62% increased survival in mouse leukemia model with evidence of KDM1A inhibition.  The biol. profile of compd. (1S,2R)-I supports its further investigation as a cancer therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraSPzAcLQ0u7Vg90H21EOLACvtfcHk0lixNlvH_v6Niw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyrtbfM&md5=b7df567ef2cf939a1365874fccac9df0</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01209%26sid%3Dliteratum%253Aachs%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DBotrugno%26aufirst%3DO.%2BA.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DDal%2BZuffo%26aufirst%3DR.%26aulast%3DDessanti%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMarrocco%26aufirst%3DB.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DG.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DStazi%26aufirst%3DG.%26aulast%3DThaler%26aufirst%3DF.%26aulast%3DTrifir%25C3%25B3%26aufirst%3DP.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520inhibitor%2520of%2520histone%2520lysine-specific%2520demethylase%25201A%2520%2528KDM1A%252FLSD1%2529%2520as%2520orally%2520active%2520antitumor%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1501%26epage%3D1517%26doi%3D10.1021%2Facs.jmedchem.5b01209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunosewoyo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.-F.</span></span> <span> </span><span class="NLM_article-title">Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2017.09.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29031059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GltrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=101-112&author=Y.-Y.+Jiauthor=S.-D.+Linauthor=Y.-J.+Wangauthor=M.-B.+Suauthor=W.+Zhangauthor=H.+Gunosewoyoauthor=F.+Yangauthor=J.+Liauthor=J.+Tangauthor=Y.-B.+Zhouauthor=L.-F.+Yu&title=Tying+up+tranylcypromine%3A+Novel+selective+histone+lysine+specific+demethylase+1+%28LSD1%29+inhibitors&doi=10.1016%2Fj.ejmech.2017.09.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors</span></div><div class="casAuthors">Ji, Yue-Yang; Lin, Sen-Dong; Wang, Yu-Jie; Su, Ming-Bo; Zhang, Wei; Gunosewoyo, Hendra; Yang, Fan; Li, Jia; Tang, Jie; Zhou, Yu-Bo; Yu, Li-Fang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Aberrant expression of lysine specific histone demethylase 1 (LSD1) has been increasingly assocd. with numerous cancer cells and several proof-of-concept studies are strongly suggestive of its potential as a druggable target.  Tranylcypromine (TCP) is an antidepressant originally known to target the monoamine oxidases A and B (MAO-A and MAO-B), which are structurally related to LSD1.  A no. of TCP derivs. have been identified as potent LSD1 inhibitors, with a handful of them currently being tested in clin. trials.  However, thus far the majority of structure-activity relationship studies reported on these TCP derivs. have been mostly limited to the racemates.  In this study, the authors present the SAR data for a novel series of conformationally-restricted TCP-based LSD1 inhibitors, both in their racemic and enantiomerically pure forms.  Compds. I and II were identified as the most potent LSD1 inhibitors within this series, possessing excellent selectivity (>10,000-fold) against MAO-A and MAO-B.  These compds. activated CD86 expression on the human MV4-11 AML cells following 10 days of exposure, accompanied with the apparent cytotoxicity.  Taken together, these findings are consistent with the pharmacol. inhibition of LSD1 and further provide structural insights on the binding modes of these TCP derivs. and their enantiomers at the LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBmzvmFTXrQ7Vg90H21EOLACvtfcHk0lgVW1PskhQbmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GltrnL&md5=fcef20fb0336c50bfa970fe6ab1a0e55</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.073%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DY.-Y.%26aulast%3DLin%26aufirst%3DS.-D.%26aulast%3DWang%26aufirst%3DY.-J.%26aulast%3DSu%26aufirst%3DM.-B.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.-B.%26aulast%3DYu%26aufirst%3DL.-F.%26atitle%3DTying%2520up%2520tranylcypromine%253A%2520Novel%2520selective%2520histone%2520lysine%2520specific%2520demethylase%25201%2520%2528LSD1%2529%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D141%26spage%3D101%26epage%3D112%26doi%3D10.1016%2Fj.ejmech.2017.09.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunosewoyo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.-F.</span></span> <span> </span><span class="NLM_article-title">Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1676</span>, <span class="refDoi"> DOI: 10.1039/C7RA13097J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1039%2FC7RA13097J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1OjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1666-1676&author=Y.+Shiauthor=Y.-R.+Wuauthor=M.-B.+Suauthor=D.-H.+Shenauthor=H.+Gunosewoyoauthor=F.+Yangauthor=J.+Liauthor=J.+Tangauthor=Y.-B.+Zhouauthor=L.-F.+Yu&title=Novel+spirocyclic+tranylcypromine+derivatives+as+lysine-specific+demethylase+1+%28LSD1%29+inhibitors&doi=10.1039%2FC7RA13097J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors</span></div><div class="casAuthors">Shi, Ying; Wu, Yan-Ran; Su, Ming-Bo; Shen, Dong-Hao; Gunosewoyo, Hendra; Yang, Fan; Li, Jia; Tang, Jie; Zhou, Yu-Bo; Yu, Li-Fang</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1666-1676</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Herein we describe the design, synthesis, and biol. evaluation of a novel series of tranylcypromine-based LSD1 inhibitors via conformational restriction using spiro ring systems.  A simple, direct spirocyclic analog of tranylcypromine (compds. 8a and 8b) was shown to be a 28- to 129-fold more potent inhibitor of LSD1 enzyme compared to tranylcypromine.  Further incorporation of various substituted benzyl groups to the amino group resulted in a suite of 2',3'-dihydrospiro[cyclopropane-1,1'-inden]-2-amines that are potent LSD1 inhibitors with excellent selectivity profiles (e.g.14a, 15b, 16a, 19a and 20b) against closely related enzymes such as MAO-A, MAO-B, and LSD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWzoUiCluAq7Vg90H21EOLACvtfcHk0lgVW1PskhQbmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1OjtA%253D%253D&md5=127597283f5185a816168b0414f501ef</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1039%2FC7RA13097J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA13097J%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.-R.%26aulast%3DSu%26aufirst%3DM.-B.%26aulast%3DShen%26aufirst%3DD.-H.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.-B.%26aulast%3DYu%26aufirst%3DL.-F.%26atitle%3DNovel%2520spirocyclic%2520tranylcypromine%2520derivatives%2520as%2520lysine-specific%2520demethylase%25201%2520%2528LSD1%2529%2520inhibitors%26jtitle%3DRSC%2520Adv.%26date%3D2018%26volume%3D8%26spage%3D1666%26epage%3D1676%26doi%3D10.1039%2FC7RA13097J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schule, R.</span></span> <span> </span><span class="NLM_article-title">LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>437</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1038/nature04020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fnature04020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=16079795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFOrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=436-439&author=E.+Metzgerauthor=M.+Wissmannauthor=N.+Yinauthor=J.+M.+Mullerauthor=R.+Schneiderauthor=A.+H.+Petersauthor=T.+Guntherauthor=R.+Buettnerauthor=R.+Schule&title=LSD1+demethylates+repressive+histone+marks+to+promote+androgen-receptor-dependent+transcription&doi=10.1038%2Fnature04020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription</span></div><div class="casAuthors">Metzger, Eric; Wissmann, Melanie; Yin, Na; Mueller, Judith M.; Schneider, Robert; Peters, Antoine H. F. M.; Guenther, Thomas; Buettner, Reinhard; Schuele, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">7057</span>),
    <span class="NLM_cas:pages">436-439</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Gene regulation in eukaryotes requires the coordinate interaction of chromatin-modulating proteins with specific transcription factors such as the androgen receptor.  Gene activation and repression is specifically regulated by histone methylation status at distinct lysine residues.  Here the authors show that lysine-specific demethylase 1 (LSD1; also known as BHC110) co-localizes with the androgen receptor in normal human prostate and prostate tumor.  LSD1 interacts with androgen receptor in vitro and in vivo, and stimulates androgen-receptor-dependent transcription.  Conversely, knockdown of LSD1 protein levels abrogates androgen-induced transcriptional activation and cell proliferation.  Chromatin immunopptn. analyses demonstrate that androgen receptor and LSD1 form chromatin-assocd. complexes in a ligand-dependent manner.  LSD1 relieves repressive histone marks by demethylation of histone H3 at lysine 9 (H3-K9), thereby leading to de-repression of androgen receptor target genes.  Furthermore, the authors identify pargyline as an inhibitor of LSD1.  Pargyline blocks demethylation of H3-K9 by LSD1 and consequently androgen-receptor-dependent transcription.  Thus, modulation of LSD1 activity offers a new strategy to regulate androgen receptor functions.  Here, the authors link demethylation of a repressive histone mark with androgen-receptor-dependent gene activation, thus providing a mechanism by which demethylases control specific gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgFgaYIdjiFbVg90H21EOLACvtfcHk0lgCE_lFRZlEmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFOrtL4%253D&md5=6cac1e6f6c21a80f59de27796cc9ee22</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fnature04020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04020%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DE.%26aulast%3DWissmann%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DN.%26aulast%3DMuller%26aufirst%3DJ.%2BM.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DA.%2BH.%26aulast%3DGunther%26aufirst%3DT.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DSchule%26aufirst%3DR.%26atitle%3DLSD1%2520demethylates%2520repressive%2520histone%2520marks%2520to%2520promote%2520androgen-receptor-dependent%2520transcription%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D436%26epage%3D439%26doi%3D10.1038%2Fnature04020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karakaidos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verigos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magklara, A.</span></span> <span> </span><span class="NLM_article-title">LSD1/KDM1A, a gate-keeper of cancer stemness and a promising therapeutic target</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1821</span>, <span class="refDoi"> DOI: 10.3390/cancers11121821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3390%2Fcancers11121821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXptVyht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1821&author=P.+Karakaidosauthor=J.+Verigosauthor=A.+Magklara&title=LSD1%2FKDM1A%2C+a+gate-keeper+of+cancer+stemness+and+a+promising+therapeutic+target&doi=10.3390%2Fcancers11121821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1/KDM1A, a gate-keeper of cancer stemness and a promising therapeutic target</span></div><div class="casAuthors">Karakaidos, Panagiotis; Verigos, John; Magklara, Angeliki</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1821</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A new exciting area in cancer research is the study of cancer stem cells (CSCs) and the translational implications for putative epigenetic therapies targeted against them.  Accumulating evidence of the effects of epigenetic modulating agents has revealed their dramatic consequences on cellular reprogramming and, particularly, reversing cancer stemness characteristics, such as self-renewal and chemoresistance.  Lysine specific demethylase 1 (LSD1/KDM1A) plays a well-established role in the normal hematopoietic and neuronal stem cells.  Overexpression of LSD1 has been documented in a variety of cancers, where the enzyme is, usually, assocd. with the more aggressive types of the disease.  Interestingly, recent studies have implicated LSD1 in the regulation of the pool of CSCs in different leukemias and solid tumors.  However, the precise mechanisms that LSD1 uses to mediate its effects on cancer stemness are largely unknown.  Herein, we review the literature on LSD1's role in normal and cancer stem cells, highlighting the analogies of its mode of action in the two biol. settings.  Given its potential as a pharmacol. target, we, also, discuss current advances in the design of novel therapeutic regimes in cancer that incorporate LSD1 inhibitors, as well as their future perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyjsYptQmktLVg90H21EOLACvtfcHk0lgCE_lFRZlEmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXptVyht7s%253D&md5=0cef1b5b1817832a8225178244c7c17c</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.3390%2Fcancers11121821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers11121821%26sid%3Dliteratum%253Aachs%26aulast%3DKarakaidos%26aufirst%3DP.%26aulast%3DVerigos%26aufirst%3DJ.%26aulast%3DMagklara%26aufirst%3DA.%26atitle%3DLSD1%252FKDM1A%252C%2520a%2520gate-keeper%2520of%2520cancer%2520stemness%2520and%2520a%2520promising%2520therapeutic%2520target%26jtitle%3DCancers%26date%3D2019%26volume%3D11%26spage%3D1821%26doi%3D10.3390%2Fcancers11121821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stazi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwergel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">LSD1 inhibitors: a patent review (2010–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1517/13543776.2016.1165209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1517%2F13543776.2016.1165209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27019002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFGqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=565-580&author=G.+Staziauthor=C.+Zwergelauthor=S.+Valenteauthor=A.+Mai&title=LSD1+inhibitors%3A+a+patent+review+%282010%E2%80%932015%29&doi=10.1517%2F13543776.2016.1165209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 inhibitors: a patent review (2010-2015)</span></div><div class="casAuthors">Stazi, Giulia; Zwergel, Clemens; Valente, Sergio; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-580</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Lysine demethylase 1 (LSD1) plays an important role in mediating the expression of genes involved in cancer and non-cancer diseases such as viral infections, cardiovascular and neurodegenerative disorders.  It is involved in a no. of processes from adipogenesis to cell adhesion to viral latency, regulating several cell pathways related with proliferation, development, and cell cycle control.  Numerous chem. entities have been studied in recent years and some of them entered the clin. arena.  This review summarizes recent efforts in the drug development of LSD1 inhibitors reported in the patent literature covering the 2010-2015 period, including their potential use as therapeutics in cancerous, neurol., inflammatory, cardiovascular, and viral diseases.  The development of novel potent and selective LSD1 inhibitors is ongoing, in order to improve their potency and selectivity against specific types of cancer or non-cancer diseases.  More in-depth studies are required to assess the role of LSD1 inhibitors in the expression of LSD1 target genes, for a better assessment of the biochem. underlying their efficacy, and to provide evidence for any possible side effects.  Furthermore, an interesting therapeutic approach is the use of LSD1 inhibitors in conjunction with other epidrugs to combine their therapeutic potential, leading to innovative, personalized treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCf5uleaXD27Vg90H21EOLACvtfcHk0lgCE_lFRZlEmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFGqs7w%253D&md5=557242114797bc59b35e9f66cec893bf</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1165209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1165209%26sid%3Dliteratum%253Aachs%26aulast%3DStazi%26aufirst%3DG.%26aulast%3DZwergel%26aufirst%3DC.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DLSD1%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D565%26epage%3D580%26doi%3D10.1517%2F13543776.2016.1165209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorna, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theisen, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearss, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vankayalapati, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span> <span> </span><span class="NLM_article-title">High-throughput virtual screening identifies novel N′-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9496</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1021/jm400870h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400870h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyks7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9496-508&author=V.+Sornaauthor=E.+R.+Theisenauthor=B.+Stephensauthor=S.+L.+Warnerauthor=D.+J.+Bearssauthor=H.+Vankayalapatiauthor=S.+Sharma&title=High-throughput+virtual+screening+identifies+novel+N%E2%80%B2-%281-phenylethylidene%29-benzohydrazides+as+potent%2C+specific%2C+and+reversible+LSD1+inhibitors&doi=10.1021%2Fjm400870h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Virtual Screening Identifies Novel N'-(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors</span></div><div class="casAuthors">Sorna, Venkataswamy; Theisen, Emily R.; Stephens, Bret; Warner, Steven L.; Bearss, David J.; Vankayalapati, Hariprasad; Sharma, Sunil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9496-9508</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) plays an important role in regulating histone lysine methylation at residues K4 and K9 on histone H3 and is an attractive therapeutic target in multiple malignancies.  Here we report a structure-based virtual screen of a compd. library contg. ∼2 million small mol. entities.  Computational docking and scoring followed by biochem. screening led to the identification of a novel N'-(1-phenylethylidene)-benzohydrazide series of LSD1 inhibitors with hits showing biochem. IC50s in the 200-400 nM range.  Hit-to-lead optimization and structure-activity relation studies aided in the discovery of compd. (I), with a Ki of 31 nM.  Compd. I is reversible and specific for LSD1 as compared to the monoamine oxidases shows minimal inhibition of CYPs and hERG and inhibits proliferation and survival in several cancer cell lines, including breast and colorectal cancer.  Compd. I may be used to probe LSD1's biol. role in these cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp97P3ef8ur6rVg90H21EOLACvtfcHk0lgCE_lFRZlEmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyks7fF&md5=47293fd790c5bc9fd944943ff4b1a58a</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm400870h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400870h%26sid%3Dliteratum%253Aachs%26aulast%3DSorna%26aufirst%3DV.%26aulast%3DTheisen%26aufirst%3DE.%2BR.%26aulast%3DStephens%26aufirst%3DB.%26aulast%3DWarner%26aufirst%3DS.%2BL.%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26aulast%3DVankayalapati%26aufirst%3DH.%26aulast%3DSharma%26aufirst%3DS.%26atitle%3DHigh-throughput%2520virtual%2520screening%2520identifies%2520novel%2520N%25E2%2580%25B2-%25281-phenylethylidene%2529-benzohydrazides%2520as%2520potent%252C%2520specific%252C%2520and%2520reversible%2520LSD1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9496%26epage%3D508%26doi%3D10.1021%2Fjm400870h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D(3) receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4962</span>– <span class="NLM_lpage">4968</span>, <span class="refDoi"> DOI: 10.1021/jm401798r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401798r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4962-4968&author=J.+Chenauthor=B.+Levantauthor=C.+Jiangauthor=T.+M.+Keckauthor=A.+H.+Newmanauthor=S.+Wang&title=Tranylcypromine+substituted+cis-hydroxycyclobutylnaphthamides+as+potent+and+selective+dopamine+D%283%29+receptor+antagonists&doi=10.1021%2Fjm401798r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Chen, Jianyong; Levant, Beth; Jiang, Cheng; Keck, Thomas M.; Newman, Amy Hauck; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4962-4968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a class of potent and selective dopamine D3 receptor antagonists based upon tranylcypromine.  Although tranylcypromine has a low affinity for the rat D3 receptor (Ki = 12.8 μM), our efforts have yielded (1R,2S)-11 (CJ-1882), which has Ki values of 2.7 and 2.8 nM at the rat and human dopamine D3 receptors, resp., and displays resp. selectivities of >10000-fold and 223-fold over the rat and human D2 receptors.  Evaluation in a β-arrestin functional assay showed that (1R,2S)-11 is a potent and competitive antagonist at the human D3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowWudWdAfWgLVg90H21EOLACvtfcHk0lg3rXSXifMLWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D&md5=e2ddf0711d00103be281cb043b19ec3a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm401798r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401798r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTranylcypromine%2520substituted%2520cis-hydroxycyclobutylnaphthamides%2520as%2520potent%2520and%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4962%26epage%3D4968%26doi%3D10.1021%2Fjm401798r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2020.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.apsb.2020.02.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=L.+Maauthor=H.+Wangauthor=Y.+Youauthor=C.+Maauthor=Y.+Liuauthor=F.+Yangauthor=Y.+Zhengauthor=H.+Liu&title=Exploration+of+5-cyano-6-phenylpyrimidin+derivatives+containing+an+1%2C2%2C3-triazole+moiety+as+potent+FAD-based+LSD1+inhibitors&doi=10.1016%2Fj.apsb.2020.02.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2020.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2020.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DExploration%2520of%25205-cyano-6-phenylpyrimidin%2520derivatives%2520containing%2520an%25201%252C2%252C3-triazole%2520moiety%2520as%2520potent%2520FAD-based%2520LSD1%2520inhibitors%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2020%26doi%3D10.1016%2Fj.apsb.2020.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, W.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.-W.</span></span> <span> </span><span class="NLM_article-title">Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.04.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2019.04.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31096156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVGisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2019&pages=357-372&author=H.-M.+Liuauthor=F.-Z.+Suoauthor=X.-B.+Liauthor=Y.-H.+Youauthor=C.-T.+Lvauthor=C.-X.+Zhengauthor=G.-C.+Zhangauthor=Y.-J.+Liuauthor=W.-T.+Kangauthor=Y.-C.+Zhengauthor=H.-W.+Xu&title=Discovery+and+synthesis+of+novel+indole+derivatives-containing+3-methylenedihydrofuran-2%283H%29-one+as+irreversible+LSD1+inhibitors&doi=10.1016%2Fj.ejmech.2019.04.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors</span></div><div class="casAuthors">Liu, Hong-Min; Suo, Feng-Zhi; Li, Xiao-Bo; You, Ying-Hua; Lv, Chun-Tao; Zheng, Chen-Xing; Zhang, Guo-Chen; Liu, Yue-Jiao; Kang, Wen-Ting; Zheng, Yi-Chao; Xu, Hai-Wei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">357-372</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of new indole derivs. were designed and synthesized based on a lead compd. obtained by a high-throughput screening with our inhouse compd. library.  Among the synthetic compds., compd. I was characterized as a potent LSD1 inhibitor with an IC50 of 1.230 μM and inhibited the proliferation of THP-1 cells effectively.  And most importantly, this was the first irreversible LSD1 inhibitor that is not derived from monoamine oxidase inhibitors.  Hence, the discovery of compd. I may serve as a proof of concept work for AML treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-rtJCJCweTrVg90H21EOLACvtfcHk0lg3rXSXifMLWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVGisr0%253D&md5=4c21ccd38a1bf02c94425b7ee78e550d</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.04.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.04.065%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.-M.%26aulast%3DSuo%26aufirst%3DF.-Z.%26aulast%3DLi%26aufirst%3DX.-B.%26aulast%3DYou%26aufirst%3DY.-H.%26aulast%3DLv%26aufirst%3DC.-T.%26aulast%3DZheng%26aufirst%3DC.-X.%26aulast%3DZhang%26aufirst%3DG.-C.%26aulast%3DLiu%26aufirst%3DY.-J.%26aulast%3DKang%26aufirst%3DW.-T.%26aulast%3DZheng%26aufirst%3DY.-C.%26aulast%3DXu%26aufirst%3DH.-W.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520novel%2520indole%2520derivatives-containing%25203-methylenedihydrofuran-2%25283H%2529-one%2520as%2520irreversible%2520LSD1%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D175%26spage%3D357%26epage%3D372%26doi%3D10.1016%2Fj.ejmech.2019.04.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">6000</span>– <span class="NLM_lpage">6014</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmc.2018.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30448189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1WltrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=6000-6014&author=Y.+Duanauthor=W.+Qinauthor=F.+Suoauthor=X.+Zhaiauthor=Y.+Guanauthor=X.+Wangauthor=Y.+Zhengauthor=H.+Liu&title=Design%2C+synthesis+and+in+vitro+evaluation+of+stilbene+derivatives+as+novel+LSD1+inhibitors+for+AML+therapy&doi=10.1016%2Fj.bmc.2018.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy</span></div><div class="casAuthors">Duan, Yingchao; Qin, Wenping; Suo, Fengzhi; Zhai, Xiaoyu; Guan, Yuanyuan; Wang, Xiaojuan; Zheng, Yichao; Liu, Hongmin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23-24</span>),
    <span class="NLM_cas:pages">6000-6014</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">LSD1 is implicated in a no. of malignancies and has emerged as an exciting target.  As part of our sustained efforts to develop novel reversible LSD1 inhibitors for epigenetic therapy of cancers, in this study, we reported a series of stilbene derivs. and evaluated their LSD1 inhibitory activities, obtaining several compds. as potent LSD1 inhibitors with IC50 values in submicromolar range.  Enzyme kinetics studies and SPR assay suggested that compd. 8c, the most active LSD1 inhibitor (IC50 = 283 nM), potently inhibited LSD1 in a reversible and FAD competitive manner.  Consistent with the kinetics data, mol. docking showed that compd. 8c can be well docked into the FAD binding site of LSD1.  Flow cytometry anal. showed that compd. 8c was capable of up-regulating the expression of the surrogate cellular biomarker CD86 in THP-1 human leukemia cells, suggesting the ability to block LSD1 activity in cells.  Compd. 8c showed good inhibition against THP-1 and MOLM-13 cells with IC50 values of 5.76 and 8.34 μM, resp.  Moreover, compd. 8c significantly inhibited colony formation of THP-1 cells dose dependently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQHvTfU4lSbVg90H21EOLACvtfcHk0li6dr3GqE5znQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1WltrjJ&md5=989826c422d025071b5533a8be86edae</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DW.%26aulast%3DSuo%26aufirst%3DF.%26aulast%3DZhai%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520stilbene%2520derivatives%2520as%2520novel%2520LSD1%2520inhibitors%2520for%2520AML%2520therapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D6000%26epage%3D6014%26doi%3D10.1016%2Fj.bmc.2018.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine derivatives as novel LSD1 Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjslyju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=384-389&author=Z.+H.+Liauthor=X.+Q.+Liuauthor=P.+F.+Gengauthor=F.+Z.+Suoauthor=J.+L.+Maauthor=B.+Yuauthor=T.+Q.+Zhaoauthor=Z.+Q.+Zhouauthor=C.+X.+Huangauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Discovery+of+%5B1%2C2%2C3%5DTriazolo%5B4%2C5-d%5Dpyrimidine+derivatives+as+novel+LSD1+Inhibitors&doi=10.1021%2Facsmedchemlett.6b00423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Novel LSD1 Inhibitors</span></div><div class="casAuthors">Li, Zhong-Hua; Liu, Xue-Qi; Geng, Peng-Fei; Suo, Feng-Zhi; Ma, Jin-Lian; Yu, Bin; Zhao, Tao-Qian; Zhou, Zhao-Qing; Huang, Chen-Xi; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">384-389</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1) plays a pivotal role in regulating the lysine methylation.  The aberrant overexpression of LSD1 was reported to be involved in the progression of certain human malignant tumors.  Abrogation of LSD1 with RNAi or small mol. inhibitors may lead to the inhibition of cancer proliferation and migration.  Herein, a series of [1,2,3]triazolo[4,5-d]pyrimidine derivs. were synthesized and evaluated for their LSD1 inhibitory effects.  The structure-activity relation studies (SARs) were conducted by exploring three regions of this scaffold, leading to the discovery of compd. 27 as potent LSD1 inhibitor (IC50 = 0.564 μM).  Compd. 27 was identified as a reversible LSD1 inhibitor and showed certain selectivity to LSD1 over monoamine oxidase A/B (MAO-A/B).  When MGC-803 cells were treated with compd. 27, the activity of LSD1 can be significantly inhibited, and the cell migration ability was also suppressed.  Docking studies indicated that the hydrogen interaction between the nitrogen atom in the pyridine ring and Met332 could be responsible for the improved activity of 2-thiopyridine series.  The [1,2,3]triazolo[4,5-d]pyrimidine scaffold can be used as the template for designing new LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeTW4tbCivwLVg90H21EOLACvtfcHk0li6dr3GqE5znQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjslyju74%253D&md5=dc8bb933eebb850e165663d6de2b8270</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00423%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DLiu%26aufirst%3DX.%2BQ.%26aulast%3DGeng%26aufirst%3DP.%2BF.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DT.%2BQ.%26aulast%3DZhou%26aufirst%3DZ.%2BQ.%26aulast%3DHuang%26aufirst%3DC.%2BX.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DDiscovery%2520of%2520%255B1%252C2%252C3%255DTriazolo%255B4%252C5-d%255Dpyrimidine%2520derivatives%2520as%2520novel%2520LSD1%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D384%26epage%3D389%26doi%3D10.1021%2Facsmedchemlett.6b00423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.11.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2016.11.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27888721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGqsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=246-258&author=Y.+C.+Duanauthor=Y.+Y.+Guanauthor=X.+Y.+Zhaiauthor=L.+N.+Dingauthor=W.+P.+Qinauthor=D.+D.+Shenauthor=X.+Q.+Liuauthor=X.+D.+Sunauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Discovery+of+resveratrol+derivatives+as+novel+LSD1+inhibitors%3A+Design%2C+synthesis+and+their+biological+evaluation&doi=10.1016%2Fj.ejmech.2016.11.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation</span></div><div class="casAuthors">Duan, Ying-Chao; Guan, Yuan-Yuan; Zhai, Xiao-Yu; Ding, Li-Na; Qin, Wen-Ping; Shen, Dan-Dan; Liu, Xue-Qi; Sun, Xu-Dong; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">246-258</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Inhibition of lysine-specific demethylase 1 (LSD1) has recently emerged as an attractive therapeutic target for treating cancer and other diseases.  As a continuity of our ongoing effort to identify novel small-mol. LSD1-inhibitors, we designed and synthesized a series of resveratrol derivs., which were shown to be potent inhibitors of LSD1.  Among them, compds. I and II displayed the most potent LSD1-inhibitory activities in enzyme assays, with IC50 values of 121 nM and 123 nM, resp.  Biochem. study and docking anal. indicated that compds. I and II were reversible LSD1 inhibitors.  High content anal. showed that I and II induced a dose-dependent increase of dimethylated Lys4 of histone H3 and had no impact on the expression of LSD1 in MGC-803 cells.  Furthermore, I or II could remarkably increase the mRNA level of CD86, a surrogate cellular biomarker for LSD1 activity, in MGC-803 cells, suggesting that they are likely to exhibit LSD1-inhibitory activities intracellularly.  These findings should encourage further modification of these compds. to produce more potent LSD1 inhibitors with potential anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWLdv3p7rUK7Vg90H21EOLACvtfcHk0li6dr3GqE5znQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGqsrbN&md5=812cb448167dda2f2a2f69b269a4c594</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.11.035%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%2BC.%26aulast%3DGuan%26aufirst%3DY.%2BY.%26aulast%3DZhai%26aufirst%3DX.%2BY.%26aulast%3DDing%26aufirst%3DL.%2BN.%26aulast%3DQin%26aufirst%3DW.%2BP.%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DLiu%26aufirst%3DX.%2BQ.%26aulast%3DSun%26aufirst%3DX.%2BD.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DDiscovery%2520of%2520resveratrol%2520derivatives%2520as%2520novel%2520LSD1%2520inhibitors%253A%2520Design%252C%2520synthesis%2520and%2520their%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D246%26epage%3D258%26doi%3D10.1016%2Fj.ejmech.2016.11.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.11.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.ejmech.2018.11.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30472603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit12ltLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=555-567&author=Q.+S.+Maauthor=Y.+Yaoauthor=Y.+C.+Zhengauthor=S.+Fengauthor=J.+Changauthor=B.+Yuauthor=H.+M.+Liu&title=Ligand-based+design%2C+synthesis+and+biological+evaluation+of+xanthine+derivatives+as+LSD1%2FKDM1A+inhibitors&doi=10.1016%2Fj.ejmech.2018.11.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors</span></div><div class="casAuthors">Ma, Qi-Sheng; Yao, Yongfang; Zheng, Yi-Chao; Feng, Siqi; Chang, Junbiao; Yu, Bin; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">555-567</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Histone lysine specific demethylase 1 (LSD1, KDM1A) has been recognized as an important epigenetic target for disease treatment.  To date, a large no. of LSD1 inhibitors have been developed, some of which are currently being evaluated in clin. trials for the treatment of cancers, virus infection, and neurodegenerative diseases.  In this paper, we for the first time reported the ligand-based design of fragment-like xanthine derivs. as LSD1 inhibitors, of which compd. 4 possessed acceptable pharmacol. inhibition against LSD1 (IC50 = 6.45 μM) and favorable fragment-like nature, and therefore could be used as a promising template to design new LSD1 inhibitors.  Interestingly, compds. 6c and 6i strongly suppressed growth of MGC-803 cells partly dependent on their LSD1 inhibition, and were also found to be able to inhibit BRD4 and IDO1.  The docking studies were performed to rationalize the biochem. potency against LSD1 and to explain the obsd. activity discrepancy.  The proof-of-concept work may provide an example for other natural ligand-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNwIGUA6safrVg90H21EOLACvtfcHk0lhD1NRZi0IjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit12ltLvO&md5=3b4bd4668111aad864a366d55ab6c777</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.11.035%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%2BS.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DLigand-based%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520xanthine%2520derivatives%2520as%2520LSD1%252FKDM1A%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D162%26spage%3D555%26epage%3D567%26doi%3D10.1016%2Fj.ejmech.2018.11.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1705</span>– <span class="NLM_lpage">1716</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1705-1716&author=L.+Y.+Maauthor=Y.+C.+Zhengauthor=S.+Q.+Wangauthor=B.+Wangauthor=Z.+R.+Wangauthor=L.+P.+Pangauthor=M.+Zhangauthor=J.+W.+Wangauthor=L.+Dingauthor=J.+Liauthor=C.+Wangauthor=B.+Huauthor=Y.+Liuauthor=X.+D.+Zhangauthor=J.+J.+Wangauthor=Z.+J.+Wangauthor=W.+Zhaoauthor=H.+M.+Liu&title=Design%2C+synthesis%2C+and+structure-activity+relationship+of+novel+LSD1+inhibitors+based+on+pyrimidine-thiourea+hybrids+as+potent%2C+orally+active+antitumor+agents&doi=10.1021%2Facs.jmedchem.5b00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship of Novel LSD1 Inhibitors Based on Pyrimidine-Thiourea Hybrids As Potent, Orally Active Antitumor Agents</span></div><div class="casAuthors">Ma, Li-Ying; Zheng, Yi-Chao; Wang, Sai-Qi; Wang, Bo; Wang, Zhi-Ru; Pang, Lu-Ping; Zhang, Miao; Wang, Jun-Wei; Ding, Lina; Li, Juan; Wang, Cong; Hu, Biao; Liu, Ying; Zhang, Xiao-Dan; Wang, Jia-Jia; Wang, Zhi-Jian; Zhao, Wen; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1705-1716</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone lysine specific demethylase 1 (LSD1) was reported to be overexpressed in several human cancers and recognized as a promising anticancer drug target.  In the current study, we designed and synthesized a novel series of pyrimidine-thiourea hybrids and evaluated their potential LSD1 inhibitory effect.  One of the compds., 6b, contg. a terminal alkyne appendage, was shown to be the most potent and selective LSD1 inhibitor in vitro and exhibited strong cytotoxicity against LSD1 overexpressed gastric cancer cells.  Compd. 6b also showed marked inhibition of cell migration and invasion as well as significant in vivo tumor suppressing and antimetastasis role, without significant side effects by oral administration.  Our findings indicate that the pyrimidine-thiourea-based LSD1 inactivator may serve as a leading compd. targeting LSD1 overexpressed cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy8SIAhdqGGbVg90H21EOLACvtfcHk0lhD1NRZi0IjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyksbw%253D&md5=7256792e23b75e5f26bac47dfa773b11</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00037%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%2BY.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DZ.%2BR.%26aulast%3DPang%26aufirst%3DL.%2BP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%2BD.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DZ.%2BJ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520novel%2520LSD1%2520inhibitors%2520based%2520on%2520pyrimidine-thiourea%2520hybrids%2520as%2520potent%252C%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1705%26epage%3D1716%26doi%3D10.1021%2Facs.jmedchem.5b00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8543</span>– <span class="NLM_lpage">8560</span>, <span class="refDoi"> DOI: 10.1021/jm401002r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401002r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8543-8560&author=Y.+C.+Zhengauthor=Y.+C.+Duanauthor=J.+L.+Maauthor=R.+M.+Xuauthor=X.+Ziauthor=W.+L.+Lvauthor=M.+M.+Wangauthor=X.+W.+Yeauthor=S.+Zhuauthor=D.+Mobleyauthor=Y.+Y.+Zhuauthor=J.+W.+Wangauthor=J.+F.+Liauthor=Z.+R.+Wangauthor=W.+Zhaoauthor=H.+M.+Liu&title=Triazole-dithiocarbamate+based+selective+lysine+specific+demethylase+1+%28LSD1%29+inactivators+inhibit+gastric+cancer+cell+growth%2C+invasion%2C+and+migration&doi=10.1021%2Fjm401002r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Triazole-Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration</span></div><div class="casAuthors">Zheng, Yi-Chao; Duan, Ying-Chao; Ma, Jin-Lian; Xu, Rui-Min; Zi, Xiaolin; Lv, Wen-Lei; Wang, Meng-Meng; Ye, Xian-Wei; Zhu, Shun; Mobley, David; Zhu, Yan-Yan; Wang, Jun-Wei; Li, Jin-Feng; Wang, Zhi-Ru; Zhao, Wen; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8543-8560</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine specific demethylase 1 (LSD1), the first identified histone demethylase, plays an important role in epigenetic regulation of gene activation and repression.  The up-regulated LSD1's expression has been reported in several malignant tumors.  In the current study, we designed and synthesized five series of 1,2,3-triazole-dithiocarbamate hybrids and screened their inhibitory activity toward LSD1.  We found that some of these compds., esp. compd. (I), exhibited the most specific and robust inhibition of LSD1.  Interestingly, compd. I also showed potent and selective cytotoxicity against LSD1 overexpressing gastric cancer cell lines MGC-803 and HGC-27, as well as marked inhibition of cell migration and invasion, compared to 2-PCPA.  Furthermore, compd. I effectively reduced the tumor growth bared by human gastric cancer cells in vivo with no signs of adverse side effects.  These findings suggested that compd. I deserves further investigation as a lead compd. in the treatment of LSD1 overexpressing gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjGdOvultbebVg90H21EOLACvtfcHk0lhD1NRZi0IjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nL&md5=4e4594271ff6b62237ff17a87d6f04d8</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm401002r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401002r%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DDuan%26aufirst%3DY.%2BC.%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DXu%26aufirst%3DR.%2BM.%26aulast%3DZi%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DW.%2BL.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DYe%26aufirst%3DX.%2BW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DMobley%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DY.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DLi%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DZ.%2BR.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DTriazole-dithiocarbamate%2520based%2520selective%2520lysine%2520specific%2520demethylase%25201%2520%2528LSD1%2529%2520inactivators%2520inhibit%2520gastric%2520cancer%2520cell%2520growth%252C%2520invasion%252C%2520and%2520migration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8543%26epage%3D8560%26doi%3D10.1021%2Fjm401002r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magliulo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messina, S.</span></span> <span> </span><span class="NLM_article-title">Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">255</span>, <span class="refDoi"> DOI: 10.3389/fonc.2018.00255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3389%2Ffonc.2018.00255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30073149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ks1GqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=255&author=D.+Magliuloauthor=R.+Bernardiauthor=S.+Messina&title=Lysine-specific+demethylase+1A+as+a+promising+target+in+acute+myeloid+leukemia&doi=10.3389%2Ffonc.2018.00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia</span></div><div class="casAuthors">Magliulo Daniela; Magliulo Daniela; Bernardi Rosa; Messina Samantha</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">255</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Acute myeloid leukemia (AML) is a heterogeneous hematopoietic malignancy characterized by the accumulation of incompletely differentiated progenitor cells (blasts) in the bone marrow and blood, and by suppression of normal hematopoiesis.  It has recently become apparent that the AML genome is characterized by recurrent mutations and dysregulations in epigenetic regulators.  These mutations frequently occur before the onset of full blown leukemia, at the pre-leukemic phase, and persist in residual disease that remains after therapeutic intervention, thus suggesting that targeting the AML epigenome may help to eradicate minimal residual disease and prevent relapse.  Within the AML epigenome, lysine-specific demethylase 1 A (LSD1) is a histone demethylase that is found frequently overexpressed, albeit not mutated, in AML.  LSD1 is a required constituent of critical transcription repressor complexes like CoREST and nucleosome remodeling and deacetylase (NuRD), and abrogation of LSD1 expression results in impaired self-renewal and proliferation, and increased differentiation and apoptosis in AML models and primary cells, particularly in AMLs with MLL- and AML1-rearrangements, or erythroid and megakaryoblastic differentiation block.  On this basis, a number of LSD1 inhibitors have been developed in the past decade, and few of them are currently being tested in clinical trials for patients with AML, along with other malignancies.  To date, the most promising application of this therapeutic strategy appears to be combination therapy of LSD1 inhibitors with all-trans retinoic acid (ATRA) to reactivate myeloid differentiation in cells that are not spontaneously susceptible to ATRA treatment.  In this review, we provide an overview of LSD1 function in normal hematopoiesis and leukemia, and of the current clinical application of LSD1 inhibitors for the treatment of patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZvJytNRFkvDC850By6mxpfW6udTcc2eZSx9sH04g3MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ks1GqtQ%253D%253D&md5=7aaddbc35e569064c3fa8da358299840</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2018.00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2018.00255%26sid%3Dliteratum%253Aachs%26aulast%3DMagliulo%26aufirst%3DD.%26aulast%3DBernardi%26aufirst%3DR.%26aulast%3DMessina%26aufirst%3DS.%26atitle%3DLysine-specific%2520demethylase%25201A%2520as%2520a%2520promising%2520target%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DFront.%2520Oncol.%26date%3D2018%26volume%3D8%26spage%3D255%26doi%3D10.3389%2Ffonc.2018.00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Baicalin, a natural LSD1 inhibitor</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2016.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2016.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27814566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2016&pages=129-131&author=Y.+C.+Zhengauthor=D.+D.+Shenauthor=M.+Renauthor=X.+Q.+Liuauthor=Z.+R.+Wangauthor=Y.+Liuauthor=Q.+N.+Zhangauthor=L.+J.+Zhaoauthor=L.+J.+Zhaoauthor=J.+L.+Maauthor=B.+Yuauthor=H.+M.+Liu&title=Baicalin%2C+a+natural+LSD1+inhibitor&doi=10.1016%2Fj.bioorg.2016.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Baicalin, a natural LSD1 inhibitor</span></div><div class="casAuthors">Zheng, Yi-Chao; Shen, Dan-Dan; Ren, Meng; Liu, Xue-Qi; Wang, Zhi-Ru; Liu, Ying; Zhang, Qian-Na; Zhao, Li-Juan; Zhao, Li-Jie; Ma, Jin-Lian; Yu, Bin; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129-131</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Baicalin is one of the active ingredients in the skullcap, with a variety of pharmacol. effects, such as blood pressure redn., sedation, liver-protection, gallbladder-protection, antibacteria, and anti-inflammation.  In the study, baicalin was first characterized as a LSD1 inhibitor with an IC50 of 3.01 μM and showed strong LSD1 inhibitory effect in cells.  Baicalin may serve as a template for designing flavone-based LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRTkjAeKcWbVg90H21EOLACvtfcHk0lhfu6G7qHqqWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqsbnK&md5=0fef2e4a12b491f203d24f4a23823b80</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2016.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2016.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DRen%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%2BQ.%26aulast%3DWang%26aufirst%3DZ.%2BR.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%2BN.%26aulast%3DZhao%26aufirst%3DL.%2BJ.%26aulast%3DZhao%26aufirst%3DL.%2BJ.%26aulast%3DMa%26aufirst%3DJ.%2BL.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DBaicalin%252C%2520a%2520natural%2520LSD1%2520inhibitor%26jtitle%3DBioorg.%2520Chem.%26date%3D2016%26volume%3D69%26spage%3D129%26epage%3D131%26doi%3D10.1016%2Fj.bioorg.2016.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Speranzini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciossani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrocco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forgione, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forneris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehdipour, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e1601017</span> <span class="refDoi"> DOI: 10.1126/sciadv.1601017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1126%2Fsciadv.1601017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27626075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVWisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&author=V.+Speranziniauthor=D.+Rotiliauthor=G.+Ciossaniauthor=S.+Pilottoauthor=B.+Marroccoauthor=M.+Forgioneauthor=A.+Lucidiauthor=F.+Fornerisauthor=P.+Mehdipourauthor=S.+Velankarauthor=A.+Maiauthor=A.+Mattevi&title=Polymyxins+and+quinazolines+are+LSD1%2FKDM1A+inhibitors+with+unusual+structural+features&doi=10.1126%2Fsciadv.1601017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features</span></div><div class="casAuthors">Speranzini, Valentina; Rotili, Dante; Ciossani, Giuseppe; Pilotto, Simona; Marrocco, Biagina; Forgione, Mariantonietta; Lucidi, Alessia; Forneris, Federico; Mehdipour, Parinaz; Velankar, Sameer; Mai, Antonello; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Science Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1601017/1-e1601017/8</span>CODEN:
                <span class="NLM_cas:coden">SACDAF</span>;
        ISSN:<span class="NLM_cas:issn">2375-2548</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Because of its involvement in the progression of several malignant tumors, the histone lysine-specific demethylase1 (LSD1) has become a prominent drug target in modern medicinal chem. research.  We report on the discoveryof two classes of noncovalent inhibitors displaying unique structural features.  The antibiotics polymyxins bind atthe entrance of the substrate cleft, where their highly charged cyclic moiety interacts with a cluster of pos. charged amino acids.  The same site is occupied by quinazoline-based compds., which were found to inhibit theenzyme through a most peculiar mode because they form a pile of five to seven mols. that obstruct accessto the active center.  These data significantly indicate unpredictable strategies for the development of epigenetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs4C4ugZSy5bVg90H21EOLACvtfcHk0lhfu6G7qHqqWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVWisL8%253D&md5=1bb63c0077a5f83a3d270933314b7d9d</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1601017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1601017%26sid%3Dliteratum%253Aachs%26aulast%3DSperanzini%26aufirst%3DV.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DCiossani%26aufirst%3DG.%26aulast%3DPilotto%26aufirst%3DS.%26aulast%3DMarrocco%26aufirst%3DB.%26aulast%3DForgione%26aufirst%3DM.%26aulast%3DLucidi%26aufirst%3DA.%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DMehdipour%26aufirst%3DP.%26aulast%3DVelankar%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DPolymyxins%2520and%2520quinazolines%2520are%2520LSD1%252FKDM1A%2520inhibitors%2520with%2520unusual%2520structural%2520features%26jtitle%3DSci.%2520Adv.%26date%3D2016%26volume%3D2%26doi%3D10.1126%2Fsciadv.1601017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span> <span> </span><span class="NLM_article-title">Bioactivity evaluation of natural product alpha-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2017.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29274582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWltr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2018&pages=415-419&author=C.+Hanauthor=Z.+Liauthor=J.+Houauthor=Z.+Wangauthor=D.+Xuauthor=G.+Xueauthor=L.+Kong&title=Bioactivity+evaluation+of+natural+product+alpha-mangostin+as+a+novel+xanthone-based+lysine-specific+demethylase+1+inhibitor+to+against+tumor+metastasis&doi=10.1016%2Fj.bioorg.2017.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivity evaluation of natural product α-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis</span></div><div class="casAuthors">Han, Chao; Li, Zhongrui; Hou, Jiqin; Wang, Zhen; Xu, Dingqiao; Xue, Guimin; Kong, Lingyi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">415-419</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1), which has been reported to be overexpressed in several human cancers, has recently emerged as an attractive therapeutic target for treating cancer.  To date, almost all the developed LSD1 inhibitors are chemo-synthesized mols., while α-mangostin is first characterized as xanthone-based natural inhibitor in the current study with IC50 values of 2.81±0.44μM.  Bioactivity study and docking anal. indicated that α-mangostin could inhibit MDA-MB-231 cells migration and evasion through inhibit intracellular LSD1 activity.  These findings provides new mol. skeleton for LSD1 inhibitor study and should encourage further modification of α-mangostin to produce more potent LSD1 inhibitors with potential anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGpOCbxAuNLVg90H21EOLACvtfcHk0lh9E9eRxjq5dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWltr3J&md5=27679988f1a7c98127c71c3799734c5f</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DXue%26aufirst%3DG.%26aulast%3DKong%26aufirst%3DL.%26atitle%3DBioactivity%2520evaluation%2520of%2520natural%2520product%2520alpha-mangostin%2520as%2520a%2520novel%2520xanthone-based%2520lysine-specific%2520demethylase%25201%2520inhibitor%2520to%2520against%2520tumor%2520metastasis%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D76%26spage%3D415%26epage%3D419%26doi%3D10.1016%2Fj.bioorg.2017.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span> <span> </span><span class="NLM_article-title">Bioactivity-guided cut countercurrent chromatography for isolation of lysine-specific demethylase 1 inhibitors from Scutellaria baicalensis Georgi</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1016</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.aca.2018.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.aca.2018.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29534805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFaqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1016&publication_year=2018&pages=59-68&author=C.+Hanauthor=S.+Wangauthor=Z.+Liauthor=C.+Chenauthor=J.+Houauthor=D.+Xuauthor=R.+Wangauthor=Y.+Linauthor=J.+Luoauthor=L.+Kong&title=Bioactivity-guided+cut+countercurrent+chromatography+for+isolation+of+lysine-specific+demethylase+1+inhibitors+from+Scutellaria+baicalensis+Georgi&doi=10.1016%2Fj.aca.2018.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivity-guided cut countercurrent chromatography for isolation of lysine-specific demethylase 1 inhibitors from Scutellaria baicalensis Georgi</span></div><div class="casAuthors">Han, Chao; Wang, Shanshan; Li, Zhongrui; Chen, Chen; Hou, Jiqin; Xu, Dingqiao; Wang, Ruizhi; Lin, Yaolan; Luo, Jianguang; Kong, Lingyi</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-68</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Countercurrent chromatog. (CCC) has gradually become a widely used method for preparative sepn. of bioactive natural mols.  These mols. generally contain distinct scaffolds and characteristics that cannot be readily isolated from plants.  While one-dimensional CCC is typically used for the initial purifn. with insufficiently resolved peaks after locating bioactive components, two-dimensional (2D) or multi-dimensional CCC strategies are employed to improve the resoln. of peaks.  However, these methods usually present certain disadvantages, such as complicated procedures and increased time consumption, exptl. costs, and equipment requirements.  Here, a bioactivity-guided cut CCC strategy was established to isolate lysine-specific demethylase 1 (LSD1) inhibitors from Scutellaria baicalensis Georgi.  Gradient-elution CCC coupled with real-time detection of LSD1 inhibition by the collected fractions was developed.  Next, an online-storage recycling CCC mode was designed to enable the active fractions to be stored in coils, and these active fractions were further sepd. to obtain pure compds. by using sequential recycling elution.  In this strategy, active fractions are first identified, and then pure LSD1 inhibitors are isolated in the 2D CCC mode through continuous sepn. on a single instrument.  By using our bioactivity-guided cut CCC strategy, we successfully isolated six natural LSD1 inhibitors from S. baicalensis Georgi, five of which were identified for the first time as natural LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHMApE4g-b17Vg90H21EOLACvtfcHk0lh9E9eRxjq5dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFaqsbs%253D&md5=862344f018da2cf3a708e3476e5e5d6b</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.aca.2018.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.aca.2018.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DL.%26atitle%3DBioactivity-guided%2520cut%2520countercurrent%2520chromatography%2520for%2520isolation%2520of%2520lysine-specific%2520demethylase%25201%2520inhibitors%2520from%2520Scutellaria%2520baicalensis%2520Georgi%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2018%26volume%3D1016%26spage%3D59%26epage%3D68%26doi%3D10.1016%2Fj.aca.2018.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">126683</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bmcl.2019.126683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31627991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvF2gsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=126683&author=J.+Wangauthor=X.+Zhangauthor=J.+Yanauthor=W.+Liauthor=Q.+Jiangauthor=X.+Wangauthor=D.+Zhaoauthor=M.+Cheng&title=Design%2C+synthesis+and+biological+evaluation+of+curcumin+analogues+as+novel+LSD1+inhibitors&doi=10.1016%2Fj.bmcl.2019.126683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors</span></div><div class="casAuthors">Wang, Jiming; Zhang, Xiangyu; Yan, Jiangkun; Li, Wei; Jiang, Qinwen; Wang, Xinran; Zhao, Dongmei; Cheng, Maosheng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">126683</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone lysine-specific demethylase 1 (LSD1) was the first discovered histone demethylase.  Inactivating LSD1 or downregulating its expression inhibits cancer-cell development, and thus, it is an attractive mol. target for the development of novel cancer therapeutics.  In this study, we worked on the structural optimization of natural products and identified 30 novel LSD1 inhibitors.  Utilizing a structure-based drug design strategy, we designed and synthesized a series of curcumin analogs that were shown to be potent LSD1 inhibitors in the enzyme assay.  Compd. WB07 (I) displayed the most potent LSD1 inhibitory activity, with an IC50 value of 0.8μM.  Moreover, WA20 (II) showed an anticlonogenic effect on A549 cells with an IC50 value of 4.4μM.  Mol. docking simulations were also carried out, and the results indicated that the inhibitors bound to the protein active site located around the key residues of Asp555 and Asp556.  These findings suggested that compds. II and I are the first curcumin analog-based LSD1 inhibitors with remarkable A549 suppressive activity, providing a novel scaffold for the development of LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTnlsmI6uw3LVg90H21EOLACvtfcHk0lh9E9eRxjq5dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvF2gsrzF&md5=2c6688ce5e03fcaee6f0634423523f41</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126683%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520curcumin%2520analogues%2520as%2520novel%2520LSD1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D126683%26doi%3D10.1016%2Fj.bmcl.2019.126683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Identification and biological evaluation of natural product Biochanin A</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">103674</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2020.103674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32097796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjvVKjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2020&pages=103674&author=L.+Wangauthor=L.+Liauthor=Q.+Hanauthor=X.+Wangauthor=D.+Zhaoauthor=J.+Liu&title=Identification+and+biological+evaluation+of+natural+product+Biochanin+A&doi=10.1016%2Fj.bioorg.2020.103674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biological evaluation of natural product Biochanin A</span></div><div class="casAuthors">Wang, Lei; Li, Lingzhao; Han, Quanxiang; Wang, Xiaofang; Zhao, Di; Liu, Junqi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103674</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Natural products have shown promise for epigenetic modulations and thus are therapeutically potential for cancer prevention and treatment.  In this work, we report the identification of natural product Biochanin A as a new LSD1 inhibitor and further biol. evaluation in gastric MGC-803 cells.  Biochanin A effectively and reversibly inhibited LSD1 (IC50 = 2.95μM) and showed selective inhibition to LSD1 over MAO-A/B.  In gastric MGC-803 cells, Biochanin A induced accumulation of H3K4me1/2, inhibited cell growth moderately (IC50 = 6.77μM), but was less toxic to normal GES-1 (IC50 > 32μM).  Mechanistic studies showed that Biochanin A suppressed colony formation, cell apoptosis, and migration of MGC-803 cells.  This study may help to elucidate the anticancer mechanisms of Biochanin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWmRkIH8HF7Vg90H21EOLACvtfcHk0lgG7JVPFy3nQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjvVKjs7c%253D&md5=b0ff6f75858691d6b21d6a4b6d6f3a4e</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103674%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520biological%2520evaluation%2520of%2520natural%2520product%2520Biochanin%2520A%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D97%26spage%3D103674%26doi%3D10.1016%2Fj.bioorg.2020.103674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. M.</span></span> <span> </span><span class="NLM_article-title">Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">103648</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.bioorg.2020.103648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32065882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFajsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2020&pages=103648&author=Z.+R.+Liauthor=F.+Z.+Suoauthor=Y.+J.+Guoauthor=H.+F.+Chengauthor=S.+H.+Niuauthor=D.+D.+Shenauthor=L.+J.+Zhaoauthor=Z.+Z.+Liuauthor=M.+Maaauthor=B.+Yuauthor=Y.+C.+Zhengauthor=H.+M.+Liu&title=Natural+protoberberine+alkaloids%2C+identified+as+potent+selective+LSD1+inhibitors%2C+induce+AML+cell+differentiation&doi=10.1016%2Fj.bioorg.2020.103648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation</span></div><div class="casAuthors">Li, Zhong-Rui; Suo, Feng-Zhi; Guo, Yan-Jia; Cheng, Hai-Fang; Niu, Sheng-Hui; Shen, Dan-Dan; Zhao, Li-Juan; Liu, Zhen-Zhen; Maa, Mamun; Yu, Bin; Zheng, Yi-Chao; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103648</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Natural protoberberine alkaloids were first identified and characterized as potent, selective and cellular active lysine specific demethylase 1 (LSD1) inhibitors.  Due to our study, isoquinoline-based tetracyclic scaffold was identified as the key structural element for their anti-LSD1 activity, subtle changes of substituents attached to the core structure led to dramatic changes of the activity.  Among these protoberberine alkaloids, epiberberine potently inhibited LSD1 (IC50 = 0.14 ± 0.01μM) and was highly selective to LSD1 over MAO-A/B.  Furthermore, epiberberine could induce the expression of CD86, CD11b and CD14 in THP-1 and HL-60 cells, confirming its cellular activity of inducing acute myeloid leukemia (AML) cells differentiation.  Moreover, epiberberine prolonged the survival of THP-1 cells bearing mice and inhibited the growth of AML cells in vivo without obvious global toxicity.  These findings give the potential application of epiberberine in AML treatment, and the isoquinoline-based tetracyclic scaffold could be used for further development of LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3QhTkrzh9qrVg90H21EOLACvtfcHk0lgG7JVPFy3nQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFajsr0%253D&md5=4868d9e25f504a93a3c79b01dce5ccc1</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103648%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%2BR.%26aulast%3DSuo%26aufirst%3DF.%2BZ.%26aulast%3DGuo%26aufirst%3DY.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BF.%26aulast%3DNiu%26aufirst%3DS.%2BH.%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DZhao%26aufirst%3DL.%2BJ.%26aulast%3DLiu%26aufirst%3DZ.%2BZ.%26aulast%3DMaa%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DH.%2BM.%26atitle%3DNatural%2520protoberberine%2520alkaloids%252C%2520identified%2520as%2520potent%2520selective%2520LSD1%2520inhibitors%252C%2520induce%2520AML%2520cell%2520differentiation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D97%26spage%3D103648%26doi%3D10.1016%2Fj.bioorg.2020.103648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forneris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglioli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Structural basis of LSD1-CoREST selectivity in histone H3 recognition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">20070</span>– <span class="NLM_lpage">20074</span>, <span class="refDoi"> DOI: 10.1074/jbc.C700100200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1074%2Fjbc.C700100200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=17537733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFWntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=20070-20074&author=F.+Fornerisauthor=C.+Bindaauthor=A.+Adamoauthor=E.+Battaglioliauthor=A.+Mattevi&title=Structural+basis+of+LSD1-CoREST+selectivity+in+histone+H3+recognition&doi=10.1074%2Fjbc.C700100200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of LSD1-CoREST Selectivity in Histone H3 Recognition</span></div><div class="casAuthors">Forneris, Federico; Binda, Claudia; Adamo, Antonio; Battaglioli, Elena; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">20070-20074</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Histone demethylase LSD1 regulates transcription by demethylating Lys4 of histone H3.  The crystal structure of the enzyme in complex with CoREST and a substrate-like peptide inhibitor highlights an intricate network of interactions and a folded conformation of the bound peptide.  The core of the peptide structure is formed by Arg2, Gln5, and Ser10, which are engaged in specific intramol. H-bonds.  Several charged side chains on the surface of the substrate-binding pocket establish electrostatic interactions with the peptide.  The three-dimensional structure predicts that methylated Lys4 binds in a solvent inaccessible position in front of the flavin cofactor.  This geometry is fully consistent with the demethylation reaction being catalyzed through a flavin-mediated oxidn. of the substrate amino-Me group.  These features dictate the exquisite substrate specificity of LSD1 and provide a structural framework to explain the fine tuning of its catalytic activity and the active role of CoREST in substrate recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD8PHQpzggArVg90H21EOLACvtfcHk0lgG7JVPFy3nQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFWntr0%253D&md5=a8af3e0892441bf3fc64ce80c19d0c3b</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C700100200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C700100200%26sid%3Dliteratum%253Aachs%26aulast%3DForneris%26aufirst%3DF.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DAdamo%26aufirst%3DA.%26aulast%3DBattaglioli%26aufirst%3DE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520of%2520LSD1-CoREST%2520selectivity%2520in%2520histone%2520H3%2520recognition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D20070%26epage%3D20074%26doi%3D10.1074%2Fjbc.C700100200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Molecular mimicry and ligand recognition in binding and catalysis by the histone demethylase LSD1-CoREST complex</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.str.2011.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.str.2011.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=21300290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=212-220&author=R.+Baronauthor=C.+Bindaauthor=M.+Tortoriciauthor=J.+A.+McCammonauthor=A.+Mattevi&title=Molecular+mimicry+and+ligand+recognition+in+binding+and+catalysis+by+the+histone+demethylase+LSD1-CoREST+complex&doi=10.1016%2Fj.str.2011.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mimicry and Ligand Recognition in Binding and Catalysis by the Histone Demethylase LSD1-CoREST Complex</span></div><div class="casAuthors">Baron, Riccardo; Binda, Claudia; Tortorici, Marcello; McCammon, J. Andrew; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-220</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone demethylases LSD1 and LSD2 (KDM1A/B) catalyze the oxidative demethylation of Lys4 of histone H3.  We used mol. dynamics simulations to probe the diffusion of the oxygen substrate.  Oxygen can reach the catalytic center independently from the presence of a bound histone peptide, implying that LSD1 can complete subsequent demethylation cycles without detaching from the nucleosomal particle.  The simulations highlight the role of a strictly conserved active-site Lys residue providing general insight into the enzymic mechanism of oxygen-reacting flavoenzymes.  The crystal structure of LSD1-CoREST bound to a peptide of the transcription factor SNAIL1 unravels a fascinating example of mol. mimicry.  The SNAIL1 N-terminal residues bind to the enzyme active-site cleft, effectively mimicking the H3 tail.  This finding predicts that other members of the SNAIL/Scratch transcription factor family might assoc. to LSD1/2.  The combination of selective histone-modifying activity with the distinct recognition mechanisms underlies the biol. complexity of LSD1/2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGdKxxD93hm7Vg90H21EOLACvtfcHk0li32j20y4mgGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyitL4%253D&md5=61b4d3cf137e45643c3066f3369f18d5</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2011.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2011.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DMolecular%2520mimicry%2520and%2520ligand%2520recognition%2520in%2520binding%2520and%2520catalysis%2520by%2520the%2520histone%2520demethylase%2520LSD1-CoREST%2520complex%26jtitle%3DStructure%26date%3D2011%26volume%3D19%26spage%3D212%26epage%3D220%26doi%3D10.1016%2Fj.str.2011.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talibov, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peintner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geitmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebastiano, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobritzsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danielson, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic peptides uncover a novel binding mode for reversible inhibitors of LSD1</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3979</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/acsomega.9b03493</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b03493" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFansLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=3979-3995&author=J.+Yangauthor=V.+O.+Talibovauthor=S.+Peintnerauthor=C.+Rheeauthor=V.+Poongavanamauthor=M.+Geitmannauthor=M.+R.+Sebastianoauthor=B.+Simonauthor=J.+Hennigauthor=D.+Dobritzschauthor=U.+H.+Danielsonauthor=J.+Kihlberg&title=Macrocyclic+peptides+uncover+a+novel+binding+mode+for+reversible+inhibitors+of+LSD1&doi=10.1021%2Facsomega.9b03493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic Peptides Uncover a Novel Binding Mode for Reversible Inhibitors of LSD1</span></div><div class="casAuthors">Yang, Jie; Talibov, Vladimir O.; Peintner, Stefan; Rhee, Claire; Poongavanam, Vasanthanathan; Geitmann, Matthis; Sebastiano, Matteo Rossi; Simon, Bernd; Hennig, Janosch; Dobritzsch, Doreen; Danielson, U. Helena; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3979-3995</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) is an epigenetic enzyme which regulates the methylation of Lys4 of histone 3 (H3) and is overexpressed in certain cancers.  We used structures of H3 substrate analogs bound to LSD1 to design macrocyclic peptide inhibitors of LSD1.  A linear, Lys4 to Met-substituted, 11-mer (4) was identified as the shortest peptide distinctly interacting with LSD1.  It was evolved into macrocycle 31, which was >40 fold more potent (Ki = 2.3μM) than 4.  Linear and macrocyclic peptides exhibited unexpected differences in structure-activity relationships for interactions with LSD1, indicating that they bind LSD1 differently.  This was confirmed by the crystal structure of 31 in complex with LSD1-CoREST1, which revealed a novel binding mode at the outer rim of the LSD1 active site and without a direct interaction with FAD.  NMR spectroscopy of 31 suggests that macrocyclization restricts its soln. ensemble to conformations that include the one in the cryst. complex.  Our results provide a solid basis for the design of optimized reversible LSD1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSVg23mFeHAbVg90H21EOLACvtfcHk0li32j20y4mgGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFansLc%253D&md5=34987d78346262625897765eefc198cf</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b03493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b03493%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DTalibov%26aufirst%3DV.%2BO.%26aulast%3DPeintner%26aufirst%3DS.%26aulast%3DRhee%26aufirst%3DC.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DGeitmann%26aufirst%3DM.%26aulast%3DSebastiano%26aufirst%3DM.%2BR.%26aulast%3DSimon%26aufirst%3DB.%26aulast%3DHennig%26aufirst%3DJ.%26aulast%3DDobritzsch%26aufirst%3DD.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520peptides%2520uncover%2520a%2520novel%2520binding%2520mode%2520for%2520reversible%2520inhibitors%2520of%2520LSD1%26jtitle%3DACS%2520Omega%26date%3D2020%26volume%3D5%26spage%3D3979%26epage%3D3995%26doi%3D10.1021%2Facsomega.9b03493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of LSD1 for cancer treatment</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3194</span>, <span class="refDoi"> DOI: 10.3390/molecules23123194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3390%2Fmolecules23123194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=3194&author=G.+J.+Yangauthor=P.+M.+Leiauthor=S.+Y.+Wongauthor=D.+L.+Maauthor=C.+H.+Leung&title=Pharmacological+inhibition+of+LSD1+for+cancer+treatment&doi=10.3390%2Fmolecules23123194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of LSD1 for cancer treatment</span></div><div class="casAuthors">Yang, Guan-Jun; Lei, Pui-Man; Wong, Suk-Yu; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3194/1-3194/20</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Lysine-specific demethylase 1A (LSD1, also named KDM1A) is a demethylase that can remove Me groups from histones H3K4me1/2 and H3K9me1/2.  It is aberrantly expressed in many cancers, where it impedes differentiation and contributes to cancer cell proliferation, cell metastasis and invasiveness, and is assocd. with inferior prognosis.  Pharmacol. inhibition of LSD1 has been reported to significantly attenuate tumor progression in vitro and in vivo in a range of solid tumors and acute myeloid leukemia.  This review will present the structural aspects of LSD1, its role in carcinogenesis, a comparison of currently available approaches for screening LSD1 inhibitors, a classification of LSD1 inhibitors, and its potential as a drug target in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSEBy-HsQHlrVg90H21EOLACvtfcHk0li32j20y4mgGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms1yrtb8%253D&md5=87fe2ac11e363e75ac0ef22ff6412d24</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23123194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23123194%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%2BJ.%26aulast%3DLei%26aufirst%3DP.%2BM.%26aulast%3DWong%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DPharmacological%2520inhibition%2520of%2520LSD1%2520for%2520cancer%2520treatment%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D3194%26doi%3D10.3390%2Fmolecules23123194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerneil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niegisch, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the therapeutic potential of the novel isotype specific HDAC Inhibitor 4SC-202 in urothelial carcinoma cell lines</span>. <i>Target Oncol</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1007/s11523-016-0444-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1007%2Fs11523-016-0444-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=27250763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FlslWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=783-798&author=M.+Pinkerneilauthor=M.+J.+Hoffmannauthor=H.+Kohlhofauthor=W.+A.+Schulzauthor=G.+Niegisch&title=Evaluation+of+the+therapeutic+potential+of+the+novel+isotype+specific+HDAC+Inhibitor+4SC-202+in+urothelial+carcinoma+cell+lines&doi=10.1007%2Fs11523-016-0444-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines</span></div><div class="casAuthors">Pinkerneil Maria; Hoffmann Michele J; Schulz Wolfgang A; Niegisch Gunter; Kohlhof Hella</div><div class="citationInfo"><span class="NLM_cas:title">Targeted oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">783-798</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Targeting of class I histone deacetylases (HDACs) exerts antineoplastic actions in various cancer types by modulation of transcription, upregulation of tumor suppressors, induction of cell cycle arrest, replication stress and promotion of apoptosis.  Class I HDACs are often deregulated in urothelial cancer. 4SC-202, a novel oral benzamide type HDAC inhibitor (HDACi) specific for class I HDACs HDAC1, HDAC2 and HDAC3 and the histone demethylase LSD1, shows substantial anti-tumor activity in a broad range of cancer cell lines and xenograft tumor models.  AIM:  The aim of this study was to investigate the therapeutic potential of 4SC-202 in urothelial carcinoma (UC) cell lines.  METHODS:  We determined dose response curves of 4SC-202 by MTT assay in seven UC cell lines with distinct HDAC1, HDAC2 and HDAC3 expression profiles.  Cellular effects were further analyzed in VM-CUB1 and UM-UC-3 cells by colony forming assay, caspase-3/7 assay, flow cytometry, senescence assay, LDH release assay, and immunofluorescence staining.  Response markers were followed by quantitative real-time PCR and western blotting.  Treatment with the class I HDAC specific inhibitor SAHA (vorinostat) served as a general control.  RESULTS:  4SC-202 significantly reduced proliferation of all epithelial and mesenchymal UC cell lines (IC50 0.15-0.51 μM), inhibited clonogenic growth and induced caspase activity.  Flow cytometry revealed increased G2/M and subG1 fractions in VM-CUB1 and UM-UC-3 cells.  Both effects were stronger than with SAHA treatment.  CONCLUSION:  Specific pharmacological inhibition of class I HDACs by 4SC-202 impairs UC cell viability, inducing cell cycle disturbances and cell death.  Combined inhibition of HDAC1, HDAC2 and HDAC3 seems to be a promising treatment strategy for UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQWgp4rVh4BHp3bfzSLaX5fW6udTcc2ebsXao_sqLBzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FlslWjsQ%253D%253D&md5=8decc6b1e3ff3d96fc12e0661246fe7c</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1007%2Fs11523-016-0444-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11523-016-0444-7%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerneil%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DM.%2BJ.%26aulast%3DKohlhof%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DW.%2BA.%26aulast%3DNiegisch%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520the%2520therapeutic%2520potential%2520of%2520the%2520novel%2520isotype%2520specific%2520HDAC%2520Inhibitor%25204SC-202%2520in%2520urothelial%2520carcinoma%2520cell%2520lines%26jtitle%3DTarget%2520Oncol%26date%3D2016%26volume%3D11%26spage%3D783%26epage%3D798%26doi%3D10.1007%2Fs11523-016-0444-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zylla, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miskimins, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Puente, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnimpieba, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerli, S. M.</span></span> <span> </span><span class="NLM_article-title">Analysis of dual class I histone deacetylase and lysine demethylase inhibitor domatinostat (4SC-202) on growth and cellular and genomic landscape of atypical teratoid/rhabdoid</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">756</span>, <span class="refDoi"> DOI: 10.3390/cancers12030756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.3390%2Fcancers12030756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVShtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=756&author=M.+M.+Hoffmanauthor=J.+S.+Zyllaauthor=S.+Bhattacharyaauthor=K.+Calarauthor=T.+W.+Hartmanauthor=R.+D.+Bhardwajauthor=W.+K.+Miskiminsauthor=P.+de+la+Puenteauthor=E.+Z.+Gnimpiebaauthor=S.+M.+Messerli&title=Analysis+of+dual+class+I+histone+deacetylase+and+lysine+demethylase+inhibitor+domatinostat+%284SC-202%29+on+growth+and+cellular+and+genomic+landscape+of+atypical+teratoid%2Frhabdoid&doi=10.3390%2Fcancers12030756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of dual class I histone deacetylase and lysine demethylase inhibitor domatinostat (4SC-202) on growth and cellular and genomic landscape of atypical teratoid/rhabdoid</span></div><div class="casAuthors">Hoffman, Mariah M.; Zylla, Jessica S.; Bhattacharya, Somshuvra; Calar, Kristin; Hartman, Timothy W.; Bhardwaj, Ratan D.; Miskimins, W. Keith; de la Puente, Pilar; Gnimpieba, Etienne Z.; Messerli, Shanta M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">756</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Central nervous system atypical teratoid/rhabdoid tumors (ATRTs) are rare and aggressive tumors with a very poor prognosis.  Current treatments for ATRT include resection of the tumor, followed by systemic chemotherapy and radiation therapy, which have toxic side effects for young children.  Gene expression analyses of human ATRTs and normal brain samples indicate that ATRTs have aberrant expression of epigenetic markers including class I histone deacetylases (HDAC's) and lysine demethylase (LSD1).  Here, we investigate the effect of a small mol. epigenetic modulator known as Domatinostat (4SC-202), which inhibits both class I HDAC's and Lysine Demethylase (LSD1), on ATRT cell survival and single cell heterogeneity.  Our findings suggest that 4SC-202 is both cytotoxic and cytostatic to ATRT in 2D and 3D scaffold cell culture models and may target cancer stem cells.  Single-cell RNA sequencing data from ATRT-06 spheroids treated with 4SC-202 have a reduced population of cells overexpressing stem cell-related genes, including SOX2.  Flow cytometry and immunofluorescence on 3D ATRT-06 scaffold models support these results suggesting that 4SC-202 reduces expression of cancer stem cell markers SOX2, CD133, and FOXM1.  Drug-induced changes to the systems biol. landscape are also explored by multi-omics enrichment analyses.  In summary, our data indicate that 4SC-202 has both cytotoxic and cytostatic effects on ATRT, targets specific cell sub-populations, including those with cancer stem-like features, and is an important potential cancer therapeutic to be investigated in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ0LyYtW0QabVg90H21EOLACvtfcHk0lhW-Pz7I5n5Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVShtr3M&md5=26d4293a3e4025eda9745e8099460f26</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.3390%2Fcancers12030756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers12030756%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DM.%2BM.%26aulast%3DZylla%26aufirst%3DJ.%2BS.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DCalar%26aufirst%3DK.%26aulast%3DHartman%26aufirst%3DT.%2BW.%26aulast%3DBhardwaj%26aufirst%3DR.%2BD.%26aulast%3DMiskimins%26aufirst%3DW.%2BK.%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DP.%26aulast%3DGnimpieba%26aufirst%3DE.%2BZ.%26aulast%3DMesserli%26aufirst%3DS.%2BM.%26atitle%3DAnalysis%2520of%2520dual%2520class%2520I%2520histone%2520deacetylase%2520and%2520lysine%2520demethylase%2520inhibitor%2520domatinostat%2520%25284SC-202%2529%2520on%2520growth%2520and%2520cellular%2520and%2520genomic%2520landscape%2520of%2520atypical%2520teratoid%252Frhabdoid%26jtitle%3DCancers%26date%3D2020%26volume%3D12%26spage%3D756%26doi%3D10.3390%2Fcancers12030756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFleur, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Carvalho, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.05.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1016%2Fj.cell.2018.05.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29937226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFymsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2018&pages=549-563&author=W.+Shengauthor=M.+W.+LaFleurauthor=T.+H.+Nguyenauthor=S.+Chenauthor=A.+Chakravarthyauthor=J.+R.+Conwayauthor=Y.+Liauthor=H.+Chenauthor=H.+Yangauthor=P.+H.+Hsuauthor=E.+M.+Van+Allenauthor=G.+J.+Freemanauthor=D.+D.+De+Carvalhoauthor=H.+H.+Heauthor=A.+H.+Sharpeauthor=Y.+Shi&title=LSD1+ablation+stimulates+anti-tumor+immunity+and+enables+checkpoint+blockade&doi=10.1016%2Fj.cell.2018.05.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade</span></div><div class="casAuthors">Sheng, Wanqiang; LaFleur, Martin W.; Nguyen, Thao H.; Chen, Sujun; Chakravarthy, Ankur; Conway, Jake Ryan; Li, Ying; Chen, Hao; Yang, Henry; Hsu, Pang-Hung; Van Allen, Eliezer M.; Freeman, Gordon J.; De Carvalho, Daniel D.; He, Housheng Hansen; Sharpe, Arlene H.; Shi, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">549-563.e19</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Chromatin regulators play a broad role in regulating gene expression and, when gone awry, can lead to cancer.  Here, we demonstrate that ablation of the histone demethylase LSD1 in cancer cells increases repetitive element expression, including endogenous retroviral elements (ERVs), and decreases expression of RNA-induced silencing complex (RISC) components.  Significantly, this leads to double-stranded RNA (dsRNA) stress and activation of type 1 interferon, which stimulates anti-tumor T cell immunity and restrains tumor growth.  Furthermore, LSD1 depletion enhances tumor immunogenicity and T cell infiltration in poorly immunogenic tumors and elicits significant responses of checkpoint blockade-refractory mouse melanoma to anti-PD-1 therapy.  Consistently, TCGA data anal. shows an inverse correlation between LSD1 expression and CD8+ T cell infiltration in various human cancers.  Our study identifies LSD1 as a potent inhibitor of anti-tumor immunity and responsiveness to immunotherapy and suggests LSD1 inhibition combined with PD-(L)1 blockade as a novel cancer treatment strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE26ECJjxIc7Vg90H21EOLACvtfcHk0lhW-Pz7I5n5Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFymsrbE&md5=4f113b8f2b641165dc35dc7aa7da4fe8</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.05.052%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DW.%26aulast%3DLaFleur%26aufirst%3DM.%2BW.%26aulast%3DNguyen%26aufirst%3DT.%2BH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChakravarthy%26aufirst%3DA.%26aulast%3DConway%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHsu%26aufirst%3DP.%2BH.%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DFreeman%26aufirst%3DG.%2BJ.%26aulast%3DDe%2BCarvalho%26aufirst%3DD.%2BD.%26aulast%3DHe%26aufirst%3DH.%2BH.%26aulast%3DSharpe%26aufirst%3DA.%2BH.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DLSD1%2520ablation%2520stimulates%2520anti-tumor%2520immunity%2520and%2520enables%2520checkpoint%2520blockade%26jtitle%3DCell%26date%3D2018%26volume%3D174%26spage%3D549%26epage%3D563%26doi%3D10.1016%2Fj.cell.2018.05.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinyard, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegenfeld, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterbury, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedy, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosavi, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senzer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinello, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liau, B. B.</span></span> <span> </span><span class="NLM_article-title">CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/s41589-019-0263-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1038%2Fs41589-019-0263-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=30992567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXos12gsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=529-539&author=M.+E.+Vinyardauthor=C.+Suauthor=A.+P.+Siegenfeldauthor=A.+L.+Waterburyauthor=A.+M.+Freedyauthor=P.+M.+Gosaviauthor=Y.+Parkauthor=E.+E.+Kwanauthor=B.+D.+Senzerauthor=J.+G.+Doenchauthor=D.+E.+Bauerauthor=L.+Pinelloauthor=B.+B.+Liau&title=CRISPR-suppressor+scanning+reveals+a+nonenzymatic+role+of+LSD1+in+AML&doi=10.1038%2Fs41589-019-0263-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML</span></div><div class="casAuthors">Vinyard, Michael E.; Su, Cindy; Siegenfeld, Allison P.; Waterbury, Amanda L.; Freedy, Allyson M.; Gosavi, Pallavi M.; Park, Yongho; Kwan, Eugene E.; Senzer, Benjamin D.; Doench, John G.; Bauer, Daniel E.; Pinello, Luca; Liau, Brian B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">529-539</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Understanding the mechanism of small mols. is a crit. challenge in chem. biol. and drug discovery.  Medicinal chem. is essential for elucidating drug mechanism, enabling variation of small mol. structure to gain structure-activity relationships (SARs).  However, the development of complementary approaches that systematically vary target protein structure could provide equally informative SARs for investigating drug mechanism and protein function.  Here we explore the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chem. inhibitors in the context of acute myeloid leukemia (AML).  Through this approach, termed CRISPR-suppressor scanning, we elucidate drug mechanism of action by showing that LSD1 enzyme activity is not required for AML survival and that LSD1 inhibitors instead function by disrupting interactions between LSD1 and the transcription factor GFI1B on chromatin.  Our studies clarify how LSD1 inhibitors mechanistically operate in AML and demonstrate how CRISPR-suppressor scanning can uncover novel aspects of target biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoekAhOtw79I7Vg90H21EOLACvtfcHk0ljUlnASG7WqZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXos12gsb4%253D&md5=49115c4d215f413dfe6f3f45abd6bfd2</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1038%2Fs41589-019-0263-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-019-0263-0%26sid%3Dliteratum%253Aachs%26aulast%3DVinyard%26aufirst%3DM.%2BE.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DSiegenfeld%26aufirst%3DA.%2BP.%26aulast%3DWaterbury%26aufirst%3DA.%2BL.%26aulast%3DFreedy%26aufirst%3DA.%2BM.%26aulast%3DGosavi%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DKwan%26aufirst%3DE.%2BE.%26aulast%3DSenzer%26aufirst%3DB.%2BD.%26aulast%3DDoench%26aufirst%3DJ.%2BG.%26aulast%3DBauer%26aufirst%3DD.%2BE.%26aulast%3DPinello%26aufirst%3DL.%26aulast%3DLiau%26aufirst%3DB.%2BB.%26atitle%3DCRISPR-suppressor%2520scanning%2520reveals%2520a%2520nonenzymatic%2520role%2520of%2520LSD1%2520in%2520AML%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26spage%3D529%26epage%3D539%26doi%3D10.1038%2Fs41589-019-0263-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">12311</span>– <span class="NLM_lpage">12320</span>, <span class="refDoi"> DOI: 10.1073/pnas.1902012116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1902012116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31152129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFyktr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=12311-12320&author=H.+Lanauthor=M.+Tanauthor=Q.+Zhangauthor=F.+Yangauthor=S.+Wangauthor=H.+Liauthor=X.+Xiongauthor=Y.+Sun&title=LSD1+destabilizes+FBXW7+and+abrogates+FBXW7+functions+independent+of+its+demethylase+activity&doi=10.1073%2Fpnas.1902012116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity</span></div><div class="casAuthors">Lan, Huiyin; Tan, Mingjia; Zhang, Qiang; Yang, Fei; Wang, Siyuan; Li, Hua; Xiong, Xiufang; Sun, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">12311-12320</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">FBXW7 acts as a typical tumor suppressor, with loss-of-function alterations in human cancers, by promoting ubiquitylation and degrdn. of many oncoproteins.  Lysine-specific demethylase 1 (LSD1) is a well-characterized histone demethylase.  Whether LSD1 has demethylase-independent activity remains elusive.  Here we report that LSD1 directly binds to FBXW7 to destabilize FBXW7 independent of its demethylase activity.  Specifically, LSD1 is a pseudosubstrate of FBXW7 and LSD-FBXW7 binding does not trigger LSD1 ubiquitylation, but instead promotes FBXW7 self-ubiquitylation by preventing FBXW7 dimerization.  The self-ubiquitylated FBXW7 is subjected to degrdn. by proteasome as well as lysosome in a manner dependent on autophagy protein p62/SQSTM1.  Biol., LSD1 destabilizes FBXW7 to abrogate its functions in growth suppression, nonhomologous end-joining repair, and radioprotection.  Collectively, our study revealed a previously unknown activity of LSD1, which likely contributes to its oncogenic function.  Targeting LSD1 protein, not only its demethylase activity, might be a unique approach for LSD1-based drug discovery for anticancer application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNb1Flt8cl9LVg90H21EOLACvtfcHk0ljUlnASG7WqZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFyktr3M&md5=d67de38a5b9ea4eef7bf0a81cb7f4e0a</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1902012116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1902012116%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DLSD1%2520destabilizes%2520FBXW7%2520and%2520abrogates%2520FBXW7%2520functions%2520independent%2520of%2520its%2520demethylase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D12311%26epage%3D12320%26doi%3D10.1073%2Fpnas.1902012116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span> <span> </span><span class="NLM_article-title">LSD1: A single target to combat lineage plasticity in lethal prostate cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">4530</span>– <span class="NLM_lpage">4531</span>, <span class="refDoi"> DOI: 10.1073/pnas.1804205115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1804205115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29666280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGhtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=4530-4531&author=L.+Ellisauthor=M.+Loda&title=LSD1%3A+A+single+target+to+combat+lineage+plasticity+in+lethal+prostate+cancer&doi=10.1073%2Fpnas.1804205115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1: a single target to combat lineage plasticity in lethal prostate cancer</span></div><div class="casAuthors">Ellis, Leigh; Loda, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4530-4531</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostate cancer initiation and progression to a lethal metastatic castration-resistant (mCRPC) phenotype remains largely dependent on the function of the androgen receptor.  Recently, however, more potent androgen-deprivation therapy (ADT) regimens that target the AR and the androgen biosynthesis pathways have led to the emergence, in a subset of cases, of resistance mechanisms independent of AR activity (CRPCAI).  The lysine-specific demethylase 1(LSD1) is a regulator of gene expression in stem cells.  Prior literature demonstrated that LSD1 acts by demethylation of both H3K4me1/2 and H3K9me1/2, providing dual functionality of gene repression and activation,resp.  The latter includes AR target genes, suggesting a functional role for LSD1 in androgen-sensitive disease.  In this review with commentary we provide recent data on what governs the emergence of lineage plasticity and ADT resistance, and novel therapeutic targets to treat this lethal phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFAp3OS8nbLVg90H21EOLACvtfcHk0ljUlnASG7WqZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGhtb7K&md5=bc7b1e2d1f4ea6c1ca52162ca75bb380</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1804205115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1804205115%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DLoda%26aufirst%3DM.%26atitle%3DLSD1%253A%2520A%2520single%2520target%2520to%2520combat%2520lineage%2520plasticity%2520in%2520lethal%2520prostate%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3D4530%26epage%3D4531%26doi%3D10.1073%2Fpnas.1804205115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehrawat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankhead, A.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWeeney, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartzman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urrutia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallakury, B. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Eeden, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alumkal, J. J.</span></span> <span> </span><span class="NLM_article-title">LSD1 activates a lethal prostate cancer gene network independently of its demethylase function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E4179</span>– <span class="NLM_lpage">E4188</span>, <span class="refDoi"> DOI: 10.1073/pnas.1719168115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1073%2Fpnas.1719168115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29581250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGht7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E4179-E4188&author=A.+Sehrawatauthor=L.+Gaoauthor=Y.+Wangauthor=A.+Bankheadauthor=S.+K.+McWeeneyauthor=C.+J.+Kingauthor=J.+Schwartzmanauthor=J.+Urrutiaauthor=W.+H.+Bissonauthor=D.+J.+Colemanauthor=S.+K.+Joshiauthor=D.+H.+Kimauthor=D.+A.+Sampsonauthor=S.+Weinmannauthor=B.+V.+S.+Kallakuryauthor=D.+L.+Berryauthor=R.+Haqueauthor=S.+K.+Van+Den+Eedenauthor=S.+Sharmaauthor=J.+Bearssauthor=T.+M.+Beerauthor=G.+V.+Thomasauthor=L.+M.+Heiserauthor=J.+J.+Alumkal&title=LSD1+activates+a+lethal+prostate+cancer+gene+network+independently+of+its+demethylase+function&doi=10.1073%2Fpnas.1719168115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 activates a lethal prostate cancer gene network independently of its demethylase function</span></div><div class="casAuthors">Sehrawat, Archana; Gao, Lina; Wang, Yuliang; Bankhead, Armand, III; McWeeney, Shannon K.; King, Carly J.; Schwartzman, Jacob; Urrutia, Joshua; Bisson, William H.; Coleman, Daniel J.; Joshi, Sunil K.; Kim, Dae-Hwan; Sampson, David A.; Weinmann, Sheila; Kallakury, Bhaskar V. S.; Berry, Deborah L.; Haque, Reina; Van Den Eeden, Stephen K.; Sharma, Sunil; Bearss, Jared; Beer, Tomasz M.; Thomas, George V.; Heiser, Laura M.; Alumkal, Joshi J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">E4179-E4188</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Medical castration that interferes with androgen receptor (AR) function is the principal treatment for advanced prostate cancer.  However, clin. progression is universal, and tumors with AR-independent resistance mechanisms appear to be increasing in frequency.  Consequently, there is an urgent need to develop new treatments targeting mol. pathways enriched in lethal prostate cancer.  Lysine-specific demethylase 1 (LSD1) is a histone demethylase and an important regulator of gene expression.  Here, we show that LSD1 promotes the survival of prostate cancer cells, including those that are castration-resistant, independently of its demethylase function and of the AR.  Importantly, this effect is explained in part by activation of a lethal prostate cancer gene network in collaboration with LSD1's binding protein, ZNF217.  Finally, that a small-mol. LSD1 inhibitor-SP-2509-blocks important demethylase-independent functions and suppresses castration-resistant prostate cancer cell viability demonstrates the potential of LSD1 inhibition in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG9LmMzLAzw7Vg90H21EOLACvtfcHk0lig7mmje4QF_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGht7bJ&md5=3cc0558c15fe5496e7cdd9dc737c0780</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1719168115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1719168115%26sid%3Dliteratum%253Aachs%26aulast%3DSehrawat%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBankhead%26aufirst%3DA.%26aulast%3DMcWeeney%26aufirst%3DS.%2BK.%26aulast%3DKing%26aufirst%3DC.%2BJ.%26aulast%3DSchwartzman%26aufirst%3DJ.%26aulast%3DUrrutia%26aufirst%3DJ.%26aulast%3DBisson%26aufirst%3DW.%2BH.%26aulast%3DColeman%26aufirst%3DD.%2BJ.%26aulast%3DJoshi%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DSampson%26aufirst%3DD.%2BA.%26aulast%3DWeinmann%26aufirst%3DS.%26aulast%3DKallakury%26aufirst%3DB.%2BV.%2BS.%26aulast%3DBerry%26aufirst%3DD.%2BL.%26aulast%3DHaque%26aufirst%3DR.%26aulast%3DVan%2BDen%2BEeden%26aufirst%3DS.%2BK.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DBearss%26aufirst%3DJ.%26aulast%3DBeer%26aufirst%3DT.%2BM.%26aulast%3DThomas%26aufirst%3DG.%2BV.%26aulast%3DHeiser%26aufirst%3DL.%2BM.%26aulast%3DAlumkal%26aufirst%3DJ.%2BJ.%26atitle%3DLSD1%2520activates%2520a%2520lethal%2520prostate%2520cancer%2520gene%2520network%2520independently%2520of%2520its%2520demethylase%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE4179%26epage%3DE4188%26doi%3D10.1073%2Fpnas.1719168115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, H.</span></span> <span> </span><span class="NLM_article-title">Biological roles of LSD1 beyond its demethylase activity</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3350</span>, <span class="refDoi"> DOI: 10.1007/s00018-020-03489-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1007%2Fs00018-020-03489-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=32193608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1Grsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2020&pages=3341-3350&author=F.+Guauthor=Y.+Linauthor=Z.+Wangauthor=X.+Wuauthor=Z.+Yeauthor=Y.+Wangauthor=H.+Lan&title=Biological+roles+of+LSD1+beyond+its+demethylase+activity&doi=10.1007%2Fs00018-020-03489-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Biological roles of LSD1 beyond its demethylase activity</span></div><div class="casAuthors">Gu, Feiying; Lin, Yuxin; Wang, Zhun; Wu, Xiaoxin; Ye, Zhenyue; Wang, Yuezhen; Lan, Huiyin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3341-3350</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Abstr.: It is well-established that Lysine-specific demethylase 1 (LSD1, also known as KDM1A) roles as a lysine demethylase canonically acting on H3K4me1/2 and H3K9me1/2 for regulating gene expression.  Though the discovery of non-histone substrates methylated by LSD1 has largely expanded the functions of LSD1 as a typical demethylase, recent groundbreaking studies unveiled its non-catalytic functions as a second life for this demethylase.  We and others found that LSD1 is implicated in the interaction with a line of proteins to exhibit addnl. non-canonical functions in a demethylase-independent manner.  Here, we present an integrated overview of these recent literatures charging LSD1 with unforeseen functions to re-evaluate and summarize its non-catalytic biol. roles beyond the current understanding of its demethylase activity.  Given LSD1 is reported to be ubiquitously overexpressed in a variety of tumors, it has been generally considered as an innovative target for cancer therapy.  We anticipate that these non-canonical functions of LSD1 will arouse the consideration that extending the LSD1-based drug discovery to targeting LSD1 protein interactions non-catalytically, not only its demethylase activity, may be a novel strategy for cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeSPlo5zskFLVg90H21EOLACvtfcHk0lig7mmje4QF_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1Grsb4%253D&md5=50d0f7b94c7ed1512766c271c7879a73</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs00018-020-03489-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-020-03489-9%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DH.%26atitle%3DBiological%2520roles%2520of%2520LSD1%2520beyond%2520its%2520demethylase%2520activity%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2020%26volume%3D77%26spage%3D3341%26epage%3D3350%26doi%3D10.1007%2Fs00018-020-03489-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romo-Morales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aladowicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, J. M.</span></span> <span> </span><span class="NLM_article-title">Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy</span>. <i>Pediatr. Blood Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>66</i></span>, <span class="NLM_elocation-id">e27888</span> <span class="refDoi"> DOI: 10.1002/pbc.27888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1002%2Fpbc.27888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=31207107" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2019&author=A.+Romo-Moralesauthor=E.+Aladowiczauthor=J.+Blaggauthor=S.+A.+Gatzauthor=J.+M.+Shipley&title=Catalytic+inhibition+of+KDM1A+in+Ewing+sarcoma+is+insufficient+as+a+therapeutic+strategy&doi=10.1002%2Fpbc.27888"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1002%2Fpbc.27888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.27888%26sid%3Dliteratum%253Aachs%26aulast%3DRomo-Morales%26aufirst%3DA.%26aulast%3DAladowicz%26aufirst%3DE.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DGatz%26aufirst%3DS.%2BA.%26aulast%3DShipley%26aufirst%3DJ.%2BM.%26atitle%3DCatalytic%2520inhibition%2520of%2520KDM1A%2520in%2520Ewing%2520sarcoma%2520is%2520insufficient%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2019%26volume%3D66%26doi%3D10.1002%2Fpbc.27888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sonnemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauterjung, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, J. F.</span></span> <span> </span><span class="NLM_article-title">LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells</span>. <i>Br. J. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1111/bjh.14983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=10.1111%2Fbjh.14983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=29205263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;key=1%3ACAS%3A280%3ADC%252BC1M3nvFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2018&pages=494-497&author=J.+Sonnemannauthor=M.+Zimmermannauthor=C.+Marxauthor=F.+Ebertauthor=S.+Beckerauthor=M.+L.+Lauterjungauthor=J.+F.+Beck&title=LSD1+%28KDM1A%29-independent+effects+of+the+LSD1+inhibitor+SP2509+in+cancer+cells&doi=10.1111%2Fbjh.14983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells</span></div><div class="casAuthors">Sonnemann Jurgen; Zimmermann Miriam; Ebert Franziska; Becker Sabine; Lauterjung Marie-Luise; Beck James F; Sonnemann Jurgen; Zimmermann Miriam; Ebert Franziska; Becker Sabine; Marx Christian</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">494-497</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgjJY71tdjTSCEBeYuoi7AfW6udTcc2eapf7fZecMOBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3nvFGgsQ%253D%253D&md5=7c590c5ff28614d7dba0892e76fd6cec</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1111%2Fbjh.14983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjh.14983%26sid%3Dliteratum%253Aachs%26aulast%3DSonnemann%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DM.%26aulast%3DMarx%26aufirst%3DC.%26aulast%3DEbert%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DLauterjung%26aufirst%3DM.%2BL.%26aulast%3DBeck%26aufirst%3DJ.%2BF.%26atitle%3DLSD1%2520%2528KDM1A%2529-independent%2520effects%2520of%2520the%2520LSD1%2520inhibitor%2520SP2509%2520in%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2018%26volume%3D183%26spage%3D494%26epage%3D497%26doi%3D10.1111%2Fbjh.14983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQU','PDB','6NQU'); return false;">PDB: 6NQU</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00919&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00919%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00919" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679945b949b623f8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
